data_1zfi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zfi _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.769 0.318 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -150.56 141.81 23.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.799 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.1 t -110.91 145.89 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -127.22 130.99 50.7 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.407 178.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.15 103.54 15.58 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.4 m -87.61 152.65 22.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.281 0.562 . . . . 0.0 111.903 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.431 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 11.1 t80 -125.33 138.29 54.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.767 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.96 158.38 75.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 5.0 Cg_endo -46.87 -14.19 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.164 2.576 . . . . 0.0 113.628 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 15.8 t70 -164.94 29.18 0.06 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.776 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.85 165.56 35.69 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 111.812 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -144.03 131.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.904 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.44 ' HB3' ' CE1' ' A' ' 20' ' ' PHE . 11.7 m -124.37 135.85 53.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 112.078 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.804 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 17.7 p -116.97 111.08 19.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.846 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.851 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -134.7 136.4 42.71 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 8' ' ' SER . 4.0 mt -108.47 95.26 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.377 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 5.0 m -76.82 -176.95 4.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.905 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.605 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.66 62.89 1.32 Allowed 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.33 17.91 7.43 Favored Glycine 0 C--N 1.351 1.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.414 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.548 ' CB ' ' CD2' ' A' ' 53' ' ' TYR . . . -138.5 -159.7 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.621 0.71 . . . . 0.0 111.857 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . . . -140.38 179.5 1.25 Allowed Pre-proline 0 C--N 1.339 0.132 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 88.3 Cg_endo -83.61 111.1 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.293 1.995 . . . . 0.0 112.791 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 111.71 15.76 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.728 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.11 161.82 26.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.564 2.176 . . . . 0.0 112.34 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.25 -52.11 0.4 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.016 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -145.68 30.49 1.09 Allowed 'General case' 0 C--N 1.352 0.701 0 O-C-N 122.01 -0.431 . . . . 0.0 111.663 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . -167.95 -139.07 2.6 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.301 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.67 -165.28 1.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.259 0.529 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.6 m -155.74 169.97 23.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 110.379 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -144.68 162.2 39.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.254 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.26 129.85 10.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.8 t-80 -161.14 114.75 1.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -35.48 -68.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.11 -154.56 0.52 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.628 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . . . -156.21 133.19 6.37 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 122.417 -0.177 . . . . 0.0 111.331 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 4.4 Cg_exo -74.44 -23.75 14.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.85 2.366 . . . . 0.0 112.659 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.804 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 5.4 p-90 -84.98 -38.3 19.44 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -45.96 -59.28 2.93 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.442 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -66.88 -36.08 81.49 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 21.0 tt0 -55.24 -17.34 4.35 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.477 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.36 -31.42 0.42 Allowed Glycine 0 C--N 1.369 2.376 0 C-N-CA 117.124 -2.465 . . . . 0.0 114.048 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.848 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -103.8 -115.44 0.22 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.258 0.551 . . . . 0.0 112.305 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.1 p 175.53 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.651 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -151.37 -166.92 2.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.81 ' CE3' ' HB2' ' A' ' 58' ' ' CYS . 3.9 t90 -154.73 -146.09 0.18 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.321 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 1.2 t 153.07 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 117.877 0.308 . . . . 0.0 111.294 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' A' ' 50' ' ' TRP . 7.2 Cg_exo -75.38 92.22 1.02 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.742 2.295 . . . . 0.0 115.34 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.631 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 41.3 t80 -128.01 129.99 47.6 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -36.23 -70.0 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.409 ' CG2' ' HB1' ' A' ' 25' ' ' ALA . 1.6 t -73.31 -19.32 61.06 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.09 -168.33 25.97 Favored Glycine 0 C--N 1.362 1.974 0 C-N-CA 118.348 -1.882 . . . . 0.0 113.416 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.66 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.1 tt0 -103.44 136.6 42.89 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 119.373 1.586 . . . . 0.0 108.49 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.81 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 56.0 m -123.92 -172.32 2.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.901 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.574 ' HA ' ' CB ' ' A' ' 50' ' ' TRP . 39.6 ptt85 -166.03 111.45 0.85 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.0 -0.438 . . . . 0.0 110.752 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.851 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 164.0 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.202 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.848 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 6.4 t -144.37 -173.87 4.15 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 1.8 m -143.78 153.09 42.04 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 122.916 0.486 . . . . 0.0 109.96 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.527 HG21 HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -166.7 163.39 10.98 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.244 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 18.0 Cg_exo -66.07 -161.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.595 2.196 . . . . 0.0 111.439 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.492 ' CE2' ' HA ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.68 0.276 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -169.33 157.56 7.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 48.2 t -104.21 152.4 22.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.3 0.572 . . . . 0.0 112.162 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -129.07 137.09 51.06 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.542 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.4 117.35 29.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.726 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 27' ' ' PRO . 74.2 m -100.36 141.36 33.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -128.19 130.12 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.59 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -142.02 150.01 54.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.27 5.54 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.377 2.051 . . . . 0.0 113.097 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.5 m-20 -126.58 -17.34 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.502 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -165.71 172.03 12.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.201 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -134.07 119.28 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.041 178.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.0 m -121.85 149.16 43.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.881 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 12.3 p -132.52 124.41 28.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.839 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.845 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -141.16 138.75 33.65 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.661 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 6.7 mt -101.1 125.59 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.452 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 7.8 m -145.72 -172.59 3.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 118.291 -1.364 . . . . 0.0 114.289 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.61 63.53 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 150.95 -36.44 0.89 Allowed Glycine 0 C--N 1.348 1.212 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.442 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.46 ' HB1' ' HB ' ' A' ' 55' ' ' THR . . . 175.36 -161.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . 179.82 -57.71 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 56.4 Cg_endo -101.49 111.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.775 2.316 . . . . 0.0 114.28 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.06 112.24 28.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -39.09 113.22 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.961 2.44 . . . . 0.0 113.001 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -142.63 -49.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.328 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.67 34.22 0.45 Allowed 'General case' 0 C--N 1.353 0.76 0 CA-C-N 118.443 0.565 . . . . 0.0 112.168 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -173.49 46.26 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.608 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.86 -165.15 1.47 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.671 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.9 m -154.08 179.32 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 163.94 22.44 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.25 136.8 32.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.894 2.396 . . . . 0.0 112.631 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 t-160 -171.3 101.83 0.4 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.064 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' SER . 47.5 Cg_exo -33.33 -65.8 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.165 2.577 . . . . 0.0 113.29 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 51.8 p -151.3 -157.43 0.81 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.301 0.376 . . . . 0.0 110.397 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.5 173.6 3.5 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.763 0.316 . . . . 0.0 111.456 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.45 -48.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.893 2.395 . . . . 0.0 112.701 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.881 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 19.2 p-90 -71.87 -41.14 68.42 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.02 -56.65 3.23 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -78.37 -33.14 49.15 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.204 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.504 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 1.4 tp10 -41.15 -37.02 0.82 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 119.06 -0.495 . . . . 0.0 112.134 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.42 10.67 0.85 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 118.106 -1.997 . . . . 0.0 113.875 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.794 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -108.49 75.9 1.0 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 117.504 0.652 . . . . 0.0 111.416 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.579 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -23.83 -82.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.047 178.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 175.09 -132.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.541 ' O ' ' O ' ' A' ' 49' ' ' GLU . 5.4 m95 -0.05 132.54 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -162.94 136.56 4.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 112.921 -1.945 . . . . 0.0 108.099 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.76 121.5 2.51 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.144 1.896 . . . . 0.0 114.303 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.567 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 53.4 t80 -118.69 121.88 41.18 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.6 m -39.51 -47.47 1.88 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.102 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.46 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 72.5 m -77.82 -29.43 50.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.339 0.518 . . . . 0.0 112.271 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.06 175.67 37.7 Favored Glycine 0 C--N 1.359 1.843 0 C-N-CA 118.787 -1.673 . . . . 0.0 113.471 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.1 tt0 -87.87 112.25 22.3 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.114 0.957 . . . . 0.0 109.77 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 1.6 m -99.83 -171.64 2.09 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 21' ' ' ILE . 11.3 ptt180 172.08 101.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.845 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 170.63 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.794 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 14.6 t -141.25 -176.8 4.84 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.486 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 1.3 m -148.67 153.08 37.77 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 123.422 0.689 . . . . 0.0 109.188 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -172.11 164.75 4.11 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 111.796 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.502 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 71.7 Cg_endo -97.64 153.93 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.786 2.99 . . . . 0.0 112.086 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.435 ' HB3' ' CG2' ' A' ' 17' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.777 0.323 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -142.65 140.18 31.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' HIS . 3.4 t -119.43 154.53 33.56 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.865 0.84 . . . . 0.0 112.438 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 1.1 p90 -143.43 140.53 30.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.65 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.17 137.13 37.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.887 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.9 m -117.45 150.76 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 111.771 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.583 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 22.8 t80 -113.44 124.9 53.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.803 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -134.72 144.6 51.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.74 5.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.693 2.262 . . . . 0.0 113.548 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -116.03 -34.72 4.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.442 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.459 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -176.01 -169.18 0.31 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.81 115.64 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -102.8 132.72 48.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.765 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 5.4 t -112.57 148.65 34.08 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.942 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.629 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.425 0.631 . . . . 0.0 111.714 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.13 122.08 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.259 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 37.8 m -110.11 -175.13 2.65 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -155.7 51.49 0.56 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.81 13.71 5.98 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.295 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -169.85 -160.03 0.23 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.904 0.852 . . . . 0.0 112.058 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . . . -174.55 123.66 0.38 Allowed Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 7.8 Cg_endo -50.13 143.68 24.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.411 2.074 . . . . 0.0 112.01 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -71.64 114.65 30.18 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.62 169.79 2.99 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.609 2.206 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -170.77 -45.4 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.719 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.43 30.54 1.28 Allowed 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.267 0.485 . . . . 0.0 112.287 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 150.24 -146.14 14.94 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.863 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -128.49 -169.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.897 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 m -156.51 173.69 16.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.396 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -151.62 164.41 20.36 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.491 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.96 145.64 56.57 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.575 2.183 . . . . 0.0 112.473 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' SER . 15.6 t-80 -172.58 111.83 0.36 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 37' ' ' HIS . 52.7 Cg_exo -29.59 -72.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.05 2.5 . . . . 0.0 112.85 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -174.11 -163.15 0.15 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.358 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB3' ' CD1' ' A' ' 42' ' ' TRP . . . -164.49 161.64 15.68 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 74.8 Cg_endo -77.72 -14.15 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.475 2.117 . . . . 0.0 112.452 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.755 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 24.0 p-90 -94.68 -51.19 4.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 119.477 -0.297 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.606 ' O ' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -48.44 -49.25 36.09 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.129 178.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.31 -41.67 72.98 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.999 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -38.94 -34.95 0.17 Allowed 'General case' 0 C--N 1.361 1.092 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.749 178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.63 63.46 0.29 Allowed Glycine 0 C--N 1.357 1.739 0 C-N-CA 119.911 -1.137 . . . . 0.0 111.095 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.754 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -78.87 1.11 24.6 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.632 ' HB ' ' O ' ' A' ' 60' ' ' THR . 55.8 t -163.11 -90.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -170.99 150.37 3.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.723 0.296 . . . . 0.0 111.58 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.476 ' CZ2' ' HG2' ' A' ' 57' ' ' GLN . 60.5 t-105 -73.63 152.6 40.46 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.472 ' CG2' ' HD2' ' A' ' 52' ' ' PRO . 7.8 p -160.42 145.17 10.81 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.495 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 51' ' ' VAL . 69.7 Cg_endo -93.74 122.13 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.857 2.372 . . . . 0.0 113.584 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.542 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 1.9 t80 -98.7 139.44 34.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -42.86 -62.66 0.95 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -25.55 64.92 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -167.77 176.6 42.39 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.228 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -100.3 129.4 46.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.107 1.454 . . . . 0.0 111.262 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.3 t -142.45 -177.68 5.39 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -162.34 140.9 8.97 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 122.162 -0.336 . . . . 0.0 110.413 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.632 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 2.7 t -89.36 158.71 17.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.765 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 1.5 p -152.05 173.28 15.08 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -177.1 153.05 0.94 Allowed 'General case' 0 C--N 1.353 0.757 0 CA-C-N 120.075 1.307 . . . . 0.0 111.953 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.456 HG22 ' CE3' ' A' ' 42' ' ' TRP . 5.0 pt -161.82 166.5 14.41 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.19 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 50.8 Cg_exo -53.91 171.47 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.118 1.879 . . . . 0.0 111.575 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 C--N 1.327 -0.391 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.619 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.729 0.299 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.0 140.33 17.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.876 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 22.7 t -114.19 149.48 35.69 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -128.29 145.22 51.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.55 130.34 50.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 99.4 m -106.06 145.95 30.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.3 m-85 -126.25 136.79 53.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.194 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -131.14 159.39 71.78 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.656 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.62 -10.79 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.776 2.317 . . . . 0.0 113.199 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 2.0 t70 -162.61 31.24 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.466 -0.494 . . . . 0.0 112.014 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -163.1 171.29 16.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.542 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' CG2' HG13 ' A' ' 63' ' ' ILE . 16.2 m -146.15 139.39 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.015 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.18 134.38 44.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.714 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.725 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 47.4 t -119.28 136.74 54.09 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.864 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.2 OUTLIER -144.13 122.72 12.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HG2' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -110.7 99.61 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.4 m -106.62 -164.94 1.04 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.487 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.88 66.11 0.79 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.38 9.97 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.779 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -165.51 -160.65 0.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.378 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -175.88 129.79 0.39 Allowed Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 116.87 -0.15 . . . . 0.0 110.647 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD2' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -43.43 140.9 3.75 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.737 2.291 . . . . 0.0 112.203 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.18 118.1 70.78 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.63 -173.91 1.93 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.597 2.198 . . . . 0.0 111.94 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.23 -51.87 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -93.31 31.95 1.41 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 118.237 0.471 . . . . 0.0 112.086 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.05 -166.27 39.1 Favored Glycine 0 N--CA 1.462 0.368 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.723 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 6.7 pm0 -120.53 -169.59 1.84 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 33' ' ' GLU . 3.1 m -155.95 176.82 12.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.926 0.393 . . . . 0.0 111.198 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.454 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 51.4 p-10 -162.44 159.05 20.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.817 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 35' ' ' ASN . 18.1 Cg_endo -59.47 151.83 65.96 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.795 2.33 . . . . 0.0 112.941 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 8' ' ' SER . 29.8 t-80 179.24 110.24 0.18 Allowed Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.742 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 8' ' ' SER . 35.1 Cg_exo -27.91 -75.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.339 2.692 . . . . 0.0 113.728 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.455 ' CG2' HG12 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -163.6 -169.69 2.0 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 42' ' ' TRP . . . -160.27 146.46 11.76 Favored Pre-proline 0 C--N 1.345 0.406 0 CA-C-N 118.382 0.537 . . . . 0.0 111.25 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.597 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 58.6 Cg_endo -71.64 -6.17 18.59 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.634 2.222 . . . . 0.0 112.866 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.725 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 61.6 p-90 -96.65 -35.77 10.93 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.42 ' CB ' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -55.54 -43.12 75.49 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 -41.05 24.52 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.1 tt0 -59.99 -9.4 3.04 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.618 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.16 -31.34 2.46 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 117.827 -2.13 . . . . 0.0 111.639 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.805 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -129.8 -109.78 0.27 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.385 0.612 . . . . 0.0 111.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.459 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER 176.56 -85.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.826 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' CG ' ' HB2' ' A' ' 59' ' ' ARG . 51.2 mt-10 -162.14 158.9 25.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.796 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -155.37 69.29 0.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.79 1.281 . . . . 0.0 111.884 178.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.596 ' CG1' ' HG2' ' A' ' 57' ' ' GLN . 10.7 m -46.31 -39.37 13.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 112.875 -1.966 . . . . 0.0 113.885 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 37.0 Cg_endo -64.12 74.22 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.313 1.342 . . . . 0.0 114.343 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.592 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 65.0 t80 -115.82 129.12 56.31 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 m -41.94 -58.85 1.91 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.448 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 63.2 m -65.37 -30.64 71.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.204 0.457 . . . . 0.0 112.161 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -176.98 -161.97 26.62 Favored Glycine 0 CA--C 1.545 1.924 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.596 ' HG2' ' CG1' ' A' ' 51' ' ' VAL . 8.4 tt0 -88.36 130.03 35.25 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 119.793 1.796 . . . . 0.0 108.748 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.796 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 1.2 m -121.5 167.62 12.64 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.053 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.761 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -163.96 100.79 0.88 Allowed 'General case' 0 C--N 1.37 1.47 0 CA-C-N 118.784 0.72 . . . . 0.0 111.476 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.864 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 167.38 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.805 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 7.5 t -161.66 -163.29 0.96 Allowed 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.407 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -135.5 167.07 21.76 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.117 0.567 . . . . 0.0 110.23 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.474 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 8.0 pt -158.68 157.0 28.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.033 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 16' ' ' GLN . 30.0 Cg_endo -63.15 -16.89 57.3 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.424 2.083 . . . . 0.0 113.302 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.093 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.45 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.847 0.356 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.85 154.33 27.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.328 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.539 ' HB2' ' CG1' ' A' ' 21' ' ' ILE . 2.4 t -113.11 159.67 18.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.305 0.574 . . . . 0.0 112.131 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -134.1 133.95 41.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.274 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.407 HD23 ' CE2' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -95.61 117.52 30.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.231 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.9 m -102.0 138.25 39.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.776 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -123.94 144.22 49.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.41 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.89 162.36 56.3 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.604 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.11 -12.92 1.62 Allowed 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.638 2.225 . . . . 0.0 112.879 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -160.67 32.22 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.617 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 64' ' ' PRO . 16.2 mt-30 -158.49 156.14 29.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.313 0.578 . . . . 0.0 112.349 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.28 106.45 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.064 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 20' ' ' PHE . 12.9 m -113.43 118.78 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.806 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.679 ' O ' ' HB ' ' A' ' 60' ' ' THR . 0.9 OUTLIER -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.904 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -143.6 139.36 29.63 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.568 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 3.4 mt -110.91 136.16 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.2 m -146.27 -174.92 4.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.058 -1.057 . . . . 0.0 113.367 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -146.07 63.59 1.23 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.17 -33.57 0.6 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.458 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' CB ' ' HB ' ' A' ' 55' ' ' THR . . . -177.12 -154.26 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.006 0.403 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -156.92 157.78 30.91 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-O 120.524 0.202 . . . . 0.0 110.485 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 37.4 Cg_exo -57.52 151.41 54.19 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.4 2.067 . . . . 0.0 112.089 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.38 109.22 18.02 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.02 178.57 5.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.454 2.102 . . . . 0.0 112.215 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.9 t -160.4 -55.33 0.05 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.356 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -94.25 32.53 1.51 Allowed 'General case' 0 C--N 1.352 0.692 0 O-C-N 122.022 -0.424 . . . . 0.0 111.714 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.81 -169.54 41.98 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.577 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -128.69 -164.43 1.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.159 -0.217 . . . . 0.0 110.532 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.9 m -154.46 178.07 10.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.036 0.446 . . . . 0.0 111.189 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -153.72 161.98 27.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.21 135.99 33.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.544 2.163 . . . . 0.0 112.581 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -165.38 106.84 0.77 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.294 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 8' ' ' SER . 68.1 Cg_exo -37.63 -70.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.96 2.44 . . . . 0.0 113.133 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.8 p -154.42 -158.92 0.9 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.349 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 179.53 148.84 0.46 Allowed Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 111.585 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 55.9 Cg_endo -69.7 -24.47 29.93 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.655 2.237 . . . . 0.0 111.631 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 90.4 t90 -73.34 -45.74 53.44 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.961 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -44.87 -49.05 11.13 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.18 -33.08 24.27 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 2.5 tt0 -48.93 -20.62 0.53 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.319 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.68 -35.25 0.86 Allowed Glycine 0 C--N 1.363 2.029 0 C-N-CA 118.381 -1.866 . . . . 0.0 112.085 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.817 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -141.87 100.16 3.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.991 0.395 . . . . 0.0 111.217 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -24.4 -90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 123.745 0.653 . . . . 0.0 110.439 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 2.2 mt-10 172.24 130.73 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.675 ' HA ' ' CE3' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 141.96 136.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 112.927 -1.942 . . . . 0.0 111.72 176.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 7.3 p 175.45 83.9 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.911 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 51' ' ' VAL . 1.6 Cg_endo -42.88 140.63 2.94 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.284 2.656 . . . . 0.0 113.607 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.65 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 47.8 t80 -133.46 132.57 41.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.518 -0.764 . . . . 0.0 108.953 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -50.92 5.97 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.423 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 19.5 m -73.72 -30.94 63.12 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.959 -0.463 . . . . 0.0 112.031 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -163.58 173.69 39.71 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.358 -1.401 . . . . 0.0 112.399 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ARG . 4.6 tt0 -87.03 112.63 22.04 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 118.904 1.352 . . . . 0.0 110.005 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 1.5 m -97.42 -171.98 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.406 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.597 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 25.7 ptt180 173.66 102.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.941 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.904 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 172.72 -150.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.817 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 14.6 t -157.2 -170.71 3.35 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 19.6 t -165.77 156.7 13.56 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -152.65 166.83 14.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.696 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' ' CG ' ' A' ' 65' ' ' TYR . 9.3 Cg_endo -51.88 -24.35 18.58 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.261 1.974 . . . . 0.0 112.282 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CG ' ' O ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.308 -1.218 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.182 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -144.37 141.19 29.53 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 35.2 t -113.29 143.99 43.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.488 0.661 . . . . 0.0 112.704 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 134.77 48.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.108 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.67 119.07 34.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.023 0.439 . . . . 0.0 110.606 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.4 m -100.81 128.74 46.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.331 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -113.9 137.61 51.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.4 OUTLIER -138.64 145.82 47.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.32 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.41 -0.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.705 2.27 . . . . 0.0 113.663 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.8 t0 -122.2 -30.83 3.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -158.8 -175.16 5.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.187 0.518 . . . . 0.0 111.779 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 63' ' ' ILE . 8.3 m -141.24 126.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.909 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.1 m -118.06 141.13 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.632 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.757 ' O ' ' HB ' ' A' ' 60' ' ' THR . 41.8 t -123.97 131.61 53.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.866 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -137.94 136.31 36.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mt -103.43 103.93 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.9 m -95.13 -174.2 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.757 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -150.47 60.51 0.95 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.71 26.22 8.16 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.011 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB1' ' N ' ' A' ' 56' ' ' GLY . . . -151.2 -161.26 1.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.04 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -178.04 114.53 0.23 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-O 120.449 0.166 . . . . 0.0 110.682 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 70.1 Cg_exo -49.78 142.93 24.24 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.467 2.111 . . . . 0.0 112.414 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.87 112.49 22.84 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.42 173.89 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.617 2.211 . . . . 0.0 112.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.4 m -155.55 -52.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.638 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -124.39 33.47 5.25 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 118.288 0.494 . . . . 0.0 112.106 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.96 -169.61 41.56 Favored Glycine 0 N--CA 1.462 0.432 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.792 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.29 -162.77 0.99 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -154.83 164.12 39.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.344 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -140.84 167.66 16.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.666 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.22 136.56 29.46 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.587 2.191 . . . . 0.0 112.691 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 8' ' ' SER . 20.9 t-160 -165.06 93.91 0.9 Allowed Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -30.93 -70.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.359 2.706 . . . . 0.0 113.627 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.25 -159.19 0.94 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.815 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -176.63 169.15 1.25 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-O 120.699 0.285 . . . . 0.0 111.373 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 93.8 Cg_endo -83.66 -35.14 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.015 2.477 . . . . 0.0 112.848 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 19' ' ' CYS . 17.2 p-90 -88.05 -42.57 12.32 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 60' ' ' THR . 0.5 OUTLIER -42.62 -58.44 2.29 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -70.59 -36.63 73.65 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.219 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 5.3 tt0 -42.96 -32.35 0.63 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.105 0.411 . . . . 0.0 111.492 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -139.94 13.38 3.11 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 118.868 -1.634 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 60' ' ' THR . . . -66.14 66.53 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 111.896 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' GLY . 21.5 t -141.8 53.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.96 23.44 0.66 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.262 0.937 . . . . 0.0 112.845 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.761 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -148.85 -173.53 4.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 2.5 t 153.08 -44.8 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.621 0.769 . . . . 0.0 110.022 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 4.7 Cg_endo -87.82 91.18 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.844 2.362 . . . . 0.0 114.796 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.538 ' CD1' ' CZ2' ' A' ' 50' ' ' TRP . 10.0 t80 -121.88 128.85 52.05 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 m -40.3 -55.99 2.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.3 m -66.98 -29.17 68.94 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -177.38 -173.07 42.56 Favored Glycine 0 C--N 1.359 1.822 0 C-N-CA 119.272 -1.442 . . . . 0.0 112.324 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.641 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 1.7 tm0? -100.07 125.9 46.21 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 119.637 1.719 . . . . 0.0 109.488 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.761 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 50.1 t -136.19 -178.78 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.745 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.3 OUTLIER 174.68 137.71 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.741 1.155 . . . . 0.0 111.594 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.866 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 179.44 -147.08 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.0 t -151.12 -171.13 3.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.604 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 69.7 m -146.23 173.08 12.54 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.458 HD12 ' CE3' ' A' ' 42' ' ' TRP . 6.3 pt -158.07 156.54 28.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.782 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 19.4 Cg_endo -58.24 -19.42 42.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.406 2.071 . . . . 0.0 113.012 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.309 -1.186 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.945 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 C--O 1.231 0.109 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.43 141.06 21.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.206 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.5 t -118.11 144.33 45.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.85 133.12 54.88 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.348 177.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.53 123.08 34.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 110.504 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -99.2 138.86 35.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.213 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -118.45 129.79 55.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.064 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.9 OUTLIER -138.34 146.79 52.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.857 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 4.48 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.45 2.1 . . . . 0.0 112.698 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -115.97 -32.65 5.34 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.525 0.202 . . . . 0.0 111.216 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -172.92 -170.58 0.67 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 0.0 111.265 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.458 ' CG2' ' CE1' ' A' ' 65' ' ' TYR . 1.8 t -133.36 124.7 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.29 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.5 m -124.54 141.35 52.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 111.747 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.632 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 3.1 p -117.03 147.11 42.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.861 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -148.65 128.02 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 8' ' ' SER . 1.1 mp -97.6 106.86 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.344 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 2.2 m -84.86 -178.03 6.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.011 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.12 55.89 1.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.27 25.33 6.74 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.247 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.53 -160.59 1.05 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.729 0.764 . . . . 0.0 112.043 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.88 94.66 0.19 Allowed Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.326 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 72.0 Cg_exo -34.7 141.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.238 2.625 . . . . 0.0 113.14 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -80.8 112.76 34.71 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.17 169.05 1.64 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.531 2.154 . . . . 0.0 112.324 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -153.66 -57.86 0.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.207 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.65 29.52 7.34 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.01 -0.431 . . . . 0.0 111.426 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.17 -169.65 42.3 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.514 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.61 -161.43 0.89 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.225 -0.19 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.13 161.18 39.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.153 0.501 . . . . 0.0 111.391 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.4 173.59 4.36 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.75 136.26 20.71 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.066 2.511 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.4 t-80 -173.84 93.29 0.34 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.882 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -29.15 -71.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.608 2.872 . . . . 0.0 113.846 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.413 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 13.8 p -151.2 -155.79 0.66 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.136 0.272 . . . . 0.0 110.762 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 179.93 164.84 0.84 Allowed Pre-proline 0 N--CA 1.473 0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 111.5 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.15 -28.51 10.73 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.17 2.58 . . . . 0.0 112.193 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.632 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 20.8 p-90 -86.71 -39.87 15.61 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.6 -58.42 2.66 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -33.07 65.25 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.229 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 2.8 tt0 -39.6 -42.82 1.23 Allowed 'General case' 0 C--N 1.361 1.089 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.081 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -146.1 16.42 1.72 Allowed Glycine 0 C--N 1.357 1.723 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.456 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.68 ' CA ' ' OG1' ' A' ' 61' ' ' THR . . . -51.92 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.42 0.629 . . . . 0.0 112.562 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 46' ' ' GLY . 7.7 p -65.82 49.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.169 -1.378 . . . . 0.0 107.936 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -26.57 116.81 0.07 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -121.94 73.85 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.358 177.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.78 ' HA ' ' H ' ' A' ' 58' ' ' CYS . 14.0 m -57.32 -38.53 69.04 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.71 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 51' ' ' VAL . 9.7 Cg_endo -51.97 77.53 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.594 1.53 . . . . 0.0 113.587 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.668 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 62.3 t80 -121.7 132.96 54.92 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.5 m -45.26 -58.97 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.5 m -61.91 -30.64 71.02 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 122.014 -0.429 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -179.01 -165.88 34.08 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.916 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.78 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.7 mt-30 -109.98 127.7 54.95 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 120.179 1.99 . . . . 0.0 110.045 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.78 ' H ' ' HA ' ' A' ' 51' ' ' VAL . 14.0 m -131.93 -171.26 2.58 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 4.9 ttp180 -140.06 135.03 32.19 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.488 ' HB ' ' CZ2' ' A' ' 50' ' ' TRP . 8.8 t -119.38 135.31 54.79 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.68 ' OG1' ' CA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -135.21 165.96 24.2 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 176.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.539 ' N ' HG21 ' A' ' 61' ' ' THR . 75.7 m -156.74 153.44 28.41 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.894 1.225 . . . . 0.0 110.56 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.419 HG12 ' CZ3' ' A' ' 42' ' ' TRP . 12.9 pt -148.98 136.72 11.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.53 134.28 2.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.925 2.417 . . . . 0.0 112.277 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE1' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.165 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.792 0.329 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -130.03 140.26 50.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.3 m -123.67 155.41 37.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.523 0.678 . . . . 0.0 112.211 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 27' ' ' PRO . 0.8 OUTLIER -136.58 129.38 30.77 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.866 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.07 124.82 37.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.403 ' HB2' ' HE1' ' A' ' 20' ' ' PHE . 3.8 m -105.58 153.04 22.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.761 0.791 . . . . 0.0 112.86 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.423 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 21.9 t80 -118.68 114.56 22.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.521 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.525 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -120.11 144.76 38.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.35 6.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 113.338 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.4 m-20 -118.42 -33.05 4.45 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.462 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.507 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -170.25 -165.16 0.45 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 122.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -118.36 148.36 42.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.583 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 39.3 t -128.28 143.56 51.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -138.96 138.5 37.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 112.188 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 59' ' ' ARG . 3.3 mt -112.39 140.63 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.759 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 13.1 m -143.64 -173.62 4.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 119.336 -0.946 . . . . 0.0 113.165 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -149.59 60.58 1.01 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 152.16 -29.09 0.89 Allowed Glycine 0 C--N 1.35 1.316 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.441 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -176.14 -156.05 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.68 0.74 . . . . 0.0 111.907 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.472 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -150.09 154.52 36.78 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-O 120.561 0.22 . . . . 0.0 110.714 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 40.3 Cg_endo -66.86 159.23 52.59 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.373 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -74.48 111.79 14.46 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 161.91 38.51 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.573 2.182 . . . . 0.0 112.215 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 t -164.9 -49.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.409 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -92.73 32.59 1.22 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.123 0.42 . . . . 0.0 111.784 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 163.44 169.22 26.6 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.461 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -101.82 -164.27 1.08 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.59 161.04 35.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 110.853 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -140.98 147.5 48.17 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.49 129.3 33.97 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.431 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 39' ' ' THR . 6.5 t-160 -159.55 102.31 1.5 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -33.19 -70.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.18 2.586 . . . . 0.0 113.36 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.42 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -147.55 -157.77 0.84 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.655 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -175.54 151.82 1.3 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.687 0.28 . . . . 0.0 111.116 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.58 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 73.6 Cg_endo -75.68 -26.57 9.74 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.589 2.193 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.729 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 40.9 p-90 -90.69 -40.38 11.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.418 ' HA ' HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -44.06 -59.79 2.16 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -33.93 61.06 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.225 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.729 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -47.86 -30.0 3.74 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 119.003 0.82 . . . . 0.0 111.667 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.72 -2.55 4.8 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 118.527 -1.796 . . . . 0.0 113.758 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -83.98 62.04 6.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.618 0.709 . . . . 0.0 110.643 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.11 27.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.759 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.99 142.92 38.33 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -105.18 158.36 16.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.416 . . . . 0.0 111.334 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.69 104.05 7.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.211 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 111.3 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.546 2.164 . . . . 0.0 113.275 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.603 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 5.1 t80 -101.57 129.29 47.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.24 -45.6 5.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.251 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.5 m -78.14 -32.73 50.48 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.075 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.57 171.74 40.12 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.032 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ARG . 20.8 tt0 -83.57 122.96 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.499 1.149 . . . . 0.0 109.688 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -112.46 -174.82 2.54 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.561 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -161.62 132.98 5.37 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.4 m -116.86 139.31 50.77 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.523 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -148.35 167.25 25.72 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.074 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.441 ' N ' HG21 ' A' ' 61' ' ' THR . 81.0 m -156.7 158.35 36.78 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.501 1.046 . . . . 0.0 110.852 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.47 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 9.2 pt -155.47 157.25 31.57 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 9.5 Cg_endo -51.85 167.53 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.575 2.183 . . . . 0.0 112.092 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.44 ' HD1' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.805 0.336 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 147.56 45.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 33.8 t -130.83 155.87 45.97 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.515 0.674 . . . . 0.0 111.907 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -139.28 137.65 36.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.07 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -95.26 131.61 41.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.698 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.3 m -113.93 154.16 28.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.557 0.694 . . . . 0.0 111.955 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.681 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 16.3 t80 -125.53 130.68 52.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.506 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.549 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -133.81 139.9 34.89 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 18.4 Cg_endo -59.26 7.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.445 2.096 . . . . 0.0 112.888 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.549 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.0 OUTLIER -119.79 -32.65 4.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.441 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 11.0 mt-30 -164.47 -168.86 1.62 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.306 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.14 145.92 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.316 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -151.52 139.95 20.5 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 49.4 t -120.41 150.86 40.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.583 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -146.55 133.55 20.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.533 0.682 . . . . 0.0 112.748 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 21' ' ' ILE . 3.1 mp -105.41 139.26 27.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.29 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.6 m -139.88 -170.75 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 119.201 -1.0 . . . . 0.0 113.353 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.68 58.66 0.81 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.03 18.08 9.07 Favored Glycine 0 C--N 1.349 1.299 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.359 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -157.09 -166.63 2.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.707 0.754 . . . . 0.0 112.051 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.432 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . 179.81 129.19 0.24 Allowed Pre-proline 0 N--CA 1.469 0.483 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.428 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 50.3 Cg_exo -53.89 140.58 68.34 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.134 1.89 . . . . 0.0 112.051 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.1 111.83 7.52 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.26 162.14 17.56 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.699 2.266 . . . . 0.0 112.331 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -174.83 -39.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.516 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.1 pm0 -91.08 32.6 1.0 Allowed 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.932 -0.48 . . . . 0.0 111.929 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 158.53 -163.79 33.21 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.683 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -121.81 -169.8 1.94 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 117.179 0.489 . . . . 0.0 110.616 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 4.3 m -156.98 161.47 39.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -135.35 150.82 73.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.27 140.48 81.61 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.594 2.196 . . . . 0.0 112.363 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.7 t-160 -168.62 90.07 0.63 Allowed Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -73.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.48 2.787 . . . . 0.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.6 p -157.28 -163.95 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 168.92 158.87 0.17 Allowed Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 120.701 0.286 . . . . 0.0 110.93 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 71.8 Cg_endo -76.73 -3.44 13.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.47 2.113 . . . . 0.0 112.119 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.524 ' HZ3' ' HB3' ' A' ' 19' ' ' CYS . 66.1 t90 -93.75 -55.23 3.32 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.275 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 33.6 m -54.12 -32.54 55.34 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.59 -41.83 16.04 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.915 -0.49 . . . . 0.0 109.734 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.1 tt0 -51.32 -24.53 4.74 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.549 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.47 -16.82 4.99 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 118.38 -1.867 . . . . 0.0 113.316 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB2' ' HD3' ' A' ' 59' ' ' ARG . . . -106.84 67.88 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.381 0.59 . . . . 0.0 111.091 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.37 30.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.351 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -130.74 142.72 50.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.657 0.265 . . . . 0.0 110.403 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.412 ' CZ2' ' NH2' ' A' ' 59' ' ' ARG . 33.6 m95 -94.96 149.64 21.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.56 107.85 7.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.131 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.48 120.31 7.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 113.762 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 1.2 t80 -107.45 135.04 49.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.97 -54.66 6.29 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -69.48 -29.15 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -174.35 -178.23 44.09 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 119.208 -1.472 . . . . 0.0 112.291 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ARG . 2.3 tt0 -81.91 142.42 32.49 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.334 1.567 . . . . 0.0 110.16 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -136.03 -179.2 5.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.309 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.583 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 25.7 ttm180 -161.72 122.59 2.7 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 20' ' ' PHE . 3.3 t -108.17 144.86 35.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -147.89 158.26 43.95 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.12 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 91.6 m -155.41 162.09 40.85 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 120.045 1.293 . . . . 0.0 111.463 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -158.93 166.11 17.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.403 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 30.4 Cg_exo -61.87 161.42 25.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.134 . . . . 0.0 112.463 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.427 ' OH ' ' CE2' ' A' ' 12' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.062 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.738 0.304 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.6 139.14 33.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.056 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 5.8 t -119.1 149.03 42.37 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -129.71 144.56 51.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.036 178.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 132.76 47.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.26 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 64.4 m -106.86 146.81 30.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.996 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -125.21 132.44 52.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.5 OUTLIER -118.26 157.16 49.77 Favored Pre-proline 0 CA--C 1.51 -0.559 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.128 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.92 -11.46 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.797 1.665 . . . . 0.0 110.975 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 13' ' ' GLN . 5.0 t0 -164.11 28.21 0.07 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.503 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.5 154.37 31.7 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.204 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -130.0 128.8 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.519 179.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -133.43 138.14 46.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.465 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 16.4 t -127.9 152.71 47.52 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.484 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -151.7 141.98 22.39 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -112.15 122.97 67.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.184 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 11.4 m -116.43 -176.04 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.02 58.72 0.85 Allowed 'General case' 0 C--N 1.348 0.509 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.421 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 139.46 -13.74 3.22 Favored Glycine 0 C--N 1.348 1.21 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.184 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 55' ' ' THR . . . -174.38 -154.96 0.06 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.434 0.617 . . . . 0.0 111.682 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.408 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -158.54 138.41 8.68 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-O 120.661 0.267 . . . . 0.0 111.045 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 18.2 Cg_endo -59.64 159.6 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.661 2.241 . . . . 0.0 112.179 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.15 156.46 57.35 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.47 -179.99 5.34 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.656 2.238 . . . . 0.0 112.148 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -149.52 -52.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.27 33.3 3.61 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.583 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -162.71 30.94 Favored Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.438 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 7.1 pm0 -116.72 -171.86 2.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 33' ' ' GLU . 2.8 m -155.82 177.49 11.34 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.4 m120 -159.56 167.72 13.61 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 35' ' ' ASN . 49.6 Cg_endo -69.11 150.79 72.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.565 2.177 . . . . 0.0 112.809 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' SER . 16.5 t-80 -172.78 104.87 0.33 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' HIS . 35.8 Cg_exo -28.09 -81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -160.46 -160.29 0.76 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.61 148.72 0.24 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.04 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.87 -16.4 54.58 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.487 2.125 . . . . 0.0 111.989 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 91.1 t90 -92.46 -51.09 5.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 58.9 m -51.96 -34.97 44.55 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.246 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.03 -39.76 20.83 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.5 OUTLIER -50.98 -24.7 3.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.412 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.33 -6.1 5.85 Favored Glycine 0 C--N 1.363 2.06 0 C-N-CA 118.498 -1.811 . . . . 0.0 113.797 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 43' ' ' CYS . . . -85.64 52.32 2.43 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.641 0.72 . . . . 0.0 110.943 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.3 32.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.857 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 2.1 tt0 -128.96 127.36 41.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 110.207 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.419 ' CZ3' ' HD2' ' A' ' 59' ' ' ARG . 4.1 m95 -81.36 152.54 27.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.376 0.608 . . . . 0.0 111.748 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.53 99.41 3.37 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.907 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.43 98.78 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.429 2.086 . . . . 0.0 113.277 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -93.22 129.65 39.19 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -40.5 -36.05 0.52 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.054 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -102.19 -23.48 14.03 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.547 0.612 . . . . 0.0 112.6 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -163.23 169.2 38.26 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 118.784 -1.674 . . . . 0.0 113.501 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -98.42 137.38 37.2 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.841 0.82 . . . . 0.0 109.979 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 24.1 t -148.42 179.74 7.57 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.491 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -147.06 126.55 13.22 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 t -115.79 135.84 53.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 168.01 16.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.358 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.418 ' O ' HG23 ' A' ' 63' ' ' ILE . 94.4 m -154.45 169.35 23.97 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.201 0.909 . . . . 0.0 111.553 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.459 ' CD1' ' CZ2' ' A' ' 42' ' ' TRP . 11.2 pt -160.28 130.19 3.41 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.698 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.6 118.83 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.711 2.274 . . . . 0.0 112.549 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 17' ' ' VAL . 40.2 m-85 . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.277 0.56 . . . . 0.0 112.106 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.11 141.62 38.11 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.636 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 5.6 t -115.46 154.52 29.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.777 0.799 . . . . 0.0 112.742 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 26' ' ' ALA . 1.3 p90 -138.87 129.78 26.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.531 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.431 HD13 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -89.71 122.55 32.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.354 . . . . 0.0 110.217 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -108.2 133.28 52.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.225 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.7 m-85 -107.71 137.12 46.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.559 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -111.55 157.39 39.39 Favored Pre-proline 0 CA--C 1.51 -0.567 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.207 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.18 -8.81 2.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.784 1.656 . . . . 0.0 110.885 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -164.09 29.7 0.08 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.245 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -164.16 162.4 22.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.189 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.6 140.41 49.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.89 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 68.3 m -151.21 137.73 18.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.605 ' O ' ' HB ' ' A' ' 60' ' ' THR . 46.5 t -126.61 131.08 51.57 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.887 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -130.12 143.62 50.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.433 ' N ' HG22 ' A' ' 60' ' ' THR . 5.1 mt -115.42 123.36 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.961 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.499 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.7 m -125.86 -174.19 3.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -145.7 63.77 1.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 157.98 -28.97 0.47 Allowed Glycine 0 C--N 1.346 1.126 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.942 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.538 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -176.17 -157.2 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 27' ' ' PRO . . . 179.68 -58.72 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.365 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 26' ' ' ALA . 7.2 Cg_exo -34.87 78.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.17 3.247 . . . . 0.0 115.01 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 26' ' ' ALA . 5.2 tp -105.46 69.13 0.19 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.176 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' O ' ' A' ' 27' ' ' PRO . 36.7 Cg_endo -65.29 122.68 10.46 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.408 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 m -157.01 -51.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -122.35 29.8 6.81 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.113 0.415 . . . . 0.0 111.793 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.97 -153.56 24.84 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.63 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.39 -168.31 1.89 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -156.03 171.57 19.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.862 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.415 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -143.24 170.67 8.19 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.208 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 52.1 Cg_endo -69.45 137.59 36.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.083 . . . . 0.0 112.71 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.431 ' CD2' HD13 ' A' ' 10' ' ' LEU . 7.7 t-80 -163.43 93.55 1.11 Allowed Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' O ' ' HB3' ' A' ' 8' ' ' SER . 59.7 Cg_exo -37.45 -77.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.4 2.733 . . . . 0.0 114.211 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -177.16 43.06 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.361 0.124 . . . . 0.0 111.032 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HB1' ' NE2' ' A' ' 37' ' ' HIS . . . -50.01 172.11 0.12 Allowed Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 120.931 0.396 . . . . 0.0 111.631 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 45' ' ' GLU . 44.4 Cg_exo -57.46 -17.12 26.1 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.999 2.466 . . . . 0.0 113.337 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.566 ' CZ3' ' HB3' ' A' ' 19' ' ' CYS . 6.4 t90 -71.88 -65.84 0.72 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.409 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -50.79 -53.59 30.7 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -35.28 75.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.491 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 1.8 mt-10 -49.33 -40.66 36.11 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.461 0.573 . . . . 0.0 111.209 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.533 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -126.35 5.61 7.67 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 118.355 -1.878 . . . . 0.0 113.48 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 60' ' ' THR . . . -70.1 54.55 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.993 0.397 . . . . 0.0 111.677 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 t -106.03 36.61 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.519 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -147.83 152.04 36.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 111.016 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 59' ' ' ARG . 12.7 m95 -92.62 158.87 15.74 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.6 t -151.18 144.34 17.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.332 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -99.29 121.84 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.049 2.5 . . . . 0.0 113.805 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.729 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 35.5 t80 -121.51 130.83 53.79 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t -39.09 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.414 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -70.17 -11.43 60.89 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -154.3 168.49 32.58 Favored Glycine 0 C--N 1.366 2.216 0 C-N-CA 118.167 -1.968 . . . . 0.0 114.398 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ARG . 8.6 tt0 -94.55 117.99 30.98 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 121.878 -0.777 . . . . 0.0 110.397 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.589 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 5.1 m -97.2 178.86 5.1 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.134 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB3' ' O ' ' A' ' 58' ' ' CYS . 22.4 ptt180 171.03 115.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.106 0.867 . . . . 0.0 110.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.887 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -179.49 -147.87 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 6.3 t -142.8 -172.11 3.58 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.2 m -143.95 174.33 10.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.444 HG23 ' CH2' ' A' ' 42' ' ' TRP . 8.7 pt -157.07 166.82 15.81 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.155 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.418 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 4.2 Cg_exo -76.3 165.26 29.69 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.333 . . . . 0.0 111.398 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 0.0 110.699 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.857 0.361 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 166.72 12.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -132.12 153.53 50.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.408 0.623 . . . . 0.0 111.814 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.458 ' CE2' ' HD2' ' A' ' 27' ' ' PRO . 1.6 p90 -135.36 131.62 36.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.122 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.51 121.44 38.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.665 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 m -102.61 154.89 18.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.758 0.789 . . . . 0.0 112.782 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.466 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.9 t80 -119.11 115.69 24.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.198 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.53 162.51 20.57 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.02 -11.7 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.919 2.413 . . . . 0.0 113.333 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 4.8 t0 -170.19 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.144 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.2 mt-30 -160.64 163.58 32.46 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.168 0.509 . . . . 0.0 111.714 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.424 HG23 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.91 117.33 47.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.715 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.1 m -123.01 138.17 54.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 38.9 t -122.38 146.48 47.3 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.343 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -140.1 134.78 31.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.326 0.584 . . . . 0.0 111.9 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.3 mp -107.39 131.0 58.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.511 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 49.8 m -131.75 -172.84 2.97 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 119.286 -0.966 . . . . 0.0 113.363 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -151.76 60.35 0.87 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.65 0.53 7.22 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 119.998 -1.096 . . . . 0.0 114.063 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -167.5 -160.56 0.36 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.263 1.031 . . . . 0.0 112.759 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -173.23 139.06 0.83 Allowed Pre-proline 0 C--N 1.346 0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD2' ' CE2' ' A' ' 9' ' ' PHE . 51.7 Cg_exo -55.35 142.37 79.75 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.231 1.954 . . . . 0.0 112.019 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.1 tp -64.77 110.04 3.61 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.11 152.55 80.62 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.582 2.188 . . . . 0.0 112.167 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 p -165.81 -50.53 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.99 33.22 1.36 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 122.048 -0.407 . . . . 0.0 111.637 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 160.85 169.14 23.72 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.771 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.97 -163.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.52 159.51 27.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.235 0.54 . . . . 0.0 111.146 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.68 153.65 74.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.673 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.36 128.5 25.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.722 2.281 . . . . 0.0 112.37 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -157.83 89.81 2.35 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.771 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -30.85 -68.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.537 2.824 . . . . 0.0 113.358 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.93 -160.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.48 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 171.05 154.31 0.21 Allowed Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 120.614 0.245 . . . . 0.0 110.796 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 56.2 Cg_endo -70.04 -13.89 34.51 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.328 2.019 . . . . 0.0 111.954 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 90.1 t90 -93.91 -53.49 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.213 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 73.8 m -50.02 -33.76 19.1 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -88.44 -39.36 14.31 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 4.1 mt-10 -48.82 -26.84 2.62 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.308 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.3 -23.73 2.85 Favored Glycine 0 C--N 1.36 1.916 0 C-N-CA 118.487 -1.816 . . . . 0.0 113.497 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 60.28 2.48 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.699 0.75 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.11 31.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -125.75 147.12 49.48 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.676 0.274 . . . . 0.0 110.293 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.438 ' CZ3' ' HD3' ' A' ' 59' ' ' ARG . 1.2 m95 -90.21 164.11 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.027 0.441 . . . . 0.0 111.058 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.3 t -147.23 130.42 8.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.595 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -93.83 87.76 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.637 2.225 . . . . 0.0 113.667 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -100.42 124.93 46.55 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.3 m -42.55 -49.6 5.4 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.027 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -32.55 69.55 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.656 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -172.04 179.78 43.47 Favored Glycine 0 C--N 1.359 1.823 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.286 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -89.95 145.36 25.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 118.354 1.077 . . . . 0.0 110.192 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 m -129.31 177.62 7.04 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 4.6 mmm180 -150.54 126.92 10.71 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.2 m -109.11 137.99 46.15 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 47' ' ' ALA . 1.9 m -142.64 152.33 42.35 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.443 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.415 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 35.3 m -155.75 156.55 35.03 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 120.656 1.571 . . . . 0.0 112.306 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.468 ' CD1' ' CZ2' ' A' ' 42' ' ' TRP . 32.2 pt -161.81 156.75 19.86 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.49 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.12 164.66 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.055 . . . . 0.0 112.22 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.437 ' CE2' ' N ' ' A' ' 16' ' ' GLN . 10.8 m-85 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.888 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 . . . . . 0 N--CA 1.461 0.125 0 CA-C-O 120.734 0.302 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.79 140.98 23.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 30.9 t -118.31 152.26 36.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.727 0.775 . . . . 0.0 112.671 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 27' ' ' PRO . 3.3 p90 -130.9 130.85 44.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.016 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -94.49 126.15 39.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.067 0.46 . . . . 0.0 110.212 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 17.3 m -105.04 154.31 20.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.693 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -130.0 126.6 38.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -114.06 164.69 15.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.321 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.8 -19.14 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.227 2.618 . . . . 0.0 113.955 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.43 28.76 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.0 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.6 mt-30 -153.83 147.2 24.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.016 0.436 . . . . 0.0 111.834 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.545 HG22 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -119.97 122.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.002 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.5 m -134.58 141.77 46.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.498 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 41.5 t -122.1 146.43 47.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.82 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.0 139.29 28.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.285 0.565 . . . . 0.0 112.518 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.27 120.32 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.253 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 58.8 m -108.96 -176.16 2.96 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.096 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.58 54.95 0.74 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.409 ' C ' ' HA3' ' A' ' 56' ' ' GLY . . . 108.24 21.87 7.46 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.544 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.452 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -130.76 -157.45 0.82 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.391 0.596 . . . . 0.0 111.99 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' CB ' ' HD2' ' A' ' 27' ' ' PRO . . . -146.57 177.85 1.63 Allowed Pre-proline 0 C--N 1.34 0.179 0 CA-C-O 120.593 0.235 . . . . 0.0 110.902 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.514 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 98.3 Cg_endo -81.16 124.06 4.73 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.642 2.228 . . . . 0.0 113.126 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.6 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 3.5 tt -71.24 -35.87 4.38 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.594 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 96.2 Cg_exo -44.81 170.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.516 2.144 . . . . 0.0 112.98 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -151.25 -37.1 0.13 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.92 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -82.79 30.75 0.43 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.59 0.632 . . . . 0.0 111.825 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.56 163.6 34.67 Favored Glycine 0 N--CA 1.466 0.698 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.15 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -100.62 -166.31 1.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.436 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -160.77 159.94 30.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.358 0.599 . . . . 0.0 112.072 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.409 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -137.7 173.05 5.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.427 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 74.4 Cg_endo -75.61 135.3 17.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.539 2.16 . . . . 0.0 113.036 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.525 ' CE1' ' HB1' ' A' ' 40' ' ' ALA . 60.9 t-80 -164.37 95.73 0.95 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.76 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 8' ' ' SER . 2.6 Cg_endo -39.71 -81.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.394 2.729 . . . . 0.0 114.21 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -176.03 53.5 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.825 0.078 . . . . 0.0 110.885 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' A' ' 37' ' ' HIS . . . -59.38 174.06 0.45 Allowed Pre-proline 0 N--CA 1.471 0.622 0 O-C-N 122.022 -0.424 . . . . 0.0 111.555 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 40' ' ' ALA . 37.2 Cg_endo -65.76 1.74 2.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.575 2.183 . . . . 0.0 113.045 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.498 ' HZ3' ' HB3' ' A' ' 19' ' ' CYS . 21.1 t90 -90.06 -56.22 3.31 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 53.2 m -64.74 -32.93 74.84 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -78.06 -44.47 26.26 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.406 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 9.5 tt0 -64.49 -19.64 65.7 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.98 -18.5 6.82 Favored Glycine 0 C--N 1.364 2.09 0 C-N-CA 118.095 -2.002 . . . . 0.0 112.683 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.476 ' O ' ' HD2' ' A' ' 59' ' ' ARG . . . -93.73 68.28 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.296 0.57 . . . . 0.0 110.434 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 m -89.27 29.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.56 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -145.02 133.31 21.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -95.64 167.8 11.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.218 0.532 . . . . 0.0 111.922 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 58' ' ' CYS . 11.5 p -155.97 139.04 10.79 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.73 120.59 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.597 2.198 . . . . 0.0 113.963 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.478 ' CB ' ' O ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -104.53 132.48 50.73 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -61.8 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -26.58 68.02 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.152 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -168.48 176.8 42.74 Favored Glycine 0 C--N 1.359 1.821 0 C-N-CA 118.989 -1.576 . . . . 0.0 112.808 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.0 tt0 -93.15 127.56 38.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.665 1.232 . . . . 0.0 110.447 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -136.82 -173.98 3.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.216 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 47' ' ' ALA . 6.2 ttp180 -156.66 127.37 6.71 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.1 t -104.05 130.97 51.75 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -127.93 162.36 26.93 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.9 m -150.91 170.5 19.17 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 119.863 1.21 . . . . 0.0 111.538 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.545 HG13 HG22 ' A' ' 17' ' ' VAL . 5.5 pt -157.19 151.58 20.29 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.605 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' ILE . 7.7 Cg_exo -71.53 125.9 11.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.881 2.387 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.486 ' CG ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.969 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 p30 . . . . . 0 N--CA 1.461 0.076 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -148.11 141.07 24.82 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 0.7 OUTLIER -121.18 148.87 43.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.69 0.757 . . . . 0.0 112.903 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -135.4 132.18 37.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.51 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.91 125.58 42.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.07 0.462 . . . . 0.0 109.805 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -103.8 143.54 32.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.163 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.39 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.82 162.6 32.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.883 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -44.29 -18.07 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.399 . . . . 0.0 113.694 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.38 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.413 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.61 166.93 29.69 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.048 0.451 . . . . 0.0 111.704 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.416 HG22 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -141.43 108.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.245 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.1 m -114.37 134.75 54.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 111.818 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.6 t -119.27 144.16 46.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.576 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.632 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -150.81 139.91 21.11 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 1.3 mt -111.86 110.52 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.562 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 1.3 m -86.94 -175.51 5.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.84 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.94 51.71 0.98 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.55 22.5 4.02 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.484 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB3' ' N ' ' A' ' 56' ' ' GLY . . . -162.54 -156.63 0.41 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.033 0.916 . . . . 0.0 112.051 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -163.68 132.92 2.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' A' ' 9' ' ' PHE . 15.4 Cg_endo -56.93 145.72 83.4 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.511 2.141 . . . . 0.0 112.647 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.53 111.81 21.91 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.053 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.51 151.46 29.05 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.534 2.156 . . . . 0.0 112.127 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 -55.6 0.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.301 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -95.1 29.52 2.42 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 118.108 0.413 . . . . 0.0 111.55 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.27 -162.53 36.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.75 -162.86 1.15 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.686 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.07 163.29 39.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.107 0.48 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 155.24 72.83 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.77 130.09 28.34 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.615 2.21 . . . . 0.0 112.438 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' SER . 17.9 t-160 -157.87 100.68 1.8 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -30.04 -73.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.316 2.677 . . . . 0.0 113.378 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.402 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 10.5 t -154.13 -159.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 178.88 130.42 0.22 Allowed Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.032 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 38.8 Cg_exo -56.73 -20.69 36.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.289 1.993 . . . . 0.0 112.088 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.474 ' CZ2' ' CD1' ' A' ' 63' ' ' ILE . 63.3 t90 -86.9 -47.95 8.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -42.43 -57.57 2.57 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -69.96 -35.81 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.164 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 71.4 tt0 -46.15 -31.12 2.22 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 118.284 0.493 . . . . 0.0 111.582 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.8 10.68 3.96 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 118.338 -1.887 . . . . 0.0 113.907 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . . . -92.21 45.76 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.383 0.591 . . . . 0.0 111.24 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.57 33.84 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.99 15.87 4.7 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -130.24 -175.11 3.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.281 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 2.3 t 142.82 -42.5 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.08 0 O-C-N 123.746 0.654 . . . . 0.0 110.038 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 98.6 Cg_endo -86.69 78.89 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 114.447 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.5 t80 -109.35 130.57 55.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.61 -60.49 1.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -30.35 70.34 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.54 -172.59 37.75 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.619 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.715 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -95.19 132.64 39.93 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.53 1.665 . . . . 0.0 109.273 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.665 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 19.1 m -135.99 -174.19 3.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.828 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.632 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.76 132.22 20.84 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 t -125.73 139.77 53.25 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.54 162.24 35.82 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.4 m -157.29 146.82 20.31 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 119.96 1.255 . . . . 0.0 111.506 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 HG23 HD11 ' A' ' 63' ' ' ILE . 3.5 pt -149.18 165.29 18.04 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.737 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 32.7 Cg_exo -59.54 164.8 10.58 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 0.0 111.979 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.156 0.503 . . . . 0.0 110.788 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 7' ' ' GLU . 1.5 p30 . . . . . 0 CA--C 1.502 -0.868 0 CA-C-O 122.478 1.132 . . . . 0.0 108.734 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.571 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 9.6 mt-10 -177.64 -167.56 0.15 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.159 -2.291 . . . . 0.0 109.653 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 37' ' ' HIS . 32.8 t -135.21 142.12 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.316 0.579 . . . . 0.0 111.791 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 31.1 p90 -124.79 132.78 53.32 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.613 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -97.74 131.3 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.703 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.9 m -116.36 133.27 56.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.629 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.31 130.71 56.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.47 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -126.11 149.85 67.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.496 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.24 4.5 0.13 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.673 2.248 . . . . 0.0 113.358 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 13' ' ' GLN . 3.8 m-20 -117.57 -29.94 5.63 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 15' ' ' ASP . 1.2 mt-30 -172.27 -167.22 0.45 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.684 0.278 . . . . 0.0 110.838 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG22 HG12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -125.95 144.83 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.208 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -145.08 145.64 31.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 112.113 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.535 ' CB ' ' CH2' ' A' ' 42' ' ' TRP . 2.3 t -127.38 152.78 47.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -144.02 135.17 25.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.342 0.591 . . . . 0.0 111.759 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' CYS . 37.8 mt -104.92 110.28 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.225 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.664 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 70.5 m -100.6 172.41 7.12 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.836 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.73 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -148.81 46.86 1.02 Allowed 'General case' 0 C--N 1.354 0.78 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . . . 128.21 30.95 0.7 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.7 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.715 ' HB1' ' CG ' ' A' ' 53' ' ' TYR . . . -123.09 -165.7 1.35 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.203 1.001 . . . . 0.0 112.287 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.432 ' O ' ' OH ' ' A' ' 53' ' ' TYR . . . -125.74 99.07 32.99 Favored Pre-proline 0 C--N 1.344 0.332 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.613 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.51 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 32.6 Cg_exo -32.38 90.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.45 2.767 . . . . 0.0 113.485 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 tp -98.7 122.66 52.45 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.8 -170.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.501 2.134 . . . . 0.0 112.119 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 p -149.28 -52.8 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.413 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.86 30.47 3.71 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.252 0.478 . . . . 0.0 111.681 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.36 -146.16 7.27 Favored Glycine 0 N--CA 1.461 0.364 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.365 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -116.46 -169.77 1.69 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.333 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -156.07 166.39 33.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.034 0.445 . . . . 0.0 111.359 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -143.0 168.58 12.73 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.544 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.71 134.99 22.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.67 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.9 t60 -157.65 93.13 2.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -28.6 -85.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.9 3.066 . . . . 0.0 114.628 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 p -162.43 55.65 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.463 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -43.49 166.85 0.09 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 CA-C-N 118.468 0.576 . . . . 0.0 111.869 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 52.6 Cg_exo -56.56 -47.23 24.83 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.213 2.608 . . . . 0.0 113.993 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.535 ' CH2' ' CB ' ' A' ' 19' ' ' CYS . 38.5 p-90 -72.65 -45.82 57.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 1.3 m -47.24 -45.66 23.72 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -31.68 21.91 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.865 -0.522 . . . . 0.0 109.951 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 1.7 tm-20 -47.71 -31.72 5.04 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.705 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.51 -11.82 1.46 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 118.214 -1.946 . . . . 0.0 114.711 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.767 ' C ' ' HG2' ' A' ' 59' ' ' ARG . . . -72.14 64.13 0.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.441 1.12 . . . . 0.0 111.635 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.23 52.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.463 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HG2' ' CZ ' ' A' ' 59' ' ' ARG . 7.7 pt-20 -134.37 -15.87 2.16 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.812 ' HB3' ' HA ' ' A' ' 59' ' ' ARG . 8.6 t90 -102.33 -166.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.964 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 170.01 -38.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 7.7 Cg_exo -75.59 81.15 2.39 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.178 1.919 . . . . 0.0 116.267 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.715 ' CG ' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -112.57 129.45 56.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.2 p -26.01 -73.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -22.45 50.66 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.44 -165.98 19.3 Favored Glycine 0 C--N 1.356 1.644 0 C-N-CA 118.911 -1.614 . . . . 0.0 111.945 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 4.1 mt-30 -95.26 166.3 11.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.523 2.161 . . . . 0.0 109.321 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.664 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 44.8 t -175.84 -176.54 0.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.333 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.812 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -158.17 145.66 18.18 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 118.515 0.598 . . . . 0.0 111.591 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.513 ' N ' ' HD2' ' A' ' 59' ' ' ARG . 9.5 t -112.58 104.03 12.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.57 172.63 6.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.128 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m -155.84 158.57 38.29 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 118.993 0.815 . . . . 0.0 111.42 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 ' CH2' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -153.87 162.19 27.36 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.209 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 160.47 7.83 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.773 2.316 . . . . 0.0 112.623 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.835 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p30 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.766 0.317 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -142.25 153.91 44.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.681 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -130.53 149.6 52.12 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 112.596 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -132.61 135.41 45.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.04 178.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.64 118.01 35.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.825 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.2 m -106.44 139.28 41.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.483 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -133.76 151.09 76.39 Favored Pre-proline 0 CA--C 1.511 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.258 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.84 -1.51 1.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.619 1.546 . . . . 0.0 110.861 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.4 t0 -114.34 -29.29 6.95 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.534 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.412 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -179.33 173.5 1.1 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.99 0.424 . . . . 0.0 111.604 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.449 HG13 ' CE2' ' A' ' 65' ' ' TYR . 2.3 m -111.57 118.97 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.405 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 3.5 m -110.43 128.9 55.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.814 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.485 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 51.8 t -112.19 145.78 39.27 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.341 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -152.29 138.45 18.31 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.174 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.441 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 1.7 mt -108.83 113.79 45.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.659 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 1.3 m -93.61 -177.3 4.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.528 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 57' ' ' GLN . 18.0 tpt85 -145.19 49.18 1.27 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.42 25.68 3.68 Favored Glycine 0 C--N 1.348 1.211 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -158.51 -157.74 0.65 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.848 0.824 . . . . 0.0 112.154 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' O ' ' CZ ' ' A' ' 53' ' ' TYR . . . -155.43 179.98 1.22 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.32 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 26' ' ' ALA . 67.2 Cg_endo -91.36 138.7 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.739 2.292 . . . . 0.0 113.219 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.11 64.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.276 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 27' ' ' PRO . 67.8 Cg_endo -72.11 -161.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.588 2.192 . . . . 0.0 111.994 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.99 -54.87 3.04 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.23 -95.03 0.1 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 39.64 -161.9 0.01 OUTLIER Glycine 0 N--CA 1.474 1.231 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.743 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.1 178.54 7.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 m -157.82 178.99 9.62 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 119.042 0.837 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -157.86 145.31 13.58 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.26 135.25 68.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.527 2.151 . . . . 0.0 112.372 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' SER . 27.3 t60 -161.6 98.65 1.23 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.933 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -29.35 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.377 2.718 . . . . 0.0 113.448 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -155.43 -161.95 1.26 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 177.72 158.89 0.55 Allowed Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.026 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 72.8 Cg_endo -74.74 -16.38 20.95 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.446 2.097 . . . . 0.0 112.131 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.63 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 44.4 t90 -87.1 -51.97 5.69 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.272 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.45 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 0.1 OUTLIER -45.3 -57.68 3.84 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -35.8 80.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.416 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.63 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 2.9 mt-10 -48.56 -30.81 5.69 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.351 0.523 . . . . 0.0 111.813 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.12 17.68 2.53 Favored Glycine 0 C--N 1.357 1.75 0 C-N-CA 118.208 -1.949 . . . . 0.0 113.842 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 60' ' ' THR . . . -107.52 58.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 111.141 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.4 p -93.85 31.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.301 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.726 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.51 119.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.886 0.374 . . . . 0.0 111.703 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.726 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 1.6 t90 155.86 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.167 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG2' ' HD3' ' A' ' 52' ' ' PRO . 11.1 m -50.31 -32.18 5.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.105 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.574 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 2.9 Cg_exo -77.27 62.65 7.63 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.983 1.789 . . . . 0.0 114.678 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 2.5 t80 -106.41 116.49 32.02 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -36.7 -58.34 0.74 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.469 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.98 69.98 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.003 -0.523 . . . . 0.0 112.0 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.21 -178.96 42.04 Favored Glycine 0 C--N 1.361 1.921 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.761 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.9 tt0 -96.72 124.21 40.64 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.373 -1.075 . . . . 0.0 109.791 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.586 ' CB ' ' CE3' ' A' ' 50' ' ' TRP . 10.1 m -131.62 -172.95 2.99 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' CA ' ' HB3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -150.36 133.45 16.17 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 85.1 m -117.62 147.81 42.52 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.45 ' CG2' ' HA ' ' A' ' 43' ' ' CYS . 1.8 t -151.58 174.09 13.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.78 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -173.22 159.92 3.94 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 118.865 0.757 . . . . 0.0 110.919 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.476 HG22 ' CZ2' ' A' ' 42' ' ' TRP . 1.7 pt -149.38 151.74 34.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.425 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 68.3 Cg_endo -90.02 93.76 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.226 2.617 . . . . 0.0 112.283 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.449 ' CE2' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.841 0.353 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -143.11 140.59 30.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 37' ' ' HIS . 13.3 t -111.78 147.95 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.726 0.774 . . . . 0.0 112.372 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 2.0 p90 -134.07 137.26 44.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.328 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.56 127.17 43.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.978 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.1 m -107.36 142.83 36.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 111.976 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.513 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.7 t80 -108.95 130.9 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.262 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -138.97 142.35 33.17 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.07 6.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.619 2.213 . . . . 0.0 113.321 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.1 p30 -118.95 -33.53 4.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.3 mp0 -169.4 -170.22 1.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.436 HG21 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -125.76 117.23 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.4 146.79 40.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.092 0.473 . . . . 0.0 112.212 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.584 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 51.9 t -125.68 150.58 47.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.625 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -149.49 140.44 22.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 3.7 mp -103.85 118.42 50.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.662 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 94.0 m -107.43 -174.03 2.43 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.2 57.37 0.71 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.95 -19.92 1.11 Allowed Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.622 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' CB ' ' HB ' ' A' ' 55' ' ' THR . . . -174.77 -155.44 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.289 0.545 . . . . 0.0 110.62 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 27' ' ' PRO . . . 173.56 -58.24 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 26' ' ' ALA . 9.2 Cg_endo -51.06 78.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.288 2.658 . . . . 0.0 114.631 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 53' ' ' TYR . 18.7 tp -134.01 50.5 5.23 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 89.8 Cg_endo -77.83 -171.74 1.28 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.706 2.271 . . . . 0.0 112.727 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 t -159.44 -56.4 0.06 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.9 32.21 4.06 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.012 -0.43 . . . . 0.0 111.617 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 175.12 -152.19 13.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.297 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.55 -167.75 1.99 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 m -156.68 157.11 34.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.756 0.313 . . . . 0.0 110.629 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.57 151.43 75.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 141.06 93.48 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' SER . 82.0 t60 -169.19 97.49 0.51 Allowed Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.813 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -30.54 -71.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.455 2.77 . . . . 0.0 113.551 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.51 -157.89 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.799 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 177.3 167.3 0.49 Allowed Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 120.6 0.238 . . . . 0.0 111.082 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.55 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 72.7 Cg_endo -76.09 -25.85 9.81 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.584 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 26.9 p-90 -92.44 -41.14 10.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.413 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 96.6 m -51.68 -37.94 52.8 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.43 -36.12 17.9 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 121.711 -0.618 . . . . 0.0 109.369 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -46.85 -29.77 2.15 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.003 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.18 -10.73 4.53 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.781 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 43' ' ' CYS . . . -94.42 45.15 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.857 0.829 . . . . 0.0 111.091 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 m -95.09 32.06 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.51 143.26 33.71 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -79.82 151.75 30.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 58' ' ' CYS . 12.0 p -162.75 94.72 1.17 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.863 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -42.16 110.73 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.931 2.42 . . . . 0.0 113.635 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.639 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.7 t80 -93.26 145.84 24.14 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -32.87 -89.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 44.7 m -68.53 -7.78 35.52 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -166.16 173.1 41.66 Favored Glycine 0 C--N 1.363 2.031 0 C-N-CA 118.769 -1.682 . . . . 0.0 112.679 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -78.04 152.98 32.72 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.706 1.253 . . . . 0.0 109.663 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.8 t -159.67 -171.71 3.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.692 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' CG ' ' HB ' ' A' ' 21' ' ' ILE . 1.6 ptt-85 -155.15 125.94 7.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -105.59 136.98 44.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.82 171.39 14.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.615 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.7 m -154.76 168.73 25.87 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.578 1.081 . . . . 0.0 111.688 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.422 HG22 ' CE3' ' A' ' 42' ' ' TRP . 28.4 pt -154.15 137.29 10.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.841 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.49 124.98 3.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.763 2.308 . . . . 0.0 112.795 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.465 ' OH ' ' CZ ' ' A' ' 12' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.833 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.31 141.21 33.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -121.7 146.27 47.19 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.505 0.669 . . . . 0.0 111.921 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.542 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -130.6 130.74 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.701 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.84 121.07 33.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.656 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -102.65 145.24 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 0.0 112.637 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.448 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.4 t80 -110.54 113.26 25.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.574 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -117.77 140.69 27.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.87 7.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.699 2.266 . . . . 0.0 113.443 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 13' ' ' GLN . 5.6 t0 -118.63 -37.08 3.34 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.245 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 8.4 mp0 -165.77 -175.49 3.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.06 113.97 45.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 m -110.09 129.68 55.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 43.6 t -108.1 140.32 41.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.744 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.66 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -135.36 143.95 46.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 112.746 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' ARG . 2.5 mp -116.84 138.28 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.489 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 16.9 m -145.81 -171.1 3.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.64 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -156.82 60.74 0.53 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.79 8.86 5.04 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 119.897 -1.145 . . . . 0.0 114.355 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.468 ' HB3' ' N ' ' A' ' 56' ' ' GLY . . . -167.13 -160.54 0.38 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.67 1.235 . . . . 0.0 113.157 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . -173.49 132.05 0.58 Allowed Pre-proline 0 C--N 1.347 0.481 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 9' ' ' PHE . 9.7 Cg_endo -49.84 147.2 14.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 112.159 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.36 111.28 5.72 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.2 152.39 16.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.653 2.235 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 t -166.31 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.131 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.54 33.93 1.37 Allowed 'General case' 0 C--N 1.352 0.695 0 O-C-N 122.068 -0.395 . . . . 0.0 111.548 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 168.18 167.9 29.5 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.829 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.53 -161.49 0.84 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.73 160.38 33.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -139.12 152.72 70.43 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.617 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.43 127.52 21.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.263 . . . . 0.0 112.452 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 12.9 t-160 -160.58 82.51 2.12 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.22 -63.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.782 2.988 . . . . 0.0 113.443 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.425 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -140.53 -161.39 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.103 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB2' ' CE1' ' A' ' 37' ' ' HIS . . . 172.81 131.41 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.005 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 31.2 Cg_exo -58.22 -18.66 38.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.076 1.851 . . . . 0.0 111.726 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.492 ' HZ3' ' HB2' ' A' ' 19' ' ' CYS . 48.1 t90 -86.36 -51.89 5.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.357 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -45.54 -56.37 5.19 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.57 -36.18 83.4 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.0 tt0 -49.68 -34.39 18.42 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.73 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.49 -2.94 2.81 Favored Glycine 0 C--N 1.358 1.767 0 C-N-CA 118.405 -1.855 . . . . 0.0 114.376 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -95.13 63.41 2.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.861 0.831 . . . . 0.0 110.356 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 t -94.44 32.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.387 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -124.55 136.15 53.74 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.667 ' CZ3' ' HG2' ' A' ' 57' ' ' GLN . 4.2 t-105 -96.24 135.84 37.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.518 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 9.6 p -131.93 120.61 17.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.987 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.563 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 71.8 Cg_endo -76.6 114.92 3.96 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.619 2.213 . . . . 0.0 114.091 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 27' ' ' PRO . 1.1 t80 -104.61 128.14 52.55 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -42.63 -48.01 5.37 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.933 -0.122 . . . . 0.0 111.242 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.08 -30.74 61.03 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.468 ' N ' ' HB3' ' A' ' 25' ' ' ALA . . . -172.46 179.57 43.92 Favored Glycine 0 C--N 1.359 1.84 0 C-N-CA 118.948 -1.596 . . . . 0.0 113.253 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.667 ' HG2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -81.62 120.31 24.92 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 118.544 1.172 . . . . 0.0 110.337 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -117.94 -178.84 3.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.66 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -160.67 133.81 6.57 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.44 ' HA ' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -120.3 130.59 54.52 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.525 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -139.43 164.79 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.012 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 t -176.87 155.56 1.26 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 120.506 1.503 . . . . 0.0 112.515 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.592 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 7.8 pt -159.08 161.81 27.33 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.118 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 5.3 Cg_endo -47.16 174.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.6 2.2 . . . . 0.0 112.482 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.709 179.477 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 120.848 0.356 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -142.07 141.04 32.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.417 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' HIS . 29.3 t -117.11 141.32 48.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.628 0.727 . . . . 0.0 112.54 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.94 137.97 46.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.605 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.52 128.53 50.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.138 0.494 . . . . 0.0 110.475 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 74.0 m -107.98 139.24 42.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.108 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -119.4 128.48 54.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.502 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.04 146.39 56.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.866 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.76 3.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 113.38 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 13' ' ' GLN . 32.0 m-20 -111.67 -36.74 5.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.588 0.232 . . . . 0.0 111.109 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.428 ' CG ' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -172.51 -175.31 1.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.907 0.384 . . . . 0.0 111.181 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.22 130.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.123 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 99.9 m -128.81 129.66 45.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 112.047 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 34.5 t -112.99 152.72 29.08 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.836 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.611 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -154.48 133.59 12.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.069 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.33 102.14 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.585 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 68.9 m -90.04 -172.46 3.51 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.628 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.83 60.18 0.67 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.63 16.43 9.39 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.16 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 55' ' ' THR . . . -164.7 -161.17 0.55 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.86 151.78 16.93 Favored Pre-proline 0 C--N 1.34 0.18 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.285 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HG3' ' CD1' ' A' ' 20' ' ' PHE . 73.4 Cg_endo -75.79 132.77 14.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.474 2.116 . . . . 0.0 112.234 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.5 tp -74.05 112.08 15.22 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.32 -174.46 2.11 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.4 p -164.23 -55.8 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.535 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -102.1 33.4 3.08 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.99 -0.444 . . . . 0.0 111.924 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.91 -176.05 47.72 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.673 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -120.15 -164.85 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.7 m -154.15 178.42 10.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.995 0.426 . . . . 0.0 111.442 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.8 165.59 18.44 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.957 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.04 137.77 41.93 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.848 2.365 . . . . 0.0 112.729 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.0 t-160 -163.08 92.67 1.18 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 8' ' ' SER . 37.1 Cg_exo -25.49 -71.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.865 3.043 . . . . 0.0 113.819 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.38 -161.07 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.463 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . . . 173.6 142.2 0.17 Allowed Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.024 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 20.2 Cg_exo -64.95 -12.44 34.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.411 2.074 . . . . 0.0 112.106 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.511 ' HZ3' ' HB2' ' A' ' 19' ' ' CYS . 67.2 t90 -91.56 -52.73 4.63 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.321 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 11.1 m -49.55 -36.23 22.92 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -37.27 20.14 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.735 -0.603 . . . . 0.0 109.754 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -51.12 -25.55 5.32 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.604 179.555 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.48 -6.96 4.52 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 118.221 -1.942 . . . . 0.0 114.192 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -92.01 61.34 4.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.051 0.926 . . . . 0.0 111.259 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.8 t -111.98 38.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.256 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.45 13.41 1.96 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.903 0.382 . . . . 0.0 111.844 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.771 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -128.5 169.04 14.82 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.363 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER 158.17 -34.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.473 0.709 . . . . 0.0 110.801 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 73.2 Cg_endo -93.3 68.41 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.083 1.856 . . . . 0.0 113.725 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.772 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 76.4 t80 -97.12 126.84 42.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -37.31 -57.6 0.89 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.445 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 66.1 m -69.7 -27.3 64.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.772 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -174.06 -178.27 43.86 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.325 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -95.54 126.73 41.03 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 119.582 1.691 . . . . 0.0 109.203 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.771 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 43.3 t -142.42 -178.76 5.91 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.174 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.745 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 15.5 mmm-85 -138.3 134.14 33.94 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.425 HG22 ' CE2' ' A' ' 20' ' ' PHE . 91.8 m -117.2 142.78 46.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 19' ' ' CYS . 1.4 t -147.46 160.38 42.64 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.81 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.43 ' O ' HG21 ' A' ' 63' ' ' ILE . 81.7 m -158.01 160.73 37.78 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-N 119.541 1.064 . . . . 0.0 110.879 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 63' ' ' ILE . 3.5 pt -151.65 154.45 33.19 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.444 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 69.1 Cg_endo -89.77 126.39 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.183 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.254 179.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.752 ' N ' ' O ' ' A' ' 22' ' ' CYS . 1.9 m-20 . . . . . 0 CA--C 1.506 -0.741 0 CA-C-O 122.532 1.158 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 162.01 -176.46 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.484 -2.144 . . . . 0.0 110.728 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 6.9 t -119.43 158.45 26.19 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.296 0.569 . . . . 0.0 112.136 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 20' ' ' PHE . 2.1 p90 -141.32 126.87 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.257 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.63 128.61 39.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HB2' ' HE1' ' A' ' 20' ' ' PHE . 6.7 m -111.2 142.86 42.84 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.996 -178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.76 128.05 54.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.517 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.82 145.82 52.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.759 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.38 5.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.809 2.339 . . . . 0.0 113.423 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -116.6 -34.92 4.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.214 -0.194 . . . . 0.0 111.343 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.2 mt-30 -174.54 -174.28 0.83 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.58 121.08 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.958 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -114.69 125.72 54.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 1.5 p -107.01 138.31 43.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.73 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -140.04 147.24 40.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.97 0.891 . . . . 0.0 112.82 178.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 59' ' ' ARG . 25.7 mt -132.38 142.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.461 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 6' ' ' ASP . 4.5 m -142.94 -179.12 6.16 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.938 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HA ' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -154.71 69.77 0.75 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 6' ' ' ASP . . . 132.6 -5.62 5.2 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.235 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.533 ' CB ' ' CD2' ' A' ' 53' ' ' TYR . . . -126.73 -162.14 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.58 0.69 . . . . 0.0 111.788 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.45 171.59 8.76 Favored Pre-proline 0 C--N 1.34 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.918 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.477 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 64.3 Cg_endo -87.46 114.38 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.876 2.384 . . . . 0.0 112.901 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tp -113.79 83.56 7.57 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.015 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 27' ' ' PRO . 32.6 Cg_exo -57.59 -172.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.644 2.229 . . . . 0.0 112.263 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -55.37 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.246 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -115.81 29.23 8.12 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.94 -0.475 . . . . 0.0 111.672 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.75 -161.85 26.76 Favored Glycine 0 N--CA 1.462 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.394 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.32 -166.7 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.748 0.274 . . . . 0.0 110.777 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 171.26 19.75 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.293 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -149.76 153.71 36.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.23 128.91 25.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.627 2.218 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 8' ' ' SER . 42.9 t60 -158.3 114.08 1.73 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.772 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -38.89 -77.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.654 2.236 . . . . 0.0 112.947 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -156.55 -158.64 0.8 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -177.51 143.7 0.52 Allowed Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.264 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 24.6 Cg_exo -62.65 -15.9 49.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.489 2.126 . . . . 0.0 112.203 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 19' ' ' CYS . 32.6 t90 -84.68 -50.33 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.871 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.13 -53.02 8.55 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.26 -36.42 82.95 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 25.1 tt0 -47.41 -36.89 10.43 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.351 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.26 2.56 1.14 Allowed Glycine 0 C--N 1.359 1.814 0 C-N-CA 118.112 -1.994 . . . . 0.0 115.224 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -82.65 65.03 7.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.404 1.102 . . . . 0.0 110.136 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -49.35 -22.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.69 160.45 32.62 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.057 -0.402 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.463 ' CZ2' ' NH1' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -161.07 15.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.655 ' HA ' ' HA ' ' A' ' 57' ' ' GLN . 7.6 p -156.0 6.29 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 51' ' ' VAL . 14.5 Cg_endo -56.51 32.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 N-CA-C 118.795 2.575 . . . . 0.0 118.795 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.649 ' O ' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -137.21 116.62 12.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.26 1.391 . . . . 0.0 109.669 176.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.8 t -46.64 -53.25 11.96 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.356 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 m -70.57 -21.12 62.73 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.95 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 53' ' ' TYR . . . -159.53 167.77 35.23 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.836 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 5.0 mt-30 -80.75 129.47 34.54 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 121.683 -0.893 . . . . 0.0 109.288 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 52' ' ' PRO . 1.1 m -120.77 -169.03 1.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.95 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.73 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.7 OUTLIER -162.46 132.97 4.77 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.6 t -131.59 132.87 44.42 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -143.9 169.0 18.62 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.128 177.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.471 ' N ' HG21 ' A' ' 61' ' ' THR . 0.1 OUTLIER -170.62 156.32 5.28 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.47 1.032 . . . . 0.0 111.161 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.476 HG12 ' CZ2' ' A' ' 42' ' ' TRP . 3.4 pt -149.5 156.1 39.17 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.539 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 73.7 Cg_endo -90.21 125.32 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.206 2.604 . . . . 0.0 111.921 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.408 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p 58.18 27.5 15.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 111.056 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.02 125.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.9 p -128.51 149.36 71.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.82 -162.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.651 2.234 . . . . 0.0 112.097 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -69.74 151.93 45.24 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.522 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -150.56 141.81 23.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.799 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.1 t -110.91 145.89 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -127.22 130.99 50.7 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.407 178.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.15 103.54 15.58 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.4 m -87.61 152.65 22.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.281 0.562 . . . . 0.0 111.903 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.431 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 11.1 t80 -125.33 138.29 54.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.767 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.96 158.38 75.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 5.0 Cg_endo -46.87 -14.19 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.164 2.576 . . . . 0.0 113.628 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 15.8 t70 -164.94 29.18 0.06 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.776 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.85 165.56 35.69 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 111.812 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -144.03 131.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.904 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.44 ' HB3' ' CE1' ' A' ' 20' ' ' PHE . 11.7 m -124.37 135.85 53.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 112.078 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.804 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 17.7 p -116.97 111.08 19.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.846 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.851 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -134.7 136.4 42.71 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 8' ' ' SER . 4.0 mt -108.47 95.26 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.377 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 5.0 m -76.82 -176.95 4.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.905 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.605 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.66 62.89 1.32 Allowed 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.33 17.91 7.43 Favored Glycine 0 C--N 1.351 1.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.414 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.548 ' CB ' ' CD2' ' A' ' 53' ' ' TYR . . . -138.5 -159.7 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.621 0.71 . . . . 0.0 111.857 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . . . -140.38 179.5 1.25 Allowed Pre-proline 0 C--N 1.339 0.132 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 88.3 Cg_endo -83.61 111.1 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.293 1.995 . . . . 0.0 112.791 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 111.71 15.76 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.728 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.11 161.82 26.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.564 2.176 . . . . 0.0 112.34 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.25 -52.11 0.4 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.016 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.44 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -145.68 30.49 1.09 Allowed 'General case' 0 C--N 1.352 0.701 0 O-C-N 122.01 -0.431 . . . . 0.0 111.663 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . -167.95 -139.07 2.6 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.301 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.67 -165.28 1.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.259 0.529 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 10.6 m -155.74 169.97 23.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 110.379 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -144.68 162.2 39.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.254 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.26 129.85 10.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.8 t-80 -161.14 114.75 1.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -35.48 -68.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.11 -154.56 0.52 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.628 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . . . -156.21 133.19 6.37 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 122.417 -0.177 . . . . 0.0 111.331 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 4.4 Cg_exo -74.44 -23.75 14.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.85 2.366 . . . . 0.0 112.659 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.804 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 5.4 p-90 -84.98 -38.3 19.44 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -45.96 -59.28 2.93 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.442 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -66.88 -36.08 81.49 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 21.0 tt0 -55.24 -17.34 4.35 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.477 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.36 -31.42 0.42 Allowed Glycine 0 C--N 1.369 2.376 0 C-N-CA 117.124 -2.465 . . . . 0.0 114.048 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.848 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -103.8 -115.44 0.22 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.258 0.551 . . . . 0.0 112.305 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.1 p 175.53 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.651 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -151.37 -166.92 2.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.81 ' CE3' ' HB2' ' A' ' 58' ' ' CYS . 3.9 t90 -154.73 -146.09 0.18 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.321 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 1.2 t 153.07 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 117.877 0.308 . . . . 0.0 111.294 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.432 ' HD2' ' CD1' ' A' ' 50' ' ' TRP . 7.2 Cg_exo -75.38 92.22 1.02 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.742 2.295 . . . . 0.0 115.34 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.631 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 41.3 t80 -128.01 129.99 47.6 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -36.23 -70.0 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.409 ' CG2' ' HB1' ' A' ' 25' ' ' ALA . 1.6 t -73.31 -19.32 61.06 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.631 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.09 -168.33 25.97 Favored Glycine 0 C--N 1.362 1.974 0 C-N-CA 118.348 -1.882 . . . . 0.0 113.416 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.66 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.1 tt0 -103.44 136.6 42.89 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 119.373 1.586 . . . . 0.0 108.49 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.81 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 56.0 m -123.92 -172.32 2.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.901 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.574 ' HA ' ' CB ' ' A' ' 50' ' ' TRP . 39.6 ptt85 -166.03 111.45 0.85 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.0 -0.438 . . . . 0.0 110.752 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.851 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 164.0 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.202 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.848 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 6.4 t -144.37 -173.87 4.15 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.436 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 1.8 m -143.78 153.09 42.04 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 122.916 0.486 . . . . 0.0 109.96 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.527 HG21 HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -166.7 163.39 10.98 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.244 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 18.0 Cg_exo -66.07 -161.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.595 2.196 . . . . 0.0 111.439 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.492 ' CE2' ' HA ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -75.54 -144.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.439 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 15.8 t -82.41 -27.15 8.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.745 0.307 . . . . 0.0 111.098 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.923 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 t -58.63 150.94 21.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.728 0.299 . . . . 0.0 110.876 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.85 -41.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.427 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -170.73 -62.81 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.999 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 4' ' ' THR . 38.2 Cg_endo -66.92 64.68 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.482 2.121 . . . . 0.0 112.48 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -149.16 140.39 23.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.491 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -169.33 157.56 7.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 48.2 t -104.21 152.4 22.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.3 0.572 . . . . 0.0 112.162 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -129.07 137.09 51.06 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.542 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.4 117.35 29.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.726 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 27' ' ' PRO . 74.2 m -100.36 141.36 33.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -128.19 130.12 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.59 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -142.02 150.01 54.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.27 5.54 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.377 2.051 . . . . 0.0 113.097 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.5 m-20 -126.58 -17.34 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.502 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -165.71 172.03 12.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.201 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.435 ' CG2' ' HB3' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -134.07 119.28 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.041 178.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.0 m -121.85 149.16 43.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.881 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 12.3 p -132.52 124.41 28.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.839 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.845 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -141.16 138.75 33.65 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.661 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 6.7 mt -101.1 125.59 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.452 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 7.8 m -145.72 -172.59 3.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 118.291 -1.364 . . . . 0.0 114.289 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.61 63.53 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 150.95 -36.44 0.89 Allowed Glycine 0 C--N 1.348 1.212 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.442 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.46 ' HB1' ' HB ' ' A' ' 55' ' ' THR . . . 175.36 -161.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . 179.82 -57.71 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 56.4 Cg_endo -101.49 111.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.775 2.316 . . . . 0.0 114.28 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.06 112.24 28.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -39.09 113.22 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.961 2.44 . . . . 0.0 113.001 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -142.63 -49.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.328 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.67 34.22 0.45 Allowed 'General case' 0 C--N 1.353 0.76 0 CA-C-N 118.443 0.565 . . . . 0.0 112.168 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -173.49 46.26 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.608 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.86 -165.15 1.47 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.671 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.9 m -154.08 179.32 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 163.94 22.44 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.25 136.8 32.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.894 2.396 . . . . 0.0 112.631 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 t-160 -171.3 101.83 0.4 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.064 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' SER . 47.5 Cg_exo -33.33 -65.8 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.165 2.577 . . . . 0.0 113.29 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 51.8 p -151.3 -157.43 0.81 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.301 0.376 . . . . 0.0 110.397 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.5 173.6 3.5 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.763 0.316 . . . . 0.0 111.456 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -81.45 -48.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.893 2.395 . . . . 0.0 112.701 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.881 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 19.2 p-90 -71.87 -41.14 68.42 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.02 -56.65 3.23 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -78.37 -33.14 49.15 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.204 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 1.4 tp10 -41.15 -37.02 0.82 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 119.06 -0.495 . . . . 0.0 112.134 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.42 10.67 0.85 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 118.106 -1.997 . . . . 0.0 113.875 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.794 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -108.49 75.9 1.0 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 117.504 0.652 . . . . 0.0 111.416 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.579 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -23.83 -82.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.047 178.108 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 175.09 -132.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.541 ' O ' ' O ' ' A' ' 49' ' ' GLU . 5.4 m95 -0.05 132.54 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -162.94 136.56 4.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 112.921 -1.945 . . . . 0.0 108.099 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.76 121.5 2.51 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.144 1.896 . . . . 0.0 114.303 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.567 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 53.4 t80 -118.69 121.88 41.18 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.6 m -39.51 -47.47 1.88 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.102 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.46 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 72.5 m -77.82 -29.43 50.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.339 0.518 . . . . 0.0 112.271 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.06 175.67 37.7 Favored Glycine 0 C--N 1.359 1.843 0 C-N-CA 118.787 -1.673 . . . . 0.0 113.471 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.1 tt0 -87.87 112.25 22.3 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.114 0.957 . . . . 0.0 109.77 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 1.6 m -99.83 -171.64 2.09 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.661 ' HG2' ' O ' ' A' ' 21' ' ' ILE . 11.3 ptt180 172.08 101.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.845 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 170.63 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.794 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 14.6 t -141.25 -176.8 4.84 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.486 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 1.3 m -148.67 153.08 37.77 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 123.422 0.689 . . . . 0.0 109.188 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.52 HD12 HG21 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -172.11 164.75 4.11 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 111.796 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.502 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 71.7 Cg_endo -97.64 153.93 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.786 2.99 . . . . 0.0 112.086 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.45 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -136.06 -147.94 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.45 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 9.7 p -93.87 155.04 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.914 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 t 60.59 179.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.752 0.311 . . . . 0.0 110.999 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -176.62 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.96 154.94 46.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.69 60.76 4.4 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.566 2.177 . . . . 0.0 112.49 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -109.54 159.88 16.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -142.65 140.18 31.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 37' ' ' HIS . 3.4 t -119.43 154.53 33.56 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.865 0.84 . . . . 0.0 112.438 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 1.1 p90 -143.43 140.53 30.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.65 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.17 137.13 37.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.887 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 91.9 m -117.45 150.76 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 111.771 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.583 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 22.8 t80 -113.44 124.9 53.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.803 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.52 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -134.72 144.6 51.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.74 5.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.693 2.262 . . . . 0.0 113.548 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -116.03 -34.72 4.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.442 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.459 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -176.01 -169.18 0.31 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.81 115.64 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -102.8 132.72 48.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.765 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 5.4 t -112.57 148.65 34.08 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.942 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.629 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.425 0.631 . . . . 0.0 111.714 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.13 122.08 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.259 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 37.8 m -110.11 -175.13 2.65 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -155.7 51.49 0.56 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.81 13.71 5.98 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.295 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -169.85 -160.03 0.23 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.904 0.852 . . . . 0.0 112.058 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.405 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . . . -174.55 123.66 0.38 Allowed Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 7.8 Cg_endo -50.13 143.68 24.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.411 2.074 . . . . 0.0 112.01 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -71.64 114.65 30.18 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.62 169.79 2.99 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.609 2.206 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -170.77 -45.4 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.719 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.43 30.54 1.28 Allowed 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.267 0.485 . . . . 0.0 112.287 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 150.24 -146.14 14.94 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.863 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -128.49 -169.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.897 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 m -156.51 173.69 16.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.396 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -151.62 164.41 20.36 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.491 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.96 145.64 56.57 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.575 2.183 . . . . 0.0 112.473 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' SER . 15.6 t-80 -172.58 111.83 0.36 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 37' ' ' HIS . 52.7 Cg_exo -29.59 -72.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.05 2.5 . . . . 0.0 112.85 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -174.11 -163.15 0.15 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.358 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB3' ' CD1' ' A' ' 42' ' ' TRP . . . -164.49 161.64 15.68 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 74.8 Cg_endo -77.72 -14.15 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.475 2.117 . . . . 0.0 112.452 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.755 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 24.0 p-90 -94.68 -51.19 4.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 119.477 -0.297 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.606 ' O ' HG23 ' A' ' 61' ' ' THR . 0.0 OUTLIER -48.44 -49.25 36.09 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.129 178.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.31 -41.67 72.98 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.999 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.486 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -38.94 -34.95 0.17 Allowed 'General case' 0 C--N 1.361 1.092 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.749 178.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.63 63.46 0.29 Allowed Glycine 0 C--N 1.357 1.739 0 C-N-CA 119.911 -1.137 . . . . 0.0 111.095 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.754 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -78.87 1.11 24.6 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.632 ' HB ' ' O ' ' A' ' 60' ' ' THR . 55.8 t -163.11 -90.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -170.99 150.37 3.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.723 0.296 . . . . 0.0 111.58 -178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.476 ' CZ2' ' HG2' ' A' ' 57' ' ' GLN . 60.5 t-105 -73.63 152.6 40.46 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.472 ' CG2' ' HD2' ' A' ' 52' ' ' PRO . 7.8 p -160.42 145.17 10.81 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.495 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 51' ' ' VAL . 69.7 Cg_endo -93.74 122.13 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.857 2.372 . . . . 0.0 113.584 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.542 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 1.9 t80 -98.7 139.44 34.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -42.86 -62.66 0.95 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.6 -25.55 64.92 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -167.77 176.6 42.39 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.228 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -100.3 129.4 46.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.107 1.454 . . . . 0.0 111.262 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.3 t -142.45 -177.68 5.39 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -162.34 140.9 8.97 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 122.162 -0.336 . . . . 0.0 110.413 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.632 ' O ' ' HB ' ' A' ' 48' ' ' VAL . 2.7 t -89.36 158.71 17.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.765 ' OG1' ' HB3' ' A' ' 19' ' ' CYS . 1.5 p -152.05 173.28 15.08 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -177.1 153.05 0.94 Allowed 'General case' 0 C--N 1.353 0.757 0 CA-C-N 120.075 1.307 . . . . 0.0 111.953 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.456 HG22 ' CE3' ' A' ' 42' ' ' TRP . 5.0 pt -161.82 166.5 14.41 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.19 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 50.8 Cg_exo -53.91 171.47 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.118 1.879 . . . . 0.0 111.575 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -71.66 -143.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.46 178.64 4.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -146.08 -60.02 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -84.33 170.2 13.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.97 59.83 7.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.71 46.95 2.17 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.824 2.349 . . . . 0.0 112.826 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -123.63 144.48 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.651 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.0 140.33 17.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.876 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 22.7 t -114.19 149.48 35.69 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -128.29 145.22 51.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.55 130.34 50.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 99.4 m -106.06 145.95 30.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.3 m-85 -126.25 136.79 53.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.194 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -131.14 159.39 71.78 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.656 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.62 -10.79 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.776 2.317 . . . . 0.0 113.199 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.533 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 2.0 t70 -162.61 31.24 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.466 -0.494 . . . . 0.0 112.014 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -163.1 171.29 16.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.542 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' CG2' HG13 ' A' ' 63' ' ' ILE . 16.2 m -146.15 139.39 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.015 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.18 134.38 44.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.714 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.725 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 47.4 t -119.28 136.74 54.09 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.864 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.2 OUTLIER -144.13 122.72 12.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HG2' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -110.7 99.61 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 76.4 m -106.62 -164.94 1.04 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.487 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.88 66.11 0.79 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.38 9.97 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.779 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -165.51 -160.65 0.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.378 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -175.88 129.79 0.39 Allowed Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 116.87 -0.15 . . . . 0.0 110.647 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD2' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -43.43 140.9 3.75 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.737 2.291 . . . . 0.0 112.203 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.18 118.1 70.78 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.63 -173.91 1.93 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.597 2.198 . . . . 0.0 111.94 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.23 -51.87 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -93.31 31.95 1.41 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 118.237 0.471 . . . . 0.0 112.086 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.05 -166.27 39.1 Favored Glycine 0 N--CA 1.462 0.368 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.723 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 6.7 pm0 -120.53 -169.59 1.84 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 33' ' ' GLU . 3.1 m -155.95 176.82 12.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.926 0.393 . . . . 0.0 111.198 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.454 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 51.4 p-10 -162.44 159.05 20.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.817 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 35' ' ' ASN . 18.1 Cg_endo -59.47 151.83 65.96 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.795 2.33 . . . . 0.0 112.941 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 8' ' ' SER . 29.8 t-80 179.24 110.24 0.18 Allowed Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.742 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 8' ' ' SER . 35.1 Cg_exo -27.91 -75.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.339 2.692 . . . . 0.0 113.728 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.455 ' CG2' HG12 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -163.6 -169.69 2.0 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 42' ' ' TRP . . . -160.27 146.46 11.76 Favored Pre-proline 0 C--N 1.345 0.406 0 CA-C-N 118.382 0.537 . . . . 0.0 111.25 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.597 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 58.6 Cg_endo -71.64 -6.17 18.59 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.634 2.222 . . . . 0.0 112.866 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.725 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 61.6 p-90 -96.65 -35.77 10.93 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.42 ' CB ' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -55.54 -43.12 75.49 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 -41.05 24.52 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.597 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.1 tt0 -59.99 -9.4 3.04 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.618 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.16 -31.34 2.46 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 117.827 -2.13 . . . . 0.0 111.639 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.805 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -129.8 -109.78 0.27 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.385 0.612 . . . . 0.0 111.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER 176.56 -85.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.826 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' CG ' ' HB2' ' A' ' 59' ' ' ARG . 51.2 mt-10 -162.14 158.9 25.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.796 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -155.37 69.29 0.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.79 1.281 . . . . 0.0 111.884 178.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.596 ' CG1' ' HG2' ' A' ' 57' ' ' GLN . 10.7 m -46.31 -39.37 13.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 112.875 -1.966 . . . . 0.0 113.885 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 37.0 Cg_endo -64.12 74.22 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.313 1.342 . . . . 0.0 114.343 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.592 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 65.0 t80 -115.82 129.12 56.31 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 m -41.94 -58.85 1.91 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.448 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 63.2 m -65.37 -30.64 71.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.204 0.457 . . . . 0.0 112.161 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.592 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -176.98 -161.97 26.62 Favored Glycine 0 CA--C 1.545 1.924 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.596 ' HG2' ' CG1' ' A' ' 51' ' ' VAL . 8.4 tt0 -88.36 130.03 35.25 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 119.793 1.796 . . . . 0.0 108.748 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.796 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 1.2 m -121.5 167.62 12.64 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.053 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.761 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -163.96 100.79 0.88 Allowed 'General case' 0 C--N 1.37 1.47 0 CA-C-N 118.784 0.72 . . . . 0.0 111.476 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.864 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 167.38 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.805 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 7.5 t -161.66 -163.29 0.96 Allowed 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.407 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -135.5 167.07 21.76 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.117 0.567 . . . . 0.0 110.23 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.474 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 8.0 pt -158.68 157.0 28.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.033 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 16' ' ' GLN . 30.0 Cg_endo -63.15 -16.89 57.3 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.424 2.083 . . . . 0.0 113.302 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.533 ' CE2' ' HA ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER 165.64 -140.49 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.45 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.451 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 11.9 m -105.63 -37.52 4.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 120.823 0.344 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.909 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.2 p -117.68 39.55 3.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -103.43 73.74 1.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -54.14 1.34 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.03 -178.5 4.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.531 2.154 . . . . 0.0 112.506 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -102.27 140.16 36.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.728 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.85 154.33 27.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.328 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.539 ' HB2' ' CG1' ' A' ' 21' ' ' ILE . 2.4 t -113.11 159.67 18.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.305 0.574 . . . . 0.0 112.131 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -134.1 133.95 41.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.274 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.407 HD23 ' CE2' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -95.61 117.52 30.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.231 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.9 m -102.0 138.25 39.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.776 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -123.94 144.22 49.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.41 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.89 162.36 56.3 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.604 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.11 -12.92 1.62 Allowed 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.638 2.225 . . . . 0.0 112.879 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -160.67 32.22 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.617 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 64' ' ' PRO . 16.2 mt-30 -158.49 156.14 29.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.313 0.578 . . . . 0.0 112.349 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -141.28 106.45 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.064 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 20' ' ' PHE . 12.9 m -113.43 118.78 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.806 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.679 ' O ' ' HB ' ' A' ' 60' ' ' THR . 0.9 OUTLIER -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.904 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -143.6 139.36 29.63 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.568 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 3.4 mt -110.91 136.16 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.2 m -146.27 -174.92 4.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.058 -1.057 . . . . 0.0 113.367 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -146.07 63.59 1.23 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.17 -33.57 0.6 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.458 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' CB ' ' HB ' ' A' ' 55' ' ' THR . . . -177.12 -154.26 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.006 0.403 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -156.92 157.78 30.91 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-O 120.524 0.202 . . . . 0.0 110.485 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 37.4 Cg_exo -57.52 151.41 54.19 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.4 2.067 . . . . 0.0 112.089 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.38 109.22 18.02 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.02 178.57 5.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.454 2.102 . . . . 0.0 112.215 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.9 t -160.4 -55.33 0.05 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.356 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -94.25 32.53 1.51 Allowed 'General case' 0 C--N 1.352 0.692 0 O-C-N 122.022 -0.424 . . . . 0.0 111.714 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.81 -169.54 41.98 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.577 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -128.69 -164.43 1.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.159 -0.217 . . . . 0.0 110.532 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.9 m -154.46 178.07 10.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.036 0.446 . . . . 0.0 111.189 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -153.72 161.98 27.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.21 135.99 33.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.544 2.163 . . . . 0.0 112.581 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -165.38 106.84 0.77 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.294 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 8' ' ' SER . 68.1 Cg_exo -37.63 -70.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.96 2.44 . . . . 0.0 113.133 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.8 p -154.42 -158.92 0.9 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.349 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 179.53 148.84 0.46 Allowed Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 111.585 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 55.9 Cg_endo -69.7 -24.47 29.93 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.655 2.237 . . . . 0.0 111.631 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 45' ' ' GLU . 90.4 t90 -73.34 -45.74 53.44 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.961 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -44.87 -49.05 11.13 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.18 -33.08 24.27 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 2.5 tt0 -48.93 -20.62 0.53 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.319 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.68 -35.25 0.86 Allowed Glycine 0 C--N 1.363 2.029 0 C-N-CA 118.381 -1.866 . . . . 0.0 112.085 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.817 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -141.87 100.16 3.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.991 0.395 . . . . 0.0 111.217 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -24.4 -90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 123.745 0.653 . . . . 0.0 110.439 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 2.2 mt-10 172.24 130.73 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.675 ' HA ' ' CE3' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 141.96 136.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 112.927 -1.942 . . . . 0.0 111.72 176.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.415 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 7.3 p 175.45 83.9 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.911 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 51' ' ' VAL . 1.6 Cg_endo -42.88 140.63 2.94 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.284 2.656 . . . . 0.0 113.607 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.65 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 47.8 t80 -133.46 132.57 41.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.518 -0.764 . . . . 0.0 108.953 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -50.92 5.97 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.423 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 19.5 m -73.72 -30.94 63.12 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.959 -0.463 . . . . 0.0 112.031 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -163.58 173.69 39.71 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.358 -1.401 . . . . 0.0 112.399 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ARG . 4.6 tt0 -87.03 112.63 22.04 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 118.904 1.352 . . . . 0.0 110.005 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 1.5 m -97.42 -171.98 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.406 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.597 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 25.7 ptt180 173.66 102.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.941 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.904 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 172.72 -150.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.817 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 14.6 t -157.2 -170.71 3.35 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.421 ' HB2' ' HB3' ' A' ' 18' ' ' CYS . 19.6 t -165.77 156.7 13.56 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.45 HG22 HD11 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -152.65 166.83 14.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.696 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' ' CG ' ' A' ' 65' ' ' TYR . 9.3 Cg_endo -51.88 -24.35 18.58 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.261 1.974 . . . . 0.0 112.282 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER 175.67 -144.99 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.182 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.481 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 11.0 p -117.75 113.45 42.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.832 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t 61.02 84.71 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.59 117.19 22.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.82 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.6 102.63 39.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -51.95 109.28 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.434 2.089 . . . . 0.0 112.351 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -119.06 160.74 21.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.796 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -144.37 141.19 29.53 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 35.2 t -113.29 143.99 43.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.488 0.661 . . . . 0.0 112.704 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 134.77 48.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.108 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.67 119.07 34.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.023 0.439 . . . . 0.0 110.606 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.4 m -100.81 128.74 46.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.331 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -113.9 137.61 51.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.496 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.4 OUTLIER -138.64 145.82 47.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.32 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.41 -0.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.705 2.27 . . . . 0.0 113.663 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.8 t0 -122.2 -30.83 3.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -158.8 -175.16 5.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.187 0.518 . . . . 0.0 111.779 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.435 ' CG2' HG13 ' A' ' 63' ' ' ILE . 8.3 m -141.24 126.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.909 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.1 m -118.06 141.13 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.632 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.757 ' O ' ' HB ' ' A' ' 60' ' ' THR . 41.8 t -123.97 131.61 53.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.866 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -137.94 136.31 36.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mt -103.43 103.93 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.9 m -95.13 -174.2 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.757 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -150.47 60.51 0.95 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.71 26.22 8.16 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.011 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB1' ' N ' ' A' ' 56' ' ' GLY . . . -151.2 -161.26 1.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.04 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -178.04 114.53 0.23 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-O 120.449 0.166 . . . . 0.0 110.682 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 70.1 Cg_exo -49.78 142.93 24.24 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.467 2.111 . . . . 0.0 112.414 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.87 112.49 22.84 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.42 173.89 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.617 2.211 . . . . 0.0 112.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.4 m -155.55 -52.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.638 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -124.39 33.47 5.25 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 118.288 0.494 . . . . 0.0 112.106 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.96 -169.61 41.56 Favored Glycine 0 N--CA 1.462 0.432 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.792 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.29 -162.77 0.99 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -154.83 164.12 39.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.344 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -140.84 167.66 16.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.666 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.22 136.56 29.46 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.587 2.191 . . . . 0.0 112.691 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' A' ' 8' ' ' SER . 20.9 t-160 -165.06 93.91 0.9 Allowed Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -30.93 -70.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.359 2.706 . . . . 0.0 113.627 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.25 -159.19 0.94 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.815 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -176.63 169.15 1.25 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-O 120.699 0.285 . . . . 0.0 111.373 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 93.8 Cg_endo -83.66 -35.14 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.015 2.477 . . . . 0.0 112.848 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' A' ' 19' ' ' CYS . 17.2 p-90 -88.05 -42.57 12.32 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.555 ' SG ' HG22 ' A' ' 60' ' ' THR . 0.5 OUTLIER -42.62 -58.44 2.29 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.447 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -70.59 -36.63 73.65 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.219 178.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 5.3 tt0 -42.96 -32.35 0.63 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.105 0.411 . . . . 0.0 111.492 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -139.94 13.38 3.11 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 118.868 -1.634 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.628 ' HA ' ' HA ' ' A' ' 60' ' ' THR . . . -66.14 66.53 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 111.896 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.41 ' N ' ' O ' ' A' ' 46' ' ' GLY . 21.5 t -141.8 53.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.96 23.44 0.66 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.262 0.937 . . . . 0.0 112.845 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.761 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -148.85 -173.53 4.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 2.5 t 153.08 -44.8 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.621 0.769 . . . . 0.0 110.022 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 4.7 Cg_endo -87.82 91.18 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.844 2.362 . . . . 0.0 114.796 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.538 ' CD1' ' CZ2' ' A' ' 50' ' ' TRP . 10.0 t80 -121.88 128.85 52.05 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 m -40.3 -55.99 2.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.3 m -66.98 -29.17 68.94 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -177.38 -173.07 42.56 Favored Glycine 0 C--N 1.359 1.822 0 C-N-CA 119.272 -1.442 . . . . 0.0 112.324 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.641 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 1.7 tm0? -100.07 125.9 46.21 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 119.637 1.719 . . . . 0.0 109.488 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.761 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 50.1 t -136.19 -178.78 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.745 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.3 OUTLIER 174.68 137.71 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.741 1.155 . . . . 0.0 111.594 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.866 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 179.44 -147.08 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.0 t -151.12 -171.13 3.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.604 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 69.7 m -146.23 173.08 12.54 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.458 HD12 ' CE3' ' A' ' 42' ' ' TRP . 6.3 pt -158.07 156.54 28.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.782 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 19.4 Cg_endo -58.24 -19.42 42.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.406 2.071 . . . . 0.0 113.012 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.464 ' HB3' ' H ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER 166.24 -141.12 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.945 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.464 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 12.2 p -100.44 -31.24 3.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.863 0.363 . . . . 0.0 110.961 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 61.01 90.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 0.0 110.944 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -118.25 -55.75 2.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.623 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 7.7 t -82.54 -31.61 0.54 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.185 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 4' ' ' THR . 38.7 Cg_exo -60.79 119.59 6.84 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.132 1.888 . . . . 0.0 112.564 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -124.86 154.46 41.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.344 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.43 141.06 21.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.206 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.5 t -118.11 144.33 45.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.85 133.12 54.88 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.348 177.718 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.53 123.08 34.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 110.504 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -99.2 138.86 35.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.213 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -118.45 129.79 55.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.064 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.9 OUTLIER -138.34 146.79 52.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.857 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 4.48 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.45 2.1 . . . . 0.0 112.698 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -115.97 -32.65 5.34 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.525 0.202 . . . . 0.0 111.216 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -172.92 -170.58 0.67 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 0.0 111.265 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.458 ' CG2' ' CE1' ' A' ' 65' ' ' TYR . 1.8 t -133.36 124.7 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.29 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.5 m -124.54 141.35 52.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 111.747 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.632 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 3.1 p -117.03 147.11 42.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.861 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -148.65 128.02 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 8' ' ' SER . 1.1 mp -97.6 106.86 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.344 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 2.2 m -84.86 -178.03 6.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.011 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.12 55.89 1.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.27 25.33 6.74 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.247 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -155.53 -160.59 1.05 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.729 0.764 . . . . 0.0 112.043 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.88 94.66 0.19 Allowed Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.326 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 72.0 Cg_exo -34.7 141.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.238 2.625 . . . . 0.0 113.14 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -80.8 112.76 34.71 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.17 169.05 1.64 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.531 2.154 . . . . 0.0 112.324 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -153.66 -57.86 0.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.207 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.65 29.52 7.34 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.01 -0.431 . . . . 0.0 111.426 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.17 -169.65 42.3 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.514 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.61 -161.43 0.89 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.225 -0.19 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.13 161.18 39.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.153 0.501 . . . . 0.0 111.391 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.4 173.59 4.36 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.75 136.26 20.71 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.066 2.511 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.4 t-80 -173.84 93.29 0.34 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.882 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -29.15 -71.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.608 2.872 . . . . 0.0 113.846 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.413 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 13.8 p -151.2 -155.79 0.66 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.136 0.272 . . . . 0.0 110.762 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 179.93 164.84 0.84 Allowed Pre-proline 0 N--CA 1.473 0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 111.5 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.15 -28.51 10.73 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.17 2.58 . . . . 0.0 112.193 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.632 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 20.8 p-90 -86.71 -39.87 15.61 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.6 -58.42 2.66 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -33.07 65.25 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.229 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 2.8 tt0 -39.6 -42.82 1.23 Allowed 'General case' 0 C--N 1.361 1.089 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.081 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -146.1 16.42 1.72 Allowed Glycine 0 C--N 1.357 1.723 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.456 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.68 ' CA ' ' OG1' ' A' ' 61' ' ' THR . . . -51.92 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.42 0.629 . . . . 0.0 112.562 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 46' ' ' GLY . 7.7 p -65.82 49.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.169 -1.378 . . . . 0.0 107.936 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.567 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -26.57 116.81 0.07 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -121.94 73.85 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.358 177.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.78 ' HA ' ' H ' ' A' ' 58' ' ' CYS . 14.0 m -57.32 -38.53 69.04 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.71 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.655 ' HD2' ' N ' ' A' ' 51' ' ' VAL . 9.7 Cg_endo -51.97 77.53 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.594 1.53 . . . . 0.0 113.587 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.668 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 62.3 t80 -121.7 132.96 54.92 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.5 m -45.26 -58.97 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.5 m -61.91 -30.64 71.02 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 122.014 -0.429 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.668 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -179.01 -165.88 34.08 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.916 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.78 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.7 mt-30 -109.98 127.7 54.95 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 120.179 1.99 . . . . 0.0 110.045 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.78 ' H ' ' HA ' ' A' ' 51' ' ' VAL . 14.0 m -131.93 -171.26 2.58 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 4.9 ttp180 -140.06 135.03 32.19 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.488 ' HB ' ' CZ2' ' A' ' 50' ' ' TRP . 8.8 t -119.38 135.31 54.79 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.68 ' OG1' ' CA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -135.21 165.96 24.2 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 176.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.539 ' N ' HG21 ' A' ' 61' ' ' THR . 75.7 m -156.74 153.44 28.41 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.894 1.225 . . . . 0.0 110.56 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.419 HG12 ' CZ3' ' A' ' 42' ' ' TRP . 12.9 pt -148.98 136.72 11.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.53 134.28 2.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.925 2.417 . . . . 0.0 112.277 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE1' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -141.83 -148.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.165 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 21.2 t -149.97 105.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.82 0.343 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.409 ' CB ' ' CE2' ' A' ' 65' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.884 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -84.47 136.72 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.15 97.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 m -159.27 58.44 1.22 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.83 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.11 135.86 25.92 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.642 2.228 . . . . 0.0 112.37 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -129.44 148.43 51.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -130.03 140.26 50.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.3 m -123.67 155.41 37.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.523 0.678 . . . . 0.0 112.211 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.483 ' CZ ' ' HD2' ' A' ' 27' ' ' PRO . 0.8 OUTLIER -136.58 129.38 30.77 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.866 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.07 124.82 37.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.403 ' HB2' ' HE1' ' A' ' 20' ' ' PHE . 3.8 m -105.58 153.04 22.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.761 0.791 . . . . 0.0 112.86 -177.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.423 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 21.9 t80 -118.68 114.56 22.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.521 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.525 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -120.11 144.76 38.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.35 6.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 113.338 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.4 m-20 -118.42 -33.05 4.45 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.462 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.507 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -170.25 -165.16 0.45 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.93 122.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -118.36 148.36 42.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.583 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 39.3 t -128.28 143.56 51.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -138.96 138.5 37.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 112.188 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.432 ' HB ' ' HD2' ' A' ' 59' ' ' ARG . 3.3 mt -112.39 140.63 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.759 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 13.1 m -143.64 -173.62 4.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 119.336 -0.946 . . . . 0.0 113.165 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -149.59 60.58 1.01 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 152.16 -29.09 0.89 Allowed Glycine 0 C--N 1.35 1.316 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.441 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -176.14 -156.05 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.68 0.74 . . . . 0.0 111.907 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -150.09 154.52 36.78 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-O 120.561 0.22 . . . . 0.0 110.714 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.483 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 40.3 Cg_endo -66.86 159.23 52.59 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.373 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -74.48 111.79 14.46 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 161.91 38.51 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.573 2.182 . . . . 0.0 112.215 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 t -164.9 -49.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.409 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.8 pm0 -92.73 32.59 1.22 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.123 0.42 . . . . 0.0 111.784 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 163.44 169.22 26.6 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.461 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -101.82 -164.27 1.08 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.59 161.04 35.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 110.853 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -140.98 147.5 48.17 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.49 129.3 33.97 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.431 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 39' ' ' THR . 6.5 t-160 -159.55 102.31 1.5 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -33.19 -70.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.18 2.586 . . . . 0.0 113.36 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.42 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -147.55 -157.77 0.84 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.655 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -175.54 151.82 1.3 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.687 0.28 . . . . 0.0 111.116 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.58 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 73.6 Cg_endo -75.68 -26.57 9.74 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.589 2.193 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.729 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 40.9 p-90 -90.69 -40.38 11.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.418 ' HA ' HG23 ' A' ' 61' ' ' THR . 0.8 OUTLIER -44.06 -59.79 2.16 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -33.93 61.06 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.225 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.729 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -47.86 -30.0 3.74 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 119.003 0.82 . . . . 0.0 111.667 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.72 -2.55 4.8 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 118.527 -1.796 . . . . 0.0 113.758 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.523 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -83.98 62.04 6.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.618 0.709 . . . . 0.0 110.643 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.11 27.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.759 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.99 142.92 38.33 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -105.18 158.36 16.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.416 . . . . 0.0 111.334 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.69 104.05 7.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.211 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 111.3 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.546 2.164 . . . . 0.0 113.275 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.603 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 5.1 t80 -101.57 129.29 47.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.24 -45.6 5.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.251 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.5 m -78.14 -32.73 50.48 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.075 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.57 171.74 40.12 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.032 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ARG . 20.8 tt0 -83.57 122.96 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.499 1.149 . . . . 0.0 109.688 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -112.46 -174.82 2.54 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.561 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -161.62 132.98 5.37 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.4 m -116.86 139.31 50.77 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.523 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -148.35 167.25 25.72 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.074 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.441 ' N ' HG21 ' A' ' 61' ' ' THR . 81.0 m -156.7 158.35 36.78 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.501 1.046 . . . . 0.0 110.852 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.47 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 9.2 pt -155.47 157.25 31.57 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 9.5 Cg_endo -51.85 167.53 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.575 2.183 . . . . 0.0 112.092 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.44 ' HD1' ' HA ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -77.45 -142.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.34 95.33 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.991 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p -167.47 130.94 1.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -135.62 -178.07 4.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 p -70.87 114.83 30.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.7 -164.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.392 2.061 . . . . 0.0 112.301 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -105.33 149.62 25.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 147.56 45.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 33.8 t -130.83 155.87 45.97 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.515 0.674 . . . . 0.0 111.907 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -139.28 137.65 36.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.07 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -95.26 131.61 41.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.698 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 84.3 m -113.93 154.16 28.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.557 0.694 . . . . 0.0 111.955 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.681 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 16.3 t80 -125.53 130.68 52.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.506 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.549 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -133.81 139.9 34.89 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 18.4 Cg_endo -59.26 7.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.445 2.096 . . . . 0.0 112.888 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.549 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.0 OUTLIER -119.79 -32.65 4.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.441 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 11.0 mt-30 -164.47 -168.86 1.62 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.306 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.14 145.92 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.316 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -151.52 139.95 20.5 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.524 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 49.4 t -120.41 150.86 40.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.583 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -146.55 133.55 20.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.533 0.682 . . . . 0.0 112.748 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' CD1' ' N ' ' A' ' 21' ' ' ILE . 3.1 mp -105.41 139.26 27.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.29 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.6 m -139.88 -170.75 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 119.201 -1.0 . . . . 0.0 113.353 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.68 58.66 0.81 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.03 18.08 9.07 Favored Glycine 0 C--N 1.349 1.299 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.359 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -157.09 -166.63 2.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.707 0.754 . . . . 0.0 112.051 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.432 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . 179.81 129.19 0.24 Allowed Pre-proline 0 N--CA 1.469 0.483 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.428 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 50.3 Cg_exo -53.89 140.58 68.34 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.134 1.89 . . . . 0.0 112.051 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.1 111.83 7.52 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.26 162.14 17.56 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.699 2.266 . . . . 0.0 112.331 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -174.83 -39.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.516 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.1 pm0 -91.08 32.6 1.0 Allowed 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.932 -0.48 . . . . 0.0 111.929 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 158.53 -163.79 33.21 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.683 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -121.81 -169.8 1.94 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 117.179 0.489 . . . . 0.0 110.616 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 4.3 m -156.98 161.47 39.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -135.35 150.82 73.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.27 140.48 81.61 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.594 2.196 . . . . 0.0 112.363 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.7 t-160 -168.62 90.07 0.63 Allowed Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -73.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.48 2.787 . . . . 0.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.6 p -157.28 -163.95 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 168.92 158.87 0.17 Allowed Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 120.701 0.286 . . . . 0.0 110.93 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 71.8 Cg_endo -76.73 -3.44 13.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.47 2.113 . . . . 0.0 112.119 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.524 ' HZ3' ' HB3' ' A' ' 19' ' ' CYS . 66.1 t90 -93.75 -55.23 3.32 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.275 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 33.6 m -54.12 -32.54 55.34 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.59 -41.83 16.04 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.915 -0.49 . . . . 0.0 109.734 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.1 tt0 -51.32 -24.53 4.74 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.549 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.47 -16.82 4.99 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 118.38 -1.867 . . . . 0.0 113.316 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB2' ' HD3' ' A' ' 59' ' ' ARG . . . -106.84 67.88 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.381 0.59 . . . . 0.0 111.091 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.2 p -90.37 30.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.351 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -130.74 142.72 50.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.657 0.265 . . . . 0.0 110.403 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.412 ' CZ2' ' NH2' ' A' ' 59' ' ' ARG . 33.6 m95 -94.96 149.64 21.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.56 107.85 7.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.131 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.48 120.31 7.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 113.762 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 1.2 t80 -107.45 135.04 49.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.97 -54.66 6.29 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -69.48 -29.15 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -174.35 -178.23 44.09 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 119.208 -1.472 . . . . 0.0 112.291 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ARG . 2.3 tt0 -81.91 142.42 32.49 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.334 1.567 . . . . 0.0 110.16 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -136.03 -179.2 5.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.309 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.583 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 25.7 ttm180 -161.72 122.59 2.7 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 20' ' ' PHE . 3.3 t -108.17 144.86 35.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -147.89 158.26 43.95 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.12 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 91.6 m -155.41 162.09 40.85 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 120.045 1.293 . . . . 0.0 111.463 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.423 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 0.1 OUTLIER -158.93 166.11 17.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 30.4 Cg_exo -61.87 161.42 25.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.134 . . . . 0.0 112.463 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.5 ' HB3' ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.69 -140.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.062 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.5 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 9.0 p -110.2 -25.53 3.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.866 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 p -176.44 89.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -140.02 -70.06 0.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.437 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -91.25 -49.88 0.33 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.4 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 4' ' ' THR . 75.4 Cg_exo -50.97 136.47 44.21 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.46 2.107 . . . . 0.0 112.607 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -137.16 165.57 25.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.715 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.6 139.14 33.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.056 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 5.8 t -119.1 149.03 42.37 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -129.71 144.56 51.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.036 178.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 132.76 47.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.26 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 64.4 m -106.86 146.81 30.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.996 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -125.21 132.44 52.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.408 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.5 OUTLIER -118.26 157.16 49.77 Favored Pre-proline 0 CA--C 1.51 -0.559 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.128 179.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.92 -11.46 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.797 1.665 . . . . 0.0 110.975 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 13' ' ' GLN . 5.0 t0 -164.11 28.21 0.07 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.503 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.5 154.37 31.7 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.204 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.475 HG21 ' CE1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -130.0 128.8 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.519 179.078 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -133.43 138.14 46.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.465 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 16.4 t -127.9 152.71 47.52 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.484 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -151.7 141.98 22.39 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 mp -112.15 122.97 67.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.184 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 11.4 m -116.43 -176.04 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.02 58.72 0.85 Allowed 'General case' 0 C--N 1.348 0.509 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 139.46 -13.74 3.22 Favored Glycine 0 C--N 1.348 1.21 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.184 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 55' ' ' THR . . . -174.38 -154.96 0.06 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.434 0.617 . . . . 0.0 111.682 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.408 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -158.54 138.41 8.68 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-O 120.661 0.267 . . . . 0.0 111.045 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 18.2 Cg_endo -59.64 159.6 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.661 2.241 . . . . 0.0 112.179 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.15 156.46 57.35 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.47 -179.99 5.34 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.656 2.238 . . . . 0.0 112.148 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -149.52 -52.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.27 33.3 3.61 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.583 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -162.71 30.94 Favored Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.438 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 7.1 pm0 -116.72 -171.86 2.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 33' ' ' GLU . 2.8 m -155.82 177.49 11.34 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.4 m120 -159.56 167.72 13.61 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 35' ' ' ASN . 49.6 Cg_endo -69.11 150.79 72.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.565 2.177 . . . . 0.0 112.809 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' SER . 16.5 t-80 -172.78 104.87 0.33 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' HIS . 35.8 Cg_exo -28.09 -81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -160.46 -160.29 0.76 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 174.61 148.72 0.24 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.04 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.87 -16.4 54.58 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.487 2.125 . . . . 0.0 111.989 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 91.1 t90 -92.46 -51.09 5.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 58.9 m -51.96 -34.97 44.55 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.246 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.03 -39.76 20.83 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.5 OUTLIER -50.98 -24.7 3.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.412 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.33 -6.1 5.85 Favored Glycine 0 C--N 1.363 2.06 0 C-N-CA 118.498 -1.811 . . . . 0.0 113.797 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 43' ' ' CYS . . . -85.64 52.32 2.43 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.641 0.72 . . . . 0.0 110.943 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.3 32.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.857 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 2.1 tt0 -128.96 127.36 41.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 110.207 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.419 ' CZ3' ' HD2' ' A' ' 59' ' ' ARG . 4.1 m95 -81.36 152.54 27.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.376 0.608 . . . . 0.0 111.748 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.53 99.41 3.37 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.907 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.43 98.78 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.429 2.086 . . . . 0.0 113.277 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -93.22 129.65 39.19 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.528 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -40.5 -36.05 0.52 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.054 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -102.19 -23.48 14.03 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.547 0.612 . . . . 0.0 112.6 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -163.23 169.2 38.26 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 118.784 -1.674 . . . . 0.0 113.501 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -98.42 137.38 37.2 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.841 0.82 . . . . 0.0 109.979 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 24.1 t -148.42 179.74 7.57 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.491 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -147.06 126.55 13.22 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 t -115.79 135.84 53.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 168.01 16.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.358 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.418 ' O ' HG23 ' A' ' 63' ' ' ILE . 94.4 m -154.45 169.35 23.97 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.201 0.909 . . . . 0.0 111.553 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.459 ' CD1' ' CZ2' ' A' ' 42' ' ' TRP . 11.2 pt -160.28 130.19 3.41 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.698 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.6 118.83 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.711 2.274 . . . . 0.0 112.549 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.475 ' CE1' HG21 ' A' ' 17' ' ' VAL . 40.2 m-85 -44.02 -28.31 0.46 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.277 0.56 . . . . 0.0 112.106 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 m -96.15 110.97 25.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.063 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.926 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.92 81.27 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -106.06 168.8 8.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 m 61.42 66.52 1.57 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.97 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.15 131.23 20.27 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.553 2.169 . . . . 0.0 112.211 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -121.56 139.79 53.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.035 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.11 141.62 38.11 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.636 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 5.6 t -115.46 154.52 29.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.777 0.799 . . . . 0.0 112.742 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.48 ' CE1' ' CB ' ' A' ' 26' ' ' ALA . 1.3 p90 -138.87 129.78 26.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.531 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.431 HD13 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -89.71 122.55 32.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.354 . . . . 0.0 110.217 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -108.2 133.28 52.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.225 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.7 m-85 -107.71 137.12 46.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.559 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.422 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -111.55 157.39 39.39 Favored Pre-proline 0 CA--C 1.51 -0.567 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.207 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.18 -8.81 2.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.784 1.656 . . . . 0.0 110.885 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -164.09 29.7 0.08 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.245 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -164.16 162.4 22.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.189 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.6 140.41 49.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.89 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 68.3 m -151.21 137.73 18.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.605 ' O ' ' HB ' ' A' ' 60' ' ' THR . 46.5 t -126.61 131.08 51.57 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.887 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -130.12 143.62 50.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.433 ' N ' HG22 ' A' ' 60' ' ' THR . 5.1 mt -115.42 123.36 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.961 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.499 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.7 m -125.86 -174.19 3.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -145.7 63.77 1.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 157.98 -28.97 0.47 Allowed Glycine 0 C--N 1.346 1.126 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.942 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.538 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -176.17 -157.2 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 27' ' ' PRO . . . 179.68 -58.72 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.365 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 26' ' ' ALA . 7.2 Cg_exo -34.87 78.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.17 3.247 . . . . 0.0 115.01 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.519 ' N ' ' O ' ' A' ' 26' ' ' ALA . 5.2 tp -105.46 69.13 0.19 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.176 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' O ' ' A' ' 27' ' ' PRO . 36.7 Cg_endo -65.29 122.68 10.46 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.408 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 m -157.01 -51.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -122.35 29.8 6.81 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.113 0.415 . . . . 0.0 111.793 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.97 -153.56 24.84 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.63 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.39 -168.31 1.89 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -156.03 171.57 19.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.862 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.415 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -143.24 170.67 8.19 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.208 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 52.1 Cg_endo -69.45 137.59 36.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.083 . . . . 0.0 112.71 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.431 ' CD2' HD13 ' A' ' 10' ' ' LEU . 7.7 t-80 -163.43 93.55 1.11 Allowed Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.431 ' O ' ' HB3' ' A' ' 8' ' ' SER . 59.7 Cg_exo -37.45 -77.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.4 2.733 . . . . 0.0 114.211 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -177.16 43.06 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.361 0.124 . . . . 0.0 111.032 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HB1' ' NE2' ' A' ' 37' ' ' HIS . . . -50.01 172.11 0.12 Allowed Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 120.931 0.396 . . . . 0.0 111.631 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 45' ' ' GLU . 44.4 Cg_exo -57.46 -17.12 26.1 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.999 2.466 . . . . 0.0 113.337 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.566 ' CZ3' ' HB3' ' A' ' 19' ' ' CYS . 6.4 t90 -71.88 -65.84 0.72 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.409 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -50.79 -53.59 30.7 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -35.28 75.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.491 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 1.8 mt-10 -49.33 -40.66 36.11 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.461 0.573 . . . . 0.0 111.209 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.533 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -126.35 5.61 7.67 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 118.355 -1.878 . . . . 0.0 113.48 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 60' ' ' THR . . . -70.1 54.55 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.993 0.397 . . . . 0.0 111.677 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 t -106.03 36.61 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.519 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -147.83 152.04 36.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 111.016 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.572 ' CE3' ' HB3' ' A' ' 59' ' ' ARG . 12.7 m95 -92.62 158.87 15.74 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.6 t -151.18 144.34 17.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.332 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -99.29 121.84 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.049 2.5 . . . . 0.0 113.805 -178.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.729 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 35.5 t80 -121.51 130.83 53.79 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t -39.09 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.414 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -70.17 -11.43 60.89 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -154.3 168.49 32.58 Favored Glycine 0 C--N 1.366 2.216 0 C-N-CA 118.167 -1.968 . . . . 0.0 114.398 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ARG . 8.6 tt0 -94.55 117.99 30.98 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 121.878 -0.777 . . . . 0.0 110.397 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.589 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 5.1 m -97.2 178.86 5.1 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.134 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB3' ' O ' ' A' ' 58' ' ' CYS . 22.4 ptt180 171.03 115.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.106 0.867 . . . . 0.0 110.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.887 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -179.49 -147.87 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 6.3 t -142.8 -172.11 3.58 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.2 m -143.95 174.33 10.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.444 HG23 ' CH2' ' A' ' 42' ' ' TRP . 8.7 pt -157.07 166.82 15.81 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.155 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.418 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 4.2 Cg_exo -76.3 165.26 29.69 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.333 . . . . 0.0 111.398 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.2 -140.35 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 0.0 110.699 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.2 m -120.55 116.71 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.039 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.904 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -169.76 -46.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -177.32 -173.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.779 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.1 t -49.76 103.67 0.38 Allowed Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.963 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -91.41 33.13 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.887 2.392 . . . . 0.0 112.808 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -107.34 137.64 45.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.72 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 166.72 12.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.4 m -132.12 153.53 50.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.408 0.623 . . . . 0.0 111.814 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.458 ' CE2' ' HD2' ' A' ' 27' ' ' PRO . 1.6 p90 -135.36 131.62 36.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.122 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -96.51 121.44 38.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.665 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.6 m -102.61 154.89 18.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.758 0.789 . . . . 0.0 112.782 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.466 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.9 t80 -119.11 115.69 24.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.198 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.53 162.51 20.57 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.02 -11.7 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.919 2.413 . . . . 0.0 113.333 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 4.8 t0 -170.19 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.144 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.2 mt-30 -160.64 163.58 32.46 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.168 0.509 . . . . 0.0 111.714 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.424 HG23 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.91 117.33 47.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.715 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.1 m -123.01 138.17 54.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.434 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 38.9 t -122.38 146.48 47.3 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.343 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -140.1 134.78 31.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.326 0.584 . . . . 0.0 111.9 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.3 mp -107.39 131.0 58.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.511 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 49.8 m -131.75 -172.84 2.97 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 119.286 -0.966 . . . . 0.0 113.363 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -151.76 60.35 0.87 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.65 0.53 7.22 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 119.998 -1.096 . . . . 0.0 114.063 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.454 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -167.5 -160.56 0.36 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.263 1.031 . . . . 0.0 112.759 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -173.23 139.06 0.83 Allowed Pre-proline 0 C--N 1.346 0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD2' ' CE2' ' A' ' 9' ' ' PHE . 51.7 Cg_exo -55.35 142.37 79.75 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.231 1.954 . . . . 0.0 112.019 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.1 tp -64.77 110.04 3.61 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.11 152.55 80.62 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.582 2.188 . . . . 0.0 112.167 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 p -165.81 -50.53 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.99 33.22 1.36 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 122.048 -0.407 . . . . 0.0 111.637 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 160.85 169.14 23.72 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.771 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.97 -163.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.52 159.51 27.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.235 0.54 . . . . 0.0 111.146 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.68 153.65 74.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.673 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.36 128.5 25.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.722 2.281 . . . . 0.0 112.37 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 -157.83 89.81 2.35 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.771 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -30.85 -68.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.537 2.824 . . . . 0.0 113.358 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.93 -160.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.48 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 171.05 154.31 0.21 Allowed Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 120.614 0.245 . . . . 0.0 110.796 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 56.2 Cg_endo -70.04 -13.89 34.51 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.328 2.019 . . . . 0.0 111.954 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 90.1 t90 -93.91 -53.49 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.213 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 73.8 m -50.02 -33.76 19.1 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -88.44 -39.36 14.31 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 4.1 mt-10 -48.82 -26.84 2.62 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.308 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.3 -23.73 2.85 Favored Glycine 0 C--N 1.36 1.916 0 C-N-CA 118.487 -1.816 . . . . 0.0 113.497 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 60.28 2.48 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.699 0.75 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.3 p -93.11 31.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -125.75 147.12 49.48 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.676 0.274 . . . . 0.0 110.293 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.438 ' CZ3' ' HD3' ' A' ' 59' ' ' ARG . 1.2 m95 -90.21 164.11 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.027 0.441 . . . . 0.0 111.058 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.3 t -147.23 130.42 8.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.595 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -93.83 87.76 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.637 2.225 . . . . 0.0 113.667 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.454 ' CD2' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -100.42 124.93 46.55 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.3 m -42.55 -49.6 5.4 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.027 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -32.55 69.55 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.656 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -172.04 179.78 43.47 Favored Glycine 0 C--N 1.359 1.823 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.286 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -89.95 145.36 25.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 118.354 1.077 . . . . 0.0 110.192 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 m -129.31 177.62 7.04 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 4.6 mmm180 -150.54 126.92 10.71 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.2 m -109.11 137.99 46.15 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 47' ' ' ALA . 1.9 m -142.64 152.33 42.35 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.443 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.415 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 35.3 m -155.75 156.55 35.03 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 120.656 1.571 . . . . 0.0 112.306 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.468 ' CD1' ' CZ2' ' A' ' 42' ' ' TRP . 32.2 pt -161.81 156.75 19.86 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.49 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.12 164.66 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.055 . . . . 0.0 112.22 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.437 ' CE2' ' N ' ' A' ' 16' ' ' GLN . 10.8 m-85 -74.01 -145.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.888 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.425 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 16.2 t -106.05 55.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.908 179.979 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.97 -69.45 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.25 166.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.843 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -60.27 114.43 9.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.869 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.27 155.48 70.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.399 2.066 . . . . 0.0 112.294 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -98.02 158.85 15.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.75 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.79 140.98 23.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 30.9 t -118.31 152.26 36.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.727 0.775 . . . . 0.0 112.671 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 27' ' ' PRO . 3.3 p90 -130.9 130.85 44.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.016 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.476 HD23 ' HB2' ' A' ' 19' ' ' CYS . 0.8 OUTLIER -94.49 126.15 39.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.067 0.46 . . . . 0.0 110.212 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 17.3 m -105.04 154.31 20.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.693 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -130.0 126.6 38.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -114.06 164.69 15.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.321 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.8 -19.14 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.227 2.618 . . . . 0.0 113.955 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.43 28.76 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.0 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.554 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.6 mt-30 -153.83 147.2 24.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.016 0.436 . . . . 0.0 111.834 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.545 HG22 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -119.97 122.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.002 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.5 m -134.58 141.77 46.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.498 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 41.5 t -122.1 146.43 47.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.82 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.0 139.29 28.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.285 0.565 . . . . 0.0 112.518 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.27 120.32 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.253 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 58.8 m -108.96 -176.16 2.96 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.096 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.58 54.95 0.74 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.409 ' C ' ' HA3' ' A' ' 56' ' ' GLY . . . 108.24 21.87 7.46 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.544 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.452 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -130.76 -157.45 0.82 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.391 0.596 . . . . 0.0 111.99 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' CB ' ' HD2' ' A' ' 27' ' ' PRO . . . -146.57 177.85 1.63 Allowed Pre-proline 0 C--N 1.34 0.179 0 CA-C-O 120.593 0.235 . . . . 0.0 110.902 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.514 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 98.3 Cg_endo -81.16 124.06 4.73 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.642 2.228 . . . . 0.0 113.126 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.6 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 3.5 tt -71.24 -35.87 4.38 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.594 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 96.2 Cg_exo -44.81 170.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.516 2.144 . . . . 0.0 112.98 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -151.25 -37.1 0.13 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.92 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -82.79 30.75 0.43 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.59 0.632 . . . . 0.0 111.825 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.56 163.6 34.67 Favored Glycine 0 N--CA 1.466 0.698 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.15 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -100.62 -166.31 1.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.436 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -160.77 159.94 30.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.358 0.599 . . . . 0.0 112.072 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.409 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -137.7 173.05 5.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.427 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 74.4 Cg_endo -75.61 135.3 17.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.539 2.16 . . . . 0.0 113.036 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.525 ' CE1' ' HB1' ' A' ' 40' ' ' ALA . 60.9 t-80 -164.37 95.73 0.95 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.76 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 8' ' ' SER . 2.6 Cg_endo -39.71 -81.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.394 2.729 . . . . 0.0 114.21 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -176.03 53.5 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.825 0.078 . . . . 0.0 110.885 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.525 ' HB1' ' CE1' ' A' ' 37' ' ' HIS . . . -59.38 174.06 0.45 Allowed Pre-proline 0 N--CA 1.471 0.622 0 O-C-N 122.022 -0.424 . . . . 0.0 111.555 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 40' ' ' ALA . 37.2 Cg_endo -65.76 1.74 2.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.575 2.183 . . . . 0.0 113.045 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.498 ' HZ3' ' HB3' ' A' ' 19' ' ' CYS . 21.1 t90 -90.06 -56.22 3.31 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 53.2 m -64.74 -32.93 74.84 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -78.06 -44.47 26.26 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.406 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 9.5 tt0 -64.49 -19.64 65.7 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.98 -18.5 6.82 Favored Glycine 0 C--N 1.364 2.09 0 C-N-CA 118.095 -2.002 . . . . 0.0 112.683 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.476 ' O ' ' HD2' ' A' ' 59' ' ' ARG . . . -93.73 68.28 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.296 0.57 . . . . 0.0 110.434 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 m -89.27 29.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.56 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -145.02 133.31 21.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -95.64 167.8 11.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.218 0.532 . . . . 0.0 111.922 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 58' ' ' CYS . 11.5 p -155.97 139.04 10.79 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.73 120.59 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.597 2.198 . . . . 0.0 113.963 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.478 ' CB ' ' O ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -104.53 132.48 50.73 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.039 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -61.8 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -26.58 68.02 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.152 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -168.48 176.8 42.74 Favored Glycine 0 C--N 1.359 1.821 0 C-N-CA 118.989 -1.576 . . . . 0.0 112.808 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.0 tt0 -93.15 127.56 38.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.665 1.232 . . . . 0.0 110.447 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.567 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -136.82 -173.98 3.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.216 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 47' ' ' ALA . 6.2 ttp180 -156.66 127.37 6.71 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.1 t -104.05 130.97 51.75 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -127.93 162.36 26.93 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.9 m -150.91 170.5 19.17 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 119.863 1.21 . . . . 0.0 111.538 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.545 HG13 HG22 ' A' ' 17' ' ' VAL . 5.5 pt -157.19 151.58 20.29 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.605 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' ILE . 7.7 Cg_exo -71.53 125.9 11.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.881 2.387 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.486 ' CG ' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -80.76 -139.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.969 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.417 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 12.2 p -100.19 125.03 54.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.994 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.837 -179.936 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -63.56 146.0 54.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.886 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.69 102.68 15.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.68 115.22 28.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.66 176.98 5.23 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.365 2.043 . . . . 0.0 112.287 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -120.98 163.88 17.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -148.11 141.07 24.82 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 0.7 OUTLIER -121.18 148.87 43.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.69 0.757 . . . . 0.0 112.903 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -135.4 132.18 37.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.51 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.91 125.58 42.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.07 0.462 . . . . 0.0 109.805 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -103.8 143.54 32.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.163 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.39 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.82 162.6 32.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.883 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -44.29 -18.07 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.399 . . . . 0.0 113.694 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.38 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.413 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.61 166.93 29.69 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.048 0.451 . . . . 0.0 111.704 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.416 HG22 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -141.43 108.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.245 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 91.1 m -114.37 134.75 54.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 111.818 -179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.6 t -119.27 144.16 46.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.576 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.632 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -150.81 139.91 21.11 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.452 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 1.3 mt -111.86 110.52 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.562 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 1.3 m -86.94 -175.51 5.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.84 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.94 51.71 0.98 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.55 22.5 4.02 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.484 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB3' ' N ' ' A' ' 56' ' ' GLY . . . -162.54 -156.63 0.41 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.033 0.916 . . . . 0.0 112.051 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -163.68 132.92 2.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' A' ' 9' ' ' PHE . 15.4 Cg_endo -56.93 145.72 83.4 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.511 2.141 . . . . 0.0 112.647 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.53 111.81 21.91 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.053 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.51 151.46 29.05 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.534 2.156 . . . . 0.0 112.127 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 -55.6 0.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.301 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -95.1 29.52 2.42 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 118.108 0.413 . . . . 0.0 111.55 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.27 -162.53 36.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.75 -162.86 1.15 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.686 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.07 163.29 39.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.107 0.48 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 155.24 72.83 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.77 130.09 28.34 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.615 2.21 . . . . 0.0 112.438 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' A' ' 8' ' ' SER . 17.9 t-160 -157.87 100.68 1.8 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -30.04 -73.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.316 2.677 . . . . 0.0 113.378 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.402 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 10.5 t -154.13 -159.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 178.88 130.42 0.22 Allowed Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.032 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.543 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 38.8 Cg_exo -56.73 -20.69 36.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.289 1.993 . . . . 0.0 112.088 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.474 ' CZ2' ' CD1' ' A' ' 63' ' ' ILE . 63.3 t90 -86.9 -47.95 8.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -42.43 -57.57 2.57 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -69.96 -35.81 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.164 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 71.4 tt0 -46.15 -31.12 2.22 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 118.284 0.493 . . . . 0.0 111.582 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.8 10.68 3.96 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 118.338 -1.887 . . . . 0.0 113.907 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . . . -92.21 45.76 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.383 0.591 . . . . 0.0 111.24 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.57 33.84 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.99 15.87 4.7 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.665 ' CE3' ' HB2' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -130.24 -175.11 3.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.281 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 2.3 t 142.82 -42.5 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.08 0 O-C-N 123.746 0.654 . . . . 0.0 110.038 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 98.6 Cg_endo -86.69 78.89 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 114.447 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.586 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.5 t80 -109.35 130.57 55.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.61 -60.49 1.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.11 -30.35 70.34 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.586 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.54 -172.59 37.75 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.619 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.715 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -95.19 132.64 39.93 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.53 1.665 . . . . 0.0 109.273 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.665 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 19.1 m -135.99 -174.19 3.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.828 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.632 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.76 132.22 20.84 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 t -125.73 139.77 53.25 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.54 162.24 35.82 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.4 m -157.29 146.82 20.31 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 119.96 1.255 . . . . 0.0 111.506 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 HG23 HD11 ' A' ' 63' ' ' ILE . 3.5 pt -149.18 165.29 18.04 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.737 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 32.7 Cg_exo -59.54 164.8 10.58 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 0.0 111.979 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -139.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.156 0.503 . . . . 0.0 110.788 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.58 85.06 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.033 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.918 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -144.58 -179.62 6.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.832 0.349 . . . . 0.0 111.047 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -158.75 -56.42 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 64.01 159.27 0.12 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.779 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 5.7 Cg_exo -73.83 154.11 48.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.979 2.453 . . . . 0.0 112.263 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 7' ' ' GLU . 1.5 p30 -80.6 -53.7 6.32 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.478 1.132 . . . . 0.0 108.734 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.571 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 9.6 mt-10 -177.64 -167.56 0.15 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.159 -2.291 . . . . 0.0 109.653 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 37' ' ' HIS . 32.8 t -135.21 142.12 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.316 0.579 . . . . 0.0 111.791 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 31.1 p90 -124.79 132.78 53.32 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.613 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -97.74 131.3 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.703 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.9 m -116.36 133.27 56.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.629 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.31 130.71 56.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.47 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -126.11 149.85 67.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.496 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.24 4.5 0.13 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.673 2.248 . . . . 0.0 113.358 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 13' ' ' GLN . 3.8 m-20 -117.57 -29.94 5.63 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 15' ' ' ASP . 1.2 mt-30 -172.27 -167.22 0.45 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.684 0.278 . . . . 0.0 110.838 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG22 HG12 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -125.95 144.83 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.208 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -145.08 145.64 31.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 112.113 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.535 ' CB ' ' CH2' ' A' ' 42' ' ' TRP . 2.3 t -127.38 152.78 47.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.741 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -144.02 135.17 25.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.342 0.591 . . . . 0.0 111.759 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.498 ' CG2' ' HB3' ' A' ' 5' ' ' PRO . 37.8 mt -104.92 110.28 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.225 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.664 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 70.5 m -100.6 172.41 7.12 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.836 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.779 ' HB3' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -148.81 46.86 1.02 Allowed 'General case' 0 C--N 1.354 0.78 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . . . 128.21 30.95 0.7 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.7 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.715 ' HB1' ' CG ' ' A' ' 53' ' ' TYR . . . -123.09 -165.7 1.35 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.203 1.001 . . . . 0.0 112.287 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.432 ' O ' ' OH ' ' A' ' 53' ' ' TYR . . . -125.74 99.07 32.99 Favored Pre-proline 0 C--N 1.344 0.332 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.613 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.51 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 32.6 Cg_exo -32.38 90.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.45 2.767 . . . . 0.0 113.485 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 tp -98.7 122.66 52.45 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.8 -170.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.501 2.134 . . . . 0.0 112.119 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 p -149.28 -52.8 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.413 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.86 30.47 3.71 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.252 0.478 . . . . 0.0 111.681 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.36 -146.16 7.27 Favored Glycine 0 N--CA 1.461 0.364 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.365 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -116.46 -169.77 1.69 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.333 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -156.07 166.39 33.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.034 0.445 . . . . 0.0 111.359 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -143.0 168.58 12.73 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.544 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.71 134.99 22.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.67 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.42 ' O ' ' O ' ' A' ' 8' ' ' SER . 6.9 t60 -157.65 93.13 2.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -28.6 -85.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.9 3.066 . . . . 0.0 114.628 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.7 p -162.43 55.65 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.463 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -43.49 166.85 0.09 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 CA-C-N 118.468 0.576 . . . . 0.0 111.869 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 52.6 Cg_exo -56.56 -47.23 24.83 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.213 2.608 . . . . 0.0 113.993 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.535 ' CH2' ' CB ' ' A' ' 19' ' ' CYS . 38.5 p-90 -72.65 -45.82 57.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 1.3 m -47.24 -45.66 23.72 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -31.68 21.91 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.865 -0.522 . . . . 0.0 109.951 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 1.7 tm-20 -47.71 -31.72 5.04 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.705 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.51 -11.82 1.46 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 118.214 -1.946 . . . . 0.0 114.711 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.767 ' C ' ' HG2' ' A' ' 59' ' ' ARG . . . -72.14 64.13 0.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.441 1.12 . . . . 0.0 111.635 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.23 52.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.463 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HG2' ' CZ ' ' A' ' 59' ' ' ARG . 7.7 pt-20 -134.37 -15.87 2.16 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.812 ' HB3' ' HA ' ' A' ' 59' ' ' ARG . 8.6 t90 -102.33 -166.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.964 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER 170.01 -38.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.625 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 7.7 Cg_exo -75.59 81.15 2.39 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.178 1.919 . . . . 0.0 116.267 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.715 ' CG ' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -112.57 129.45 56.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.2 p -26.01 -73.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -22.45 50.66 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.511 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.44 -165.98 19.3 Favored Glycine 0 C--N 1.356 1.644 0 C-N-CA 118.911 -1.614 . . . . 0.0 111.945 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.678 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 4.1 mt-30 -95.26 166.3 11.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.523 2.161 . . . . 0.0 109.321 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.664 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 44.8 t -175.84 -176.54 0.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.333 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.812 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -158.17 145.66 18.18 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 118.515 0.598 . . . . 0.0 111.591 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.513 ' N ' ' HD2' ' A' ' 59' ' ' ARG . 9.5 t -112.58 104.03 12.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.57 172.63 6.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.128 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m -155.84 158.57 38.29 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 118.993 0.815 . . . . 0.0 111.42 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.454 HD12 ' CH2' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -153.87 162.19 27.36 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.209 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 160.47 7.83 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.773 2.316 . . . . 0.0 112.623 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -78.55 -140.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.835 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -124.11 -43.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.084 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.939 -179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 t -88.78 -52.43 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -89.76 -45.09 9.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.794 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.7 m 63.4 139.43 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.016 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -64.16 -161.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.512 2.141 . . . . 0.0 112.029 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -67.17 152.85 45.01 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.454 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -142.25 153.91 44.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.681 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -130.53 149.6 52.12 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 112.596 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.466 ' CZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -132.61 135.41 45.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.04 178.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.64 118.01 35.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.825 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.2 m -106.44 139.28 41.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.483 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -133.76 151.09 76.39 Favored Pre-proline 0 CA--C 1.511 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.258 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.84 -1.51 1.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.619 1.546 . . . . 0.0 110.861 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.4 t0 -114.34 -29.29 6.95 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.534 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.412 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 0.3 OUTLIER -179.33 173.5 1.1 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.99 0.424 . . . . 0.0 111.604 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.449 HG13 ' CE2' ' A' ' 65' ' ' TYR . 2.3 m -111.57 118.97 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.405 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 3.5 m -110.43 128.9 55.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.814 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.485 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 51.8 t -112.19 145.78 39.27 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.341 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -152.29 138.45 18.31 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.174 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.441 ' HB ' ' HG3' ' A' ' 59' ' ' ARG . 1.7 mt -108.83 113.79 45.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.659 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 1.3 m -93.61 -177.3 4.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.528 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 57' ' ' GLN . 18.0 tpt85 -145.19 49.18 1.27 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.42 25.68 3.68 Favored Glycine 0 C--N 1.348 1.211 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -158.51 -157.74 0.65 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.848 0.824 . . . . 0.0 112.154 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' O ' ' CZ ' ' A' ' 53' ' ' TYR . . . -155.43 179.98 1.22 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.32 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 26' ' ' ALA . 67.2 Cg_endo -91.36 138.7 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.739 2.292 . . . . 0.0 113.219 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.11 64.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.276 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 27' ' ' PRO . 67.8 Cg_endo -72.11 -161.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.588 2.192 . . . . 0.0 111.994 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.99 -54.87 3.04 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.23 -95.03 0.1 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 39.64 -161.9 0.01 OUTLIER Glycine 0 N--CA 1.474 1.231 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.743 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.1 178.54 7.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 m -157.82 178.99 9.62 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 119.042 0.837 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -157.86 145.31 13.58 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.26 135.25 68.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.527 2.151 . . . . 0.0 112.372 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' SER . 27.3 t60 -161.6 98.65 1.23 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.933 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -29.35 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.377 2.718 . . . . 0.0 113.448 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -155.43 -161.95 1.26 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 177.72 158.89 0.55 Allowed Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.026 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 72.8 Cg_endo -74.74 -16.38 20.95 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.446 2.097 . . . . 0.0 112.131 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.63 ' HA ' ' HB2' ' A' ' 45' ' ' GLU . 44.4 t90 -87.1 -51.97 5.69 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.272 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.45 ' HA ' ' CG2' ' A' ' 61' ' ' THR . 0.1 OUTLIER -45.3 -57.68 3.84 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.787 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -35.8 80.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.416 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.63 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 2.9 mt-10 -48.56 -30.81 5.69 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.351 0.523 . . . . 0.0 111.813 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.12 17.68 2.53 Favored Glycine 0 C--N 1.357 1.75 0 C-N-CA 118.208 -1.949 . . . . 0.0 113.842 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 60' ' ' THR . . . -107.52 58.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 111.141 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 13.4 p -93.85 31.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.301 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.726 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.51 119.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.886 0.374 . . . . 0.0 111.703 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.726 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 1.6 t90 155.86 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.167 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.574 ' CG2' ' HD3' ' A' ' 52' ' ' PRO . 11.1 m -50.31 -32.18 5.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.105 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.574 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 2.9 Cg_exo -77.27 62.65 7.63 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.983 1.789 . . . . 0.0 114.678 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.577 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 2.5 t80 -106.41 116.49 32.02 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -36.7 -58.34 0.74 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.469 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.98 69.98 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.003 -0.523 . . . . 0.0 112.0 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.21 -178.96 42.04 Favored Glycine 0 C--N 1.361 1.921 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.761 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.569 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.9 tt0 -96.72 124.21 40.64 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.373 -1.075 . . . . 0.0 109.791 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.586 ' CB ' ' CE3' ' A' ' 50' ' ' TRP . 10.1 m -131.62 -172.95 2.99 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' CA ' ' HB3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -150.36 133.45 16.17 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 85.1 m -117.62 147.81 42.52 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.45 ' CG2' ' HA ' ' A' ' 43' ' ' CYS . 1.8 t -151.58 174.09 13.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.78 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.417 ' O ' HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -173.22 159.92 3.94 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 118.865 0.757 . . . . 0.0 110.919 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.476 HG22 ' CZ2' ' A' ' 42' ' ' TRP . 1.7 pt -149.38 151.74 34.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.425 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 68.3 Cg_endo -90.02 93.76 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.226 2.617 . . . . 0.0 112.283 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -100.14 -147.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.474 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 19.2 t -97.07 128.65 48.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 111.045 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 t -170.7 -45.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -162.63 177.15 9.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.6 p -89.67 146.26 35.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.47 -166.48 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.511 2.141 . . . . 0.0 112.297 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.07 153.22 19.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.788 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -143.11 140.59 30.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 37' ' ' HIS . 13.3 t -111.78 147.95 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.726 0.774 . . . . 0.0 112.372 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 2.0 p90 -134.07 137.26 44.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.328 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.56 127.17 43.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.978 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.1 m -107.36 142.83 36.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 111.976 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.513 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.7 t80 -108.95 130.9 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.262 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -138.97 142.35 33.17 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.07 6.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.619 2.213 . . . . 0.0 113.321 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.1 p30 -118.95 -33.53 4.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.454 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.3 mp0 -169.4 -170.22 1.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.436 HG21 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -125.76 117.23 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.4 146.79 40.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.092 0.473 . . . . 0.0 112.212 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.584 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 51.9 t -125.68 150.58 47.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.625 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -149.49 140.44 22.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' CG ' ' A' ' 59' ' ' ARG . 3.7 mp -103.85 118.42 50.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.662 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 94.0 m -107.43 -174.03 2.43 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.2 57.37 0.71 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.95 -19.92 1.11 Allowed Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.622 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' CB ' ' HB ' ' A' ' 55' ' ' THR . . . -174.77 -155.44 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.289 0.545 . . . . 0.0 110.62 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 27' ' ' PRO . . . 173.56 -58.24 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 26' ' ' ALA . 9.2 Cg_endo -51.06 78.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.288 2.658 . . . . 0.0 114.631 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 53' ' ' TYR . 18.7 tp -134.01 50.5 5.23 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 89.8 Cg_endo -77.83 -171.74 1.28 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.706 2.271 . . . . 0.0 112.727 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 t -159.44 -56.4 0.06 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.9 32.21 4.06 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.012 -0.43 . . . . 0.0 111.617 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 175.12 -152.19 13.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.297 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.55 -167.75 1.99 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 m -156.68 157.11 34.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.756 0.313 . . . . 0.0 110.629 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.57 151.43 75.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 141.06 93.48 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' SER . 82.0 t60 -169.19 97.49 0.51 Allowed Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.813 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -30.54 -71.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.455 2.77 . . . . 0.0 113.551 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.51 -157.89 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.799 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 177.3 167.3 0.49 Allowed Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 120.6 0.238 . . . . 0.0 111.082 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.55 ' O ' ' HB3' ' A' ' 45' ' ' GLU . 72.7 Cg_endo -76.09 -25.85 9.81 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.584 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 26.9 p-90 -92.44 -41.14 10.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.413 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 96.6 m -51.68 -37.94 52.8 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.46 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.43 -36.12 17.9 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 121.711 -0.618 . . . . 0.0 109.369 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.55 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -46.85 -29.77 2.15 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.003 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.18 -10.73 4.53 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.781 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 43' ' ' CYS . . . -94.42 45.15 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.857 0.829 . . . . 0.0 111.091 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.9 m -95.09 32.06 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.51 143.26 33.71 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -79.82 151.75 30.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 58' ' ' CYS . 12.0 p -162.75 94.72 1.17 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.863 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -42.16 110.73 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.931 2.42 . . . . 0.0 113.635 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.639 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.7 t80 -93.26 145.84 24.14 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -32.87 -89.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.504 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 44.7 m -68.53 -7.78 35.52 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.639 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -166.16 173.1 41.66 Favored Glycine 0 C--N 1.363 2.031 0 C-N-CA 118.769 -1.682 . . . . 0.0 112.679 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -78.04 152.98 32.72 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.706 1.253 . . . . 0.0 109.663 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.8 t -159.67 -171.71 3.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.692 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' CG ' ' HB ' ' A' ' 21' ' ' ILE . 1.6 ptt-85 -155.15 125.94 7.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -105.59 136.98 44.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.82 171.39 14.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.615 177.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.7 m -154.76 168.73 25.87 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.578 1.081 . . . . 0.0 111.688 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.422 HG22 ' CE3' ' A' ' 42' ' ' TRP . 28.4 pt -154.15 137.29 10.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.841 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.49 124.98 3.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.763 2.308 . . . . 0.0 112.795 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.476 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 0.9 OUTLIER -133.44 -150.45 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.833 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 24.1 t -143.77 -58.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.818 0.342 . . . . 0.0 110.968 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.828 179.897 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 t 61.18 64.39 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.895 0.378 . . . . 0.0 110.738 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -131.62 49.44 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.036 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.42 HG21 ' CD ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -169.51 -61.98 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' CD ' HG21 ' A' ' 4' ' ' THR . 57.1 Cg_endo -70.62 167.87 24.31 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.275 1.983 . . . . 0.0 112.226 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -115.12 148.62 38.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.31 141.21 33.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -121.7 146.27 47.19 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.505 0.669 . . . . 0.0 111.921 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.542 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -130.6 130.74 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.701 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.84 121.07 33.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.656 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 m -102.65 145.24 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 0.0 112.637 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.448 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.4 t80 -110.54 113.26 25.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.574 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -117.77 140.69 27.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.87 7.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.699 2.266 . . . . 0.0 113.443 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 13' ' ' GLN . 5.6 t0 -118.63 -37.08 3.34 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.245 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 8.4 mp0 -165.77 -175.49 3.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.06 113.97 45.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 m -110.09 129.68 55.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.492 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 43.6 t -108.1 140.32 41.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.744 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.66 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -135.36 143.95 46.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 112.746 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' ARG . 2.5 mp -116.84 138.28 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.489 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 16.9 m -145.81 -171.1 3.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.64 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -156.82 60.74 0.53 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.79 8.86 5.04 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 119.897 -1.145 . . . . 0.0 114.355 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.468 ' HB3' ' N ' ' A' ' 56' ' ' GLY . . . -167.13 -160.54 0.38 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.67 1.235 . . . . 0.0 113.157 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . -173.49 132.05 0.58 Allowed Pre-proline 0 C--N 1.347 0.481 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.441 ' HD2' ' CE2' ' A' ' 9' ' ' PHE . 9.7 Cg_endo -49.84 147.2 14.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 112.159 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.36 111.28 5.72 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.2 152.39 16.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.653 2.235 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 t -166.31 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.131 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.54 33.93 1.37 Allowed 'General case' 0 C--N 1.352 0.695 0 O-C-N 122.068 -0.395 . . . . 0.0 111.548 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 168.18 167.9 29.5 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.829 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.53 -161.49 0.84 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.73 160.38 33.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -139.12 152.72 70.43 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.617 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.43 127.52 21.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.263 . . . . 0.0 112.452 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 12.9 t-160 -160.58 82.51 2.12 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.22 -63.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.782 2.988 . . . . 0.0 113.443 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.425 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -140.53 -161.39 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.103 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB2' ' CE1' ' A' ' 37' ' ' HIS . . . 172.81 131.41 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.005 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 31.2 Cg_exo -58.22 -18.66 38.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.076 1.851 . . . . 0.0 111.726 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.492 ' HZ3' ' HB2' ' A' ' 19' ' ' CYS . 48.1 t90 -86.36 -51.89 5.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.357 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -45.54 -56.37 5.19 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.57 -36.18 83.4 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.0 tt0 -49.68 -34.39 18.42 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.73 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.49 -2.94 2.81 Favored Glycine 0 C--N 1.358 1.767 0 C-N-CA 118.405 -1.855 . . . . 0.0 114.376 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -95.13 63.41 2.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.861 0.831 . . . . 0.0 110.356 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 t -94.44 32.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.387 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -124.55 136.15 53.74 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.667 ' CZ3' ' HG2' ' A' ' 57' ' ' GLN . 4.2 t-105 -96.24 135.84 37.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.518 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 9.6 p -131.93 120.61 17.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.987 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.563 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 71.8 Cg_endo -76.6 114.92 3.96 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.619 2.213 . . . . 0.0 114.091 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.439 ' CE1' ' HA ' ' A' ' 27' ' ' PRO . 1.1 t80 -104.61 128.14 52.55 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -42.63 -48.01 5.37 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.933 -0.122 . . . . 0.0 111.242 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.08 -30.74 61.03 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.468 ' N ' ' HB3' ' A' ' 25' ' ' ALA . . . -172.46 179.57 43.92 Favored Glycine 0 C--N 1.359 1.84 0 C-N-CA 118.948 -1.596 . . . . 0.0 113.253 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.667 ' HG2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -81.62 120.31 24.92 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 118.544 1.172 . . . . 0.0 110.337 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -117.94 -178.84 3.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.66 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -160.67 133.81 6.57 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.44 ' HA ' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -120.3 130.59 54.52 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.525 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -139.43 164.79 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.012 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 t -176.87 155.56 1.26 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 120.506 1.503 . . . . 0.0 112.515 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.592 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 7.8 pt -159.08 161.81 27.33 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.118 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 5.3 Cg_endo -47.16 174.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.6 2.2 . . . . 0.0 112.482 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.455 ' HB3' ' H ' ' A' ' 66' ' ' VAL . 2.4 m-30 -67.65 -143.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.709 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 30.6 m -121.71 124.62 71.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -122.25 167.93 12.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.822 0.344 . . . . 0.0 110.819 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -143.17 115.22 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.997 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.449 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 1.5 m -172.1 -63.78 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.696 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.449 ' HD3' ' HB ' ' A' ' 4' ' ' THR . 74.1 Cg_endo -74.32 77.61 2.83 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.393 2.062 . . . . 0.0 112.186 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -123.66 158.8 30.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -142.07 141.04 32.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.417 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' HIS . 29.3 t -117.11 141.32 48.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.628 0.727 . . . . 0.0 112.54 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.94 137.97 46.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.605 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.52 128.53 50.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.138 0.494 . . . . 0.0 110.475 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 74.0 m -107.98 139.24 42.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.108 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -119.4 128.48 54.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.502 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.04 146.39 56.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.866 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.76 3.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 113.38 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 13' ' ' GLN . 32.0 m-20 -111.67 -36.74 5.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.588 0.232 . . . . 0.0 111.109 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.428 ' CG ' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -172.51 -175.31 1.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.907 0.384 . . . . 0.0 111.181 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.22 130.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.123 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 99.9 m -128.81 129.66 45.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 112.047 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.511 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 34.5 t -112.99 152.72 29.08 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.836 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.611 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -154.48 133.59 12.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.069 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.7 mp -101.33 102.14 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.585 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.582 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 68.9 m -90.04 -172.46 3.51 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.628 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.83 60.18 0.67 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.63 16.43 9.39 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.16 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 55' ' ' THR . . . -164.7 -161.17 0.55 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.86 151.78 16.93 Favored Pre-proline 0 C--N 1.34 0.18 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.285 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HG3' ' CD1' ' A' ' 20' ' ' PHE . 73.4 Cg_endo -75.79 132.77 14.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.474 2.116 . . . . 0.0 112.234 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 14.5 tp -74.05 112.08 15.22 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -82.32 -174.46 2.11 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.4 p -164.23 -55.8 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.535 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -102.1 33.4 3.08 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.99 -0.444 . . . . 0.0 111.924 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.91 -176.05 47.72 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.673 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -120.15 -164.85 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.7 m -154.15 178.42 10.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.995 0.426 . . . . 0.0 111.442 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.8 165.59 18.44 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.957 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.04 137.77 41.93 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.848 2.365 . . . . 0.0 112.729 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.453 ' O ' ' O ' ' A' ' 8' ' ' SER . 11.0 t-160 -163.08 92.67 1.18 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 8' ' ' SER . 37.1 Cg_exo -25.49 -71.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.865 3.043 . . . . 0.0 113.819 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.38 -161.07 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.463 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . . . 173.6 142.2 0.17 Allowed Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.024 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 20.2 Cg_exo -64.95 -12.44 34.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.411 2.074 . . . . 0.0 112.106 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.511 ' HZ3' ' HB2' ' A' ' 19' ' ' CYS . 67.2 t90 -91.56 -52.73 4.63 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.321 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 11.1 m -49.55 -36.23 22.92 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -37.27 20.14 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.735 -0.603 . . . . 0.0 109.754 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -51.12 -25.55 5.32 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.604 179.555 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.48 -6.96 4.52 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 118.221 -1.942 . . . . 0.0 114.192 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.527 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -92.01 61.34 4.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.051 0.926 . . . . 0.0 111.259 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.8 t -111.98 38.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.256 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.45 13.41 1.96 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.903 0.382 . . . . 0.0 111.844 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.771 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -128.5 169.04 14.82 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.363 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 0.1 OUTLIER 158.17 -34.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.473 0.709 . . . . 0.0 110.801 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 73.2 Cg_endo -93.3 68.41 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.083 1.856 . . . . 0.0 113.725 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.772 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 76.4 t80 -97.12 126.84 42.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -37.31 -57.6 0.89 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.445 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 66.1 m -69.7 -27.3 64.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.772 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -174.06 -178.27 43.86 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.325 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.673 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -95.54 126.73 41.03 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 119.582 1.691 . . . . 0.0 109.203 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.771 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 43.3 t -142.42 -178.76 5.91 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.174 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.745 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 15.5 mmm-85 -138.3 134.14 33.94 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.425 HG22 ' CE2' ' A' ' 20' ' ' PHE . 91.8 m -117.2 142.78 46.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 19' ' ' CYS . 1.4 t -147.46 160.38 42.64 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.81 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.43 ' O ' HG21 ' A' ' 63' ' ' ILE . 81.7 m -158.01 160.73 37.78 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-N 119.541 1.064 . . . . 0.0 110.879 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 63' ' ' ILE . 3.5 pt -151.65 154.45 33.19 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.444 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 69.1 Cg_endo -89.77 126.39 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.183 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.431 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 1.2 p90 -133.83 -148.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.254 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.431 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 31.2 m -99.1 178.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.812 0.339 . . . . 0.0 111.192 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.852 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 t -87.12 -55.32 3.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -96.09 42.06 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.485 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -59.17 -61.29 8.14 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' HA ' ' CB ' ' A' ' 23' ' ' ARG . 2.7 Cg_endo -39.53 153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.474 2.783 . . . . 0.0 112.619 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.752 ' N ' ' O ' ' A' ' 22' ' ' CYS . 1.9 m-20 -63.29 -43.14 98.73 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.532 1.158 . . . . 0.0 109.377 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 162.01 -176.46 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.484 -2.144 . . . . 0.0 110.728 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 6.9 t -119.43 158.45 26.19 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.296 0.569 . . . . 0.0 112.136 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 20' ' ' PHE . 2.1 p90 -141.32 126.87 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.257 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.63 128.61 39.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HB2' ' HE1' ' A' ' 20' ' ' PHE . 6.7 m -111.2 142.86 42.84 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.996 -178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.76 128.05 54.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.517 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.82 145.82 52.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.759 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.38 5.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.809 2.339 . . . . 0.0 113.423 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -116.6 -34.92 4.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.214 -0.194 . . . . 0.0 111.343 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.2 mt-30 -174.54 -174.28 0.83 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.58 121.08 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.958 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -114.69 125.72 54.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 1.5 p -107.01 138.31 43.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.73 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -140.04 147.24 40.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.97 0.891 . . . . 0.0 112.82 178.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 59' ' ' ARG . 25.7 mt -132.38 142.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.461 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 6' ' ' ASP . 4.5 m -142.94 -179.12 6.16 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.938 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' CB ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -154.71 69.77 0.75 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.494 ' N ' ' OD1' ' A' ' 6' ' ' ASP . . . 132.6 -5.62 5.2 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.235 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.533 ' CB ' ' CD2' ' A' ' 53' ' ' TYR . . . -126.73 -162.14 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.58 0.69 . . . . 0.0 111.788 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -134.45 171.59 8.76 Favored Pre-proline 0 C--N 1.34 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.918 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.477 ' HB3' ' CE2' ' A' ' 9' ' ' PHE . 64.3 Cg_endo -87.46 114.38 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.876 2.384 . . . . 0.0 112.901 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tp -113.79 83.56 7.57 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.015 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 27' ' ' PRO . 32.6 Cg_exo -57.59 -172.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.644 2.229 . . . . 0.0 112.263 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -55.37 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.246 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -115.81 29.23 8.12 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.94 -0.475 . . . . 0.0 111.672 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.75 -161.85 26.76 Favored Glycine 0 N--CA 1.462 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.394 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.32 -166.7 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.748 0.274 . . . . 0.0 110.777 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 171.26 19.75 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.293 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -149.76 153.71 36.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.23 128.91 25.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.627 2.218 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.471 ' O ' ' HB3' ' A' ' 8' ' ' SER . 42.9 t60 -158.3 114.08 1.73 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.772 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -38.89 -77.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.654 2.236 . . . . 0.0 112.947 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -156.55 -158.64 0.8 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -177.51 143.7 0.52 Allowed Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.264 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 24.6 Cg_exo -62.65 -15.9 49.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.489 2.126 . . . . 0.0 112.203 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 19' ' ' CYS . 32.6 t90 -84.68 -50.33 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.871 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -45.13 -53.02 8.55 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.26 -36.42 82.95 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 25.1 tt0 -47.41 -36.89 10.43 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.351 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.26 2.56 1.14 Allowed Glycine 0 C--N 1.359 1.814 0 C-N-CA 118.112 -1.994 . . . . 0.0 115.224 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' A' ' 61' ' ' THR . . . -82.65 65.03 7.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.404 1.102 . . . . 0.0 110.136 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -49.35 -22.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.69 160.45 32.62 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.057 -0.402 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.463 ' CZ2' ' NH1' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -161.07 15.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.655 ' HA ' ' HA ' ' A' ' 57' ' ' GLN . 7.6 p -156.0 6.29 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.635 ' CD ' ' H ' ' A' ' 51' ' ' VAL . 14.5 Cg_endo -56.51 32.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 N-CA-C 118.795 2.575 . . . . 0.0 118.795 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.649 ' O ' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -137.21 116.62 12.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.26 1.391 . . . . 0.0 109.669 176.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.8 t -46.64 -53.25 11.96 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.356 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 m -70.57 -21.12 62.73 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.95 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 53' ' ' TYR . . . -159.53 167.77 35.23 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.836 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 5.0 mt-30 -80.75 129.47 34.54 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 121.683 -0.893 . . . . 0.0 109.288 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 52' ' ' PRO . 1.1 m -120.77 -169.03 1.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.95 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.73 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.7 OUTLIER -162.46 132.97 4.77 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.6 t -131.59 132.87 44.42 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -143.9 169.0 18.62 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.128 177.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.471 ' N ' HG21 ' A' ' 61' ' ' THR . 0.1 OUTLIER -170.62 156.32 5.28 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.47 1.032 . . . . 0.0 111.161 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.476 HG12 ' CZ2' ' A' ' 42' ' ' TRP . 3.4 pt -149.5 156.1 39.17 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.539 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 73.7 Cg_endo -90.21 125.32 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.206 2.604 . . . . 0.0 111.921 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.457 ' CZ ' ' CB ' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -134.43 -145.78 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.408 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.445 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 30.5 m -66.24 -26.57 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.716 0.294 . . . . 0.0 111.256 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 65' ' ' TYR . 2.8 tt0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.836 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.583 ' HB2' HG22 ' A' ' 21' ' ' ILE . 1.6 p30 . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.769 0.318 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -150.56 141.81 23.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.783 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.1 t -110.91 145.89 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -127.22 130.99 50.7 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.407 178.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.15 103.54 15.58 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.4 m -87.61 152.65 22.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.281 0.562 . . . . 0.0 111.903 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 11.1 t80 -125.33 138.29 54.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.767 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.96 158.38 75.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 5.0 Cg_endo -46.87 -14.19 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.164 2.576 . . . . 0.0 113.628 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 15.8 t70 -164.94 29.18 0.06 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.776 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.85 165.56 35.69 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 111.812 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -144.03 131.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.904 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 20' ' ' PHE . 11.7 m -124.37 135.85 53.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 112.078 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.813 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 17.7 p -116.97 111.08 19.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.846 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.852 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -134.7 136.4 42.71 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.894 HD12 HG23 ' A' ' 60' ' ' THR . 4.0 mt -108.47 95.26 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.377 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 5.0 m -76.82 -176.95 4.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.905 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.605 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.66 62.89 1.32 Allowed 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.33 17.91 7.43 Favored Glycine 0 C--N 1.351 1.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.414 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.749 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -138.5 -159.7 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.621 0.71 . . . . 0.0 111.857 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -140.38 179.5 1.25 Allowed Pre-proline 0 C--N 1.339 0.132 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 88.3 Cg_endo -83.61 111.1 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.293 1.995 . . . . 0.0 112.791 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 111.71 15.76 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.728 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.11 161.82 26.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.564 2.176 . . . . 0.0 112.34 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.25 -52.11 0.4 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.016 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -145.68 30.49 1.09 Allowed 'General case' 0 C--N 1.352 0.701 0 O-C-N 122.01 -0.431 . . . . 0.0 111.663 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . -167.95 -139.07 2.6 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.301 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.67 -165.28 1.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.259 0.529 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 10.6 m -155.74 169.97 23.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 110.379 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -144.68 162.2 39.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.254 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.26 129.85 10.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.8 t-80 -161.14 114.75 1.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -35.48 -68.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.505 ' CG2' HD11 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -141.11 -154.56 0.52 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.628 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -156.21 133.19 6.37 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 122.417 -0.177 . . . . 0.0 111.331 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 4.4 Cg_exo -74.44 -23.75 14.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.85 2.366 . . . . 0.0 112.659 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.813 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 5.4 p-90 -84.98 -38.3 19.44 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.841 ' SG ' HG22 ' A' ' 60' ' ' THR . 0.1 OUTLIER -45.96 -59.28 2.93 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.442 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -66.88 -36.08 81.49 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 21.0 tt0 -55.24 -17.34 4.35 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.477 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.36 -31.42 0.42 Allowed Glycine 0 C--N 1.369 2.376 0 C-N-CA 117.124 -2.465 . . . . 0.0 114.048 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.801 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -103.8 -115.44 0.22 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.258 0.551 . . . . 0.0 112.305 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.71 HG13 ' H ' ' A' ' 49' ' ' GLU . 1.1 p 175.53 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.651 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.71 ' H ' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.37 -166.92 2.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.849 ' CE3' ' HB2' ' A' ' 58' ' ' CYS . 3.9 t90 -154.73 -146.09 0.18 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.321 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 50' ' ' TRP . 1.2 t 153.07 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 117.877 0.308 . . . . 0.0 111.294 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' HB ' ' A' ' 51' ' ' VAL . 7.2 Cg_exo -75.38 92.22 1.02 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.742 2.295 . . . . 0.0 115.34 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.749 ' CE2' ' HB1' ' A' ' 25' ' ' ALA . 41.3 t80 -128.01 129.99 47.6 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -36.23 -70.0 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -73.31 -19.32 61.06 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.09 -168.33 25.97 Favored Glycine 0 C--N 1.362 1.974 0 C-N-CA 118.348 -1.882 . . . . 0.0 113.416 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.1 tt0 -103.44 136.6 42.89 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 119.373 1.586 . . . . 0.0 108.49 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.849 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 56.0 m -123.92 -172.32 2.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.901 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.581 ' HA ' ' CB ' ' A' ' 50' ' ' TRP . 39.6 ptt85 -166.03 111.45 0.85 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.0 -0.438 . . . . 0.0 110.752 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.894 HG23 HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER 164.0 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.202 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.801 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 6.4 t -144.37 -173.87 4.15 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.724 ' O ' HG23 ' A' ' 63' ' ' ILE . 1.8 m -143.78 153.09 42.04 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 122.916 0.486 . . . . 0.0 109.96 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.724 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -166.7 163.39 10.98 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.244 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 18.0 Cg_exo -66.07 -161.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.595 2.196 . . . . 0.0 111.439 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.68 0.276 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -169.33 157.56 7.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 48.2 t -104.21 152.4 22.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.3 0.572 . . . . 0.0 112.162 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -129.07 137.09 51.06 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.542 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.4 117.35 29.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.726 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 27' ' ' PRO . 74.2 m -100.36 141.36 33.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -128.19 130.12 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.59 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -142.02 150.01 54.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.27 5.54 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.377 2.051 . . . . 0.0 113.097 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 2.5 m-20 -126.58 -17.34 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.474 ' NE2' ' HB3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -165.71 172.03 12.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.201 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.753 HG13 ' CE1' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -134.07 119.28 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.041 178.503 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.0 m -121.85 149.16 43.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.896 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 12.3 p -132.52 124.41 28.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.839 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.836 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -141.16 138.75 33.65 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 60' ' ' THR . 6.7 mt -101.1 125.59 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' HB2' ' A' ' 26' ' ' ALA . 7.8 m -145.72 -172.59 3.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 118.291 -1.364 . . . . 0.0 114.289 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.61 63.53 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 150.95 -36.44 0.89 Allowed Glycine 0 C--N 1.348 1.212 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.442 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . 175.36 -161.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.839 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . 179.82 -57.71 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.839 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 56.4 Cg_endo -101.49 111.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.775 2.316 . . . . 0.0 114.28 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.06 112.24 28.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -39.09 113.22 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.961 2.44 . . . . 0.0 113.001 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -142.63 -49.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.328 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.67 34.22 0.45 Allowed 'General case' 0 C--N 1.353 0.76 0 CA-C-N 118.443 0.565 . . . . 0.0 112.168 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -173.49 46.26 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.608 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.86 -165.15 1.47 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.671 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.9 m -154.08 179.32 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 163.94 22.44 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.25 136.8 32.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.894 2.396 . . . . 0.0 112.631 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 t-160 -171.3 101.83 0.4 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.064 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 8' ' ' SER . 47.5 Cg_exo -33.33 -65.8 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.165 2.577 . . . . 0.0 113.29 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 51.8 p -151.3 -157.43 0.81 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.301 0.376 . . . . 0.0 110.397 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.802 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -165.5 173.6 3.5 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.763 0.316 . . . . 0.0 111.456 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.802 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 86.2 Cg_endo -81.45 -48.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.893 2.395 . . . . 0.0 112.701 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.896 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 19.2 p-90 -71.87 -41.14 68.42 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.823 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.02 -56.65 3.23 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -78.37 -33.14 49.15 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.204 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.474 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 1.4 tp10 -41.15 -37.02 0.82 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 119.06 -0.495 . . . . 0.0 112.134 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.42 10.67 0.85 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 118.106 -1.997 . . . . 0.0 113.875 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 1.012 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -108.49 75.9 1.0 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 117.504 0.652 . . . . 0.0 111.416 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.579 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -23.83 -82.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.047 178.108 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 175.09 -132.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.559 ' N ' ' HB2' ' A' ' 59' ' ' ARG . 5.4 m95 -0.05 132.54 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.6 t -162.94 136.56 4.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 112.921 -1.945 . . . . 0.0 108.099 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.76 121.5 2.51 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.144 1.896 . . . . 0.0 114.303 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.585 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 53.4 t80 -118.69 121.88 41.18 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.6 m -39.51 -47.47 1.88 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.102 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 72.5 m -77.82 -29.43 50.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.339 0.518 . . . . 0.0 112.271 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.06 175.67 37.7 Favored Glycine 0 C--N 1.359 1.843 0 C-N-CA 118.787 -1.673 . . . . 0.0 113.471 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.1 tt0 -87.87 112.25 22.3 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.114 0.957 . . . . 0.0 109.77 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 1.6 m -99.83 -171.64 2.09 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 21' ' ' ILE . 11.3 ptt180 172.08 101.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.836 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 170.63 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.012 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 14.6 t -141.25 -176.8 4.84 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.828 ' O ' HG23 ' A' ' 63' ' ' ILE . 1.3 m -148.67 153.08 37.77 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 123.422 0.689 . . . . 0.0 109.188 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.852 HD11 ' CZ3' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -172.11 164.75 4.11 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 111.796 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HB3' ' NE2' ' A' ' 16' ' ' GLN . 71.7 Cg_endo -97.64 153.93 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.786 2.99 . . . . 0.0 112.086 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.753 ' CE1' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.777 0.323 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -142.65 140.18 31.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.823 ' HB2' HG23 ' A' ' 39' ' ' THR . 3.4 t -119.43 154.53 33.56 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.865 0.84 . . . . 0.0 112.438 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 1.1 p90 -143.43 140.53 30.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.65 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.17 137.13 37.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.887 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 91.9 m -117.45 150.76 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 111.771 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 22.8 t80 -113.44 124.9 53.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.803 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -134.72 144.6 51.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.74 5.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.693 2.262 . . . . 0.0 113.548 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -116.03 -34.72 4.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.442 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -176.01 -169.18 0.31 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.81 115.64 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -102.8 132.72 48.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.798 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 5.4 t -112.57 148.65 34.08 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.942 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.425 0.631 . . . . 0.0 111.714 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 43' ' ' CYS . 2.1 mp -107.13 122.08 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.259 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 37.8 m -110.11 -175.13 2.65 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -155.7 51.49 0.56 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.81 13.71 5.98 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.295 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -169.85 -160.03 0.23 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.904 0.852 . . . . 0.0 112.058 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . . . -174.55 123.66 0.38 Allowed Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 7.8 Cg_endo -50.13 143.68 24.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.411 2.074 . . . . 0.0 112.01 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -71.64 114.65 30.18 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.62 169.79 2.99 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.609 2.206 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -170.77 -45.4 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.719 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -91.43 30.54 1.28 Allowed 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.267 0.485 . . . . 0.0 112.287 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 150.24 -146.14 14.94 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.863 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -128.49 -169.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.897 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 6.3 m -156.51 173.69 16.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.396 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -151.62 164.41 20.36 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.491 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.96 145.64 56.57 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.575 2.183 . . . . 0.0 112.473 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' SER . 15.6 t-80 -172.58 111.83 0.36 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 37' ' ' HIS . 52.7 Cg_exo -29.59 -72.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.05 2.5 . . . . 0.0 112.85 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.823 HG23 ' HB2' ' A' ' 8' ' ' SER . 0.0 OUTLIER -174.11 -163.15 0.15 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.358 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.851 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -164.49 161.64 15.68 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 74.8 Cg_endo -77.72 -14.15 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.475 2.117 . . . . 0.0 112.452 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.786 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 24.0 p-90 -94.68 -51.19 4.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 119.477 -0.297 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.851 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -48.44 -49.25 36.09 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.129 178.629 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.31 -41.67 72.98 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.999 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -38.94 -34.95 0.17 Allowed 'General case' 0 C--N 1.361 1.092 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.749 178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.63 63.46 0.29 Allowed Glycine 0 C--N 1.357 1.739 0 C-N-CA 119.911 -1.137 . . . . 0.0 111.095 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 1.092 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -78.87 1.11 24.6 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 60' ' ' THR . 55.8 t -163.11 -90.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.607 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -170.99 150.37 3.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.723 0.296 . . . . 0.0 111.58 -178.067 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 60.5 t-105 -73.63 152.6 40.46 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.492 ' CG2' ' HD2' ' A' ' 52' ' ' PRO . 7.8 p -160.42 145.17 10.81 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.495 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HD2' ' CG2' ' A' ' 51' ' ' VAL . 69.7 Cg_endo -93.74 122.13 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.857 2.372 . . . . 0.0 113.584 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.572 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 1.9 t80 -98.7 139.44 34.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -42.86 -62.66 0.95 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -68.6 -25.55 64.92 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -167.77 176.6 42.39 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.228 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -100.3 129.4 46.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.107 1.454 . . . . 0.0 111.262 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.3 t -142.45 -177.68 5.39 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -162.34 140.9 8.97 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 122.162 -0.336 . . . . 0.0 110.413 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.737 HG23 HG11 ' A' ' 48' ' ' VAL . 2.7 t -89.36 158.71 17.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 1.092 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.5 p -152.05 173.28 15.08 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.557 ' H ' ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -177.1 153.05 0.94 Allowed 'General case' 0 C--N 1.353 0.757 0 CA-C-N 120.075 1.307 . . . . 0.0 111.953 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 ' CE3' ' A' ' 42' ' ' TRP . 5.0 pt -161.82 166.5 14.41 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.19 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 50.8 Cg_exo -53.91 171.47 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.118 1.879 . . . . 0.0 111.575 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 C--N 1.327 -0.391 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.619 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.729 0.299 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.0 140.33 17.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.876 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.7 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 22.7 t -114.19 149.48 35.69 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -128.29 145.22 51.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.49 HD21 ' HZ2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -103.55 130.34 50.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 99.4 m -106.06 145.95 30.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.3 m-85 -126.25 136.79 53.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.194 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -131.14 159.39 71.78 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.656 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 10.0 Cg_endo -51.62 -10.79 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.776 2.317 . . . . 0.0 113.199 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.549 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 2.0 t70 -162.61 31.24 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.466 -0.494 . . . . 0.0 112.014 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.485 ' CG ' ' HA ' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -163.1 171.29 16.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.542 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 65' ' ' TYR . 16.2 m -146.15 139.39 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.015 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.18 134.38 44.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.714 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.764 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 47.4 t -119.28 136.74 54.09 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.882 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.2 OUTLIER -144.13 122.72 12.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.991 HG12 HG23 ' A' ' 39' ' ' THR . 1.0 OUTLIER -110.7 99.61 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 76.4 m -106.62 -164.94 1.04 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.487 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.88 66.11 0.79 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.38 9.97 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.779 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' A' ' 55' ' ' THR . . . -165.51 -160.65 0.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.378 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.691 ' HB1' ' CE2' ' A' ' 20' ' ' PHE . . . -175.88 129.79 0.39 Allowed Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 116.87 -0.15 . . . . 0.0 110.647 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -43.43 140.9 3.75 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.737 2.291 . . . . 0.0 112.203 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.18 118.1 70.78 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.63 -173.91 1.93 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.597 2.198 . . . . 0.0 111.94 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.23 -51.87 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 3.5 pm0 -93.31 31.95 1.41 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 118.237 0.471 . . . . 0.0 112.086 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.05 -166.27 39.1 Favored Glycine 0 N--CA 1.462 0.368 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.723 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 6.7 pm0 -120.53 -169.59 1.84 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 33' ' ' GLU . 3.1 m -155.95 176.82 12.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.926 0.393 . . . . 0.0 111.198 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 51.4 p-10 -162.44 159.05 20.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.817 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 35' ' ' ASN . 18.1 Cg_endo -59.47 151.83 65.96 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.795 2.33 . . . . 0.0 112.941 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 8' ' ' SER . 29.8 t-80 179.24 110.24 0.18 Allowed Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.742 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.503 ' O ' ' HB3' ' A' ' 8' ' ' SER . 35.1 Cg_exo -27.91 -75.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.339 2.692 . . . . 0.0 113.728 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.991 HG23 HG12 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -163.6 -169.69 2.0 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.883 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -160.27 146.46 11.76 Favored Pre-proline 0 C--N 1.345 0.406 0 CA-C-N 118.382 0.537 . . . . 0.0 111.25 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 58.6 Cg_endo -71.64 -6.17 18.59 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.634 2.222 . . . . 0.0 112.866 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.764 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 61.6 p-90 -96.65 -35.77 10.93 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -55.54 -43.12 75.49 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 -41.05 24.52 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.1 tt0 -59.99 -9.4 3.04 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.618 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.16 -31.34 2.46 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 117.827 -2.13 . . . . 0.0 111.639 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.77 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -129.8 -109.78 0.27 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.385 0.612 . . . . 0.0 111.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER 176.56 -85.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.826 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 59' ' ' ARG . 51.2 mt-10 -162.14 158.9 25.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.817 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -155.37 69.29 0.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.79 1.281 . . . . 0.0 111.884 178.115 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.889 HG23 ' HD3' ' A' ' 52' ' ' PRO . 10.7 m -46.31 -39.37 13.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 112.875 -1.966 . . . . 0.0 113.885 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.889 ' HD3' HG23 ' A' ' 51' ' ' VAL . 37.0 Cg_endo -64.12 74.22 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.313 1.342 . . . . 0.0 114.343 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.61 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 65.0 t80 -115.82 129.12 56.31 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 m -41.94 -58.85 1.91 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.497 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 63.2 m -65.37 -30.64 71.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.204 0.457 . . . . 0.0 112.161 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -176.98 -161.97 26.62 Favored Glycine 0 CA--C 1.545 1.924 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.718 ' HG2' HG12 ' A' ' 51' ' ' VAL . 8.4 tt0 -88.36 130.03 35.25 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 119.793 1.796 . . . . 0.0 108.748 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.817 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 1.2 m -121.5 167.62 12.64 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.053 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.783 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -163.96 100.79 0.88 Allowed 'General case' 0 C--N 1.37 1.47 0 CA-C-N 118.784 0.72 . . . . 0.0 111.476 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.882 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 167.38 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.77 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 7.5 t -161.66 -163.29 0.96 Allowed 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' O ' HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -135.5 167.07 21.76 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.117 0.567 . . . . 0.0 110.23 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG1' HG23 ' A' ' 17' ' ' VAL . 8.0 pt -158.68 157.0 28.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.033 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 30.0 Cg_endo -63.15 -16.89 57.3 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.424 2.083 . . . . 0.0 113.302 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.825 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.093 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.45 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.847 0.356 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.85 154.33 27.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.328 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB2' ' CG1' ' A' ' 21' ' ' ILE . 2.4 t -113.11 159.67 18.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.305 0.574 . . . . 0.0 112.131 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.756 ' CE1' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -134.1 133.95 41.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.274 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.61 117.52 30.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.9 m -102.0 138.25 39.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.776 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -123.94 144.22 49.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.41 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.89 162.36 56.3 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.604 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 9.7 Cg_endo -52.11 -12.92 1.62 Allowed 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.638 2.225 . . . . 0.0 112.879 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -160.67 32.22 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.617 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 64' ' ' PRO . 16.2 mt-30 -158.49 156.14 29.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.313 0.578 . . . . 0.0 112.349 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 65' ' ' TYR . 15.8 m -141.28 106.45 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.064 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 12.9 m -113.43 118.78 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.806 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.665 ' O ' ' HB ' ' A' ' 60' ' ' THR . 0.9 OUTLIER -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.865 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -143.6 139.36 29.63 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.713 HD12 HG23 ' A' ' 60' ' ' THR . 3.4 mt -110.91 136.16 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.2 m -146.27 -174.92 4.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.058 -1.057 . . . . 0.0 113.367 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -146.07 63.59 1.23 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.17 -33.57 0.6 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.458 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.62 ' HB2' HG22 ' A' ' 55' ' ' THR . . . -177.12 -154.26 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.006 0.403 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.756 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . . . -156.92 157.78 30.91 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-O 120.524 0.202 . . . . 0.0 110.485 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 37.4 Cg_exo -57.52 151.41 54.19 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.4 2.067 . . . . 0.0 112.089 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.38 109.22 18.02 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.02 178.57 5.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.454 2.102 . . . . 0.0 112.215 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.9 t -160.4 -55.33 0.05 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.356 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 6.2 pm0 -94.25 32.53 1.51 Allowed 'General case' 0 C--N 1.352 0.692 0 O-C-N 122.022 -0.424 . . . . 0.0 111.714 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.81 -169.54 41.98 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.577 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -128.69 -164.43 1.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.159 -0.217 . . . . 0.0 110.532 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.9 m -154.46 178.07 10.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.036 0.446 . . . . 0.0 111.189 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -153.72 161.98 27.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.21 135.99 33.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.544 2.163 . . . . 0.0 112.581 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -165.38 106.84 0.77 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.294 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 8' ' ' SER . 68.1 Cg_exo -37.63 -70.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.96 2.44 . . . . 0.0 113.133 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 21.8 p -154.42 -158.92 0.9 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.349 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 179.53 148.84 0.46 Allowed Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 111.585 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 55.9 Cg_endo -69.7 -24.47 29.93 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.655 2.237 . . . . 0.0 111.631 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.899 ' CZ2' HD11 ' A' ' 63' ' ' ILE . 90.4 t90 -73.34 -45.74 53.44 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.961 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -44.87 -49.05 11.13 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.18 -33.08 24.27 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 2.5 tt0 -48.93 -20.62 0.53 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.319 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.68 -35.25 0.86 Allowed Glycine 0 C--N 1.363 2.029 0 C-N-CA 118.381 -1.866 . . . . 0.0 112.085 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.799 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -141.87 100.16 3.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.991 0.395 . . . . 0.0 111.217 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -24.4 -90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 123.745 0.653 . . . . 0.0 110.439 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 2.2 mt-10 172.24 130.73 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.678 ' HA ' ' CE3' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 141.96 136.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 112.927 -1.942 . . . . 0.0 111.72 176.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.3 p 175.45 83.9 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.911 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 51' ' ' VAL . 1.6 Cg_endo -42.88 140.63 2.94 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.284 2.656 . . . . 0.0 113.607 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.67 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 47.8 t80 -133.46 132.57 41.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.518 -0.764 . . . . 0.0 108.953 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -50.92 5.97 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 25' ' ' ALA . 19.5 m -73.72 -30.94 63.12 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.959 -0.463 . . . . 0.0 112.031 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.67 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -163.58 173.69 39.71 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.358 -1.401 . . . . 0.0 112.399 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ARG . 4.6 tt0 -87.03 112.63 22.04 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 118.904 1.352 . . . . 0.0 110.005 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.561 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 1.5 m -97.42 -171.98 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.406 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.615 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 25.7 ptt180 173.66 102.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.941 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.865 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 172.72 -150.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.799 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 14.6 t -157.2 -170.71 3.35 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.813 ' C ' HD13 ' A' ' 63' ' ' ILE . 19.6 t -165.77 156.7 13.56 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.899 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -152.65 166.83 14.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.696 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' ' CG ' ' A' ' 65' ' ' TYR . 9.3 Cg_endo -51.88 -24.35 18.58 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.261 1.974 . . . . 0.0 112.282 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.707 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.308 -1.218 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.182 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.426 ' HB2' HG22 ' A' ' 21' ' ' ILE . 2.9 p30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -144.37 141.19 29.53 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 35.2 t -113.29 143.99 43.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.488 0.661 . . . . 0.0 112.704 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 134.77 48.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.108 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.49 HD12 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -96.67 119.07 34.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.023 0.439 . . . . 0.0 110.606 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.4 m -100.81 128.74 46.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.331 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -113.9 137.61 51.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -138.64 145.82 47.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.32 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.41 -0.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.705 2.27 . . . . 0.0 113.663 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.8 t0 -122.2 -30.83 3.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -158.8 -175.16 5.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.187 0.518 . . . . 0.0 111.779 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 65' ' ' TYR . 8.3 m -141.24 126.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.909 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.1 m -118.06 141.13 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.632 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.737 ' O ' ' HB ' ' A' ' 60' ' ' THR . 41.8 t -123.97 131.61 53.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.831 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -137.94 136.31 36.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.75 HD12 HG23 ' A' ' 60' ' ' THR . 2.4 mt -103.43 103.93 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.9 m -95.13 -174.2 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.757 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -150.47 60.51 0.95 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 55' ' ' THR . . . 100.71 26.22 8.16 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.011 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.834 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -151.2 -161.26 1.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.04 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -178.04 114.53 0.23 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-O 120.449 0.166 . . . . 0.0 110.682 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.484 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 70.1 Cg_exo -49.78 142.93 24.24 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.467 2.111 . . . . 0.0 112.414 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.87 112.49 22.84 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.42 173.89 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.617 2.211 . . . . 0.0 112.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.4 m -155.55 -52.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.638 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -124.39 33.47 5.25 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 118.288 0.494 . . . . 0.0 112.106 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.96 -169.61 41.56 Favored Glycine 0 N--CA 1.462 0.432 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.792 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.29 -162.77 0.99 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -154.83 164.12 39.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.344 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 167.66 16.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.666 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.22 136.56 29.46 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.587 2.191 . . . . 0.0 112.691 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.49 ' ND1' HD12 ' A' ' 10' ' ' LEU . 20.9 t-160 -165.06 93.91 0.9 Allowed Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -30.93 -70.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.359 2.706 . . . . 0.0 113.627 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -142.25 -159.19 0.94 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.815 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.934 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -176.63 169.15 1.25 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-O 120.699 0.285 . . . . 0.0 111.373 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 93.8 Cg_endo -83.66 -35.14 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.015 2.477 . . . . 0.0 112.848 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.564 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 17.2 p-90 -88.05 -42.57 12.32 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -42.62 -58.44 2.29 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -36.63 73.65 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.219 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 5.3 tt0 -42.96 -32.35 0.63 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.105 0.411 . . . . 0.0 111.492 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -139.94 13.38 3.11 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 118.868 -1.634 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 43' ' ' CYS . . . -66.14 66.53 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 111.896 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 48' ' ' VAL . 21.5 t -141.8 53.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.96 23.44 0.66 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.262 0.937 . . . . 0.0 112.845 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.925 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -148.85 -173.53 4.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.5 t 153.08 -44.8 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.621 0.769 . . . . 0.0 110.022 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 4.7 Cg_endo -87.82 91.18 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.844 2.362 . . . . 0.0 114.796 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.834 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 10.0 t80 -121.88 128.85 52.05 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 m -40.3 -55.99 2.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 24' ' ' GLY . 64.3 m -66.98 -29.17 68.94 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.766 ' N ' ' HB2' ' A' ' 25' ' ' ALA . . . -177.38 -173.07 42.56 Favored Glycine 0 C--N 1.359 1.822 0 C-N-CA 119.272 -1.442 . . . . 0.0 112.324 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -100.07 125.9 46.21 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 119.637 1.719 . . . . 0.0 109.488 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.774 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 50.1 t -136.19 -178.78 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.797 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.3 OUTLIER 174.68 137.71 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.741 1.155 . . . . 0.0 111.594 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.831 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 179.44 -147.08 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.473 ' H ' ' HB ' ' A' ' 60' ' ' THR . 9.0 t -151.12 -171.13 3.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.604 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.516 ' O ' HG23 ' A' ' 63' ' ' ILE . 69.7 m -146.23 173.08 12.54 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 17' ' ' VAL . 6.3 pt -158.07 156.54 28.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.782 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 19.4 Cg_endo -58.24 -19.42 42.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.406 2.071 . . . . 0.0 113.012 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.776 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.309 -1.186 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.945 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.449 ' HB2' HG22 ' A' ' 21' ' ' ILE . 4.4 p30 . . . . . 0 C--O 1.231 0.109 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.43 141.06 21.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.206 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.5 t -118.11 144.33 45.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.85 133.12 54.88 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.348 177.718 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.492 HD21 ' CZ2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -91.53 123.08 34.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 110.504 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -99.2 138.86 35.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.213 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -118.45 129.79 55.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.064 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.9 OUTLIER -138.34 146.79 52.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.857 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 4.48 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.45 2.1 . . . . 0.0 112.698 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -115.97 -32.65 5.34 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.525 0.202 . . . . 0.0 111.216 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -172.92 -170.58 0.67 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 0.0 111.265 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.458 ' CG2' ' CE1' ' A' ' 65' ' ' TYR . 1.8 t -133.36 124.7 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.29 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.5 m -124.54 141.35 52.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 111.747 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.637 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 3.1 p -117.03 147.11 42.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.861 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -148.65 128.02 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.514 HD13 ' NE ' ' A' ' 59' ' ' ARG . 1.1 mp -97.6 106.86 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.344 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 2.2 m -84.86 -178.03 6.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.011 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.12 55.89 1.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.27 25.33 6.74 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.247 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.648 ' HB2' ' CA ' ' A' ' 56' ' ' GLY . . . -155.53 -160.59 1.05 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.729 0.764 . . . . 0.0 112.043 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.88 94.66 0.19 Allowed Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.326 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 72.0 Cg_exo -34.7 141.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.238 2.625 . . . . 0.0 113.14 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -80.8 112.76 34.71 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.17 169.05 1.64 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.531 2.154 . . . . 0.0 112.324 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -153.66 -57.86 0.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.207 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.65 29.52 7.34 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.01 -0.431 . . . . 0.0 111.426 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.17 -169.65 42.3 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.514 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.61 -161.43 0.89 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.225 -0.19 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.13 161.18 39.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.153 0.501 . . . . 0.0 111.391 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.4 173.59 4.36 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.75 136.26 20.71 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.066 2.511 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.4 t-80 -173.84 93.29 0.34 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.882 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -29.15 -71.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.608 2.872 . . . . 0.0 113.846 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.413 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 13.8 p -151.2 -155.79 0.66 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.136 0.272 . . . . 0.0 110.762 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . 179.93 164.84 0.84 Allowed Pre-proline 0 N--CA 1.473 0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 111.5 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.15 -28.51 10.73 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.17 2.58 . . . . 0.0 112.193 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.711 ' CE3' HD13 ' A' ' 63' ' ' ILE . 20.8 p-90 -86.71 -39.87 15.61 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.6 -58.42 2.66 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -33.07 65.25 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.229 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 2.8 tt0 -39.6 -42.82 1.23 Allowed 'General case' 0 C--N 1.361 1.089 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.081 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -146.1 16.42 1.72 Allowed Glycine 0 C--N 1.357 1.723 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.456 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 43' ' ' CYS . . . -51.92 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.42 0.629 . . . . 0.0 112.562 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 48' ' ' VAL . 7.7 p -65.82 49.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.169 -1.378 . . . . 0.0 107.936 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -26.57 116.81 0.07 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -121.94 73.85 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.358 177.035 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.856 ' HA ' ' H ' ' A' ' 58' ' ' CYS . 14.0 m -57.32 -38.53 69.04 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.71 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 51' ' ' VAL . 9.7 Cg_endo -51.97 77.53 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.594 1.53 . . . . 0.0 113.587 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.685 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 62.3 t80 -121.7 132.96 54.92 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.5 m -45.26 -58.97 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.5 m -61.91 -30.64 71.02 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 122.014 -0.429 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -179.01 -165.88 34.08 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.916 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.803 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.7 mt-30 -109.98 127.7 54.95 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 120.179 1.99 . . . . 0.0 110.045 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.856 ' H ' ' HA ' ' A' ' 51' ' ' VAL . 14.0 m -131.93 -171.26 2.58 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 4.9 ttp180 -140.06 135.03 32.19 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.557 HG23 HG13 ' A' ' 48' ' ' VAL . 8.8 t -119.38 135.31 54.79 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.68 ' OG1' ' CA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -135.21 165.96 24.2 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 176.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.7 m -156.74 153.44 28.41 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.894 1.225 . . . . 0.0 110.56 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.711 HD13 ' CE3' ' A' ' 42' ' ' TRP . 12.9 pt -148.98 136.72 11.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.53 134.28 2.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.925 2.417 . . . . 0.0 112.277 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE1' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.165 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.792 0.329 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -130.03 140.26 50.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.3 m -123.67 155.41 37.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.523 0.678 . . . . 0.0 112.211 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.511 ' CZ ' ' HD2' ' A' ' 27' ' ' PRO . 0.8 OUTLIER -136.58 129.38 30.77 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.866 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.446 HD11 ' HZ2' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -93.07 124.82 37.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.58 153.04 22.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.761 0.791 . . . . 0.0 112.86 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 21.9 t80 -118.68 114.56 22.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.521 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -120.11 144.76 38.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 19.5 Cg_endo -58.35 6.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 113.338 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.4 m-20 -118.42 -33.05 4.45 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.462 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -170.25 -165.16 0.45 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.584 HG13 ' CE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -122.93 122.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -118.36 148.36 42.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 39.3 t -128.28 143.56 51.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -138.96 138.5 37.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 112.188 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.685 HD12 ' HD3' ' A' ' 59' ' ' ARG . 3.3 mt -112.39 140.63 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.759 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 13.1 m -143.64 -173.62 4.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 119.336 -0.946 . . . . 0.0 113.165 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -149.59 60.58 1.01 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 152.16 -29.09 0.89 Allowed Glycine 0 C--N 1.35 1.316 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.441 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' HB ' ' A' ' 55' ' ' THR . . . -176.14 -156.05 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.68 0.74 . . . . 0.0 111.907 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.472 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -150.09 154.52 36.78 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-O 120.561 0.22 . . . . 0.0 110.714 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 40.3 Cg_endo -66.86 159.23 52.59 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.373 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -74.48 111.79 14.46 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 161.91 38.51 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.573 2.182 . . . . 0.0 112.215 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 t -164.9 -49.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.409 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.8 pm0 -92.73 32.59 1.22 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.123 0.42 . . . . 0.0 111.784 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 163.44 169.22 26.6 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.461 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -101.82 -164.27 1.08 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.59 161.04 35.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 110.853 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -140.98 147.5 48.17 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.49 129.3 33.97 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.431 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 39' ' ' THR . 6.5 t-160 -159.55 102.31 1.5 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -33.19 -70.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.18 2.586 . . . . 0.0 113.36 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.42 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -147.55 -157.77 0.84 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.655 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -175.54 151.82 1.3 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.687 0.28 . . . . 0.0 111.116 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 73.6 Cg_endo -75.68 -26.57 9.74 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.589 2.193 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.94 ' CE3' HD13 ' A' ' 63' ' ' ILE . 40.9 p-90 -90.69 -40.38 11.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -44.06 -59.79 2.16 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -33.93 61.06 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.225 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.738 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -47.86 -30.0 3.74 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 119.003 0.82 . . . . 0.0 111.667 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.72 -2.55 4.8 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 118.527 -1.796 . . . . 0.0 113.758 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 61' ' ' THR . . . -83.98 62.04 6.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.618 0.709 . . . . 0.0 110.643 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 48' ' ' VAL . 12.2 p -85.11 27.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.759 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.99 142.92 38.33 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -105.18 158.36 16.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.416 . . . . 0.0 111.334 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -138.69 104.05 7.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.211 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 111.3 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.546 2.164 . . . . 0.0 113.275 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.627 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 5.1 t80 -101.57 129.29 47.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.24 -45.6 5.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.251 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 18.5 m -78.14 -32.73 50.48 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.075 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.57 171.74 40.12 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.032 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ARG . 20.8 tt0 -83.57 122.96 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.499 1.149 . . . . 0.0 109.688 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -112.46 -174.82 2.54 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.685 ' HD3' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -161.62 132.98 5.37 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.4 m -116.86 139.31 50.77 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.465 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -148.35 167.25 25.72 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.074 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.426 ' N ' HG23 ' A' ' 61' ' ' THR . 81.0 m -156.7 158.35 36.78 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.501 1.046 . . . . 0.0 110.852 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.94 HD13 ' CE3' ' A' ' 42' ' ' TRP . 9.2 pt -155.47 157.25 31.57 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 9.5 Cg_endo -51.85 167.53 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.575 2.183 . . . . 0.0 112.092 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.584 ' CE1' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.805 0.336 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 147.56 45.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 33.8 t -130.83 155.87 45.97 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.515 0.674 . . . . 0.0 111.907 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -139.28 137.65 36.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.07 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -95.26 131.61 41.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.698 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 84.3 m -113.93 154.16 28.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.557 0.694 . . . . 0.0 111.955 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.692 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 16.3 t80 -125.53 130.68 52.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.506 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -133.81 139.9 34.89 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 18.4 Cg_endo -59.26 7.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.445 2.096 . . . . 0.0 112.888 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.0 OUTLIER -119.79 -32.65 4.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.441 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.7 mt-30 -164.47 -168.86 1.62 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.306 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.14 145.92 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.316 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -151.52 139.95 20.5 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.571 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 49.4 t -120.41 150.86 40.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.587 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -146.55 133.55 20.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.533 0.682 . . . . 0.0 112.748 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 43' ' ' CYS . 3.1 mp -105.41 139.26 27.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.29 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.6 m -139.88 -170.75 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 119.201 -1.0 . . . . 0.0 113.353 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.68 58.66 0.81 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.03 18.08 9.07 Favored Glycine 0 C--N 1.349 1.299 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.359 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.82 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -157.09 -166.63 2.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.707 0.754 . . . . 0.0 112.051 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.429 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . 179.81 129.19 0.24 Allowed Pre-proline 0 N--CA 1.469 0.483 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 50.3 Cg_exo -53.89 140.58 68.34 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.134 1.89 . . . . 0.0 112.051 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.1 111.83 7.52 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.26 162.14 17.56 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.699 2.266 . . . . 0.0 112.331 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -174.83 -39.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.516 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.1 pm0 -91.08 32.6 1.0 Allowed 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.932 -0.48 . . . . 0.0 111.929 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 158.53 -163.79 33.21 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.683 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -121.81 -169.8 1.94 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 117.179 0.489 . . . . 0.0 110.616 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 4.3 m -156.98 161.47 39.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -135.35 150.82 73.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.27 140.48 81.61 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.594 2.196 . . . . 0.0 112.363 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.403 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.7 t-160 -168.62 90.07 0.63 Allowed Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -73.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.48 2.787 . . . . 0.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 30.6 p -157.28 -163.95 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 168.92 158.87 0.17 Allowed Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 120.701 0.286 . . . . 0.0 110.93 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 71.8 Cg_endo -76.73 -3.44 13.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.47 2.113 . . . . 0.0 112.119 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.669 ' CH2' HD12 ' A' ' 63' ' ' ILE . 66.1 t90 -93.75 -55.23 3.32 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.275 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.733 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.6 m -54.12 -32.54 55.34 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.59 -41.83 16.04 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.915 -0.49 . . . . 0.0 109.734 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.1 tt0 -51.32 -24.53 4.74 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.549 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.47 -16.82 4.99 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 118.38 -1.867 . . . . 0.0 113.316 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.9 ' HB2' ' CB ' ' A' ' 61' ' ' THR . . . -106.84 67.88 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.381 0.59 . . . . 0.0 111.091 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 48' ' ' VAL . 14.2 p -90.37 30.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.351 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -130.74 142.72 50.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.657 0.265 . . . . 0.0 110.403 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.412 ' CZ2' ' NH2' ' A' ' 59' ' ' ARG . 33.6 m95 -94.96 149.64 21.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.5 p -139.56 107.85 7.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.131 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.48 120.31 7.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 113.762 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.82 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 1.2 t80 -107.45 135.04 49.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.97 -54.66 6.29 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -69.48 -29.15 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 25' ' ' ALA . . . -174.35 -178.23 44.09 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 119.208 -1.472 . . . . 0.0 112.291 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ARG . 2.3 tt0 -81.91 142.42 32.49 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.334 1.567 . . . . 0.0 110.16 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -136.03 -179.2 5.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.309 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 25.7 ttm180 -161.72 122.59 2.7 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 t -108.17 144.86 35.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.9 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -147.89 158.26 43.95 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.12 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 91.6 m -155.41 162.09 40.85 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 120.045 1.293 . . . . 0.0 111.463 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.669 HD12 ' CH2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -158.93 166.11 17.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 30.4 Cg_exo -61.87 161.42 25.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.134 . . . . 0.0 112.463 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.42 ' OH ' ' CE2' ' A' ' 12' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.062 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.738 0.304 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.6 139.14 33.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.056 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 5.8 t -119.1 149.03 42.37 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -129.71 144.56 51.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.036 178.249 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 132.76 47.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.26 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.42 ' SG ' ' HE1' ' A' ' 20' ' ' PHE . 64.4 m -106.86 146.81 30.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.996 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -125.21 132.44 52.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.26 157.16 49.77 Favored Pre-proline 0 CA--C 1.51 -0.559 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.128 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.92 -11.46 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.797 1.665 . . . . 0.0 110.975 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.11 28.21 0.07 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.503 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.5 154.37 31.7 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.204 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -130.0 128.8 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.519 179.078 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -133.43 138.14 46.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 16.4 t -127.9 152.71 47.52 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.484 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -151.7 141.98 22.39 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 43' ' ' CYS . 2.8 mp -112.15 122.97 67.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.184 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 11.4 m -116.43 -176.04 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.02 58.72 0.85 Allowed 'General case' 0 C--N 1.348 0.509 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 139.46 -13.74 3.22 Favored Glycine 0 C--N 1.348 1.21 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.184 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.837 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -174.38 -154.96 0.06 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.434 0.617 . . . . 0.0 111.682 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . . . -158.54 138.41 8.68 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-O 120.661 0.267 . . . . 0.0 111.045 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 18.2 Cg_endo -59.64 159.6 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.661 2.241 . . . . 0.0 112.179 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.657 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -86.15 156.46 57.35 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.47 -179.99 5.34 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.656 2.238 . . . . 0.0 112.148 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -149.52 -52.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.27 33.3 3.61 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.583 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -162.71 30.94 Favored Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.438 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 7.1 pm0 -116.72 -171.86 2.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 m -155.82 177.49 11.34 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 15.3 m-20 -159.56 167.72 13.61 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 35' ' ' ASN . 49.6 Cg_endo -69.11 150.79 72.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.565 2.177 . . . . 0.0 112.809 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' SER . 55.4 t60 -172.78 104.87 0.33 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' HIS . 35.8 Cg_exo -28.09 -81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -160.46 -160.29 0.76 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 174.61 148.72 0.24 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.04 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.87 -16.4 54.58 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.487 2.125 . . . . 0.0 111.989 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.752 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 91.1 t90 -92.46 -51.09 5.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 58.9 m -51.96 -34.97 44.55 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.246 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.03 -39.76 20.83 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.5 OUTLIER -50.98 -24.7 3.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.412 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.33 -6.1 5.85 Favored Glycine 0 C--N 1.363 2.06 0 C-N-CA 118.498 -1.811 . . . . 0.0 113.797 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 43' ' ' CYS . . . -85.64 52.32 2.43 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.641 0.72 . . . . 0.0 110.943 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.3 32.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.857 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 2.1 tt0 -128.96 127.36 41.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 110.207 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.439 ' CZ3' ' HD2' ' A' ' 59' ' ' ARG . 4.1 m95 -81.36 152.54 27.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.376 0.608 . . . . 0.0 111.748 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 58' ' ' CYS . 7.2 p -149.53 99.41 3.37 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.907 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.43 98.78 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.429 2.086 . . . . 0.0 113.277 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -93.22 129.65 39.19 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.528 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -40.5 -36.05 0.52 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.054 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.837 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -102.19 -23.48 14.03 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.547 0.612 . . . . 0.0 112.6 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -163.23 169.2 38.26 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 118.784 -1.674 . . . . 0.0 113.501 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -98.42 137.38 37.2 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.841 0.82 . . . . 0.0 109.979 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.724 ' O ' HG12 ' A' ' 51' ' ' VAL . 24.1 t -148.42 179.74 7.57 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -147.06 126.55 13.22 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 t -115.79 135.84 53.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 168.01 16.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.358 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 63' ' ' ILE . 94.4 m -154.45 169.35 23.97 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.201 0.909 . . . . 0.0 111.553 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.833 HG13 HG23 ' A' ' 17' ' ' VAL . 11.2 pt -160.28 130.19 3.41 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.698 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.6 118.83 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.711 2.274 . . . . 0.0 112.549 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.584 ' OH ' HG13 ' A' ' 17' ' ' VAL . 40.2 m-85 . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.277 0.56 . . . . 0.0 112.106 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.11 141.62 38.11 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.636 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 5.6 t -115.46 154.52 29.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.777 0.799 . . . . 0.0 112.742 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.885 ' CE1' ' HB1' ' A' ' 26' ' ' ALA . 1.3 p90 -138.87 129.78 26.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.531 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD12 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -89.71 122.55 32.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.354 . . . . 0.0 110.217 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -108.2 133.28 52.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.225 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.7 m-85 -107.71 137.12 46.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.559 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.55 157.39 39.39 Favored Pre-proline 0 CA--C 1.51 -0.567 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.207 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.18 -8.81 2.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.784 1.656 . . . . 0.0 110.885 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.09 29.7 0.08 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.245 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -164.16 162.4 22.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.189 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -128.6 140.41 49.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.89 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 68.3 m -151.21 137.73 18.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.599 ' O ' ' HB ' ' A' ' 60' ' ' THR . 46.5 t -126.61 131.08 51.57 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.897 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -130.12 143.62 50.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.77 HD12 HG23 ' A' ' 60' ' ' THR . 5.1 mt -115.42 123.36 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.961 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.7 m -125.86 -174.19 3.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -145.7 63.77 1.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 157.98 -28.97 0.47 Allowed Glycine 0 C--N 1.346 1.126 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.942 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.816 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -176.17 -157.2 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.885 ' HB1' ' CE1' ' A' ' 9' ' ' PHE . . . 179.68 -58.72 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.365 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.564 ' CD ' ' HB3' ' A' ' 26' ' ' ALA . 7.2 Cg_exo -34.87 78.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.17 3.247 . . . . 0.0 115.01 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 53' ' ' TYR . 5.2 tp -105.46 69.13 0.19 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.176 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' O ' ' A' ' 27' ' ' PRO . 36.7 Cg_endo -65.29 122.68 10.46 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.408 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 m -157.01 -51.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -122.35 29.8 6.81 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.113 0.415 . . . . 0.0 111.793 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.97 -153.56 24.84 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.63 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.39 -168.31 1.89 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -156.03 171.57 19.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.862 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -143.24 170.67 8.19 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.208 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 52.1 Cg_endo -69.45 137.59 36.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.083 . . . . 0.0 112.71 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 10' ' ' LEU . 7.7 t-80 -163.43 93.55 1.11 Allowed Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 8' ' ' SER . 59.7 Cg_exo -37.45 -77.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.4 2.733 . . . . 0.0 114.211 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -177.16 43.06 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.361 0.124 . . . . 0.0 111.032 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -50.01 172.11 0.12 Allowed Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 120.931 0.396 . . . . 0.0 111.631 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.614 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 44.4 Cg_exo -57.46 -17.12 26.1 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.999 2.466 . . . . 0.0 113.337 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.591 ' CZ3' ' HB3' ' A' ' 19' ' ' CYS . 6.4 t90 -71.88 -65.84 0.72 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.679 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -50.79 -53.59 30.7 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -35.28 75.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.491 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 1.8 mt-10 -49.33 -40.66 36.11 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.461 0.573 . . . . 0.0 111.209 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -126.35 5.61 7.67 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 118.355 -1.878 . . . . 0.0 113.48 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 60' ' ' THR . . . -70.1 54.55 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.993 0.397 . . . . 0.0 111.677 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 48' ' ' VAL . 16.3 t -106.03 36.61 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.519 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -147.83 152.04 36.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 111.016 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE3' ' HB3' ' A' ' 59' ' ' ARG . 12.7 m95 -92.62 158.87 15.74 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 52' ' ' PRO . 68.6 t -151.18 144.34 17.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.332 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' HG13 ' A' ' 51' ' ' VAL . 58.5 Cg_endo -99.29 121.84 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.049 2.5 . . . . 0.0 113.805 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.748 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 35.5 t80 -121.51 130.83 53.79 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t -39.09 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.816 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -70.17 -11.43 60.89 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -154.3 168.49 32.58 Favored Glycine 0 C--N 1.366 2.216 0 C-N-CA 118.167 -1.968 . . . . 0.0 114.398 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ARG . 3.3 tt0 -94.55 117.99 30.98 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 121.878 -0.777 . . . . 0.0 110.397 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 5.1 m -97.2 178.86 5.1 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.134 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 22.4 ptt180 171.03 115.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.106 0.867 . . . . 0.0 110.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.897 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -179.49 -147.87 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 6.3 t -142.8 -172.11 3.58 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.2 m -143.95 174.33 10.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 17' ' ' VAL . 8.7 pt -157.07 166.82 15.81 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.155 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 17' ' ' VAL . 4.2 Cg_exo -76.3 165.26 29.69 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.333 . . . . 0.0 111.398 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 0.0 110.699 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.857 0.361 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 166.72 12.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.431 ' OG ' HG23 ' A' ' 21' ' ' ILE . 65.4 m -132.12 153.53 50.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.408 0.623 . . . . 0.0 111.814 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CZ ' ' HB1' ' A' ' 26' ' ' ALA . 1.6 p90 -135.36 131.62 36.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.122 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.461 HD12 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.51 121.44 38.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.665 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.6 m -102.61 154.89 18.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.758 0.789 . . . . 0.0 112.782 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.9 t80 -119.11 115.69 24.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.198 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.53 162.51 20.57 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.02 -11.7 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.919 2.413 . . . . 0.0 113.333 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 4.8 t0 -170.19 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.144 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.2 mt-30 -160.64 163.58 32.46 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.168 0.509 . . . . 0.0 111.714 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.755 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.91 117.33 47.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.715 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.1 m -123.01 138.17 54.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.444 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 38.9 t -122.38 146.48 47.3 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.343 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -140.1 134.78 31.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.326 0.584 . . . . 0.0 111.9 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 43' ' ' CYS . 3.3 mp -107.39 131.0 58.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.511 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 49.8 m -131.75 -172.84 2.97 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 119.286 -0.966 . . . . 0.0 113.363 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -151.76 60.35 0.87 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.65 0.53 7.22 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 119.998 -1.096 . . . . 0.0 114.063 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -167.5 -160.56 0.36 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.263 1.031 . . . . 0.0 112.759 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HB1' ' CZ ' ' A' ' 9' ' ' PHE . . . -173.23 139.06 0.83 Allowed Pre-proline 0 C--N 1.346 0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.479 ' HD2' ' CE2' ' A' ' 9' ' ' PHE . 51.7 Cg_exo -55.35 142.37 79.75 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.231 1.954 . . . . 0.0 112.019 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.1 tp -64.77 110.04 3.61 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.11 152.55 80.62 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.582 2.188 . . . . 0.0 112.167 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 p -165.81 -50.53 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.99 33.22 1.36 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 122.048 -0.407 . . . . 0.0 111.637 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 160.85 169.14 23.72 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.771 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.97 -163.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -161.52 159.51 27.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.235 0.54 . . . . 0.0 111.146 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.68 153.65 74.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.673 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.36 128.5 25.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.722 2.281 . . . . 0.0 112.37 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.586 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 12.8 t-160 -157.83 89.81 2.35 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.771 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -30.85 -68.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.537 2.824 . . . . 0.0 113.358 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -157.93 -160.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.48 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' CE1' ' A' ' 37' ' ' HIS . . . 171.05 154.31 0.21 Allowed Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 120.614 0.245 . . . . 0.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 56.2 Cg_endo -70.04 -13.89 34.51 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.328 2.019 . . . . 0.0 111.954 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.718 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 90.1 t90 -93.91 -53.49 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.213 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.547 ' O ' HD11 ' A' ' 21' ' ' ILE . 73.8 m -50.02 -33.76 19.1 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -88.44 -39.36 14.31 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 4.1 mt-10 -48.82 -26.84 2.62 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.308 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.3 -23.73 2.85 Favored Glycine 0 C--N 1.36 1.916 0 C-N-CA 118.487 -1.816 . . . . 0.0 113.497 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 60.28 2.48 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.699 0.75 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.3 p -93.11 31.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -125.75 147.12 49.48 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.676 0.274 . . . . 0.0 110.293 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.459 ' CZ3' ' HD3' ' A' ' 59' ' ' ARG . 1.2 m95 -90.21 164.11 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.027 0.441 . . . . 0.0 111.058 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.3 t -147.23 130.42 8.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.595 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -93.83 87.76 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.637 2.225 . . . . 0.0 113.667 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.647 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -100.42 124.93 46.55 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.3 m -42.55 -49.6 5.4 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.027 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -70.88 -32.55 69.55 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.656 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -172.04 179.78 43.47 Favored Glycine 0 C--N 1.359 1.823 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.286 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HG2' ' CE3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -89.95 145.36 25.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 118.354 1.077 . . . . 0.0 110.192 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 m -129.31 177.62 7.04 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 4.6 mmm180 -150.54 126.92 10.71 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.2 m -109.11 137.99 46.15 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 47' ' ' ALA . 1.9 m -142.64 152.33 42.35 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.443 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.465 ' O ' HG23 ' A' ' 63' ' ' ILE . 35.3 m -155.75 156.55 35.03 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 120.656 1.571 . . . . 0.0 112.306 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.718 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 32.2 pt -161.81 156.75 19.86 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.49 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 84.8 Cg_endo -78.12 164.66 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.055 . . . . 0.0 112.22 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.755 ' CD1' HG22 ' A' ' 17' ' ' VAL . 10.8 m-85 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.888 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 . . . . . 0 N--CA 1.461 0.125 0 CA-C-O 120.734 0.302 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.79 140.98 23.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 30.9 t -118.31 152.26 36.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.727 0.775 . . . . 0.0 112.671 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 27' ' ' PRO . 3.3 p90 -130.9 130.85 44.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.016 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 18' ' ' CYS . 0.8 OUTLIER -94.49 126.15 39.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.067 0.46 . . . . 0.0 110.212 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 17.3 m -105.04 154.31 20.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.693 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -130.0 126.6 38.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -114.06 164.69 15.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.321 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.8 -19.14 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.227 2.618 . . . . 0.0 113.955 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.43 28.76 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.0 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.6 mt-30 -153.83 147.2 24.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.016 0.436 . . . . 0.0 111.834 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.638 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -119.97 122.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.002 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.658 ' O ' HD23 ' A' ' 10' ' ' LEU . 74.5 m -134.58 141.77 46.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 41.5 t -122.1 146.43 47.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.82 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.0 139.29 28.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.285 0.565 . . . . 0.0 112.518 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.27 120.32 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.253 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 58.8 m -108.96 -176.16 2.96 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.096 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.58 54.95 0.74 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.24 21.87 7.46 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.544 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -130.76 -157.45 0.82 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.391 0.596 . . . . 0.0 111.99 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -146.57 177.85 1.63 Allowed Pre-proline 0 C--N 1.34 0.179 0 CA-C-O 120.593 0.235 . . . . 0.0 110.902 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 98.3 Cg_endo -81.16 124.06 4.73 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.642 2.228 . . . . 0.0 113.126 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.6 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 3.5 tt -71.24 -35.87 4.38 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.594 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 96.2 Cg_exo -44.81 170.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.516 2.144 . . . . 0.0 112.98 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -151.25 -37.1 0.13 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.92 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -82.79 30.75 0.43 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.59 0.632 . . . . 0.0 111.825 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.56 163.6 34.67 Favored Glycine 0 N--CA 1.466 0.698 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.15 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -100.62 -166.31 1.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.436 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -160.77 159.94 30.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.358 0.599 . . . . 0.0 112.072 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -137.7 173.05 5.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.427 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 74.4 Cg_endo -75.61 135.3 17.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.539 2.16 . . . . 0.0 113.036 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.458 ' CD2' ' SG ' ' A' ' 43' ' ' CYS . 31.5 t60 -164.37 95.73 0.95 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.76 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' SER . 2.6 Cg_endo -39.71 -81.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.394 2.729 . . . . 0.0 114.21 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -176.03 53.5 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.825 0.078 . . . . 0.0 110.885 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -59.38 174.06 0.45 Allowed Pre-proline 0 N--CA 1.471 0.622 0 O-C-N 122.022 -0.424 . . . . 0.0 111.555 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.2 Cg_endo -65.76 1.74 2.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.575 2.183 . . . . 0.0 113.045 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.618 ' CZ2' HG21 ' A' ' 63' ' ' ILE . 21.1 t90 -90.06 -56.22 3.31 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.458 ' SG ' ' CD2' ' A' ' 37' ' ' HIS . 53.2 m -64.74 -32.93 74.84 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -78.06 -44.47 26.26 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.406 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 9.5 tt0 -64.49 -19.64 65.7 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.98 -18.5 6.82 Favored Glycine 0 C--N 1.364 2.09 0 C-N-CA 118.095 -2.002 . . . . 0.0 112.683 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.786 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -93.73 68.28 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.296 0.57 . . . . 0.0 110.434 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 m -89.27 29.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.56 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -145.02 133.31 21.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -95.64 167.8 11.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.218 0.532 . . . . 0.0 111.922 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 59' ' ' ARG . 11.5 p -155.97 139.04 10.79 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.73 120.59 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.597 2.198 . . . . 0.0 113.963 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.621 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -104.53 132.48 50.73 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.039 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -61.8 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -26.58 68.02 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.152 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -168.48 176.8 42.74 Favored Glycine 0 C--N 1.359 1.821 0 C-N-CA 118.989 -1.576 . . . . 0.0 112.808 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.0 tt0 -93.15 127.56 38.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.665 1.232 . . . . 0.0 110.447 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -136.82 -173.98 3.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.216 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.658 ' HA ' HG12 ' A' ' 51' ' ' VAL . 6.2 ttp180 -156.66 127.37 6.71 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.1 t -104.05 130.97 51.75 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.786 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -127.93 162.36 26.93 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.9 m -150.91 170.5 19.17 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 119.863 1.21 . . . . 0.0 111.538 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.618 HG21 ' CZ2' ' A' ' 42' ' ' TRP . 5.5 pt -157.19 151.58 20.29 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.605 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' ILE . 7.7 Cg_exo -71.53 125.9 11.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.881 2.387 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.638 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.969 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 p30 . . . . . 0 N--CA 1.461 0.076 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -148.11 141.07 24.82 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.617 ' OG ' HG23 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -121.18 148.87 43.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.69 0.757 . . . . 0.0 112.903 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -135.4 132.18 37.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.51 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -97.91 125.58 42.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.07 0.462 . . . . 0.0 109.805 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -103.8 143.54 32.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.163 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.39 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.82 162.6 32.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.883 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -44.29 -18.07 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.399 . . . . 0.0 113.694 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.38 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.413 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.61 166.93 29.69 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.048 0.451 . . . . 0.0 111.704 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.485 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -141.43 108.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.245 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.511 ' O ' HD23 ' A' ' 10' ' ' LEU . 91.1 m -114.37 134.75 54.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 111.818 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.6 t -119.27 144.16 46.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.576 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -150.81 139.91 21.11 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.452 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.907 HD11 ' HB3' ' A' ' 43' ' ' CYS . 1.3 mt -111.86 110.52 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.562 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 1.3 m -86.94 -175.51 5.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.84 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.94 51.71 0.98 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.55 22.5 4.02 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.484 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 56' ' ' GLY . . . -162.54 -156.63 0.41 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.033 0.916 . . . . 0.0 112.051 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -163.68 132.92 2.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD2' ' CE1' ' A' ' 9' ' ' PHE . 15.4 Cg_endo -56.93 145.72 83.4 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.511 2.141 . . . . 0.0 112.647 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD12 ' OH ' ' A' ' 53' ' ' TYR . 1.2 mp -78.53 111.81 21.91 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.053 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.51 151.46 29.05 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.534 2.156 . . . . 0.0 112.127 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 -55.6 0.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.301 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -95.1 29.52 2.42 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 118.108 0.413 . . . . 0.0 111.55 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.27 -162.53 36.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.75 -162.86 1.15 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.686 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.07 163.29 39.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.107 0.48 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -139.07 155.24 72.83 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.537 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.77 130.09 28.34 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.615 2.21 . . . . 0.0 112.438 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 39' ' ' THR . 3.7 t60 -157.87 100.68 1.8 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -30.04 -73.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.316 2.677 . . . . 0.0 113.378 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.571 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 10.5 t -154.13 -159.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . 178.88 130.42 0.22 Allowed Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 38.8 Cg_exo -56.73 -20.69 36.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.289 1.993 . . . . 0.0 112.088 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.816 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 63.3 t90 -86.9 -47.95 8.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.907 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -42.43 -57.57 2.57 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -69.96 -35.81 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.164 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 71.4 tt0 -46.15 -31.12 2.22 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 118.284 0.493 . . . . 0.0 111.582 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.8 10.68 3.96 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 118.338 -1.887 . . . . 0.0 113.907 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 59' ' ' ARG . . . -92.21 45.76 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.383 0.591 . . . . 0.0 111.24 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.57 33.84 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.99 15.87 4.7 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.745 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -130.24 -175.11 3.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.281 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.3 t 142.82 -42.5 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.08 0 O-C-N 123.746 0.654 . . . . 0.0 110.038 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 98.6 Cg_endo -86.69 78.89 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 114.447 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.614 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.5 t80 -109.35 130.57 55.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.61 -60.49 1.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -67.11 -30.35 70.34 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.407 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.54 -172.59 37.75 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.619 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.742 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -95.19 132.64 39.93 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.53 1.665 . . . . 0.0 109.273 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.705 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 19.1 m -135.99 -174.19 3.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.828 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.644 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.76 132.22 20.84 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 t -125.73 139.77 53.25 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -140.54 162.24 35.82 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.242 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.4 m -157.29 146.82 20.31 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 119.96 1.255 . . . . 0.0 111.506 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.816 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 3.5 pt -149.18 165.29 18.04 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.737 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 32.7 Cg_exo -59.54 164.8 10.58 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 0.0 111.979 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.156 0.503 . . . . 0.0 110.788 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 7' ' ' GLU . 1.5 p30 . . . . . 0 CA--C 1.502 -0.868 0 CA-C-O 122.478 1.132 . . . . 0.0 108.734 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.571 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 9.6 mt-10 -177.64 -167.56 0.15 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.159 -2.291 . . . . 0.0 109.653 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.436 ' HB2' HG12 ' A' ' 21' ' ' ILE . 32.8 t -135.21 142.12 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.316 0.579 . . . . 0.0 111.791 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 31.1 p90 -124.79 132.78 53.32 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.613 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.757 HD12 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -97.74 131.3 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.703 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.9 m -116.36 133.27 56.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.629 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.31 130.71 56.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -126.11 149.85 67.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.496 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.24 4.5 0.13 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.673 2.248 . . . . 0.0 113.358 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' GLN . 3.8 m-20 -117.57 -29.94 5.63 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 15' ' ' ASP . 1.2 mt-30 -172.27 -167.22 0.45 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.684 0.278 . . . . 0.0 110.838 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -125.95 144.83 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.208 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -145.08 145.64 31.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 112.113 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.535 ' CB ' ' CH2' ' A' ' 42' ' ' TRP . 2.3 t -127.38 152.78 47.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.752 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -144.02 135.17 25.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.342 0.591 . . . . 0.0 111.759 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 47' ' ' ALA . 37.8 mt -104.92 110.28 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.225 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.671 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 70.5 m -100.6 172.41 7.12 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.836 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.709 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -148.81 46.86 1.02 Allowed 'General case' 0 C--N 1.354 0.78 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . . . 128.21 30.95 0.7 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.7 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.563 ' HB1' ' CG ' ' A' ' 53' ' ' TYR . . . -123.09 -165.7 1.35 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.203 1.001 . . . . 0.0 112.287 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -125.74 99.07 32.99 Favored Pre-proline 0 C--N 1.344 0.332 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.512 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 32.6 Cg_exo -32.38 90.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.45 2.767 . . . . 0.0 113.485 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 tp -98.7 122.66 52.45 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.8 -170.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.501 2.134 . . . . 0.0 112.119 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 p -149.28 -52.8 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.413 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.86 30.47 3.71 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.252 0.478 . . . . 0.0 111.681 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.36 -146.16 7.27 Favored Glycine 0 N--CA 1.461 0.364 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.365 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -116.46 -169.77 1.69 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.333 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -156.07 166.39 33.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.034 0.445 . . . . 0.0 111.359 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -143.0 168.58 12.73 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.544 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.71 134.99 22.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.67 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.757 ' CD2' HD12 ' A' ' 10' ' ' LEU . 6.9 t60 -157.65 93.13 2.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 39' ' ' THR . 22.0 Cg_exo -28.6 -85.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.9 3.066 . . . . 0.0 114.628 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 38' ' ' PRO . 10.7 p -162.43 55.65 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.463 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.634 ' HB2' ' NE2' ' A' ' 37' ' ' HIS . . . -43.49 166.85 0.09 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 CA-C-N 118.468 0.576 . . . . 0.0 111.869 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 52.6 Cg_exo -56.56 -47.23 24.83 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.213 2.608 . . . . 0.0 113.993 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.706 ' CZ3' HD12 ' A' ' 63' ' ' ILE . 38.5 p-90 -72.65 -45.82 57.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 1.3 m -47.24 -45.66 23.72 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -31.68 21.91 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.865 -0.522 . . . . 0.0 109.951 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 1.7 tm-20 -47.71 -31.72 5.04 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.705 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.51 -11.82 1.46 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 118.214 -1.946 . . . . 0.0 114.711 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.799 ' C ' ' HG2' ' A' ' 59' ' ' ARG . . . -72.14 64.13 0.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.441 1.12 . . . . 0.0 111.635 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.23 52.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.463 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HG2' ' NE ' ' A' ' 59' ' ' ARG . 7.7 pt-20 -134.37 -15.87 2.16 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.858 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.6 t90 -102.33 -166.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.964 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 170.01 -38.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.839 ' HD3' HG23 ' A' ' 51' ' ' VAL . 7.7 Cg_exo -75.59 81.15 2.39 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.178 1.919 . . . . 0.0 116.267 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.563 ' CG ' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -112.57 129.45 56.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.691 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.2 p -26.01 -73.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -22.45 50.66 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.44 -165.98 19.3 Favored Glycine 0 C--N 1.356 1.644 0 C-N-CA 118.911 -1.614 . . . . 0.0 111.945 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 4.1 mt-30 -95.26 166.3 11.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.523 2.161 . . . . 0.0 109.321 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.671 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 44.8 t -175.84 -176.54 0.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.333 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.83 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -158.17 145.66 18.18 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 118.515 0.598 . . . . 0.0 111.591 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 60' ' ' THR . 9.5 t -112.58 104.03 12.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.568 ' CG2' ' HB2' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.57 172.63 6.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.128 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m -155.84 158.57 38.29 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 118.993 0.815 . . . . 0.0 111.42 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.706 HD12 ' CZ3' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -153.87 162.19 27.36 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.209 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 51.2 Cg_exo -54.98 160.47 7.83 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.773 2.316 . . . . 0.0 112.623 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.835 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p30 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.766 0.317 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -142.25 153.91 44.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.681 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.464 ' OG ' HG23 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -130.53 149.6 52.12 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 112.596 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -132.61 135.41 45.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.04 178.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.64 118.01 35.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.825 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.2 m -106.44 139.28 41.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.441 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -133.76 151.09 76.39 Favored Pre-proline 0 CA--C 1.511 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.258 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.84 -1.51 1.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.619 1.546 . . . . 0.0 110.861 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.4 t0 -114.34 -29.29 6.95 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.534 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.427 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -179.33 173.5 1.1 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.99 0.424 . . . . 0.0 111.604 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' CZ ' ' A' ' 65' ' ' TYR . 2.3 m -111.57 118.97 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.405 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 3.5 m -110.43 128.9 55.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.814 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 51.8 t -112.19 145.78 39.27 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.341 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -152.29 138.45 18.31 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.174 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.821 HD11 ' HB3' ' A' ' 43' ' ' CYS . 1.7 mt -108.83 113.79 45.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.659 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 1.3 m -93.61 -177.3 4.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.528 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 57' ' ' GLN . 18.0 tpt85 -145.19 49.18 1.27 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.42 25.68 3.68 Favored Glycine 0 C--N 1.348 1.211 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -158.51 -157.74 0.65 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.848 0.824 . . . . 0.0 112.154 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -155.43 179.98 1.22 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.32 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 67.2 Cg_endo -91.36 138.7 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.739 2.292 . . . . 0.0 113.219 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.494 HD12 ' OH ' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -108.11 64.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.276 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 27' ' ' PRO . 67.8 Cg_endo -72.11 -161.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.588 2.192 . . . . 0.0 111.994 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.99 -54.87 3.04 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.23 -95.03 0.1 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 39.64 -161.9 0.01 OUTLIER Glycine 0 N--CA 1.474 1.231 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.743 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.1 178.54 7.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 m -157.82 178.99 9.62 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 119.042 0.837 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -157.86 145.31 13.58 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.26 135.25 68.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.527 2.151 . . . . 0.0 112.372 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' SER . 27.3 t60 -161.6 98.65 1.23 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.933 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -29.35 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.377 2.718 . . . . 0.0 113.448 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -155.43 -161.95 1.26 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 177.72 158.89 0.55 Allowed Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.026 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 72.8 Cg_endo -74.74 -16.38 20.95 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.446 2.097 . . . . 0.0 112.131 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.676 ' HZ2' HG23 ' A' ' 63' ' ' ILE . 44.4 t90 -87.1 -51.97 5.69 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.272 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.821 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -45.3 -57.68 3.84 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.787 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -35.8 80.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.416 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 2.9 mt-10 -48.56 -30.81 5.69 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.351 0.523 . . . . 0.0 111.813 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.12 17.68 2.53 Favored Glycine 0 C--N 1.357 1.75 0 C-N-CA 118.208 -1.949 . . . . 0.0 113.842 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 59' ' ' ARG . . . -107.52 58.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 111.141 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.4 p -93.85 31.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.301 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.744 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.51 119.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.886 0.374 . . . . 0.0 111.703 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.744 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 1.6 t90 155.86 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.167 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 11.1 m -50.31 -32.18 5.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.105 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 2.9 Cg_exo -77.27 62.65 7.63 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.983 1.789 . . . . 0.0 114.678 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.603 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 2.5 t80 -106.41 116.49 32.02 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -36.7 -58.34 0.74 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.469 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.98 69.98 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.003 -0.523 . . . . 0.0 112.0 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.21 -178.96 42.04 Favored Glycine 0 C--N 1.361 1.921 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.761 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.9 tt0 -96.72 124.21 40.64 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.373 -1.075 . . . . 0.0 109.791 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.623 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.1 m -131.62 -172.95 2.99 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -150.36 133.45 16.17 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 85.1 m -117.62 147.81 42.52 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.744 HG21 ' HA ' ' A' ' 43' ' ' CYS . 1.8 t -151.58 174.09 13.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.78 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 159.92 3.94 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 118.865 0.757 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.676 HG23 ' HZ2' ' A' ' 42' ' ' TRP . 1.7 pt -149.38 151.74 34.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.425 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 68.3 Cg_endo -90.02 93.76 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.226 2.617 . . . . 0.0 112.283 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.443 ' CZ ' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.841 0.353 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -143.11 140.59 30.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 37' ' ' HIS . 13.3 t -111.78 147.95 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.726 0.774 . . . . 0.0 112.372 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.847 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 2.0 p90 -134.07 137.26 44.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.328 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.56 127.17 43.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.978 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.1 m -107.36 142.83 36.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 111.976 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.7 t80 -108.95 130.9 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.262 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.499 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -138.97 142.35 33.17 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.07 6.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.619 2.213 . . . . 0.0 113.321 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.1 p30 -118.95 -33.53 4.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.475 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.3 mp0 -169.4 -170.22 1.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.76 117.23 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.4 146.79 40.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.092 0.473 . . . . 0.0 112.212 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 51.9 t -125.68 150.58 47.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.625 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -149.49 140.44 22.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.538 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 21' ' ' ILE . 3.7 mp -103.85 118.42 50.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.662 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 94.0 m -107.43 -174.03 2.43 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.2 57.37 0.71 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.95 -19.92 1.11 Allowed Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.622 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.567 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . . . -174.77 -155.44 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.289 0.545 . . . . 0.0 110.62 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 9' ' ' PHE . . . 173.56 -58.24 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 26' ' ' ALA . 9.2 Cg_endo -51.06 78.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.288 2.658 . . . . 0.0 114.631 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 53' ' ' TYR . 18.7 tp -134.01 50.5 5.23 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 89.8 Cg_endo -77.83 -171.74 1.28 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.706 2.271 . . . . 0.0 112.727 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 t -159.44 -56.4 0.06 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.9 32.21 4.06 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.012 -0.43 . . . . 0.0 111.617 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 175.12 -152.19 13.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.297 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.55 -167.75 1.99 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 m -156.68 157.11 34.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.756 0.313 . . . . 0.0 110.629 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.57 151.43 75.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 141.06 93.48 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' SER . 82.0 t60 -169.19 97.49 0.51 Allowed Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.813 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -30.54 -71.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.455 2.77 . . . . 0.0 113.551 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -156.51 -157.89 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.799 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 177.3 167.3 0.49 Allowed Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 120.6 0.238 . . . . 0.0 111.082 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.695 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 72.7 Cg_endo -76.09 -25.85 9.81 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.614 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 26.9 p-90 -92.44 -41.14 10.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.413 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 96.6 m -51.68 -37.94 52.8 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.43 -36.12 17.9 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 121.711 -0.618 . . . . 0.0 109.369 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -46.85 -29.77 2.15 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.003 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.18 -10.73 4.53 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.781 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 43' ' ' CYS . . . -94.42 45.15 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.857 0.829 . . . . 0.0 111.091 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 44' ' ' ARG . 7.9 m -95.09 32.06 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.51 143.26 33.71 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -79.82 151.75 30.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.0 p -162.75 94.72 1.17 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.863 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -42.16 110.73 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.931 2.42 . . . . 0.0 113.635 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.649 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.7 t80 -93.26 145.84 24.14 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -32.87 -89.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 44.7 m -68.53 -7.78 35.52 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -166.16 173.1 41.66 Favored Glycine 0 C--N 1.363 2.031 0 C-N-CA 118.769 -1.682 . . . . 0.0 112.679 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -78.04 152.98 32.72 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.706 1.253 . . . . 0.0 109.663 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.8 t -159.67 -171.71 3.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.692 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.619 ' HA ' HG12 ' A' ' 51' ' ' VAL . 1.6 ptt-85 -155.15 125.94 7.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -105.59 136.98 44.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -140.82 171.39 14.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.615 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.7 m -154.76 168.73 25.87 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.578 1.081 . . . . 0.0 111.688 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 17' ' ' VAL . 28.4 pt -154.15 137.29 10.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.841 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.49 124.98 3.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.763 2.308 . . . . 0.0 112.795 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.833 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.31 141.21 33.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -121.7 146.27 47.19 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.505 0.669 . . . . 0.0 111.921 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.541 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -130.6 130.74 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.701 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.84 121.07 33.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.656 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 m -102.65 145.24 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 0.0 112.637 -178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.456 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.4 t80 -110.54 113.26 25.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -117.77 140.69 27.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' OH ' ' A' ' 65' ' ' TYR . 52.1 Cg_exo -55.87 7.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.699 2.266 . . . . 0.0 113.443 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 13' ' ' GLN . 5.6 t0 -118.63 -37.08 3.34 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.245 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.52 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 8.4 mp0 -165.77 -175.49 3.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG22 ' HD1' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -114.06 113.97 45.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 m -110.09 129.68 55.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 43.6 t -108.1 140.32 41.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.744 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.655 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -135.36 143.95 46.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 112.746 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' ARG . 2.5 mp -116.84 138.28 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.489 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 16.9 m -145.81 -171.1 3.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.64 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -156.82 60.74 0.53 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.79 8.86 5.04 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 119.897 -1.145 . . . . 0.0 114.355 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -167.13 -160.54 0.38 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.67 1.235 . . . . 0.0 113.157 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.541 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . -173.49 132.05 0.58 Allowed Pre-proline 0 C--N 1.347 0.481 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.7 Cg_endo -49.84 147.2 14.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 112.159 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.36 111.28 5.72 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.2 152.39 16.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.653 2.235 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 t -166.31 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.131 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.54 33.93 1.37 Allowed 'General case' 0 C--N 1.352 0.695 0 O-C-N 122.068 -0.395 . . . . 0.0 111.548 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 168.18 167.9 29.5 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.829 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.53 -161.49 0.84 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -159.73 160.38 33.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -139.12 152.72 70.43 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.617 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.43 127.52 21.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.263 . . . . 0.0 112.452 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 39' ' ' THR . 12.9 t-160 -160.58 82.51 2.12 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.22 -63.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.782 2.988 . . . . 0.0 113.443 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -140.53 -161.39 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.103 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 172.81 131.41 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.005 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 31.2 Cg_exo -58.22 -18.66 38.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.076 1.851 . . . . 0.0 111.726 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 48.1 t90 -86.36 -51.89 5.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.357 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -45.54 -56.37 5.19 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.485 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.57 -36.18 83.4 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.0 tt0 -49.68 -34.39 18.42 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.73 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.49 -2.94 2.81 Favored Glycine 0 C--N 1.358 1.767 0 C-N-CA 118.405 -1.855 . . . . 0.0 114.376 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.859 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -95.13 63.41 2.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.861 0.831 . . . . 0.0 110.356 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 48' ' ' VAL . 14.9 t -94.44 32.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.387 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -124.55 136.15 53.74 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.679 ' CZ3' ' HG2' ' A' ' 57' ' ' GLN . 4.2 t-105 -96.24 135.84 37.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.518 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 9.6 p -131.93 120.61 17.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.987 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.562 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 71.8 Cg_endo -76.6 114.92 3.96 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.619 2.213 . . . . 0.0 114.091 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.604 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 1.1 t80 -104.61 128.14 52.55 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -42.63 -48.01 5.37 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.933 -0.122 . . . . 0.0 111.242 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.08 -30.74 61.03 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -172.46 179.57 43.92 Favored Glycine 0 C--N 1.359 1.84 0 C-N-CA 118.948 -1.596 . . . . 0.0 113.253 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.679 ' HG2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -81.62 120.31 24.92 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 118.544 1.172 . . . . 0.0 110.337 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -117.94 -178.84 3.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.655 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -160.67 133.81 6.57 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -120.3 130.59 54.52 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.267 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.859 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -139.43 164.79 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.012 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 t -176.87 155.56 1.26 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 120.506 1.503 . . . . 0.0 112.515 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.571 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 7.8 pt -159.08 161.81 27.33 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.118 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 5.3 Cg_endo -47.16 174.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.6 2.2 . . . . 0.0 112.482 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.543 ' HD1' HG22 ' A' ' 17' ' ' VAL . 2.4 m-30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.709 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 120.848 0.356 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 1.1 pt-20 -142.07 141.04 32.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.417 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' HIS . 29.3 t -117.11 141.32 48.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.628 0.727 . . . . 0.0 112.54 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -132.94 137.97 46.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.605 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.52 128.53 50.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.138 0.494 . . . . 0.0 110.475 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 74.0 m -107.98 139.24 42.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.108 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -119.4 128.48 54.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.04 146.39 56.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.866 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.76 3.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 113.38 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' GLN . 32.0 m-20 -111.67 -36.74 5.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.588 0.232 . . . . 0.0 111.109 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -172.51 -175.31 1.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.907 0.384 . . . . 0.0 111.181 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.22 130.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.123 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 99.9 m -128.81 129.66 45.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 112.047 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 34.5 t -112.99 152.72 29.08 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.836 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.842 ' CE2' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -154.48 133.59 12.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.069 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.604 HD11 ' HB2' ' A' ' 43' ' ' CYS . 3.7 mp -101.33 102.14 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.585 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 68.9 m -90.04 -172.46 3.51 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.628 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.83 60.18 0.67 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.63 16.43 9.39 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.16 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' HB2' ' C ' ' A' ' 55' ' ' THR . . . -164.7 -161.17 0.55 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.86 151.78 16.93 Favored Pre-proline 0 C--N 1.34 0.18 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.285 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 20' ' ' PHE . 73.4 Cg_endo -75.79 132.77 14.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.474 2.116 . . . . 0.0 112.234 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 29' ' ' PRO . 14.5 tp -74.05 112.08 15.22 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 28' ' ' LEU . 86.8 Cg_endo -82.32 -174.46 2.11 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.4 p -164.23 -55.8 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.535 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -102.1 33.4 3.08 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.99 -0.444 . . . . 0.0 111.924 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.91 -176.05 47.72 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.673 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -120.15 -164.85 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.7 m -154.15 178.42 10.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.995 0.426 . . . . 0.0 111.442 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.8 165.59 18.44 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.957 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.04 137.77 41.93 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.848 2.365 . . . . 0.0 112.729 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 39' ' ' THR . 11.4 t60 -163.08 92.67 1.18 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 8' ' ' SER . 37.1 Cg_exo -25.49 -71.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.865 3.043 . . . . 0.0 113.819 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.572 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -160.38 -161.07 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.463 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . 173.6 142.2 0.17 Allowed Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.024 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 20.2 Cg_exo -64.95 -12.44 34.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.411 2.074 . . . . 0.0 112.106 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.657 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 67.2 t90 -91.56 -52.73 4.63 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.321 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.792 ' HA ' HG21 ' A' ' 61' ' ' THR . 11.1 m -49.55 -36.23 22.92 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -37.27 20.14 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.735 -0.603 . . . . 0.0 109.754 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -51.12 -25.55 5.32 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.604 179.555 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.48 -6.96 4.52 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 118.221 -1.942 . . . . 0.0 114.192 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -92.01 61.34 4.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.051 0.926 . . . . 0.0 111.259 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 48' ' ' VAL . 18.8 t -111.98 38.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.45 13.41 1.96 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.903 0.382 . . . . 0.0 111.844 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.852 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -128.5 169.04 14.82 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.363 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 158.17 -34.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.473 0.709 . . . . 0.0 110.801 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.717 ' HD3' HG23 ' A' ' 51' ' ' VAL . 73.2 Cg_endo -93.3 68.41 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.083 1.856 . . . . 0.0 113.725 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.793 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 76.4 t80 -97.12 126.84 42.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -37.31 -57.6 0.89 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.423 ' C ' ' HB2' ' A' ' 25' ' ' ALA . 66.1 m -69.7 -27.3 64.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.793 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -174.06 -178.27 43.86 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.325 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -95.54 126.73 41.03 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 119.582 1.691 . . . . 0.0 109.203 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.779 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 43.3 t -142.42 -178.76 5.91 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.174 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.78 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 15.5 mmm-85 -138.3 134.14 33.94 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.842 HG23 ' CE2' ' A' ' 20' ' ' PHE . 91.8 m -117.2 142.78 46.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 43' ' ' CYS . 1.4 t -147.46 160.38 42.64 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.81 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 61' ' ' THR . 81.7 m -158.01 160.73 37.78 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-N 119.541 1.064 . . . . 0.0 110.879 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 3.5 pt -151.65 154.45 33.19 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.444 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 69.1 Cg_endo -89.77 126.39 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.183 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.254 179.898 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.752 ' N ' ' O ' ' A' ' 22' ' ' CYS . 1.9 m-20 . . . . . 0 CA--C 1.506 -0.741 0 CA-C-O 122.532 1.158 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 162.01 -176.46 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.484 -2.144 . . . . 0.0 110.728 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 6.9 t -119.43 158.45 26.19 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.296 0.569 . . . . 0.0 112.136 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.506 ' CE2' ' HB2' ' A' ' 20' ' ' PHE . 2.1 p90 -141.32 126.87 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.257 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.63 128.61 39.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 m -111.2 142.86 42.84 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.996 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.76 128.05 54.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.82 145.82 52.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.759 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.38 5.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.809 2.339 . . . . 0.0 113.423 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -116.6 -34.92 4.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.214 -0.194 . . . . 0.0 111.343 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.2 mt-30 -174.54 -174.28 0.83 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.664 HG13 ' CE1' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -114.58 121.08 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.958 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -114.69 125.72 54.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 1.5 p -107.01 138.31 43.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -140.04 147.24 40.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.97 0.891 . . . . 0.0 112.82 178.631 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 59' ' ' ARG . 25.7 mt -132.38 142.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.461 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 6' ' ' ASP . 4.5 m -142.94 -179.12 6.16 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.938 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.482 ' HA ' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -154.71 69.77 0.75 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.046 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' ' CG ' ' A' ' 6' ' ' ASP . . . 132.6 -5.62 5.2 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.235 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.902 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -126.73 -162.14 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.58 0.69 . . . . 0.0 111.788 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -134.45 171.59 8.76 Favored Pre-proline 0 C--N 1.34 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.918 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 64.3 Cg_endo -87.46 114.38 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.876 2.384 . . . . 0.0 112.901 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.413 ' HB2' ' OH ' ' A' ' 53' ' ' TYR . 1.9 tp -113.79 83.56 7.57 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.015 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 27' ' ' PRO . 32.6 Cg_exo -57.59 -172.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.644 2.229 . . . . 0.0 112.263 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -55.37 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.246 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 2.2 pt-20 -115.81 29.23 8.12 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.94 -0.475 . . . . 0.0 111.672 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.75 -161.85 26.76 Favored Glycine 0 N--CA 1.462 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.394 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.32 -166.7 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.748 0.274 . . . . 0.0 110.777 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 171.26 19.75 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.293 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -149.76 153.71 36.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.23 128.91 25.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.627 2.218 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' ' 8' ' ' SER . 42.9 t60 -158.3 114.08 1.73 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.772 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -38.89 -77.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.654 2.236 . . . . 0.0 112.947 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -156.55 -158.64 0.8 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -177.51 143.7 0.52 Allowed Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.264 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 24.6 Cg_exo -62.65 -15.9 49.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.489 2.126 . . . . 0.0 112.203 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.758 ' HZ2' HG23 ' A' ' 63' ' ' ILE . 32.6 t90 -84.68 -50.33 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.871 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -45.13 -53.02 8.55 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.26 -36.42 82.95 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 25.1 tt0 -47.41 -36.89 10.43 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.351 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.26 2.56 1.14 Allowed Glycine 0 C--N 1.359 1.814 0 C-N-CA 118.112 -1.994 . . . . 0.0 115.224 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.564 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -82.65 65.03 7.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.404 1.102 . . . . 0.0 110.136 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -49.35 -22.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.69 160.45 32.62 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.057 -0.402 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.463 ' CZ2' ' NH1' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -161.07 15.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.952 HG23 ' HG3' ' A' ' 57' ' ' GLN . 7.6 p -156.0 6.29 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.735 ' CD ' ' H ' ' A' ' 51' ' ' VAL . 14.5 Cg_endo -56.51 32.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 N-CA-C 118.795 2.575 . . . . 0.0 118.795 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.902 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -137.21 116.62 12.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.26 1.391 . . . . 0.0 109.669 176.557 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.8 t -46.64 -53.25 11.96 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.356 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 m -70.57 -21.12 62.73 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.95 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 53' ' ' TYR . . . -159.53 167.77 35.23 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.836 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.952 ' HG3' HG23 ' A' ' 51' ' ' VAL . 5.0 mt-30 -80.75 129.47 34.54 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 121.683 -0.893 . . . . 0.0 109.288 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 52' ' ' PRO . 1.1 m -120.77 -169.03 1.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.95 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.737 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.7 OUTLIER -162.46 132.97 4.77 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.6 t -131.59 132.87 44.42 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -143.9 169.0 18.62 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.128 177.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.416 ' N ' HG23 ' A' ' 61' ' ' THR . 0.1 OUTLIER -170.62 156.32 5.28 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.47 1.032 . . . . 0.0 111.161 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.758 HG23 ' HZ2' ' A' ' 42' ' ' TRP . 3.4 pt -149.5 156.1 39.17 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.539 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.21 125.32 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.206 2.604 . . . . 0.0 111.921 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.664 ' CE1' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.408 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p 58.18 27.5 15.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 111.056 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.02 125.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.9 p -128.51 149.36 71.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.82 -162.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.651 2.234 . . . . 0.0 112.097 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.583 ' HB2' HG22 ' A' ' 21' ' ' ILE . 1.6 p30 -69.74 151.93 45.24 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.522 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -150.56 141.81 23.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.783 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.1 t -110.91 145.89 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -127.22 130.99 50.7 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.407 178.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.15 103.54 15.58 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.4 m -87.61 152.65 22.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.281 0.562 . . . . 0.0 111.903 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 11.1 t80 -125.33 138.29 54.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.767 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.96 158.38 75.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 5.0 Cg_endo -46.87 -14.19 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.164 2.576 . . . . 0.0 113.628 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 15.8 t70 -164.94 29.18 0.06 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.776 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.85 165.56 35.69 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 111.812 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -144.03 131.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.904 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 20' ' ' PHE . 11.7 m -124.37 135.85 53.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 112.078 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.813 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 17.7 p -116.97 111.08 19.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.846 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.852 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -134.7 136.4 42.71 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.894 HD12 HG23 ' A' ' 60' ' ' THR . 4.0 mt -108.47 95.26 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.377 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 5.0 m -76.82 -176.95 4.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.905 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.605 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.66 62.89 1.32 Allowed 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.33 17.91 7.43 Favored Glycine 0 C--N 1.351 1.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.414 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.749 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -138.5 -159.7 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.621 0.71 . . . . 0.0 111.857 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -140.38 179.5 1.25 Allowed Pre-proline 0 C--N 1.339 0.132 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 88.3 Cg_endo -83.61 111.1 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.293 1.995 . . . . 0.0 112.791 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 111.71 15.76 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.728 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.11 161.82 26.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.564 2.176 . . . . 0.0 112.34 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.25 -52.11 0.4 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.016 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -145.68 30.49 1.09 Allowed 'General case' 0 C--N 1.352 0.701 0 O-C-N 122.01 -0.431 . . . . 0.0 111.663 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . -167.95 -139.07 2.6 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.301 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.67 -165.28 1.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.259 0.529 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 10.6 m -155.74 169.97 23.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 110.379 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -144.68 162.2 39.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.254 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.26 129.85 10.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.8 t-80 -161.14 114.75 1.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -35.48 -68.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.505 ' CG2' HD11 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -141.11 -154.56 0.52 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.628 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -156.21 133.19 6.37 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 122.417 -0.177 . . . . 0.0 111.331 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 4.4 Cg_exo -74.44 -23.75 14.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.85 2.366 . . . . 0.0 112.659 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.813 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 5.4 p-90 -84.98 -38.3 19.44 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.841 ' SG ' HG22 ' A' ' 60' ' ' THR . 0.1 OUTLIER -45.96 -59.28 2.93 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.442 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -66.88 -36.08 81.49 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 21.0 tt0 -55.24 -17.34 4.35 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.477 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.36 -31.42 0.42 Allowed Glycine 0 C--N 1.369 2.376 0 C-N-CA 117.124 -2.465 . . . . 0.0 114.048 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.801 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -103.8 -115.44 0.22 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.258 0.551 . . . . 0.0 112.305 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.71 HG13 ' H ' ' A' ' 49' ' ' GLU . 1.1 p 175.53 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.651 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.71 ' H ' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.37 -166.92 2.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.849 ' CE3' ' HB2' ' A' ' 58' ' ' CYS . 3.9 t90 -154.73 -146.09 0.18 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.321 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 50' ' ' TRP . 1.2 t 153.07 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 117.877 0.308 . . . . 0.0 111.294 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' HB ' ' A' ' 51' ' ' VAL . 7.2 Cg_exo -75.38 92.22 1.02 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.742 2.295 . . . . 0.0 115.34 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.749 ' CE2' ' HB1' ' A' ' 25' ' ' ALA . 41.3 t80 -128.01 129.99 47.6 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -36.23 -70.0 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -73.31 -19.32 61.06 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.09 -168.33 25.97 Favored Glycine 0 C--N 1.362 1.974 0 C-N-CA 118.348 -1.882 . . . . 0.0 113.416 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.1 tt0 -103.44 136.6 42.89 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 119.373 1.586 . . . . 0.0 108.49 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.849 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 56.0 m -123.92 -172.32 2.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.901 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.581 ' HA ' ' CB ' ' A' ' 50' ' ' TRP . 39.6 ptt85 -166.03 111.45 0.85 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.0 -0.438 . . . . 0.0 110.752 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.894 HG23 HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER 164.0 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.202 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.801 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 6.4 t -144.37 -173.87 4.15 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.724 ' O ' HG23 ' A' ' 63' ' ' ILE . 1.8 m -143.78 153.09 42.04 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 122.916 0.486 . . . . 0.0 109.96 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.724 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -166.7 163.39 10.98 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.244 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 18.0 Cg_exo -66.07 -161.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.595 2.196 . . . . 0.0 111.439 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -75.54 -144.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.457 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 15.8 t -82.41 -27.15 8.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.745 0.307 . . . . 0.0 111.098 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.923 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 t -58.63 150.94 21.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.728 0.299 . . . . 0.0 110.876 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.85 -41.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.427 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -170.73 -62.81 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.999 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 4' ' ' THR . 38.2 Cg_endo -66.92 64.68 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.482 2.121 . . . . 0.0 112.48 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -149.16 140.39 23.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.491 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -169.33 157.56 7.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 48.2 t -104.21 152.4 22.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.3 0.572 . . . . 0.0 112.162 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -129.07 137.09 51.06 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.542 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.4 117.35 29.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.726 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 27' ' ' PRO . 74.2 m -100.36 141.36 33.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -128.19 130.12 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.59 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -142.02 150.01 54.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.27 5.54 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.377 2.051 . . . . 0.0 113.097 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' O ' ' NE2' ' A' ' 16' ' ' GLN . 2.5 m-20 -126.58 -17.34 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.474 ' NE2' ' HB3' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -165.71 172.03 12.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.201 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.753 HG13 ' CE1' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -134.07 119.28 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.041 178.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.0 m -121.85 149.16 43.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.896 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 12.3 p -132.52 124.41 28.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.839 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.836 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -141.16 138.75 33.65 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 60' ' ' THR . 6.7 mt -101.1 125.59 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' HB2' ' A' ' 26' ' ' ALA . 7.8 m -145.72 -172.59 3.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 118.291 -1.364 . . . . 0.0 114.289 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.61 63.53 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 150.95 -36.44 0.89 Allowed Glycine 0 C--N 1.348 1.212 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.442 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . 175.36 -161.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.839 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . 179.82 -57.71 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.839 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 56.4 Cg_endo -101.49 111.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.775 2.316 . . . . 0.0 114.28 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.06 112.24 28.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -39.09 113.22 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.961 2.44 . . . . 0.0 113.001 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -142.63 -49.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.328 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.67 34.22 0.45 Allowed 'General case' 0 C--N 1.353 0.76 0 CA-C-N 118.443 0.565 . . . . 0.0 112.168 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -173.49 46.26 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.608 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.86 -165.15 1.47 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.671 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.9 m -154.08 179.32 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 163.94 22.44 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.25 136.8 32.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.894 2.396 . . . . 0.0 112.631 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 t-160 -171.3 101.83 0.4 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.064 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 8' ' ' SER . 47.5 Cg_exo -33.33 -65.8 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.165 2.577 . . . . 0.0 113.29 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 51.8 p -151.3 -157.43 0.81 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.301 0.376 . . . . 0.0 110.397 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.802 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -165.5 173.6 3.5 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.763 0.316 . . . . 0.0 111.456 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.802 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 86.2 Cg_endo -81.45 -48.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.893 2.395 . . . . 0.0 112.701 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.896 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 19.2 p-90 -71.87 -41.14 68.42 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.823 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.02 -56.65 3.23 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -78.37 -33.14 49.15 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.204 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.474 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 1.4 tp10 -41.15 -37.02 0.82 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 119.06 -0.495 . . . . 0.0 112.134 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.42 10.67 0.85 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 118.106 -1.997 . . . . 0.0 113.875 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 1.012 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -108.49 75.9 1.0 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 117.504 0.652 . . . . 0.0 111.416 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.579 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -23.83 -82.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.047 178.108 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 175.09 -132.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.559 ' N ' ' HB2' ' A' ' 59' ' ' ARG . 5.4 m95 -0.05 132.54 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.6 t -162.94 136.56 4.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 112.921 -1.945 . . . . 0.0 108.099 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.76 121.5 2.51 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.144 1.896 . . . . 0.0 114.303 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.585 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 53.4 t80 -118.69 121.88 41.18 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.6 m -39.51 -47.47 1.88 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.102 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 72.5 m -77.82 -29.43 50.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.339 0.518 . . . . 0.0 112.271 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.06 175.67 37.7 Favored Glycine 0 C--N 1.359 1.843 0 C-N-CA 118.787 -1.673 . . . . 0.0 113.471 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ARG . 21.6 tt0 -87.87 112.25 22.3 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.114 0.957 . . . . 0.0 109.77 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 1.6 m -99.83 -171.64 2.09 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 21' ' ' ILE . 11.3 ptt180 172.08 101.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.836 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 170.63 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.012 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 14.6 t -141.25 -176.8 4.84 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.828 ' O ' HG23 ' A' ' 63' ' ' ILE . 1.3 m -148.67 153.08 37.77 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 123.422 0.689 . . . . 0.0 109.188 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.852 HD11 ' CZ3' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -172.11 164.75 4.11 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 111.796 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HB3' ' NE2' ' A' ' 16' ' ' GLN . 71.7 Cg_endo -97.64 153.93 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.786 2.99 . . . . 0.0 112.086 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.753 ' CE1' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -136.06 -147.94 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.45 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 9.7 p -93.87 155.04 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.914 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 t 60.59 179.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.752 0.311 . . . . 0.0 110.999 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -176.62 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.96 154.94 46.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.69 60.76 4.4 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.566 2.177 . . . . 0.0 112.49 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -109.54 159.88 16.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -142.65 140.18 31.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.823 ' HB2' HG23 ' A' ' 39' ' ' THR . 3.4 t -119.43 154.53 33.56 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.865 0.84 . . . . 0.0 112.438 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 1.1 p90 -143.43 140.53 30.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.65 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.17 137.13 37.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.887 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 91.9 m -117.45 150.76 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 111.771 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 22.8 t80 -113.44 124.9 53.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.803 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -134.72 144.6 51.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.74 5.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.693 2.262 . . . . 0.0 113.548 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -116.03 -34.72 4.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.442 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -176.01 -169.18 0.31 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.81 115.64 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -102.8 132.72 48.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.798 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 5.4 t -112.57 148.65 34.08 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.942 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.425 0.631 . . . . 0.0 111.714 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 43' ' ' CYS . 2.1 mp -107.13 122.08 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.259 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 37.8 m -110.11 -175.13 2.65 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -155.7 51.49 0.56 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.81 13.71 5.98 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.295 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -169.85 -160.03 0.23 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.904 0.852 . . . . 0.0 112.058 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . . . -174.55 123.66 0.38 Allowed Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 7.8 Cg_endo -50.13 143.68 24.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.411 2.074 . . . . 0.0 112.01 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -71.64 114.65 30.18 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.62 169.79 2.99 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.609 2.206 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -170.77 -45.4 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.719 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -91.43 30.54 1.28 Allowed 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.267 0.485 . . . . 0.0 112.287 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 150.24 -146.14 14.94 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.863 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -128.49 -169.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.897 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 6.3 m -156.51 173.69 16.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.396 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -151.62 164.41 20.36 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.491 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.96 145.64 56.57 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.575 2.183 . . . . 0.0 112.473 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' SER . 15.6 t-80 -172.58 111.83 0.36 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 37' ' ' HIS . 52.7 Cg_exo -29.59 -72.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.05 2.5 . . . . 0.0 112.85 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.823 HG23 ' HB2' ' A' ' 8' ' ' SER . 0.0 OUTLIER -174.11 -163.15 0.15 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.358 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.851 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -164.49 161.64 15.68 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 74.8 Cg_endo -77.72 -14.15 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.475 2.117 . . . . 0.0 112.452 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.786 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 24.0 p-90 -94.68 -51.19 4.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 119.477 -0.297 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.851 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -48.44 -49.25 36.09 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.129 178.629 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.31 -41.67 72.98 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.999 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -38.94 -34.95 0.17 Allowed 'General case' 0 C--N 1.361 1.092 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.749 178.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.63 63.46 0.29 Allowed Glycine 0 C--N 1.357 1.739 0 C-N-CA 119.911 -1.137 . . . . 0.0 111.095 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 1.092 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -78.87 1.11 24.6 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 60' ' ' THR . 55.8 t -163.11 -90.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.607 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -170.99 150.37 3.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.723 0.296 . . . . 0.0 111.58 -178.067 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 60.5 t-105 -73.63 152.6 40.46 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.492 ' CG2' ' HD2' ' A' ' 52' ' ' PRO . 7.8 p -160.42 145.17 10.81 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.495 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HD2' ' CG2' ' A' ' 51' ' ' VAL . 69.7 Cg_endo -93.74 122.13 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.857 2.372 . . . . 0.0 113.584 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.572 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 1.9 t80 -98.7 139.44 34.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -42.86 -62.66 0.95 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -68.6 -25.55 64.92 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -167.77 176.6 42.39 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.228 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -100.3 129.4 46.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.107 1.454 . . . . 0.0 111.262 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.3 t -142.45 -177.68 5.39 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -162.34 140.9 8.97 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 122.162 -0.336 . . . . 0.0 110.413 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.737 HG23 HG11 ' A' ' 48' ' ' VAL . 2.7 t -89.36 158.71 17.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 1.092 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.5 p -152.05 173.28 15.08 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.557 ' H ' ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -177.1 153.05 0.94 Allowed 'General case' 0 C--N 1.353 0.757 0 CA-C-N 120.075 1.307 . . . . 0.0 111.953 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 ' CE3' ' A' ' 42' ' ' TRP . 5.0 pt -161.82 166.5 14.41 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.19 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 50.8 Cg_exo -53.91 171.47 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.118 1.879 . . . . 0.0 111.575 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -71.66 -143.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.46 178.64 4.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -146.08 -60.02 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -84.33 170.2 13.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.97 59.83 7.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.71 46.95 2.17 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.824 2.349 . . . . 0.0 112.826 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -123.63 144.48 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.651 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.0 140.33 17.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.876 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.7 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 22.7 t -114.19 149.48 35.69 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -128.29 145.22 51.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.49 HD21 ' HZ2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -103.55 130.34 50.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 99.4 m -106.06 145.95 30.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.3 m-85 -126.25 136.79 53.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.194 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -131.14 159.39 71.78 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.656 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 10.0 Cg_endo -51.62 -10.79 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.776 2.317 . . . . 0.0 113.199 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.549 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 2.0 t70 -162.61 31.24 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.466 -0.494 . . . . 0.0 112.014 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.485 ' CG ' ' HA ' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -163.1 171.29 16.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.542 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 65' ' ' TYR . 16.2 m -146.15 139.39 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.015 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.18 134.38 44.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.714 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.764 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 47.4 t -119.28 136.74 54.09 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.882 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.2 OUTLIER -144.13 122.72 12.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.991 HG12 HG23 ' A' ' 39' ' ' THR . 1.0 OUTLIER -110.7 99.61 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 76.4 m -106.62 -164.94 1.04 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.487 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.88 66.11 0.79 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.38 9.97 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.779 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' A' ' 55' ' ' THR . . . -165.51 -160.65 0.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.378 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.691 ' HB1' ' CE2' ' A' ' 20' ' ' PHE . . . -175.88 129.79 0.39 Allowed Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 116.87 -0.15 . . . . 0.0 110.647 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -43.43 140.9 3.75 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.737 2.291 . . . . 0.0 112.203 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.18 118.1 70.78 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.63 -173.91 1.93 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.597 2.198 . . . . 0.0 111.94 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.23 -51.87 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 3.5 pm0 -93.31 31.95 1.41 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 118.237 0.471 . . . . 0.0 112.086 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.05 -166.27 39.1 Favored Glycine 0 N--CA 1.462 0.368 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.723 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 6.7 pm0 -120.53 -169.59 1.84 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 33' ' ' GLU . 3.1 m -155.95 176.82 12.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.926 0.393 . . . . 0.0 111.198 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 51.4 p-10 -162.44 159.05 20.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.817 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 35' ' ' ASN . 18.1 Cg_endo -59.47 151.83 65.96 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.795 2.33 . . . . 0.0 112.941 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 8' ' ' SER . 29.8 t-80 179.24 110.24 0.18 Allowed Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.742 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.503 ' O ' ' HB3' ' A' ' 8' ' ' SER . 35.1 Cg_exo -27.91 -75.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.339 2.692 . . . . 0.0 113.728 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.991 HG23 HG12 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -163.6 -169.69 2.0 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.883 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -160.27 146.46 11.76 Favored Pre-proline 0 C--N 1.345 0.406 0 CA-C-N 118.382 0.537 . . . . 0.0 111.25 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 58.6 Cg_endo -71.64 -6.17 18.59 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.634 2.222 . . . . 0.0 112.866 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.764 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 61.6 p-90 -96.65 -35.77 10.93 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -55.54 -43.12 75.49 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 -41.05 24.52 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.1 tt0 -59.99 -9.4 3.04 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.618 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.16 -31.34 2.46 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 117.827 -2.13 . . . . 0.0 111.639 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.77 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -129.8 -109.78 0.27 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.385 0.612 . . . . 0.0 111.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER 176.56 -85.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.826 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 59' ' ' ARG . 51.2 mt-10 -162.14 158.9 25.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.817 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -155.37 69.29 0.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.79 1.281 . . . . 0.0 111.884 178.115 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.889 HG23 ' HD3' ' A' ' 52' ' ' PRO . 10.7 m -46.31 -39.37 13.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 112.875 -1.966 . . . . 0.0 113.885 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.889 ' HD3' HG23 ' A' ' 51' ' ' VAL . 37.0 Cg_endo -64.12 74.22 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.313 1.342 . . . . 0.0 114.343 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.61 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 65.0 t80 -115.82 129.12 56.31 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 m -41.94 -58.85 1.91 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.497 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 63.2 m -65.37 -30.64 71.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.204 0.457 . . . . 0.0 112.161 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -176.98 -161.97 26.62 Favored Glycine 0 CA--C 1.545 1.924 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.718 ' HG2' HG12 ' A' ' 51' ' ' VAL . 8.4 tt0 -88.36 130.03 35.25 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 119.793 1.796 . . . . 0.0 108.748 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.817 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 1.2 m -121.5 167.62 12.64 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.053 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.783 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -163.96 100.79 0.88 Allowed 'General case' 0 C--N 1.37 1.47 0 CA-C-N 118.784 0.72 . . . . 0.0 111.476 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.882 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 167.38 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.77 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 7.5 t -161.66 -163.29 0.96 Allowed 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' O ' HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -135.5 167.07 21.76 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.117 0.567 . . . . 0.0 110.23 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG1' HG23 ' A' ' 17' ' ' VAL . 8.0 pt -158.68 157.0 28.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.033 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 30.0 Cg_endo -63.15 -16.89 57.3 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.424 2.083 . . . . 0.0 113.302 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.825 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER 165.64 -140.49 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.45 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 11.9 m -105.63 -37.52 4.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 120.823 0.344 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.909 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.2 p -117.68 39.55 3.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -103.43 73.74 1.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.411 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -78.0 -54.14 1.34 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 4' ' ' THR . 97.6 Cg_endo -80.03 -178.5 4.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.531 2.154 . . . . 0.0 112.506 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -102.27 140.16 36.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.728 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.85 154.33 27.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.328 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB2' ' CG1' ' A' ' 21' ' ' ILE . 2.4 t -113.11 159.67 18.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.305 0.574 . . . . 0.0 112.131 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.756 ' CE1' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -134.1 133.95 41.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.274 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.61 117.52 30.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.9 m -102.0 138.25 39.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.776 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -123.94 144.22 49.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.41 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.89 162.36 56.3 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.604 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 9.7 Cg_endo -52.11 -12.92 1.62 Allowed 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.638 2.225 . . . . 0.0 112.879 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -160.67 32.22 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.617 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 64' ' ' PRO . 16.2 mt-30 -158.49 156.14 29.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.313 0.578 . . . . 0.0 112.349 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 65' ' ' TYR . 15.8 m -141.28 106.45 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.064 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 12.9 m -113.43 118.78 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.806 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.665 ' O ' ' HB ' ' A' ' 60' ' ' THR . 0.9 OUTLIER -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.865 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -143.6 139.36 29.63 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.713 HD12 HG23 ' A' ' 60' ' ' THR . 3.4 mt -110.91 136.16 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.2 m -146.27 -174.92 4.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.058 -1.057 . . . . 0.0 113.367 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -146.07 63.59 1.23 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.17 -33.57 0.6 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.458 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.62 ' HB2' HG22 ' A' ' 55' ' ' THR . . . -177.12 -154.26 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.006 0.403 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.756 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . . . -156.92 157.78 30.91 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-O 120.524 0.202 . . . . 0.0 110.485 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 37.4 Cg_exo -57.52 151.41 54.19 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.4 2.067 . . . . 0.0 112.089 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.38 109.22 18.02 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.02 178.57 5.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.454 2.102 . . . . 0.0 112.215 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.9 t -160.4 -55.33 0.05 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.356 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 6.2 pm0 -94.25 32.53 1.51 Allowed 'General case' 0 C--N 1.352 0.692 0 O-C-N 122.022 -0.424 . . . . 0.0 111.714 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.81 -169.54 41.98 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.577 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -128.69 -164.43 1.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.159 -0.217 . . . . 0.0 110.532 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.9 m -154.46 178.07 10.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.036 0.446 . . . . 0.0 111.189 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -153.72 161.98 27.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.21 135.99 33.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.544 2.163 . . . . 0.0 112.581 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -165.38 106.84 0.77 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.294 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 8' ' ' SER . 68.1 Cg_exo -37.63 -70.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.96 2.44 . . . . 0.0 113.133 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 21.8 p -154.42 -158.92 0.9 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.349 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 179.53 148.84 0.46 Allowed Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 111.585 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 55.9 Cg_endo -69.7 -24.47 29.93 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.655 2.237 . . . . 0.0 111.631 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.899 ' CZ2' HD11 ' A' ' 63' ' ' ILE . 90.4 t90 -73.34 -45.74 53.44 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.961 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -44.87 -49.05 11.13 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.18 -33.08 24.27 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 2.5 tt0 -48.93 -20.62 0.53 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.319 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.68 -35.25 0.86 Allowed Glycine 0 C--N 1.363 2.029 0 C-N-CA 118.381 -1.866 . . . . 0.0 112.085 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.799 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -141.87 100.16 3.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.991 0.395 . . . . 0.0 111.217 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -24.4 -90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 123.745 0.653 . . . . 0.0 110.439 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 2.2 mt-10 172.24 130.73 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.678 ' HA ' ' CE3' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 141.96 136.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 112.927 -1.942 . . . . 0.0 111.72 176.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.3 p 175.45 83.9 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.911 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 51' ' ' VAL . 1.6 Cg_endo -42.88 140.63 2.94 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.284 2.656 . . . . 0.0 113.607 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.67 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 47.8 t80 -133.46 132.57 41.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.518 -0.764 . . . . 0.0 108.953 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -50.92 5.97 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 25' ' ' ALA . 19.5 m -73.72 -30.94 63.12 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.959 -0.463 . . . . 0.0 112.031 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.67 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -163.58 173.69 39.71 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.358 -1.401 . . . . 0.0 112.399 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ARG . 4.6 tt0 -87.03 112.63 22.04 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 118.904 1.352 . . . . 0.0 110.005 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.561 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 1.5 m -97.42 -171.98 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.406 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.615 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 25.7 ptt180 173.66 102.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.941 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.865 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 172.72 -150.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.799 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 14.6 t -157.2 -170.71 3.35 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.813 ' C ' HD13 ' A' ' 63' ' ' ILE . 19.6 t -165.77 156.7 13.56 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.899 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -152.65 166.83 14.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.696 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' ' CG ' ' A' ' 65' ' ' TYR . 9.3 Cg_endo -51.88 -24.35 18.58 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.261 1.974 . . . . 0.0 112.282 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.707 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER 175.67 -144.99 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.182 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 66' ' ' VAL . 11.0 p -117.75 113.45 42.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.832 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t 61.02 84.71 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.59 117.19 22.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.82 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.6 102.63 39.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -51.95 109.28 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.434 2.089 . . . . 0.0 112.351 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' HB2' HG22 ' A' ' 21' ' ' ILE . 2.9 p30 -119.06 160.74 21.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.796 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -144.37 141.19 29.53 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 35.2 t -113.29 143.99 43.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.488 0.661 . . . . 0.0 112.704 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 134.77 48.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.108 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.49 HD12 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -96.67 119.07 34.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.023 0.439 . . . . 0.0 110.606 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.4 m -100.81 128.74 46.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.331 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -113.9 137.61 51.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -138.64 145.82 47.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.32 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.41 -0.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.705 2.27 . . . . 0.0 113.663 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.8 t0 -122.2 -30.83 3.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -158.8 -175.16 5.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.187 0.518 . . . . 0.0 111.779 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 65' ' ' TYR . 8.3 m -141.24 126.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.909 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.1 m -118.06 141.13 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.632 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.737 ' O ' ' HB ' ' A' ' 60' ' ' THR . 41.8 t -123.97 131.61 53.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.831 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -137.94 136.31 36.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.75 HD12 HG23 ' A' ' 60' ' ' THR . 2.4 mt -103.43 103.93 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.9 m -95.13 -174.2 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.757 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -150.47 60.51 0.95 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 55' ' ' THR . . . 100.71 26.22 8.16 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.011 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.834 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -151.2 -161.26 1.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.04 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -178.04 114.53 0.23 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-O 120.449 0.166 . . . . 0.0 110.682 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 70.1 Cg_exo -49.78 142.93 24.24 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.467 2.111 . . . . 0.0 112.414 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.87 112.49 22.84 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.42 173.89 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.617 2.211 . . . . 0.0 112.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.4 m -155.55 -52.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.638 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -124.39 33.47 5.25 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 118.288 0.494 . . . . 0.0 112.106 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.96 -169.61 41.56 Favored Glycine 0 N--CA 1.462 0.432 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.792 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.29 -162.77 0.99 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -154.83 164.12 39.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.344 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.84 167.66 16.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.666 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.22 136.56 29.46 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.587 2.191 . . . . 0.0 112.691 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.49 ' ND1' HD12 ' A' ' 10' ' ' LEU . 20.9 t-160 -165.06 93.91 0.9 Allowed Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -30.93 -70.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.359 2.706 . . . . 0.0 113.627 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -142.25 -159.19 0.94 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.815 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.934 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -176.63 169.15 1.25 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-O 120.699 0.285 . . . . 0.0 111.373 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 93.8 Cg_endo -83.66 -35.14 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.015 2.477 . . . . 0.0 112.848 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.564 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 17.2 p-90 -88.05 -42.57 12.32 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -42.62 -58.44 2.29 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -36.63 73.65 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.219 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 5.3 tt0 -42.96 -32.35 0.63 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.105 0.411 . . . . 0.0 111.492 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -139.94 13.38 3.11 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 118.868 -1.634 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 43' ' ' CYS . . . -66.14 66.53 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 111.896 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 48' ' ' VAL . 21.5 t -141.8 53.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.96 23.44 0.66 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.262 0.937 . . . . 0.0 112.845 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.925 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -148.85 -173.53 4.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.5 t 153.08 -44.8 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.621 0.769 . . . . 0.0 110.022 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 4.7 Cg_endo -87.82 91.18 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.844 2.362 . . . . 0.0 114.796 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.834 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 10.0 t80 -121.88 128.85 52.05 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 m -40.3 -55.99 2.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 24' ' ' GLY . 64.3 m -66.98 -29.17 68.94 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.766 ' N ' ' HB2' ' A' ' 25' ' ' ALA . . . -177.38 -173.07 42.56 Favored Glycine 0 C--N 1.359 1.822 0 C-N-CA 119.272 -1.442 . . . . 0.0 112.324 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -100.07 125.9 46.21 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 119.637 1.719 . . . . 0.0 109.488 179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.774 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 50.1 t -136.19 -178.78 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.797 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.3 OUTLIER 174.68 137.71 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.741 1.155 . . . . 0.0 111.594 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.831 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 179.44 -147.08 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.473 ' H ' ' HB ' ' A' ' 60' ' ' THR . 9.0 t -151.12 -171.13 3.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.604 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.516 ' O ' HG23 ' A' ' 63' ' ' ILE . 69.7 m -146.23 173.08 12.54 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 17' ' ' VAL . 6.3 pt -158.07 156.54 28.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.782 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 19.4 Cg_endo -58.24 -19.42 42.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.406 2.071 . . . . 0.0 113.012 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.776 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER 166.24 -141.12 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.945 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.509 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 12.2 p -100.44 -31.24 3.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.863 0.363 . . . . 0.0 110.961 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 61.01 90.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 0.0 110.944 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.431 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 3.4 t-80 -118.25 -55.75 2.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.652 HG22 ' HD3' ' A' ' 5' ' ' PRO . 7.7 t -82.54 -31.61 0.54 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.185 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD3' HG22 ' A' ' 4' ' ' THR . 38.7 Cg_exo -60.79 119.59 6.84 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.132 1.888 . . . . 0.0 112.564 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.449 ' HB2' HG22 ' A' ' 21' ' ' ILE . 4.4 p30 -124.86 154.46 41.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.344 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.43 141.06 21.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.206 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.5 t -118.11 144.33 45.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.85 133.12 54.88 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.348 177.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.492 HD21 ' CZ2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -91.53 123.08 34.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 110.504 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -99.2 138.86 35.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.213 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -118.45 129.79 55.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.064 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.9 OUTLIER -138.34 146.79 52.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.857 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 4.48 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.45 2.1 . . . . 0.0 112.698 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -115.97 -32.65 5.34 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.525 0.202 . . . . 0.0 111.216 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.448 ' NE2' ' O ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -172.92 -170.58 0.67 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 0.0 111.265 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.458 ' CG2' ' CE1' ' A' ' 65' ' ' TYR . 1.8 t -133.36 124.7 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.29 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.5 m -124.54 141.35 52.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 111.747 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.637 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 3.1 p -117.03 147.11 42.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.861 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -148.65 128.02 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.514 HD13 ' NE ' ' A' ' 59' ' ' ARG . 1.1 mp -97.6 106.86 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.344 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 2.2 m -84.86 -178.03 6.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.011 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.12 55.89 1.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.27 25.33 6.74 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.247 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.648 ' HB2' ' CA ' ' A' ' 56' ' ' GLY . . . -155.53 -160.59 1.05 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.729 0.764 . . . . 0.0 112.043 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.88 94.66 0.19 Allowed Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.326 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 72.0 Cg_exo -34.7 141.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.238 2.625 . . . . 0.0 113.14 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -80.8 112.76 34.71 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.17 169.05 1.64 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.531 2.154 . . . . 0.0 112.324 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -153.66 -57.86 0.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.207 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.65 29.52 7.34 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.01 -0.431 . . . . 0.0 111.426 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.17 -169.65 42.3 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.514 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.61 -161.43 0.89 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.225 -0.19 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.13 161.18 39.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.153 0.501 . . . . 0.0 111.391 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.4 173.59 4.36 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.75 136.26 20.71 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.066 2.511 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.4 t-80 -173.84 93.29 0.34 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.882 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -29.15 -71.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.608 2.872 . . . . 0.0 113.846 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.413 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 13.8 p -151.2 -155.79 0.66 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.136 0.272 . . . . 0.0 110.762 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . 179.93 164.84 0.84 Allowed Pre-proline 0 N--CA 1.473 0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 111.5 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.15 -28.51 10.73 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.17 2.58 . . . . 0.0 112.193 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.711 ' CE3' HD13 ' A' ' 63' ' ' ILE . 20.8 p-90 -86.71 -39.87 15.61 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.6 -58.42 2.66 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -33.07 65.25 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.229 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 2.8 tt0 -39.6 -42.82 1.23 Allowed 'General case' 0 C--N 1.361 1.089 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.081 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -146.1 16.42 1.72 Allowed Glycine 0 C--N 1.357 1.723 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.456 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 43' ' ' CYS . . . -51.92 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.42 0.629 . . . . 0.0 112.562 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 48' ' ' VAL . 7.7 p -65.82 49.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.169 -1.378 . . . . 0.0 107.936 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -26.57 116.81 0.07 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -121.94 73.85 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.358 177.035 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.856 ' HA ' ' H ' ' A' ' 58' ' ' CYS . 14.0 m -57.32 -38.53 69.04 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.71 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 51' ' ' VAL . 9.7 Cg_endo -51.97 77.53 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.594 1.53 . . . . 0.0 113.587 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.685 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 62.3 t80 -121.7 132.96 54.92 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.5 m -45.26 -58.97 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.5 m -61.91 -30.64 71.02 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 122.014 -0.429 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -179.01 -165.88 34.08 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.916 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.803 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.7 mt-30 -109.98 127.7 54.95 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 120.179 1.99 . . . . 0.0 110.045 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.856 ' H ' ' HA ' ' A' ' 51' ' ' VAL . 14.0 m -131.93 -171.26 2.58 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 4.9 ttp180 -140.06 135.03 32.19 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.557 HG23 HG13 ' A' ' 48' ' ' VAL . 8.8 t -119.38 135.31 54.79 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.68 ' OG1' ' CA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -135.21 165.96 24.2 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 176.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.7 m -156.74 153.44 28.41 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.894 1.225 . . . . 0.0 110.56 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.711 HD13 ' CE3' ' A' ' 42' ' ' TRP . 12.9 pt -148.98 136.72 11.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.53 134.28 2.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.925 2.417 . . . . 0.0 112.277 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE1' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -141.83 -148.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.165 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 21.2 t -149.97 105.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.82 0.343 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.884 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -84.47 136.72 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.15 97.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 m -159.27 58.44 1.22 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.83 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.11 135.86 25.92 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.642 2.228 . . . . 0.0 112.37 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -129.44 148.43 51.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -130.03 140.26 50.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.3 m -123.67 155.41 37.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.523 0.678 . . . . 0.0 112.211 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.511 ' CZ ' ' HD2' ' A' ' 27' ' ' PRO . 0.8 OUTLIER -136.58 129.38 30.77 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.866 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.446 HD11 ' HZ2' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -93.07 124.82 37.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.58 153.04 22.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.761 0.791 . . . . 0.0 112.86 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 21.9 t80 -118.68 114.56 22.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.521 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -120.11 144.76 38.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 19.5 Cg_endo -58.35 6.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 113.338 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.4 m-20 -118.42 -33.05 4.45 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.462 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -170.25 -165.16 0.45 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.584 HG13 ' CE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -122.93 122.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -118.36 148.36 42.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 39.3 t -128.28 143.56 51.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -138.96 138.5 37.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 112.188 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.685 HD12 ' HD3' ' A' ' 59' ' ' ARG . 3.3 mt -112.39 140.63 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.759 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 13.1 m -143.64 -173.62 4.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 119.336 -0.946 . . . . 0.0 113.165 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -149.59 60.58 1.01 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 152.16 -29.09 0.89 Allowed Glycine 0 C--N 1.35 1.316 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.441 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' HB ' ' A' ' 55' ' ' THR . . . -176.14 -156.05 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.68 0.74 . . . . 0.0 111.907 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -150.09 154.52 36.78 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-O 120.561 0.22 . . . . 0.0 110.714 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 40.3 Cg_endo -66.86 159.23 52.59 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.373 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -74.48 111.79 14.46 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 161.91 38.51 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.573 2.182 . . . . 0.0 112.215 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 t -164.9 -49.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.409 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.8 pm0 -92.73 32.59 1.22 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.123 0.42 . . . . 0.0 111.784 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 163.44 169.22 26.6 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.461 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -101.82 -164.27 1.08 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.59 161.04 35.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 110.853 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -140.98 147.5 48.17 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.49 129.3 33.97 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.431 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 39' ' ' THR . 6.5 t-160 -159.55 102.31 1.5 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -33.19 -70.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.18 2.586 . . . . 0.0 113.36 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.42 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -147.55 -157.77 0.84 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.655 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -175.54 151.82 1.3 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.687 0.28 . . . . 0.0 111.116 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 73.6 Cg_endo -75.68 -26.57 9.74 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.589 2.193 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.94 ' CE3' HD13 ' A' ' 63' ' ' ILE . 40.9 p-90 -90.69 -40.38 11.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -44.06 -59.79 2.16 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -33.93 61.06 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.225 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.738 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -47.86 -30.0 3.74 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 119.003 0.82 . . . . 0.0 111.667 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.72 -2.55 4.8 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 118.527 -1.796 . . . . 0.0 113.758 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 61' ' ' THR . . . -83.98 62.04 6.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.618 0.709 . . . . 0.0 110.643 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 48' ' ' VAL . 12.2 p -85.11 27.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.759 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.99 142.92 38.33 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -105.18 158.36 16.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.416 . . . . 0.0 111.334 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -138.69 104.05 7.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.211 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 111.3 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.546 2.164 . . . . 0.0 113.275 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.627 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 5.1 t80 -101.57 129.29 47.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.24 -45.6 5.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.251 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 18.5 m -78.14 -32.73 50.48 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.075 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.57 171.74 40.12 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.032 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ARG . 20.8 tt0 -83.57 122.96 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.499 1.149 . . . . 0.0 109.688 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -112.46 -174.82 2.54 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.685 ' HD3' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -161.62 132.98 5.37 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.4 m -116.86 139.31 50.77 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.465 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -148.35 167.25 25.72 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.074 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.426 ' N ' HG23 ' A' ' 61' ' ' THR . 81.0 m -156.7 158.35 36.78 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.501 1.046 . . . . 0.0 110.852 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.94 HD13 ' CE3' ' A' ' 42' ' ' TRP . 9.2 pt -155.47 157.25 31.57 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 9.5 Cg_endo -51.85 167.53 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.575 2.183 . . . . 0.0 112.092 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.584 ' CE1' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -77.45 -142.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 66' ' ' VAL . 7.1 p -126.34 95.33 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.991 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p -167.47 130.94 1.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -135.62 -178.07 4.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 p -70.87 114.83 30.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.7 -164.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.392 2.061 . . . . 0.0 112.301 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -105.33 149.62 25.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 147.56 45.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 33.8 t -130.83 155.87 45.97 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.515 0.674 . . . . 0.0 111.907 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -139.28 137.65 36.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.07 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -95.26 131.61 41.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.698 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 84.3 m -113.93 154.16 28.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.557 0.694 . . . . 0.0 111.955 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.692 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 16.3 t80 -125.53 130.68 52.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.506 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -133.81 139.9 34.89 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 18.4 Cg_endo -59.26 7.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.445 2.096 . . . . 0.0 112.888 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.0 OUTLIER -119.79 -32.65 4.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.441 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.7 mt-30 -164.47 -168.86 1.62 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.306 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.14 145.92 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.316 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -151.52 139.95 20.5 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.571 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 49.4 t -120.41 150.86 40.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.587 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -146.55 133.55 20.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.533 0.682 . . . . 0.0 112.748 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 43' ' ' CYS . 3.1 mp -105.41 139.26 27.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.29 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.6 m -139.88 -170.75 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 119.201 -1.0 . . . . 0.0 113.353 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.68 58.66 0.81 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.03 18.08 9.07 Favored Glycine 0 C--N 1.349 1.299 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.359 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.82 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -157.09 -166.63 2.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.707 0.754 . . . . 0.0 112.051 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.429 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . 179.81 129.19 0.24 Allowed Pre-proline 0 N--CA 1.469 0.483 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 50.3 Cg_exo -53.89 140.58 68.34 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.134 1.89 . . . . 0.0 112.051 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.1 111.83 7.52 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.26 162.14 17.56 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.699 2.266 . . . . 0.0 112.331 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -174.83 -39.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.516 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.1 pm0 -91.08 32.6 1.0 Allowed 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.932 -0.48 . . . . 0.0 111.929 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 158.53 -163.79 33.21 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.683 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -121.81 -169.8 1.94 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 117.179 0.489 . . . . 0.0 110.616 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 4.3 m -156.98 161.47 39.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -135.35 150.82 73.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.27 140.48 81.61 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.594 2.196 . . . . 0.0 112.363 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.403 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.7 t-160 -168.62 90.07 0.63 Allowed Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -73.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.48 2.787 . . . . 0.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 30.6 p -157.28 -163.95 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 168.92 158.87 0.17 Allowed Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 120.701 0.286 . . . . 0.0 110.93 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 71.8 Cg_endo -76.73 -3.44 13.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.47 2.113 . . . . 0.0 112.119 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.669 ' CH2' HD12 ' A' ' 63' ' ' ILE . 66.1 t90 -93.75 -55.23 3.32 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.275 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.733 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.6 m -54.12 -32.54 55.34 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.59 -41.83 16.04 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.915 -0.49 . . . . 0.0 109.734 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.1 tt0 -51.32 -24.53 4.74 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.549 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.47 -16.82 4.99 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 118.38 -1.867 . . . . 0.0 113.316 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.9 ' HB2' ' CB ' ' A' ' 61' ' ' THR . . . -106.84 67.88 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.381 0.59 . . . . 0.0 111.091 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 48' ' ' VAL . 14.2 p -90.37 30.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.351 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -130.74 142.72 50.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.657 0.265 . . . . 0.0 110.403 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.412 ' CZ2' ' NH2' ' A' ' 59' ' ' ARG . 33.6 m95 -94.96 149.64 21.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.5 p -139.56 107.85 7.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.131 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.48 120.31 7.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 113.762 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.82 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 1.2 t80 -107.45 135.04 49.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.97 -54.66 6.29 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -69.48 -29.15 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 25' ' ' ALA . . . -174.35 -178.23 44.09 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 119.208 -1.472 . . . . 0.0 112.291 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ARG . 2.3 tt0 -81.91 142.42 32.49 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.334 1.567 . . . . 0.0 110.16 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -136.03 -179.2 5.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.309 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 25.7 ttm180 -161.72 122.59 2.7 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 t -108.17 144.86 35.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.9 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -147.89 158.26 43.95 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.12 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 91.6 m -155.41 162.09 40.85 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 120.045 1.293 . . . . 0.0 111.463 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.669 HD12 ' CH2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -158.93 166.11 17.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 30.4 Cg_exo -61.87 161.42 25.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.134 . . . . 0.0 112.463 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HB3' ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.69 -140.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.062 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.429 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 9.0 p -110.2 -25.53 3.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.866 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 p -176.44 89.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -140.02 -70.06 0.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.437 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -91.25 -49.88 0.33 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.4 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 4' ' ' THR . 75.4 Cg_exo -50.97 136.47 44.21 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.46 2.107 . . . . 0.0 112.607 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -137.16 165.57 25.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.715 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.6 139.14 33.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.056 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 5.8 t -119.1 149.03 42.37 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -129.71 144.56 51.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.036 178.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 132.76 47.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.26 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.42 ' SG ' ' HE1' ' A' ' 20' ' ' PHE . 64.4 m -106.86 146.81 30.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.996 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -125.21 132.44 52.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.26 157.16 49.77 Favored Pre-proline 0 CA--C 1.51 -0.559 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.128 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.92 -11.46 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.797 1.665 . . . . 0.0 110.975 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.11 28.21 0.07 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.503 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.5 154.37 31.7 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.204 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -130.0 128.8 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.519 179.078 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -133.43 138.14 46.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 16.4 t -127.9 152.71 47.52 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.484 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -151.7 141.98 22.39 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 43' ' ' CYS . 2.8 mp -112.15 122.97 67.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.184 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 11.4 m -116.43 -176.04 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.02 58.72 0.85 Allowed 'General case' 0 C--N 1.348 0.509 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 139.46 -13.74 3.22 Favored Glycine 0 C--N 1.348 1.21 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.184 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.837 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -174.38 -154.96 0.06 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.434 0.617 . . . . 0.0 111.682 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . . . -158.54 138.41 8.68 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-O 120.661 0.267 . . . . 0.0 111.045 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 18.2 Cg_endo -59.64 159.6 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.661 2.241 . . . . 0.0 112.179 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.657 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -86.15 156.46 57.35 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.47 -179.99 5.34 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.656 2.238 . . . . 0.0 112.148 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -149.52 -52.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.27 33.3 3.61 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.583 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -162.71 30.94 Favored Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.438 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 7.1 pm0 -116.72 -171.86 2.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 m -155.82 177.49 11.34 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 15.3 m-20 -159.56 167.72 13.61 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 35' ' ' ASN . 49.6 Cg_endo -69.11 150.79 72.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.565 2.177 . . . . 0.0 112.809 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' SER . 55.4 t60 -172.78 104.87 0.33 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' HIS . 35.8 Cg_exo -28.09 -81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -160.46 -160.29 0.76 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 174.61 148.72 0.24 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.04 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.87 -16.4 54.58 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.487 2.125 . . . . 0.0 111.989 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.752 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 91.1 t90 -92.46 -51.09 5.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 58.9 m -51.96 -34.97 44.55 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.246 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.03 -39.76 20.83 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.5 OUTLIER -50.98 -24.7 3.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.412 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.33 -6.1 5.85 Favored Glycine 0 C--N 1.363 2.06 0 C-N-CA 118.498 -1.811 . . . . 0.0 113.797 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 43' ' ' CYS . . . -85.64 52.32 2.43 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.641 0.72 . . . . 0.0 110.943 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.3 32.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.857 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 2.1 tt0 -128.96 127.36 41.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 110.207 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.439 ' CZ3' ' HD2' ' A' ' 59' ' ' ARG . 4.1 m95 -81.36 152.54 27.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.376 0.608 . . . . 0.0 111.748 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 58' ' ' CYS . 7.2 p -149.53 99.41 3.37 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.907 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.43 98.78 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.429 2.086 . . . . 0.0 113.277 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -93.22 129.65 39.19 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.528 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -40.5 -36.05 0.52 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.054 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.837 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -102.19 -23.48 14.03 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.547 0.612 . . . . 0.0 112.6 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -163.23 169.2 38.26 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 118.784 -1.674 . . . . 0.0 113.501 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -98.42 137.38 37.2 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.841 0.82 . . . . 0.0 109.979 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.724 ' O ' HG12 ' A' ' 51' ' ' VAL . 24.1 t -148.42 179.74 7.57 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -147.06 126.55 13.22 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 t -115.79 135.84 53.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 168.01 16.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.358 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 63' ' ' ILE . 94.4 m -154.45 169.35 23.97 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.201 0.909 . . . . 0.0 111.553 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.833 HG13 HG23 ' A' ' 17' ' ' VAL . 11.2 pt -160.28 130.19 3.41 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.698 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.6 118.83 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.711 2.274 . . . . 0.0 112.549 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.584 ' OH ' HG13 ' A' ' 17' ' ' VAL . 40.2 m-85 -44.02 -28.31 0.46 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.277 0.56 . . . . 0.0 112.106 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 m -96.15 110.97 25.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.063 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.926 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.92 81.27 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -106.06 168.8 8.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 m 61.42 66.52 1.57 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.97 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.15 131.23 20.27 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.553 2.169 . . . . 0.0 112.211 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -121.56 139.79 53.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.035 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.11 141.62 38.11 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.636 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 5.6 t -115.46 154.52 29.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.777 0.799 . . . . 0.0 112.742 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.885 ' CE1' ' HB1' ' A' ' 26' ' ' ALA . 1.3 p90 -138.87 129.78 26.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.531 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD12 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -89.71 122.55 32.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.354 . . . . 0.0 110.217 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -108.2 133.28 52.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.225 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.7 m-85 -107.71 137.12 46.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.559 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.55 157.39 39.39 Favored Pre-proline 0 CA--C 1.51 -0.567 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.207 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.18 -8.81 2.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.784 1.656 . . . . 0.0 110.885 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.09 29.7 0.08 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.245 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -164.16 162.4 22.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.189 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -128.6 140.41 49.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.89 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 68.3 m -151.21 137.73 18.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.599 ' O ' ' HB ' ' A' ' 60' ' ' THR . 46.5 t -126.61 131.08 51.57 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.897 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -130.12 143.62 50.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.77 HD12 HG23 ' A' ' 60' ' ' THR . 5.1 mt -115.42 123.36 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.961 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.7 m -125.86 -174.19 3.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -145.7 63.77 1.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 157.98 -28.97 0.47 Allowed Glycine 0 C--N 1.346 1.126 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.942 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.816 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -176.17 -157.2 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.885 ' HB1' ' CE1' ' A' ' 9' ' ' PHE . . . 179.68 -58.72 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.365 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.564 ' CD ' ' HB3' ' A' ' 26' ' ' ALA . 7.2 Cg_exo -34.87 78.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.17 3.247 . . . . 0.0 115.01 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 53' ' ' TYR . 5.2 tp -105.46 69.13 0.19 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.176 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' O ' ' A' ' 27' ' ' PRO . 36.7 Cg_endo -65.29 122.68 10.46 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.408 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 m -157.01 -51.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -122.35 29.8 6.81 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.113 0.415 . . . . 0.0 111.793 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.97 -153.56 24.84 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.63 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.39 -168.31 1.89 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -156.03 171.57 19.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.862 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -143.24 170.67 8.19 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.208 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 52.1 Cg_endo -69.45 137.59 36.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.083 . . . . 0.0 112.71 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 10' ' ' LEU . 7.7 t-80 -163.43 93.55 1.11 Allowed Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 8' ' ' SER . 59.7 Cg_exo -37.45 -77.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.4 2.733 . . . . 0.0 114.211 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -177.16 43.06 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.361 0.124 . . . . 0.0 111.032 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -50.01 172.11 0.12 Allowed Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 120.931 0.396 . . . . 0.0 111.631 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.614 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 44.4 Cg_exo -57.46 -17.12 26.1 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.999 2.466 . . . . 0.0 113.337 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.591 ' CZ3' ' HB3' ' A' ' 19' ' ' CYS . 6.4 t90 -71.88 -65.84 0.72 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.679 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -50.79 -53.59 30.7 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -35.28 75.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.491 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 1.8 mt-10 -49.33 -40.66 36.11 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.461 0.573 . . . . 0.0 111.209 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -126.35 5.61 7.67 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 118.355 -1.878 . . . . 0.0 113.48 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 60' ' ' THR . . . -70.1 54.55 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.993 0.397 . . . . 0.0 111.677 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 48' ' ' VAL . 16.3 t -106.03 36.61 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.519 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -147.83 152.04 36.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 111.016 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE3' ' HB3' ' A' ' 59' ' ' ARG . 12.7 m95 -92.62 158.87 15.74 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 52' ' ' PRO . 68.6 t -151.18 144.34 17.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.332 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' HG13 ' A' ' 51' ' ' VAL . 58.5 Cg_endo -99.29 121.84 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.049 2.5 . . . . 0.0 113.805 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.748 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 35.5 t80 -121.51 130.83 53.79 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t -39.09 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.816 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -70.17 -11.43 60.89 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -154.3 168.49 32.58 Favored Glycine 0 C--N 1.366 2.216 0 C-N-CA 118.167 -1.968 . . . . 0.0 114.398 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ARG . 3.3 tt0 -94.55 117.99 30.98 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 121.878 -0.777 . . . . 0.0 110.397 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 5.1 m -97.2 178.86 5.1 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.134 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 22.4 ptt180 171.03 115.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.106 0.867 . . . . 0.0 110.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.897 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -179.49 -147.87 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 6.3 t -142.8 -172.11 3.58 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.2 m -143.95 174.33 10.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 17' ' ' VAL . 8.7 pt -157.07 166.82 15.81 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.155 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 17' ' ' VAL . 4.2 Cg_exo -76.3 165.26 29.69 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.333 . . . . 0.0 111.398 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.2 -140.35 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 0.0 110.699 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.2 m -120.55 116.71 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.039 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.904 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -169.76 -46.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -177.32 -173.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.779 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 4' ' ' THR . 4.1 t -49.76 103.67 0.38 Allowed Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.963 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -91.41 33.13 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.887 2.392 . . . . 0.0 112.808 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -107.34 137.64 45.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.72 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 166.72 12.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.431 ' OG ' HG23 ' A' ' 21' ' ' ILE . 65.4 m -132.12 153.53 50.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.408 0.623 . . . . 0.0 111.814 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CZ ' ' HB1' ' A' ' 26' ' ' ALA . 1.6 p90 -135.36 131.62 36.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.122 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.461 HD12 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.51 121.44 38.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.665 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.6 m -102.61 154.89 18.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.758 0.789 . . . . 0.0 112.782 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.9 t80 -119.11 115.69 24.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.198 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.53 162.51 20.57 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.02 -11.7 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.919 2.413 . . . . 0.0 113.333 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 4.8 t0 -170.19 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.144 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.2 mt-30 -160.64 163.58 32.46 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.168 0.509 . . . . 0.0 111.714 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.755 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.91 117.33 47.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.715 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.1 m -123.01 138.17 54.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 38.9 t -122.38 146.48 47.3 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.343 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -140.1 134.78 31.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.326 0.584 . . . . 0.0 111.9 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 43' ' ' CYS . 3.3 mp -107.39 131.0 58.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.511 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 49.8 m -131.75 -172.84 2.97 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 119.286 -0.966 . . . . 0.0 113.363 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -151.76 60.35 0.87 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.65 0.53 7.22 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 119.998 -1.096 . . . . 0.0 114.063 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -167.5 -160.56 0.36 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.263 1.031 . . . . 0.0 112.759 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HB1' ' CZ ' ' A' ' 9' ' ' PHE . . . -173.23 139.06 0.83 Allowed Pre-proline 0 C--N 1.346 0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.479 ' HD2' ' CE2' ' A' ' 9' ' ' PHE . 51.7 Cg_exo -55.35 142.37 79.75 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.231 1.954 . . . . 0.0 112.019 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.1 tp -64.77 110.04 3.61 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.11 152.55 80.62 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.582 2.188 . . . . 0.0 112.167 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 p -165.81 -50.53 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.99 33.22 1.36 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 122.048 -0.407 . . . . 0.0 111.637 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 160.85 169.14 23.72 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.771 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.97 -163.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -161.52 159.51 27.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.235 0.54 . . . . 0.0 111.146 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.68 153.65 74.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.673 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.36 128.5 25.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.722 2.281 . . . . 0.0 112.37 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.586 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 12.8 t-160 -157.83 89.81 2.35 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.771 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -30.85 -68.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.537 2.824 . . . . 0.0 113.358 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -157.93 -160.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.48 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' CE1' ' A' ' 37' ' ' HIS . . . 171.05 154.31 0.21 Allowed Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 120.614 0.245 . . . . 0.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 56.2 Cg_endo -70.04 -13.89 34.51 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.328 2.019 . . . . 0.0 111.954 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.718 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 90.1 t90 -93.91 -53.49 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.213 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.547 ' O ' HD11 ' A' ' 21' ' ' ILE . 73.8 m -50.02 -33.76 19.1 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -88.44 -39.36 14.31 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 4.1 mt-10 -48.82 -26.84 2.62 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.308 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.3 -23.73 2.85 Favored Glycine 0 C--N 1.36 1.916 0 C-N-CA 118.487 -1.816 . . . . 0.0 113.497 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 60.28 2.48 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.699 0.75 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.3 p -93.11 31.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -125.75 147.12 49.48 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.676 0.274 . . . . 0.0 110.293 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.459 ' CZ3' ' HD3' ' A' ' 59' ' ' ARG . 1.2 m95 -90.21 164.11 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.027 0.441 . . . . 0.0 111.058 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.3 t -147.23 130.42 8.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.595 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -93.83 87.76 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.637 2.225 . . . . 0.0 113.667 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.647 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -100.42 124.93 46.55 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.3 m -42.55 -49.6 5.4 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.027 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -70.88 -32.55 69.55 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.656 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -172.04 179.78 43.47 Favored Glycine 0 C--N 1.359 1.823 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.286 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HG2' ' CE3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -89.95 145.36 25.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 118.354 1.077 . . . . 0.0 110.192 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 m -129.31 177.62 7.04 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 4.6 mmm180 -150.54 126.92 10.71 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.2 m -109.11 137.99 46.15 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 47' ' ' ALA . 1.9 m -142.64 152.33 42.35 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.443 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.465 ' O ' HG23 ' A' ' 63' ' ' ILE . 35.3 m -155.75 156.55 35.03 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 120.656 1.571 . . . . 0.0 112.306 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.718 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 32.2 pt -161.81 156.75 19.86 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.49 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 84.8 Cg_endo -78.12 164.66 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.055 . . . . 0.0 112.22 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.755 ' CD1' HG22 ' A' ' 17' ' ' VAL . 10.8 m-85 -74.01 -145.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.888 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 t -106.05 55.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.908 179.979 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.97 -69.45 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.25 166.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.843 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -60.27 114.43 9.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.869 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.27 155.48 70.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.399 2.066 . . . . 0.0 112.294 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -98.02 158.85 15.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.75 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.79 140.98 23.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 30.9 t -118.31 152.26 36.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.727 0.775 . . . . 0.0 112.671 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 27' ' ' PRO . 3.3 p90 -130.9 130.85 44.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.016 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 18' ' ' CYS . 0.8 OUTLIER -94.49 126.15 39.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.067 0.46 . . . . 0.0 110.212 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 17.3 m -105.04 154.31 20.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.693 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -130.0 126.6 38.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -114.06 164.69 15.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.321 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.8 -19.14 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.227 2.618 . . . . 0.0 113.955 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.43 28.76 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.0 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.6 mt-30 -153.83 147.2 24.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.016 0.436 . . . . 0.0 111.834 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.638 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -119.97 122.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.002 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' O ' HD23 ' A' ' 10' ' ' LEU . 74.5 m -134.58 141.77 46.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 41.5 t -122.1 146.43 47.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.82 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.0 139.29 28.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.285 0.565 . . . . 0.0 112.518 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.27 120.32 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.253 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 58.8 m -108.96 -176.16 2.96 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.096 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.58 54.95 0.74 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.24 21.87 7.46 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.544 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -130.76 -157.45 0.82 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.391 0.596 . . . . 0.0 111.99 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -146.57 177.85 1.63 Allowed Pre-proline 0 C--N 1.34 0.179 0 CA-C-O 120.593 0.235 . . . . 0.0 110.902 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 98.3 Cg_endo -81.16 124.06 4.73 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.642 2.228 . . . . 0.0 113.126 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.6 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 3.5 tt -71.24 -35.87 4.38 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.594 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 96.2 Cg_exo -44.81 170.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.516 2.144 . . . . 0.0 112.98 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -151.25 -37.1 0.13 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.92 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -82.79 30.75 0.43 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.59 0.632 . . . . 0.0 111.825 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.56 163.6 34.67 Favored Glycine 0 N--CA 1.466 0.698 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.15 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -100.62 -166.31 1.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.436 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -160.77 159.94 30.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.358 0.599 . . . . 0.0 112.072 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -137.7 173.05 5.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.427 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 74.4 Cg_endo -75.61 135.3 17.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.539 2.16 . . . . 0.0 113.036 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.458 ' CD2' ' SG ' ' A' ' 43' ' ' CYS . 31.5 t60 -164.37 95.73 0.95 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.76 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' SER . 2.6 Cg_endo -39.71 -81.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.394 2.729 . . . . 0.0 114.21 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -176.03 53.5 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.825 0.078 . . . . 0.0 110.885 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -59.38 174.06 0.45 Allowed Pre-proline 0 N--CA 1.471 0.622 0 O-C-N 122.022 -0.424 . . . . 0.0 111.555 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.2 Cg_endo -65.76 1.74 2.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.575 2.183 . . . . 0.0 113.045 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.618 ' CZ2' HG21 ' A' ' 63' ' ' ILE . 21.1 t90 -90.06 -56.22 3.31 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.458 ' SG ' ' CD2' ' A' ' 37' ' ' HIS . 53.2 m -64.74 -32.93 74.84 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -78.06 -44.47 26.26 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.406 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 9.5 tt0 -64.49 -19.64 65.7 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.98 -18.5 6.82 Favored Glycine 0 C--N 1.364 2.09 0 C-N-CA 118.095 -2.002 . . . . 0.0 112.683 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.786 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -93.73 68.28 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.296 0.57 . . . . 0.0 110.434 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 m -89.27 29.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.56 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -145.02 133.31 21.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -95.64 167.8 11.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.218 0.532 . . . . 0.0 111.922 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 59' ' ' ARG . 11.5 p -155.97 139.04 10.79 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.73 120.59 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.597 2.198 . . . . 0.0 113.963 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.621 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -104.53 132.48 50.73 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.039 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -61.8 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -26.58 68.02 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.152 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -168.48 176.8 42.74 Favored Glycine 0 C--N 1.359 1.821 0 C-N-CA 118.989 -1.576 . . . . 0.0 112.808 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.0 tt0 -93.15 127.56 38.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.665 1.232 . . . . 0.0 110.447 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -136.82 -173.98 3.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.216 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.658 ' HA ' HG12 ' A' ' 51' ' ' VAL . 6.2 ttp180 -156.66 127.37 6.71 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.1 t -104.05 130.97 51.75 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.786 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -127.93 162.36 26.93 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.9 m -150.91 170.5 19.17 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 119.863 1.21 . . . . 0.0 111.538 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.618 HG21 ' CZ2' ' A' ' 42' ' ' TRP . 5.5 pt -157.19 151.58 20.29 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.605 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' ILE . 7.7 Cg_exo -71.53 125.9 11.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.881 2.387 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.638 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -80.76 -139.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.969 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.507 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 12.2 p -100.19 125.03 54.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.994 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.837 -179.936 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -63.56 146.0 54.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.886 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.69 102.68 15.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.68 115.22 28.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.66 176.98 5.23 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.365 2.043 . . . . 0.0 112.287 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -120.98 163.88 17.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -148.11 141.07 24.82 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.617 ' OG ' HG23 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -121.18 148.87 43.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.69 0.757 . . . . 0.0 112.903 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -135.4 132.18 37.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.51 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -97.91 125.58 42.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.07 0.462 . . . . 0.0 109.805 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -103.8 143.54 32.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.163 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.39 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.82 162.6 32.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.883 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -44.29 -18.07 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.399 . . . . 0.0 113.694 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.38 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.413 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.61 166.93 29.69 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.048 0.451 . . . . 0.0 111.704 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.485 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -141.43 108.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.245 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.511 ' O ' HD23 ' A' ' 10' ' ' LEU . 91.1 m -114.37 134.75 54.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 111.818 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.6 t -119.27 144.16 46.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.576 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -150.81 139.91 21.11 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.452 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.907 HD11 ' HB3' ' A' ' 43' ' ' CYS . 1.3 mt -111.86 110.52 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.562 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 1.3 m -86.94 -175.51 5.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.84 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.94 51.71 0.98 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.55 22.5 4.02 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.484 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 56' ' ' GLY . . . -162.54 -156.63 0.41 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.033 0.916 . . . . 0.0 112.051 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -163.68 132.92 2.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD2' ' CE1' ' A' ' 9' ' ' PHE . 15.4 Cg_endo -56.93 145.72 83.4 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.511 2.141 . . . . 0.0 112.647 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD12 ' OH ' ' A' ' 53' ' ' TYR . 1.2 mp -78.53 111.81 21.91 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.053 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.51 151.46 29.05 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.534 2.156 . . . . 0.0 112.127 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 -55.6 0.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.301 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -95.1 29.52 2.42 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 118.108 0.413 . . . . 0.0 111.55 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.27 -162.53 36.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.75 -162.86 1.15 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.686 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.07 163.29 39.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.107 0.48 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -139.07 155.24 72.83 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.537 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.77 130.09 28.34 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.615 2.21 . . . . 0.0 112.438 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 39' ' ' THR . 3.7 t60 -157.87 100.68 1.8 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -30.04 -73.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.316 2.677 . . . . 0.0 113.378 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.571 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 10.5 t -154.13 -159.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . 178.88 130.42 0.22 Allowed Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 38.8 Cg_exo -56.73 -20.69 36.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.289 1.993 . . . . 0.0 112.088 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.816 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 63.3 t90 -86.9 -47.95 8.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.907 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -42.43 -57.57 2.57 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -69.96 -35.81 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.164 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 71.4 tt0 -46.15 -31.12 2.22 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 118.284 0.493 . . . . 0.0 111.582 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.8 10.68 3.96 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 118.338 -1.887 . . . . 0.0 113.907 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 59' ' ' ARG . . . -92.21 45.76 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.383 0.591 . . . . 0.0 111.24 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.57 33.84 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.99 15.87 4.7 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.745 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -130.24 -175.11 3.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.281 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.3 t 142.82 -42.5 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.08 0 O-C-N 123.746 0.654 . . . . 0.0 110.038 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 98.6 Cg_endo -86.69 78.89 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 114.447 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.614 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.5 t80 -109.35 130.57 55.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.61 -60.49 1.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -67.11 -30.35 70.34 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.407 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.54 -172.59 37.75 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.619 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.742 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -95.19 132.64 39.93 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.53 1.665 . . . . 0.0 109.273 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.705 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 19.1 m -135.99 -174.19 3.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.828 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.644 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.76 132.22 20.84 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 t -125.73 139.77 53.25 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -140.54 162.24 35.82 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.242 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.4 m -157.29 146.82 20.31 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 119.96 1.255 . . . . 0.0 111.506 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.816 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 3.5 pt -149.18 165.29 18.04 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.737 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 32.7 Cg_exo -59.54 164.8 10.58 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 0.0 111.979 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -139.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.156 0.503 . . . . 0.0 110.788 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.58 85.06 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.033 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.918 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -144.58 -179.62 6.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.832 0.349 . . . . 0.0 111.047 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -158.75 -56.42 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.832 HG22 ' HD2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 64.01 159.27 0.12 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.832 ' HD2' HG22 ' A' ' 4' ' ' THR . 5.7 Cg_exo -73.83 154.11 48.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.979 2.453 . . . . 0.0 112.263 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 7' ' ' GLU . 1.5 p30 -80.6 -53.7 6.32 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.478 1.132 . . . . 0.0 108.734 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.571 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 9.6 mt-10 -177.64 -167.56 0.15 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.159 -2.291 . . . . 0.0 109.653 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.436 ' HB2' HG12 ' A' ' 21' ' ' ILE . 32.8 t -135.21 142.12 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.316 0.579 . . . . 0.0 111.791 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 31.1 p90 -124.79 132.78 53.32 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.613 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.757 HD12 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -97.74 131.3 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.703 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.9 m -116.36 133.27 56.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.629 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.31 130.71 56.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -126.11 149.85 67.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.496 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.24 4.5 0.13 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.673 2.248 . . . . 0.0 113.358 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' GLN . 3.8 m-20 -117.57 -29.94 5.63 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 15' ' ' ASP . 1.2 mt-30 -172.27 -167.22 0.45 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.684 0.278 . . . . 0.0 110.838 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -125.95 144.83 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.208 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -145.08 145.64 31.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 112.113 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.535 ' CB ' ' CH2' ' A' ' 42' ' ' TRP . 2.3 t -127.38 152.78 47.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.752 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -144.02 135.17 25.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.342 0.591 . . . . 0.0 111.759 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 47' ' ' ALA . 37.8 mt -104.92 110.28 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.225 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.671 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 70.5 m -100.6 172.41 7.12 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.836 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.83 ' HB3' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -148.81 46.86 1.02 Allowed 'General case' 0 C--N 1.354 0.78 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . . . 128.21 30.95 0.7 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.7 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.563 ' HB1' ' CG ' ' A' ' 53' ' ' TYR . . . -123.09 -165.7 1.35 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.203 1.001 . . . . 0.0 112.287 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -125.74 99.07 32.99 Favored Pre-proline 0 C--N 1.344 0.332 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.512 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 32.6 Cg_exo -32.38 90.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.45 2.767 . . . . 0.0 113.485 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 tp -98.7 122.66 52.45 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.8 -170.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.501 2.134 . . . . 0.0 112.119 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 p -149.28 -52.8 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.413 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.86 30.47 3.71 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.252 0.478 . . . . 0.0 111.681 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.36 -146.16 7.27 Favored Glycine 0 N--CA 1.461 0.364 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.365 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -116.46 -169.77 1.69 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.333 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -156.07 166.39 33.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.034 0.445 . . . . 0.0 111.359 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -143.0 168.58 12.73 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.544 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.71 134.99 22.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.67 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.757 ' CD2' HD12 ' A' ' 10' ' ' LEU . 6.9 t60 -157.65 93.13 2.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 39' ' ' THR . 22.0 Cg_exo -28.6 -85.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.9 3.066 . . . . 0.0 114.628 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 38' ' ' PRO . 10.7 p -162.43 55.65 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.463 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.634 ' HB2' ' NE2' ' A' ' 37' ' ' HIS . . . -43.49 166.85 0.09 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 CA-C-N 118.468 0.576 . . . . 0.0 111.869 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 52.6 Cg_exo -56.56 -47.23 24.83 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.213 2.608 . . . . 0.0 113.993 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.706 ' CZ3' HD12 ' A' ' 63' ' ' ILE . 38.5 p-90 -72.65 -45.82 57.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 1.3 m -47.24 -45.66 23.72 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -31.68 21.91 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.865 -0.522 . . . . 0.0 109.951 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 1.7 tm-20 -47.71 -31.72 5.04 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.705 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.51 -11.82 1.46 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 118.214 -1.946 . . . . 0.0 114.711 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.799 ' C ' ' HG2' ' A' ' 59' ' ' ARG . . . -72.14 64.13 0.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.441 1.12 . . . . 0.0 111.635 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.23 52.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.463 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HG2' ' NE ' ' A' ' 59' ' ' ARG . 7.7 pt-20 -134.37 -15.87 2.16 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.858 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.6 t90 -102.33 -166.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.964 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 170.01 -38.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.839 ' HD3' HG23 ' A' ' 51' ' ' VAL . 7.7 Cg_exo -75.59 81.15 2.39 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.178 1.919 . . . . 0.0 116.267 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.563 ' CG ' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -112.57 129.45 56.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.691 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.2 p -26.01 -73.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -22.45 50.66 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.44 -165.98 19.3 Favored Glycine 0 C--N 1.356 1.644 0 C-N-CA 118.911 -1.614 . . . . 0.0 111.945 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 4.1 mt-30 -95.26 166.3 11.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.523 2.161 . . . . 0.0 109.321 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.671 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 44.8 t -175.84 -176.54 0.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.333 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.83 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -158.17 145.66 18.18 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 118.515 0.598 . . . . 0.0 111.591 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 60' ' ' THR . 9.5 t -112.58 104.03 12.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.568 ' CG2' ' HB2' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.57 172.63 6.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.128 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m -155.84 158.57 38.29 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 118.993 0.815 . . . . 0.0 111.42 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.706 HD12 ' CZ3' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -153.87 162.19 27.36 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.209 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 51.2 Cg_exo -54.98 160.47 7.83 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.773 2.316 . . . . 0.0 112.623 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -78.55 -140.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.835 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 67' ' ' GLU . 12.0 p -124.11 -43.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' N ' HG13 ' A' ' 66' ' ' VAL . 12.8 pt-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.939 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 t -88.78 -52.43 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -89.76 -45.09 9.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.794 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.483 HG23 ' HD2' ' A' ' 5' ' ' PRO . 81.7 m 63.4 139.43 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.016 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' HG23 ' A' ' 4' ' ' THR . 33.9 Cg_endo -64.16 -161.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.512 2.141 . . . . 0.0 112.029 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -67.17 152.85 45.01 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.454 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -142.25 153.91 44.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.681 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.464 ' OG ' HG23 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -130.53 149.6 52.12 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 112.596 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -132.61 135.41 45.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.04 178.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.64 118.01 35.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.825 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.2 m -106.44 139.28 41.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.441 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -133.76 151.09 76.39 Favored Pre-proline 0 CA--C 1.511 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.258 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.84 -1.51 1.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.619 1.546 . . . . 0.0 110.861 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.4 t0 -114.34 -29.29 6.95 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.534 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.427 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -179.33 173.5 1.1 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.99 0.424 . . . . 0.0 111.604 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' CZ ' ' A' ' 65' ' ' TYR . 2.3 m -111.57 118.97 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.405 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 3.5 m -110.43 128.9 55.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.814 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 51.8 t -112.19 145.78 39.27 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.341 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -152.29 138.45 18.31 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.174 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.821 HD11 ' HB3' ' A' ' 43' ' ' CYS . 1.7 mt -108.83 113.79 45.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.659 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 1.3 m -93.61 -177.3 4.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.528 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 57' ' ' GLN . 18.0 tpt85 -145.19 49.18 1.27 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.42 25.68 3.68 Favored Glycine 0 C--N 1.348 1.211 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -158.51 -157.74 0.65 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.848 0.824 . . . . 0.0 112.154 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -155.43 179.98 1.22 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.32 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 67.2 Cg_endo -91.36 138.7 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.739 2.292 . . . . 0.0 113.219 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.494 HD12 ' OH ' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -108.11 64.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.276 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 27' ' ' PRO . 67.8 Cg_endo -72.11 -161.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.588 2.192 . . . . 0.0 111.994 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.99 -54.87 3.04 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.23 -95.03 0.1 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 39.64 -161.9 0.01 OUTLIER Glycine 0 N--CA 1.474 1.231 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.743 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.1 178.54 7.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 m -157.82 178.99 9.62 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 119.042 0.837 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -157.86 145.31 13.58 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.26 135.25 68.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.527 2.151 . . . . 0.0 112.372 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' SER . 27.3 t60 -161.6 98.65 1.23 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.933 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -29.35 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.377 2.718 . . . . 0.0 113.448 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -155.43 -161.95 1.26 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 177.72 158.89 0.55 Allowed Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.026 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 72.8 Cg_endo -74.74 -16.38 20.95 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.446 2.097 . . . . 0.0 112.131 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.676 ' HZ2' HG23 ' A' ' 63' ' ' ILE . 44.4 t90 -87.1 -51.97 5.69 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.272 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.821 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -45.3 -57.68 3.84 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.787 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -35.8 80.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.416 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 2.9 mt-10 -48.56 -30.81 5.69 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.351 0.523 . . . . 0.0 111.813 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.12 17.68 2.53 Favored Glycine 0 C--N 1.357 1.75 0 C-N-CA 118.208 -1.949 . . . . 0.0 113.842 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 59' ' ' ARG . . . -107.52 58.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 111.141 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.4 p -93.85 31.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.301 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.744 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.51 119.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.886 0.374 . . . . 0.0 111.703 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.744 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 1.6 t90 155.86 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.167 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 11.1 m -50.31 -32.18 5.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.105 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 2.9 Cg_exo -77.27 62.65 7.63 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.983 1.789 . . . . 0.0 114.678 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.603 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 2.5 t80 -106.41 116.49 32.02 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -36.7 -58.34 0.74 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.469 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.98 69.98 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.003 -0.523 . . . . 0.0 112.0 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.21 -178.96 42.04 Favored Glycine 0 C--N 1.361 1.921 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.761 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.9 tt0 -96.72 124.21 40.64 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.373 -1.075 . . . . 0.0 109.791 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.623 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.1 m -131.62 -172.95 2.99 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -150.36 133.45 16.17 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 85.1 m -117.62 147.81 42.52 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.744 HG21 ' HA ' ' A' ' 43' ' ' CYS . 1.8 t -151.58 174.09 13.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.78 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 159.92 3.94 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 118.865 0.757 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.676 HG23 ' HZ2' ' A' ' 42' ' ' TRP . 1.7 pt -149.38 151.74 34.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.425 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 68.3 Cg_endo -90.02 93.76 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.226 2.617 . . . . 0.0 112.283 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -100.14 -147.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.474 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 19.2 t -97.07 128.65 48.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 111.045 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 t -170.7 -45.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -162.63 177.15 9.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.6 p -89.67 146.26 35.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.47 -166.48 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.511 2.141 . . . . 0.0 112.297 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.07 153.22 19.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.788 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -143.11 140.59 30.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 37' ' ' HIS . 13.3 t -111.78 147.95 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.726 0.774 . . . . 0.0 112.372 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.847 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 2.0 p90 -134.07 137.26 44.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.328 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.56 127.17 43.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.978 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.1 m -107.36 142.83 36.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 111.976 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.7 t80 -108.95 130.9 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.262 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.499 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -138.97 142.35 33.17 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.07 6.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.619 2.213 . . . . 0.0 113.321 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.1 p30 -118.95 -33.53 4.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.475 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.3 mp0 -169.4 -170.22 1.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.76 117.23 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.4 146.79 40.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.092 0.473 . . . . 0.0 112.212 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 51.9 t -125.68 150.58 47.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.625 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -149.49 140.44 22.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.538 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 21' ' ' ILE . 3.7 mp -103.85 118.42 50.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.662 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 94.0 m -107.43 -174.03 2.43 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.2 57.37 0.71 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.95 -19.92 1.11 Allowed Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.622 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.567 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . . . -174.77 -155.44 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.289 0.545 . . . . 0.0 110.62 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 9' ' ' PHE . . . 173.56 -58.24 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 26' ' ' ALA . 9.2 Cg_endo -51.06 78.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.288 2.658 . . . . 0.0 114.631 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 53' ' ' TYR . 18.7 tp -134.01 50.5 5.23 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 89.8 Cg_endo -77.83 -171.74 1.28 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.706 2.271 . . . . 0.0 112.727 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 t -159.44 -56.4 0.06 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.9 32.21 4.06 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.012 -0.43 . . . . 0.0 111.617 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 175.12 -152.19 13.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.297 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.55 -167.75 1.99 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 m -156.68 157.11 34.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.756 0.313 . . . . 0.0 110.629 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.57 151.43 75.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 141.06 93.48 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' SER . 82.0 t60 -169.19 97.49 0.51 Allowed Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.813 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -30.54 -71.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.455 2.77 . . . . 0.0 113.551 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -156.51 -157.89 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.799 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 177.3 167.3 0.49 Allowed Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 120.6 0.238 . . . . 0.0 111.082 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.695 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 72.7 Cg_endo -76.09 -25.85 9.81 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.614 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 26.9 p-90 -92.44 -41.14 10.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.413 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 96.6 m -51.68 -37.94 52.8 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.43 -36.12 17.9 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 121.711 -0.618 . . . . 0.0 109.369 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -46.85 -29.77 2.15 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.003 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.18 -10.73 4.53 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.781 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 43' ' ' CYS . . . -94.42 45.15 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.857 0.829 . . . . 0.0 111.091 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 44' ' ' ARG . 7.9 m -95.09 32.06 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.51 143.26 33.71 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -79.82 151.75 30.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.0 p -162.75 94.72 1.17 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.863 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -42.16 110.73 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.931 2.42 . . . . 0.0 113.635 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.649 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.7 t80 -93.26 145.84 24.14 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -32.87 -89.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 44.7 m -68.53 -7.78 35.52 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -166.16 173.1 41.66 Favored Glycine 0 C--N 1.363 2.031 0 C-N-CA 118.769 -1.682 . . . . 0.0 112.679 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -78.04 152.98 32.72 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.706 1.253 . . . . 0.0 109.663 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.8 t -159.67 -171.71 3.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.692 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.619 ' HA ' HG12 ' A' ' 51' ' ' VAL . 1.6 ptt-85 -155.15 125.94 7.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -105.59 136.98 44.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -140.82 171.39 14.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.615 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.7 m -154.76 168.73 25.87 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.578 1.081 . . . . 0.0 111.688 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 17' ' ' VAL . 28.4 pt -154.15 137.29 10.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.841 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.49 124.98 3.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.763 2.308 . . . . 0.0 112.795 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -133.44 -150.45 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.833 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 24.1 t -143.77 -58.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.818 0.342 . . . . 0.0 110.968 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.828 179.897 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 t 61.18 64.39 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.895 0.378 . . . . 0.0 110.738 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.492 ' C ' HG22 ' A' ' 4' ' ' THR . 10.7 m80 -131.62 49.44 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.036 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.601 HG23 ' CD ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -169.51 -61.98 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.601 ' CD ' HG23 ' A' ' 4' ' ' THR . 57.1 Cg_endo -70.62 167.87 24.31 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.275 1.983 . . . . 0.0 112.226 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -115.12 148.62 38.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.31 141.21 33.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -121.7 146.27 47.19 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.505 0.669 . . . . 0.0 111.921 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.541 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -130.6 130.74 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.701 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.84 121.07 33.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.656 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 m -102.65 145.24 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 0.0 112.637 -178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.456 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.4 t80 -110.54 113.26 25.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -117.77 140.69 27.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' OH ' ' A' ' 65' ' ' TYR . 52.1 Cg_exo -55.87 7.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.699 2.266 . . . . 0.0 113.443 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 13' ' ' GLN . 5.6 t0 -118.63 -37.08 3.34 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.245 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.52 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 8.4 mp0 -165.77 -175.49 3.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG22 ' HD1' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -114.06 113.97 45.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 m -110.09 129.68 55.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 43.6 t -108.1 140.32 41.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.744 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.655 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -135.36 143.95 46.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 112.746 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' ARG . 2.5 mp -116.84 138.28 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.489 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 16.9 m -145.81 -171.1 3.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.64 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -156.82 60.74 0.53 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.79 8.86 5.04 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 119.897 -1.145 . . . . 0.0 114.355 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -167.13 -160.54 0.38 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.67 1.235 . . . . 0.0 113.157 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.541 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . -173.49 132.05 0.58 Allowed Pre-proline 0 C--N 1.347 0.481 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.7 Cg_endo -49.84 147.2 14.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 112.159 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.36 111.28 5.72 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.2 152.39 16.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.653 2.235 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 t -166.31 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.131 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.54 33.93 1.37 Allowed 'General case' 0 C--N 1.352 0.695 0 O-C-N 122.068 -0.395 . . . . 0.0 111.548 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 168.18 167.9 29.5 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.829 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.53 -161.49 0.84 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -159.73 160.38 33.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -139.12 152.72 70.43 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.617 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.43 127.52 21.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.263 . . . . 0.0 112.452 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 39' ' ' THR . 12.9 t-160 -160.58 82.51 2.12 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.22 -63.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.782 2.988 . . . . 0.0 113.443 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -140.53 -161.39 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.103 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 172.81 131.41 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.005 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 31.2 Cg_exo -58.22 -18.66 38.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.076 1.851 . . . . 0.0 111.726 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 48.1 t90 -86.36 -51.89 5.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.357 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -45.54 -56.37 5.19 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.485 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.57 -36.18 83.4 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.0 tt0 -49.68 -34.39 18.42 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.73 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.49 -2.94 2.81 Favored Glycine 0 C--N 1.358 1.767 0 C-N-CA 118.405 -1.855 . . . . 0.0 114.376 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.859 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -95.13 63.41 2.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.861 0.831 . . . . 0.0 110.356 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 48' ' ' VAL . 14.9 t -94.44 32.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.387 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -124.55 136.15 53.74 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.679 ' CZ3' ' HG2' ' A' ' 57' ' ' GLN . 4.2 t-105 -96.24 135.84 37.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.518 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 9.6 p -131.93 120.61 17.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.987 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.562 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 71.8 Cg_endo -76.6 114.92 3.96 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.619 2.213 . . . . 0.0 114.091 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.604 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 1.1 t80 -104.61 128.14 52.55 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -42.63 -48.01 5.37 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.933 -0.122 . . . . 0.0 111.242 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.08 -30.74 61.03 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -172.46 179.57 43.92 Favored Glycine 0 C--N 1.359 1.84 0 C-N-CA 118.948 -1.596 . . . . 0.0 113.253 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.679 ' HG2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -81.62 120.31 24.92 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 118.544 1.172 . . . . 0.0 110.337 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -117.94 -178.84 3.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.655 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -160.67 133.81 6.57 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -120.3 130.59 54.52 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.267 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.859 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -139.43 164.79 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.012 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 t -176.87 155.56 1.26 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 120.506 1.503 . . . . 0.0 112.515 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.571 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 7.8 pt -159.08 161.81 27.33 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.118 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 5.3 Cg_endo -47.16 174.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.6 2.2 . . . . 0.0 112.482 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.543 ' HD1' HG22 ' A' ' 17' ' ' VAL . 2.4 m-30 -67.65 -143.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.709 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 66' ' ' VAL . 30.6 m -121.71 124.62 71.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -122.25 167.93 12.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.822 0.344 . . . . 0.0 110.819 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.1 m80 -143.17 115.22 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.997 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.528 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 1.5 m -172.1 -63.78 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.696 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 4' ' ' THR . 74.1 Cg_endo -74.32 77.61 2.83 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.393 2.062 . . . . 0.0 112.186 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -123.66 158.8 30.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 1.1 pt-20 -142.07 141.04 32.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.417 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' HIS . 29.3 t -117.11 141.32 48.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.628 0.727 . . . . 0.0 112.54 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -132.94 137.97 46.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.605 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.52 128.53 50.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.138 0.494 . . . . 0.0 110.475 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 74.0 m -107.98 139.24 42.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.108 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -119.4 128.48 54.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.04 146.39 56.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.866 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.76 3.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 113.38 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' GLN . 32.0 m-20 -111.67 -36.74 5.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.588 0.232 . . . . 0.0 111.109 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -172.51 -175.31 1.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.907 0.384 . . . . 0.0 111.181 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.22 130.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.123 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 99.9 m -128.81 129.66 45.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 112.047 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 34.5 t -112.99 152.72 29.08 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.836 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.842 ' CE2' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -154.48 133.59 12.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.069 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.604 HD11 ' HB2' ' A' ' 43' ' ' CYS . 3.7 mp -101.33 102.14 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.585 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 68.9 m -90.04 -172.46 3.51 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.628 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.83 60.18 0.67 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.63 16.43 9.39 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.16 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' HB2' ' C ' ' A' ' 55' ' ' THR . . . -164.7 -161.17 0.55 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.86 151.78 16.93 Favored Pre-proline 0 C--N 1.34 0.18 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.285 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 20' ' ' PHE . 73.4 Cg_endo -75.79 132.77 14.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.474 2.116 . . . . 0.0 112.234 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 29' ' ' PRO . 14.5 tp -74.05 112.08 15.22 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 28' ' ' LEU . 86.8 Cg_endo -82.32 -174.46 2.11 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.4 p -164.23 -55.8 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.535 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -102.1 33.4 3.08 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.99 -0.444 . . . . 0.0 111.924 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.91 -176.05 47.72 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.673 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -120.15 -164.85 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.7 m -154.15 178.42 10.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.995 0.426 . . . . 0.0 111.442 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.8 165.59 18.44 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.957 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.04 137.77 41.93 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.848 2.365 . . . . 0.0 112.729 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 39' ' ' THR . 11.4 t60 -163.08 92.67 1.18 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 8' ' ' SER . 37.1 Cg_exo -25.49 -71.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.865 3.043 . . . . 0.0 113.819 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.572 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -160.38 -161.07 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.463 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . 173.6 142.2 0.17 Allowed Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.024 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 20.2 Cg_exo -64.95 -12.44 34.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.411 2.074 . . . . 0.0 112.106 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.657 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 67.2 t90 -91.56 -52.73 4.63 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.321 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.792 ' HA ' HG21 ' A' ' 61' ' ' THR . 11.1 m -49.55 -36.23 22.92 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -37.27 20.14 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.735 -0.603 . . . . 0.0 109.754 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -51.12 -25.55 5.32 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.604 179.555 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.48 -6.96 4.52 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 118.221 -1.942 . . . . 0.0 114.192 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -92.01 61.34 4.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.051 0.926 . . . . 0.0 111.259 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 48' ' ' VAL . 18.8 t -111.98 38.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.45 13.41 1.96 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.903 0.382 . . . . 0.0 111.844 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.852 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -128.5 169.04 14.82 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.363 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 158.17 -34.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.473 0.709 . . . . 0.0 110.801 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.717 ' HD3' HG23 ' A' ' 51' ' ' VAL . 73.2 Cg_endo -93.3 68.41 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.083 1.856 . . . . 0.0 113.725 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.793 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 76.4 t80 -97.12 126.84 42.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -37.31 -57.6 0.89 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.423 ' C ' ' HB2' ' A' ' 25' ' ' ALA . 66.1 m -69.7 -27.3 64.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.793 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -174.06 -178.27 43.86 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.325 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -95.54 126.73 41.03 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 119.582 1.691 . . . . 0.0 109.203 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.779 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 43.3 t -142.42 -178.76 5.91 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.174 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.78 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 15.5 mmm-85 -138.3 134.14 33.94 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.842 HG23 ' CE2' ' A' ' 20' ' ' PHE . 91.8 m -117.2 142.78 46.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 43' ' ' CYS . 1.4 t -147.46 160.38 42.64 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.81 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 61' ' ' THR . 81.7 m -158.01 160.73 37.78 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-N 119.541 1.064 . . . . 0.0 110.879 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 3.5 pt -151.65 154.45 33.19 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.444 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 69.1 Cg_endo -89.77 126.39 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.183 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.431 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 1.2 p90 -133.83 -148.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.254 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.431 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 31.2 m -99.1 178.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.812 0.339 . . . . 0.0 111.192 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.852 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 t -87.12 -55.32 3.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -96.09 42.06 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.49 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -59.17 -61.29 8.14 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HA ' ' CB ' ' A' ' 23' ' ' ARG . 2.7 Cg_endo -39.53 153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.474 2.783 . . . . 0.0 112.619 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.752 ' N ' ' O ' ' A' ' 22' ' ' CYS . 1.9 m-20 -63.29 -43.14 98.73 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.532 1.158 . . . . 0.0 109.377 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 162.01 -176.46 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.484 -2.144 . . . . 0.0 110.728 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 6.9 t -119.43 158.45 26.19 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.296 0.569 . . . . 0.0 112.136 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.506 ' CE2' ' HB2' ' A' ' 20' ' ' PHE . 2.1 p90 -141.32 126.87 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.257 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.63 128.61 39.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 m -111.2 142.86 42.84 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.996 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.76 128.05 54.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.82 145.82 52.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.759 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.38 5.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.809 2.339 . . . . 0.0 113.423 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -116.6 -34.92 4.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.214 -0.194 . . . . 0.0 111.343 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.2 mt-30 -174.54 -174.28 0.83 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.664 HG13 ' CE1' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -114.58 121.08 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.958 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -114.69 125.72 54.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 1.5 p -107.01 138.31 43.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -140.04 147.24 40.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.97 0.891 . . . . 0.0 112.82 178.631 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 59' ' ' ARG . 25.7 mt -132.38 142.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.461 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 6' ' ' ASP . 4.5 m -142.94 -179.12 6.16 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.938 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.528 ' CB ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -154.71 69.77 0.75 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.046 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' ' CG ' ' A' ' 6' ' ' ASP . . . 132.6 -5.62 5.2 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.235 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.902 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -126.73 -162.14 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.58 0.69 . . . . 0.0 111.788 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -134.45 171.59 8.76 Favored Pre-proline 0 C--N 1.34 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.918 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 64.3 Cg_endo -87.46 114.38 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.876 2.384 . . . . 0.0 112.901 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.413 ' HB2' ' OH ' ' A' ' 53' ' ' TYR . 1.9 tp -113.79 83.56 7.57 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.015 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 27' ' ' PRO . 32.6 Cg_exo -57.59 -172.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.644 2.229 . . . . 0.0 112.263 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -55.37 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.246 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 2.2 pt-20 -115.81 29.23 8.12 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.94 -0.475 . . . . 0.0 111.672 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.75 -161.85 26.76 Favored Glycine 0 N--CA 1.462 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.394 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.32 -166.7 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.748 0.274 . . . . 0.0 110.777 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 171.26 19.75 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.293 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -149.76 153.71 36.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.23 128.91 25.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.627 2.218 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' ' 8' ' ' SER . 42.9 t60 -158.3 114.08 1.73 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.772 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -38.89 -77.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.654 2.236 . . . . 0.0 112.947 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -156.55 -158.64 0.8 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -177.51 143.7 0.52 Allowed Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.264 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 24.6 Cg_exo -62.65 -15.9 49.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.489 2.126 . . . . 0.0 112.203 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.758 ' HZ2' HG23 ' A' ' 63' ' ' ILE . 32.6 t90 -84.68 -50.33 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.871 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -45.13 -53.02 8.55 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.26 -36.42 82.95 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 25.1 tt0 -47.41 -36.89 10.43 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.351 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.26 2.56 1.14 Allowed Glycine 0 C--N 1.359 1.814 0 C-N-CA 118.112 -1.994 . . . . 0.0 115.224 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.564 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -82.65 65.03 7.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.404 1.102 . . . . 0.0 110.136 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -49.35 -22.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.69 160.45 32.62 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.057 -0.402 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.463 ' CZ2' ' NH1' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -161.07 15.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.952 HG23 ' HG3' ' A' ' 57' ' ' GLN . 7.6 p -156.0 6.29 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.735 ' CD ' ' H ' ' A' ' 51' ' ' VAL . 14.5 Cg_endo -56.51 32.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 N-CA-C 118.795 2.575 . . . . 0.0 118.795 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.902 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -137.21 116.62 12.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.26 1.391 . . . . 0.0 109.669 176.557 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.8 t -46.64 -53.25 11.96 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.356 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 m -70.57 -21.12 62.73 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.95 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 53' ' ' TYR . . . -159.53 167.77 35.23 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.836 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.952 ' HG3' HG23 ' A' ' 51' ' ' VAL . 5.0 mt-30 -80.75 129.47 34.54 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 121.683 -0.893 . . . . 0.0 109.288 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 52' ' ' PRO . 1.1 m -120.77 -169.03 1.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.95 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.737 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.7 OUTLIER -162.46 132.97 4.77 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.6 t -131.59 132.87 44.42 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -143.9 169.0 18.62 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.128 177.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.416 ' N ' HG23 ' A' ' 61' ' ' THR . 0.1 OUTLIER -170.62 156.32 5.28 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.47 1.032 . . . . 0.0 111.161 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.758 HG23 ' HZ2' ' A' ' 42' ' ' TRP . 3.4 pt -149.5 156.1 39.17 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.539 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.21 125.32 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.206 2.604 . . . . 0.0 111.921 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.745 ' CD2' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -134.43 -145.78 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.408 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.745 HG22 ' CD2' ' A' ' 65' ' ' TYR . 30.5 m -66.24 -26.57 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.716 0.294 . . . . 0.0 111.256 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 65' ' ' TYR . 2.8 tt0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.836 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.583 ' HB2' HG22 ' A' ' 21' ' ' ILE . 1.6 p30 . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.769 0.318 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -150.56 141.81 23.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.783 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.1 t -110.91 145.89 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -127.22 130.99 50.7 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.407 178.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.15 103.54 15.58 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.4 m -87.61 152.65 22.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.281 0.562 . . . . 0.0 111.903 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 11.1 t80 -125.33 138.29 54.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.767 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.96 158.38 75.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 5.0 Cg_endo -46.87 -14.19 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.164 2.576 . . . . 0.0 113.628 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 15.8 t70 -164.94 29.18 0.06 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.776 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.85 165.56 35.69 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 111.812 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -144.03 131.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.904 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 20' ' ' PHE . 11.7 m -124.37 135.85 53.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 112.078 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.813 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 17.7 p -116.97 111.08 19.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.846 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.852 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -134.7 136.4 42.71 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.894 HD12 HG23 ' A' ' 60' ' ' THR . 4.0 mt -108.47 95.26 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.377 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 5.0 m -76.82 -176.95 4.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.905 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.605 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.66 62.89 1.32 Allowed 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.33 17.91 7.43 Favored Glycine 0 C--N 1.351 1.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.414 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.749 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -138.5 -159.7 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.621 0.71 . . . . 0.0 111.857 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -140.38 179.5 1.25 Allowed Pre-proline 0 C--N 1.339 0.132 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 88.3 Cg_endo -83.61 111.1 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.293 1.995 . . . . 0.0 112.791 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 111.71 15.76 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.728 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.11 161.82 26.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.564 2.176 . . . . 0.0 112.34 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.25 -52.11 0.4 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.016 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -145.68 30.49 1.09 Allowed 'General case' 0 C--N 1.352 0.701 0 O-C-N 122.01 -0.431 . . . . 0.0 111.663 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . -167.95 -139.07 2.6 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.301 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.67 -165.28 1.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.259 0.529 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 10.6 m -155.74 169.97 23.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 110.379 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -144.68 162.2 39.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.254 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.26 129.85 10.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.8 t-80 -161.14 114.75 1.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -35.48 -68.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.505 ' CG2' HD11 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -141.11 -154.56 0.52 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.628 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -156.21 133.19 6.37 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 122.417 -0.177 . . . . 0.0 111.331 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 4.4 Cg_exo -74.44 -23.75 14.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.85 2.366 . . . . 0.0 112.659 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.813 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 5.4 p-90 -84.98 -38.3 19.44 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.841 ' SG ' HG22 ' A' ' 60' ' ' THR . 0.1 OUTLIER -45.96 -59.28 2.93 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.442 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -66.88 -36.08 81.49 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 21.0 tt0 -55.24 -17.34 4.35 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.477 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.36 -31.42 0.42 Allowed Glycine 0 C--N 1.369 2.376 0 C-N-CA 117.124 -2.465 . . . . 0.0 114.048 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.801 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -103.8 -115.44 0.22 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.258 0.551 . . . . 0.0 112.305 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.71 HG13 ' H ' ' A' ' 49' ' ' GLU . 1.1 p 175.53 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.651 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.71 ' H ' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.37 -166.92 2.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.849 ' CE3' ' HB2' ' A' ' 58' ' ' CYS . 3.9 t90 -154.73 -146.09 0.18 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.321 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 50' ' ' TRP . 1.2 t 153.07 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 117.877 0.308 . . . . 0.0 111.294 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' HB ' ' A' ' 51' ' ' VAL . 7.2 Cg_exo -75.38 92.22 1.02 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.742 2.295 . . . . 0.0 115.34 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.749 ' CE2' ' HB1' ' A' ' 25' ' ' ALA . 41.3 t80 -128.01 129.99 47.6 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -36.23 -70.0 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -73.31 -19.32 61.06 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.09 -168.33 25.97 Favored Glycine 0 C--N 1.362 1.974 0 C-N-CA 118.348 -1.882 . . . . 0.0 113.416 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.1 tt0 -103.44 136.6 42.89 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 119.373 1.586 . . . . 0.0 108.49 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.849 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 56.0 m -123.92 -172.32 2.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.901 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.581 ' HA ' ' CB ' ' A' ' 50' ' ' TRP . 39.6 ptt85 -166.03 111.45 0.85 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.0 -0.438 . . . . 0.0 110.752 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.894 HG23 HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER 164.0 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.202 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.801 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 6.4 t -144.37 -173.87 4.15 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.724 ' O ' HG23 ' A' ' 63' ' ' ILE . 1.8 m -143.78 153.09 42.04 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 122.916 0.486 . . . . 0.0 109.96 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.724 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -166.7 163.39 10.98 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.244 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 18.0 Cg_exo -66.07 -161.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.595 2.196 . . . . 0.0 111.439 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 120.68 0.276 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -169.33 157.56 7.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 48.2 t -104.21 152.4 22.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.3 0.572 . . . . 0.0 112.162 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -129.07 137.09 51.06 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.542 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.4 117.35 29.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.726 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 27' ' ' PRO . 74.2 m -100.36 141.36 33.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -128.19 130.12 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.59 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -142.02 150.01 54.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.27 5.54 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.377 2.051 . . . . 0.0 113.097 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.5 m-20 -126.58 -17.34 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -165.71 172.03 12.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.201 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.753 HG13 ' CE1' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -134.07 119.28 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.041 178.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.0 m -121.85 149.16 43.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.896 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 12.3 p -132.52 124.41 28.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.839 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.836 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -141.16 138.75 33.65 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 60' ' ' THR . 6.7 mt -101.1 125.59 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' HB2' ' A' ' 26' ' ' ALA . 7.8 m -145.72 -172.59 3.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 118.291 -1.364 . . . . 0.0 114.289 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.61 63.53 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 150.95 -36.44 0.89 Allowed Glycine 0 C--N 1.348 1.212 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.442 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . 175.36 -161.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.839 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . 179.82 -57.71 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.839 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 56.4 Cg_endo -101.49 111.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.775 2.316 . . . . 0.0 114.28 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.06 112.24 28.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -39.09 113.22 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.961 2.44 . . . . 0.0 113.001 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -142.63 -49.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.328 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.67 34.22 0.45 Allowed 'General case' 0 C--N 1.353 0.76 0 CA-C-N 118.443 0.565 . . . . 0.0 112.168 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -173.49 46.26 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.608 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.86 -165.15 1.47 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.671 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.9 m -154.08 179.32 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 163.94 22.44 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.25 136.8 32.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.894 2.396 . . . . 0.0 112.631 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 t-160 -171.3 101.83 0.4 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.064 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 8' ' ' SER . 47.5 Cg_exo -33.33 -65.8 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.165 2.577 . . . . 0.0 113.29 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 51.8 p -151.3 -157.43 0.81 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.301 0.376 . . . . 0.0 110.397 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.802 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -165.5 173.6 3.5 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.763 0.316 . . . . 0.0 111.456 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.802 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 86.2 Cg_endo -81.45 -48.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.893 2.395 . . . . 0.0 112.701 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.896 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 19.2 p-90 -71.87 -41.14 68.42 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.823 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.02 -56.65 3.23 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -78.37 -33.14 49.15 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.204 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.474 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 1.4 tp10 -41.15 -37.02 0.82 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 119.06 -0.495 . . . . 0.0 112.134 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.42 10.67 0.85 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 118.106 -1.997 . . . . 0.0 113.875 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 1.012 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -108.49 75.9 1.0 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 117.504 0.652 . . . . 0.0 111.416 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.579 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -23.83 -82.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.047 178.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 175.09 -132.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.559 ' N ' ' HB2' ' A' ' 59' ' ' ARG . 5.4 m95 -0.05 132.54 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.6 t -162.94 136.56 4.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 112.921 -1.945 . . . . 0.0 108.099 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.76 121.5 2.51 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.144 1.896 . . . . 0.0 114.303 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.585 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 53.4 t80 -118.69 121.88 41.18 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.6 m -39.51 -47.47 1.88 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.102 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 72.5 m -77.82 -29.43 50.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.339 0.518 . . . . 0.0 112.271 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.06 175.67 37.7 Favored Glycine 0 C--N 1.359 1.843 0 C-N-CA 118.787 -1.673 . . . . 0.0 113.471 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.1 tt0 -87.87 112.25 22.3 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.114 0.957 . . . . 0.0 109.77 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 1.6 m -99.83 -171.64 2.09 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 21' ' ' ILE . 11.3 ptt180 172.08 101.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.836 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 170.63 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.012 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 14.6 t -141.25 -176.8 4.84 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.828 ' O ' HG23 ' A' ' 63' ' ' ILE . 1.3 m -148.67 153.08 37.77 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 123.422 0.689 . . . . 0.0 109.188 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.852 HD11 ' CZ3' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -172.11 164.75 4.11 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 111.796 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 71.7 Cg_endo -97.64 153.93 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.786 2.99 . . . . 0.0 112.086 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.753 ' CE1' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.777 0.323 . . . . 0.0 110.714 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -142.65 140.18 31.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.823 ' HB2' HG23 ' A' ' 39' ' ' THR . 3.4 t -119.43 154.53 33.56 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.865 0.84 . . . . 0.0 112.438 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 1.1 p90 -143.43 140.53 30.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.65 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.17 137.13 37.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.887 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 91.9 m -117.45 150.76 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 111.771 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 22.8 t80 -113.44 124.9 53.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.803 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -134.72 144.6 51.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.74 5.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.693 2.262 . . . . 0.0 113.548 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -116.03 -34.72 4.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.442 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -176.01 -169.18 0.31 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.81 115.64 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -102.8 132.72 48.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.798 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 5.4 t -112.57 148.65 34.08 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.942 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.425 0.631 . . . . 0.0 111.714 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 43' ' ' CYS . 2.1 mp -107.13 122.08 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.259 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 37.8 m -110.11 -175.13 2.65 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -155.7 51.49 0.56 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.81 13.71 5.98 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.295 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -169.85 -160.03 0.23 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.904 0.852 . . . . 0.0 112.058 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . . . -174.55 123.66 0.38 Allowed Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.497 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 7.8 Cg_endo -50.13 143.68 24.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.411 2.074 . . . . 0.0 112.01 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -71.64 114.65 30.18 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.62 169.79 2.99 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.609 2.206 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -170.77 -45.4 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.719 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -91.43 30.54 1.28 Allowed 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.267 0.485 . . . . 0.0 112.287 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 150.24 -146.14 14.94 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.863 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -128.49 -169.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.897 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 6.3 m -156.51 173.69 16.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.396 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -151.62 164.41 20.36 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.491 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.96 145.64 56.57 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.575 2.183 . . . . 0.0 112.473 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' SER . 15.6 t-80 -172.58 111.83 0.36 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 37' ' ' HIS . 52.7 Cg_exo -29.59 -72.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.05 2.5 . . . . 0.0 112.85 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.823 HG23 ' HB2' ' A' ' 8' ' ' SER . 0.0 OUTLIER -174.11 -163.15 0.15 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.358 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.851 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -164.49 161.64 15.68 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 74.8 Cg_endo -77.72 -14.15 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.475 2.117 . . . . 0.0 112.452 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.786 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 24.0 p-90 -94.68 -51.19 4.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 119.477 -0.297 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.851 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -48.44 -49.25 36.09 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.129 178.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.31 -41.67 72.98 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.999 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -38.94 -34.95 0.17 Allowed 'General case' 0 C--N 1.361 1.092 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.749 178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.63 63.46 0.29 Allowed Glycine 0 C--N 1.357 1.739 0 C-N-CA 119.911 -1.137 . . . . 0.0 111.095 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 1.092 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -78.87 1.11 24.6 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 60' ' ' THR . 55.8 t -163.11 -90.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.607 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -170.99 150.37 3.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.723 0.296 . . . . 0.0 111.58 -178.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 60.5 t-105 -73.63 152.6 40.46 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.492 ' CG2' ' HD2' ' A' ' 52' ' ' PRO . 7.8 p -160.42 145.17 10.81 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.495 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HD2' ' CG2' ' A' ' 51' ' ' VAL . 69.7 Cg_endo -93.74 122.13 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.857 2.372 . . . . 0.0 113.584 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.572 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 1.9 t80 -98.7 139.44 34.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -42.86 -62.66 0.95 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -68.6 -25.55 64.92 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -167.77 176.6 42.39 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.228 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -100.3 129.4 46.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.107 1.454 . . . . 0.0 111.262 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.3 t -142.45 -177.68 5.39 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -162.34 140.9 8.97 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 122.162 -0.336 . . . . 0.0 110.413 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.737 HG23 HG11 ' A' ' 48' ' ' VAL . 2.7 t -89.36 158.71 17.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 1.092 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.5 p -152.05 173.28 15.08 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.557 ' H ' ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -177.1 153.05 0.94 Allowed 'General case' 0 C--N 1.353 0.757 0 CA-C-N 120.075 1.307 . . . . 0.0 111.953 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 ' CE3' ' A' ' 42' ' ' TRP . 5.0 pt -161.82 166.5 14.41 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.19 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 50.8 Cg_exo -53.91 171.47 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.118 1.879 . . . . 0.0 111.575 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 . . . . . 0 C--N 1.327 -0.391 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.619 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 . . . . . 0 N--CA 1.461 0.112 0 CA-C-O 120.729 0.299 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.0 140.33 17.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.876 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.7 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 22.7 t -114.19 149.48 35.69 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -128.29 145.22 51.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.49 HD21 ' HZ2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -103.55 130.34 50.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 99.4 m -106.06 145.95 30.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.3 m-85 -126.25 136.79 53.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.194 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -131.14 159.39 71.78 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.656 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 10.0 Cg_endo -51.62 -10.79 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.776 2.317 . . . . 0.0 113.199 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.549 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 2.0 t70 -162.61 31.24 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.466 -0.494 . . . . 0.0 112.014 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.485 ' CG ' ' HA ' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -163.1 171.29 16.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.542 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 65' ' ' TYR . 16.2 m -146.15 139.39 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.015 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.18 134.38 44.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.714 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.764 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 47.4 t -119.28 136.74 54.09 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.882 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.2 OUTLIER -144.13 122.72 12.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.991 HG12 HG23 ' A' ' 39' ' ' THR . 1.0 OUTLIER -110.7 99.61 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 76.4 m -106.62 -164.94 1.04 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.487 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.88 66.11 0.79 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.38 9.97 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.779 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' A' ' 55' ' ' THR . . . -165.51 -160.65 0.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.378 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.691 ' HB1' ' CE2' ' A' ' 20' ' ' PHE . . . -175.88 129.79 0.39 Allowed Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 116.87 -0.15 . . . . 0.0 110.647 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -43.43 140.9 3.75 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.737 2.291 . . . . 0.0 112.203 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.18 118.1 70.78 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.63 -173.91 1.93 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.597 2.198 . . . . 0.0 111.94 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.23 -51.87 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 3.5 pm0 -93.31 31.95 1.41 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 118.237 0.471 . . . . 0.0 112.086 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.05 -166.27 39.1 Favored Glycine 0 N--CA 1.462 0.368 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.723 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 6.7 pm0 -120.53 -169.59 1.84 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 33' ' ' GLU . 3.1 m -155.95 176.82 12.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.926 0.393 . . . . 0.0 111.198 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 51.4 p-10 -162.44 159.05 20.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.817 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 35' ' ' ASN . 18.1 Cg_endo -59.47 151.83 65.96 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.795 2.33 . . . . 0.0 112.941 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 8' ' ' SER . 29.8 t-80 179.24 110.24 0.18 Allowed Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.742 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.503 ' O ' ' HB3' ' A' ' 8' ' ' SER . 35.1 Cg_exo -27.91 -75.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.339 2.692 . . . . 0.0 113.728 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.991 HG23 HG12 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -163.6 -169.69 2.0 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.883 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -160.27 146.46 11.76 Favored Pre-proline 0 C--N 1.345 0.406 0 CA-C-N 118.382 0.537 . . . . 0.0 111.25 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 58.6 Cg_endo -71.64 -6.17 18.59 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.634 2.222 . . . . 0.0 112.866 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.764 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 61.6 p-90 -96.65 -35.77 10.93 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -55.54 -43.12 75.49 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 -41.05 24.52 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.1 tt0 -59.99 -9.4 3.04 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.618 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.16 -31.34 2.46 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 117.827 -2.13 . . . . 0.0 111.639 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.77 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -129.8 -109.78 0.27 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.385 0.612 . . . . 0.0 111.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER 176.56 -85.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.826 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 59' ' ' ARG . 51.2 mt-10 -162.14 158.9 25.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.817 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -155.37 69.29 0.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.79 1.281 . . . . 0.0 111.884 178.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.889 HG23 ' HD3' ' A' ' 52' ' ' PRO . 10.7 m -46.31 -39.37 13.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 112.875 -1.966 . . . . 0.0 113.885 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.889 ' HD3' HG23 ' A' ' 51' ' ' VAL . 37.0 Cg_endo -64.12 74.22 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.313 1.342 . . . . 0.0 114.343 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.61 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 65.0 t80 -115.82 129.12 56.31 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 m -41.94 -58.85 1.91 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.497 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 63.2 m -65.37 -30.64 71.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.204 0.457 . . . . 0.0 112.161 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -176.98 -161.97 26.62 Favored Glycine 0 CA--C 1.545 1.924 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.718 ' HG2' HG12 ' A' ' 51' ' ' VAL . 8.4 tt0 -88.36 130.03 35.25 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 119.793 1.796 . . . . 0.0 108.748 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.817 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 1.2 m -121.5 167.62 12.64 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.053 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.783 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -163.96 100.79 0.88 Allowed 'General case' 0 C--N 1.37 1.47 0 CA-C-N 118.784 0.72 . . . . 0.0 111.476 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.882 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 167.38 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.77 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 7.5 t -161.66 -163.29 0.96 Allowed 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' O ' HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -135.5 167.07 21.76 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.117 0.567 . . . . 0.0 110.23 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG1' HG23 ' A' ' 17' ' ' VAL . 8.0 pt -158.68 157.0 28.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.033 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 30.0 Cg_endo -63.15 -16.89 57.3 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.424 2.083 . . . . 0.0 113.302 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.825 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.093 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.45 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 . . . . . 0 N--CA 1.461 0.123 0 CA-C-O 120.847 0.356 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.85 154.33 27.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.328 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB2' ' CG1' ' A' ' 21' ' ' ILE . 2.4 t -113.11 159.67 18.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.305 0.574 . . . . 0.0 112.131 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.756 ' CE1' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -134.1 133.95 41.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.274 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.61 117.52 30.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.9 m -102.0 138.25 39.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.776 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -123.94 144.22 49.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.41 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.89 162.36 56.3 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.604 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 9.7 Cg_endo -52.11 -12.92 1.62 Allowed 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.638 2.225 . . . . 0.0 112.879 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -160.67 32.22 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.617 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 64' ' ' PRO . 16.2 mt-30 -158.49 156.14 29.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.313 0.578 . . . . 0.0 112.349 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 65' ' ' TYR . 15.8 m -141.28 106.45 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.064 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 12.9 m -113.43 118.78 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.806 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.665 ' O ' ' HB ' ' A' ' 60' ' ' THR . 0.9 OUTLIER -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.865 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -143.6 139.36 29.63 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.713 HD12 HG23 ' A' ' 60' ' ' THR . 3.4 mt -110.91 136.16 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.2 m -146.27 -174.92 4.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.058 -1.057 . . . . 0.0 113.367 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -146.07 63.59 1.23 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.17 -33.57 0.6 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.458 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.62 ' HB2' HG22 ' A' ' 55' ' ' THR . . . -177.12 -154.26 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.006 0.403 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.756 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . . . -156.92 157.78 30.91 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-O 120.524 0.202 . . . . 0.0 110.485 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 37.4 Cg_exo -57.52 151.41 54.19 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.4 2.067 . . . . 0.0 112.089 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.38 109.22 18.02 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.02 178.57 5.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.454 2.102 . . . . 0.0 112.215 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.9 t -160.4 -55.33 0.05 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.356 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 6.2 pm0 -94.25 32.53 1.51 Allowed 'General case' 0 C--N 1.352 0.692 0 O-C-N 122.022 -0.424 . . . . 0.0 111.714 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.81 -169.54 41.98 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.577 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -128.69 -164.43 1.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.159 -0.217 . . . . 0.0 110.532 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.9 m -154.46 178.07 10.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.036 0.446 . . . . 0.0 111.189 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -153.72 161.98 27.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.21 135.99 33.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.544 2.163 . . . . 0.0 112.581 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -165.38 106.84 0.77 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.294 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 8' ' ' SER . 68.1 Cg_exo -37.63 -70.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.96 2.44 . . . . 0.0 113.133 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 21.8 p -154.42 -158.92 0.9 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.349 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 179.53 148.84 0.46 Allowed Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 111.585 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 55.9 Cg_endo -69.7 -24.47 29.93 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.655 2.237 . . . . 0.0 111.631 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.899 ' CZ2' HD11 ' A' ' 63' ' ' ILE . 90.4 t90 -73.34 -45.74 53.44 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.961 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -44.87 -49.05 11.13 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.18 -33.08 24.27 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 2.5 tt0 -48.93 -20.62 0.53 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.319 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.68 -35.25 0.86 Allowed Glycine 0 C--N 1.363 2.029 0 C-N-CA 118.381 -1.866 . . . . 0.0 112.085 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.799 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -141.87 100.16 3.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.991 0.395 . . . . 0.0 111.217 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -24.4 -90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 123.745 0.653 . . . . 0.0 110.439 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 2.2 mt-10 172.24 130.73 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.678 ' HA ' ' CE3' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 141.96 136.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 112.927 -1.942 . . . . 0.0 111.72 176.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.3 p 175.45 83.9 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.911 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 51' ' ' VAL . 1.6 Cg_endo -42.88 140.63 2.94 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.284 2.656 . . . . 0.0 113.607 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.67 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 47.8 t80 -133.46 132.57 41.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.518 -0.764 . . . . 0.0 108.953 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -50.92 5.97 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 25' ' ' ALA . 19.5 m -73.72 -30.94 63.12 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.959 -0.463 . . . . 0.0 112.031 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.67 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -163.58 173.69 39.71 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.358 -1.401 . . . . 0.0 112.399 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ARG . 4.6 tt0 -87.03 112.63 22.04 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 118.904 1.352 . . . . 0.0 110.005 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.561 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 1.5 m -97.42 -171.98 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.406 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.615 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 25.7 ptt180 173.66 102.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.941 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.865 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 172.72 -150.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.799 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 14.6 t -157.2 -170.71 3.35 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.813 ' C ' HD13 ' A' ' 63' ' ' ILE . 19.6 t -165.77 156.7 13.56 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.899 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -152.65 166.83 14.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.696 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' ' CG ' ' A' ' 65' ' ' TYR . 9.3 Cg_endo -51.88 -24.35 18.58 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.261 1.974 . . . . 0.0 112.282 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.707 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.308 -1.218 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.182 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.426 ' HB2' HG22 ' A' ' 21' ' ' ILE . 2.9 p30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.763 0.316 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -144.37 141.19 29.53 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 35.2 t -113.29 143.99 43.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.488 0.661 . . . . 0.0 112.704 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 134.77 48.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.108 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.49 HD12 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -96.67 119.07 34.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.023 0.439 . . . . 0.0 110.606 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.4 m -100.81 128.74 46.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.331 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -113.9 137.61 51.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -138.64 145.82 47.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.32 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.41 -0.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.705 2.27 . . . . 0.0 113.663 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.8 t0 -122.2 -30.83 3.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -158.8 -175.16 5.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.187 0.518 . . . . 0.0 111.779 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 65' ' ' TYR . 8.3 m -141.24 126.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.909 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.1 m -118.06 141.13 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.632 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.737 ' O ' ' HB ' ' A' ' 60' ' ' THR . 41.8 t -123.97 131.61 53.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.831 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -137.94 136.31 36.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.75 HD12 HG23 ' A' ' 60' ' ' THR . 2.4 mt -103.43 103.93 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.9 m -95.13 -174.2 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.757 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -150.47 60.51 0.95 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 55' ' ' THR . . . 100.71 26.22 8.16 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.011 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.834 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -151.2 -161.26 1.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.04 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -178.04 114.53 0.23 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-O 120.449 0.166 . . . . 0.0 110.682 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.484 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 70.1 Cg_exo -49.78 142.93 24.24 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.467 2.111 . . . . 0.0 112.414 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.87 112.49 22.84 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.42 173.89 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.617 2.211 . . . . 0.0 112.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.4 m -155.55 -52.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.638 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -124.39 33.47 5.25 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 118.288 0.494 . . . . 0.0 112.106 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.96 -169.61 41.56 Favored Glycine 0 N--CA 1.462 0.432 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.792 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.29 -162.77 0.99 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -154.83 164.12 39.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.344 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -140.84 167.66 16.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.666 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.22 136.56 29.46 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.587 2.191 . . . . 0.0 112.691 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.49 ' ND1' HD12 ' A' ' 10' ' ' LEU . 20.9 t-160 -165.06 93.91 0.9 Allowed Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -30.93 -70.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.359 2.706 . . . . 0.0 113.627 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -142.25 -159.19 0.94 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.815 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.934 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -176.63 169.15 1.25 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-O 120.699 0.285 . . . . 0.0 111.373 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 93.8 Cg_endo -83.66 -35.14 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.015 2.477 . . . . 0.0 112.848 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.564 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 17.2 p-90 -88.05 -42.57 12.32 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -42.62 -58.44 2.29 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -36.63 73.65 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.219 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 5.3 tt0 -42.96 -32.35 0.63 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.105 0.411 . . . . 0.0 111.492 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -139.94 13.38 3.11 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 118.868 -1.634 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 43' ' ' CYS . . . -66.14 66.53 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 111.896 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 48' ' ' VAL . 21.5 t -141.8 53.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.96 23.44 0.66 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.262 0.937 . . . . 0.0 112.845 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.925 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -148.85 -173.53 4.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.5 t 153.08 -44.8 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.621 0.769 . . . . 0.0 110.022 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 4.7 Cg_endo -87.82 91.18 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.844 2.362 . . . . 0.0 114.796 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.834 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 10.0 t80 -121.88 128.85 52.05 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 m -40.3 -55.99 2.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 24' ' ' GLY . 64.3 m -66.98 -29.17 68.94 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.766 ' N ' ' HB2' ' A' ' 25' ' ' ALA . . . -177.38 -173.07 42.56 Favored Glycine 0 C--N 1.359 1.822 0 C-N-CA 119.272 -1.442 . . . . 0.0 112.324 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 1.7 tm0? -100.07 125.9 46.21 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 119.637 1.719 . . . . 0.0 109.488 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.774 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 50.1 t -136.19 -178.78 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.797 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.3 OUTLIER 174.68 137.71 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.741 1.155 . . . . 0.0 111.594 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.831 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 179.44 -147.08 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.473 ' H ' ' HB ' ' A' ' 60' ' ' THR . 9.0 t -151.12 -171.13 3.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.604 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.516 ' O ' HG23 ' A' ' 63' ' ' ILE . 69.7 m -146.23 173.08 12.54 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 17' ' ' VAL . 6.3 pt -158.07 156.54 28.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.782 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 19.4 Cg_endo -58.24 -19.42 42.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.406 2.071 . . . . 0.0 113.012 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.776 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.309 -1.186 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.945 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.449 ' HB2' HG22 ' A' ' 21' ' ' ILE . 4.4 p30 . . . . . 0 C--O 1.231 0.109 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.43 141.06 21.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.206 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.5 t -118.11 144.33 45.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.85 133.12 54.88 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.348 177.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.492 HD21 ' CZ2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -91.53 123.08 34.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 110.504 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -99.2 138.86 35.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.213 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -118.45 129.79 55.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.064 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.9 OUTLIER -138.34 146.79 52.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.857 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 4.48 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.45 2.1 . . . . 0.0 112.698 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -115.97 -32.65 5.34 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.525 0.202 . . . . 0.0 111.216 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -172.92 -170.58 0.67 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 0.0 111.265 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.458 ' CG2' ' CE1' ' A' ' 65' ' ' TYR . 1.8 t -133.36 124.7 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.29 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.5 m -124.54 141.35 52.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 111.747 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.637 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 3.1 p -117.03 147.11 42.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.861 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -148.65 128.02 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.514 HD13 ' NE ' ' A' ' 59' ' ' ARG . 1.1 mp -97.6 106.86 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.344 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 2.2 m -84.86 -178.03 6.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.011 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.12 55.89 1.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.27 25.33 6.74 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.247 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.648 ' HB2' ' CA ' ' A' ' 56' ' ' GLY . . . -155.53 -160.59 1.05 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.729 0.764 . . . . 0.0 112.043 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.88 94.66 0.19 Allowed Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.326 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 72.0 Cg_exo -34.7 141.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.238 2.625 . . . . 0.0 113.14 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -80.8 112.76 34.71 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.17 169.05 1.64 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.531 2.154 . . . . 0.0 112.324 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -153.66 -57.86 0.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.207 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.65 29.52 7.34 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.01 -0.431 . . . . 0.0 111.426 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.17 -169.65 42.3 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.514 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.61 -161.43 0.89 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.225 -0.19 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.13 161.18 39.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.153 0.501 . . . . 0.0 111.391 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.4 173.59 4.36 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.75 136.26 20.71 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.066 2.511 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.4 t-80 -173.84 93.29 0.34 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.882 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -29.15 -71.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.608 2.872 . . . . 0.0 113.846 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.413 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 13.8 p -151.2 -155.79 0.66 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.136 0.272 . . . . 0.0 110.762 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . 179.93 164.84 0.84 Allowed Pre-proline 0 N--CA 1.473 0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 111.5 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.15 -28.51 10.73 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.17 2.58 . . . . 0.0 112.193 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.711 ' CE3' HD13 ' A' ' 63' ' ' ILE . 20.8 p-90 -86.71 -39.87 15.61 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.6 -58.42 2.66 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -33.07 65.25 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.229 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 2.8 tt0 -39.6 -42.82 1.23 Allowed 'General case' 0 C--N 1.361 1.089 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.081 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -146.1 16.42 1.72 Allowed Glycine 0 C--N 1.357 1.723 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.456 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 43' ' ' CYS . . . -51.92 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.42 0.629 . . . . 0.0 112.562 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 48' ' ' VAL . 7.7 p -65.82 49.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.169 -1.378 . . . . 0.0 107.936 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -26.57 116.81 0.07 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -121.94 73.85 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.358 177.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.856 ' HA ' ' H ' ' A' ' 58' ' ' CYS . 14.0 m -57.32 -38.53 69.04 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.71 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 51' ' ' VAL . 9.7 Cg_endo -51.97 77.53 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.594 1.53 . . . . 0.0 113.587 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.685 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 62.3 t80 -121.7 132.96 54.92 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.5 m -45.26 -58.97 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.5 m -61.91 -30.64 71.02 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 122.014 -0.429 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -179.01 -165.88 34.08 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.916 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.803 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.7 mt-30 -109.98 127.7 54.95 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 120.179 1.99 . . . . 0.0 110.045 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.856 ' H ' ' HA ' ' A' ' 51' ' ' VAL . 14.0 m -131.93 -171.26 2.58 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 4.9 ttp180 -140.06 135.03 32.19 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.557 HG23 HG13 ' A' ' 48' ' ' VAL . 8.8 t -119.38 135.31 54.79 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.68 ' OG1' ' CA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -135.21 165.96 24.2 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 176.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.7 m -156.74 153.44 28.41 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.894 1.225 . . . . 0.0 110.56 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.711 HD13 ' CE3' ' A' ' 42' ' ' TRP . 12.9 pt -148.98 136.72 11.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.53 134.28 2.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.925 2.417 . . . . 0.0 112.277 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE1' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.165 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.792 0.329 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -130.03 140.26 50.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.3 m -123.67 155.41 37.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.523 0.678 . . . . 0.0 112.211 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.511 ' CZ ' ' HD2' ' A' ' 27' ' ' PRO . 0.8 OUTLIER -136.58 129.38 30.77 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.866 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.446 HD11 ' HZ2' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -93.07 124.82 37.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.58 153.04 22.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.761 0.791 . . . . 0.0 112.86 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 21.9 t80 -118.68 114.56 22.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.521 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -120.11 144.76 38.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 19.5 Cg_endo -58.35 6.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 113.338 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.4 m-20 -118.42 -33.05 4.45 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.462 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -170.25 -165.16 0.45 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.584 HG13 ' CE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -122.93 122.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -118.36 148.36 42.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 39.3 t -128.28 143.56 51.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -138.96 138.5 37.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 112.188 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.685 HD12 ' HD3' ' A' ' 59' ' ' ARG . 3.3 mt -112.39 140.63 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.759 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 13.1 m -143.64 -173.62 4.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 119.336 -0.946 . . . . 0.0 113.165 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -149.59 60.58 1.01 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 152.16 -29.09 0.89 Allowed Glycine 0 C--N 1.35 1.316 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.441 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' HB ' ' A' ' 55' ' ' THR . . . -176.14 -156.05 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.68 0.74 . . . . 0.0 111.907 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.472 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -150.09 154.52 36.78 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-O 120.561 0.22 . . . . 0.0 110.714 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 40.3 Cg_endo -66.86 159.23 52.59 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.373 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -74.48 111.79 14.46 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 161.91 38.51 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.573 2.182 . . . . 0.0 112.215 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 t -164.9 -49.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.409 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.8 pm0 -92.73 32.59 1.22 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.123 0.42 . . . . 0.0 111.784 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 163.44 169.22 26.6 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.461 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -101.82 -164.27 1.08 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.59 161.04 35.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 110.853 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -140.98 147.5 48.17 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.49 129.3 33.97 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.431 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 39' ' ' THR . 6.5 t-160 -159.55 102.31 1.5 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -33.19 -70.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.18 2.586 . . . . 0.0 113.36 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.42 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -147.55 -157.77 0.84 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.655 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -175.54 151.82 1.3 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.687 0.28 . . . . 0.0 111.116 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 73.6 Cg_endo -75.68 -26.57 9.74 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.589 2.193 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.94 ' CE3' HD13 ' A' ' 63' ' ' ILE . 40.9 p-90 -90.69 -40.38 11.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -44.06 -59.79 2.16 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -33.93 61.06 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.225 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.738 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -47.86 -30.0 3.74 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 119.003 0.82 . . . . 0.0 111.667 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.72 -2.55 4.8 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 118.527 -1.796 . . . . 0.0 113.758 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 61' ' ' THR . . . -83.98 62.04 6.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.618 0.709 . . . . 0.0 110.643 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 48' ' ' VAL . 12.2 p -85.11 27.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.759 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.99 142.92 38.33 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -105.18 158.36 16.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.416 . . . . 0.0 111.334 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -138.69 104.05 7.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.211 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 111.3 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.546 2.164 . . . . 0.0 113.275 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.627 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 5.1 t80 -101.57 129.29 47.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.24 -45.6 5.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.251 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 18.5 m -78.14 -32.73 50.48 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.075 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.57 171.74 40.12 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.032 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ARG . 20.8 tt0 -83.57 122.96 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.499 1.149 . . . . 0.0 109.688 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -112.46 -174.82 2.54 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.685 ' HD3' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -161.62 132.98 5.37 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.4 m -116.86 139.31 50.77 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.465 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -148.35 167.25 25.72 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.074 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.426 ' N ' HG23 ' A' ' 61' ' ' THR . 81.0 m -156.7 158.35 36.78 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.501 1.046 . . . . 0.0 110.852 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.94 HD13 ' CE3' ' A' ' 42' ' ' TRP . 9.2 pt -155.47 157.25 31.57 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 9.5 Cg_endo -51.85 167.53 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.575 2.183 . . . . 0.0 112.092 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.584 ' CE1' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.805 0.336 . . . . 0.0 110.77 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 147.56 45.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 33.8 t -130.83 155.87 45.97 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.515 0.674 . . . . 0.0 111.907 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -139.28 137.65 36.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.07 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -95.26 131.61 41.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.698 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 84.3 m -113.93 154.16 28.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.557 0.694 . . . . 0.0 111.955 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.692 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 16.3 t80 -125.53 130.68 52.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.506 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -133.81 139.9 34.89 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 18.4 Cg_endo -59.26 7.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.445 2.096 . . . . 0.0 112.888 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.0 OUTLIER -119.79 -32.65 4.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.441 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 11.0 mt-30 -164.47 -168.86 1.62 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.306 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.14 145.92 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.316 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -151.52 139.95 20.5 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.571 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 49.4 t -120.41 150.86 40.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.587 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -146.55 133.55 20.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.533 0.682 . . . . 0.0 112.748 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 43' ' ' CYS . 3.1 mp -105.41 139.26 27.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.29 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.6 m -139.88 -170.75 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 119.201 -1.0 . . . . 0.0 113.353 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.68 58.66 0.81 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.03 18.08 9.07 Favored Glycine 0 C--N 1.349 1.299 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.359 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.82 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -157.09 -166.63 2.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.707 0.754 . . . . 0.0 112.051 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.429 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . 179.81 129.19 0.24 Allowed Pre-proline 0 N--CA 1.469 0.483 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 50.3 Cg_exo -53.89 140.58 68.34 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.134 1.89 . . . . 0.0 112.051 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.1 111.83 7.52 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.26 162.14 17.56 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.699 2.266 . . . . 0.0 112.331 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -174.83 -39.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.516 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.1 pm0 -91.08 32.6 1.0 Allowed 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.932 -0.48 . . . . 0.0 111.929 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 158.53 -163.79 33.21 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.683 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -121.81 -169.8 1.94 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 117.179 0.489 . . . . 0.0 110.616 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 4.3 m -156.98 161.47 39.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -135.35 150.82 73.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.27 140.48 81.61 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.594 2.196 . . . . 0.0 112.363 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.403 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.7 t-160 -168.62 90.07 0.63 Allowed Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -73.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.48 2.787 . . . . 0.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 30.6 p -157.28 -163.95 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 168.92 158.87 0.17 Allowed Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 120.701 0.286 . . . . 0.0 110.93 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 71.8 Cg_endo -76.73 -3.44 13.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.47 2.113 . . . . 0.0 112.119 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.669 ' CH2' HD12 ' A' ' 63' ' ' ILE . 66.1 t90 -93.75 -55.23 3.32 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.275 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.733 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.6 m -54.12 -32.54 55.34 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.59 -41.83 16.04 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.915 -0.49 . . . . 0.0 109.734 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.1 tt0 -51.32 -24.53 4.74 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.549 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.47 -16.82 4.99 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 118.38 -1.867 . . . . 0.0 113.316 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.9 ' HB2' ' CB ' ' A' ' 61' ' ' THR . . . -106.84 67.88 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.381 0.59 . . . . 0.0 111.091 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 48' ' ' VAL . 14.2 p -90.37 30.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.351 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -130.74 142.72 50.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.657 0.265 . . . . 0.0 110.403 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.412 ' CZ2' ' NH2' ' A' ' 59' ' ' ARG . 33.6 m95 -94.96 149.64 21.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.5 p -139.56 107.85 7.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.131 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.48 120.31 7.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 113.762 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.82 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 1.2 t80 -107.45 135.04 49.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.97 -54.66 6.29 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -69.48 -29.15 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 25' ' ' ALA . . . -174.35 -178.23 44.09 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 119.208 -1.472 . . . . 0.0 112.291 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ARG . 2.3 tt0 -81.91 142.42 32.49 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.334 1.567 . . . . 0.0 110.16 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -136.03 -179.2 5.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.309 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 25.7 ttm180 -161.72 122.59 2.7 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 t -108.17 144.86 35.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.9 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -147.89 158.26 43.95 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.12 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 91.6 m -155.41 162.09 40.85 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 120.045 1.293 . . . . 0.0 111.463 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.669 HD12 ' CH2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -158.93 166.11 17.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 30.4 Cg_exo -61.87 161.42 25.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.134 . . . . 0.0 112.463 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.42 ' OH ' ' CE2' ' A' ' 12' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.062 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.461 0.114 0 CA-C-O 120.738 0.304 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.6 139.14 33.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.056 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 5.8 t -119.1 149.03 42.37 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -129.71 144.56 51.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.036 178.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 132.76 47.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.26 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.42 ' SG ' ' HE1' ' A' ' 20' ' ' PHE . 64.4 m -106.86 146.81 30.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.996 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -125.21 132.44 52.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.26 157.16 49.77 Favored Pre-proline 0 CA--C 1.51 -0.559 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.128 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.92 -11.46 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.797 1.665 . . . . 0.0 110.975 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.11 28.21 0.07 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.503 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.5 154.37 31.7 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.204 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -130.0 128.8 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.519 179.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -133.43 138.14 46.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.477 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 16.4 t -127.9 152.71 47.52 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.484 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -151.7 141.98 22.39 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 43' ' ' CYS . 2.8 mp -112.15 122.97 67.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.184 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 11.4 m -116.43 -176.04 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.02 58.72 0.85 Allowed 'General case' 0 C--N 1.348 0.509 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 139.46 -13.74 3.22 Favored Glycine 0 C--N 1.348 1.21 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.184 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.837 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -174.38 -154.96 0.06 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.434 0.617 . . . . 0.0 111.682 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . . . -158.54 138.41 8.68 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-O 120.661 0.267 . . . . 0.0 111.045 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 18.2 Cg_endo -59.64 159.6 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.661 2.241 . . . . 0.0 112.179 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.657 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -86.15 156.46 57.35 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.47 -179.99 5.34 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.656 2.238 . . . . 0.0 112.148 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -149.52 -52.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.27 33.3 3.61 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.583 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -162.71 30.94 Favored Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.438 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 7.1 pm0 -116.72 -171.86 2.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 m -155.82 177.49 11.34 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.4 m120 -159.56 167.72 13.61 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 35' ' ' ASN . 49.6 Cg_endo -69.11 150.79 72.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.565 2.177 . . . . 0.0 112.809 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' SER . 16.5 t-80 -172.78 104.87 0.33 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' HIS . 35.8 Cg_exo -28.09 -81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -160.46 -160.29 0.76 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 174.61 148.72 0.24 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.04 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.87 -16.4 54.58 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.487 2.125 . . . . 0.0 111.989 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.752 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 91.1 t90 -92.46 -51.09 5.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 58.9 m -51.96 -34.97 44.55 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.246 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.03 -39.76 20.83 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.5 OUTLIER -50.98 -24.7 3.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.412 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.33 -6.1 5.85 Favored Glycine 0 C--N 1.363 2.06 0 C-N-CA 118.498 -1.811 . . . . 0.0 113.797 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 43' ' ' CYS . . . -85.64 52.32 2.43 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.641 0.72 . . . . 0.0 110.943 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.3 32.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.857 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 2.1 tt0 -128.96 127.36 41.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 110.207 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.439 ' CZ3' ' HD2' ' A' ' 59' ' ' ARG . 4.1 m95 -81.36 152.54 27.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.376 0.608 . . . . 0.0 111.748 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 58' ' ' CYS . 7.2 p -149.53 99.41 3.37 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.907 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.43 98.78 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.429 2.086 . . . . 0.0 113.277 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -93.22 129.65 39.19 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -40.5 -36.05 0.52 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.054 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.837 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -102.19 -23.48 14.03 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.547 0.612 . . . . 0.0 112.6 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -163.23 169.2 38.26 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 118.784 -1.674 . . . . 0.0 113.501 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -98.42 137.38 37.2 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.841 0.82 . . . . 0.0 109.979 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.724 ' O ' HG12 ' A' ' 51' ' ' VAL . 24.1 t -148.42 179.74 7.57 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -147.06 126.55 13.22 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 t -115.79 135.84 53.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 168.01 16.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.358 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 63' ' ' ILE . 94.4 m -154.45 169.35 23.97 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.201 0.909 . . . . 0.0 111.553 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.833 HG13 HG23 ' A' ' 17' ' ' VAL . 11.2 pt -160.28 130.19 3.41 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.698 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.6 118.83 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.711 2.274 . . . . 0.0 112.549 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.584 ' OH ' HG13 ' A' ' 17' ' ' VAL . 40.2 m-85 . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 121.277 0.56 . . . . 0.0 112.106 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.87 0.367 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.11 141.62 38.11 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.636 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 5.6 t -115.46 154.52 29.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.777 0.799 . . . . 0.0 112.742 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.885 ' CE1' ' HB1' ' A' ' 26' ' ' ALA . 1.3 p90 -138.87 129.78 26.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.531 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.452 HD12 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -89.71 122.55 32.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.354 . . . . 0.0 110.217 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -108.2 133.28 52.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.225 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.7 m-85 -107.71 137.12 46.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.559 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.55 157.39 39.39 Favored Pre-proline 0 CA--C 1.51 -0.567 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.207 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.18 -8.81 2.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.784 1.656 . . . . 0.0 110.885 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.09 29.7 0.08 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.245 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -164.16 162.4 22.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.189 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -128.6 140.41 49.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.89 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 68.3 m -151.21 137.73 18.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.599 ' O ' ' HB ' ' A' ' 60' ' ' THR . 46.5 t -126.61 131.08 51.57 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.897 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -130.12 143.62 50.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.77 HD12 HG23 ' A' ' 60' ' ' THR . 5.1 mt -115.42 123.36 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.961 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.7 m -125.86 -174.19 3.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -145.7 63.77 1.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 157.98 -28.97 0.47 Allowed Glycine 0 C--N 1.346 1.126 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.942 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.816 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -176.17 -157.2 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.885 ' HB1' ' CE1' ' A' ' 9' ' ' PHE . . . 179.68 -58.72 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.365 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.564 ' CD ' ' HB3' ' A' ' 26' ' ' ALA . 7.2 Cg_exo -34.87 78.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.17 3.247 . . . . 0.0 115.01 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 53' ' ' TYR . 5.2 tp -105.46 69.13 0.19 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.176 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' O ' ' A' ' 27' ' ' PRO . 36.7 Cg_endo -65.29 122.68 10.46 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.408 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 m -157.01 -51.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -122.35 29.8 6.81 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.113 0.415 . . . . 0.0 111.793 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.97 -153.56 24.84 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.63 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.39 -168.31 1.89 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -156.03 171.57 19.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.862 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -143.24 170.67 8.19 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.208 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 52.1 Cg_endo -69.45 137.59 36.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.083 . . . . 0.0 112.71 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 10' ' ' LEU . 7.7 t-80 -163.43 93.55 1.11 Allowed Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 8' ' ' SER . 59.7 Cg_exo -37.45 -77.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.4 2.733 . . . . 0.0 114.211 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -177.16 43.06 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.361 0.124 . . . . 0.0 111.032 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -50.01 172.11 0.12 Allowed Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 120.931 0.396 . . . . 0.0 111.631 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.614 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 44.4 Cg_exo -57.46 -17.12 26.1 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.999 2.466 . . . . 0.0 113.337 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.591 ' CZ3' ' HB3' ' A' ' 19' ' ' CYS . 6.4 t90 -71.88 -65.84 0.72 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.679 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -50.79 -53.59 30.7 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -35.28 75.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.491 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 1.8 mt-10 -49.33 -40.66 36.11 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.461 0.573 . . . . 0.0 111.209 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -126.35 5.61 7.67 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 118.355 -1.878 . . . . 0.0 113.48 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 60' ' ' THR . . . -70.1 54.55 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.993 0.397 . . . . 0.0 111.677 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 48' ' ' VAL . 16.3 t -106.03 36.61 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.519 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -147.83 152.04 36.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 111.016 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE3' ' HB3' ' A' ' 59' ' ' ARG . 12.7 m95 -92.62 158.87 15.74 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 52' ' ' PRO . 68.6 t -151.18 144.34 17.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.332 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' HG13 ' A' ' 51' ' ' VAL . 58.5 Cg_endo -99.29 121.84 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.049 2.5 . . . . 0.0 113.805 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.748 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 35.5 t80 -121.51 130.83 53.79 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t -39.09 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.816 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -70.17 -11.43 60.89 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -154.3 168.49 32.58 Favored Glycine 0 C--N 1.366 2.216 0 C-N-CA 118.167 -1.968 . . . . 0.0 114.398 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ARG . 8.6 tt0 -94.55 117.99 30.98 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 121.878 -0.777 . . . . 0.0 110.397 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 5.1 m -97.2 178.86 5.1 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.134 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 22.4 ptt180 171.03 115.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.106 0.867 . . . . 0.0 110.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.897 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -179.49 -147.87 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 6.3 t -142.8 -172.11 3.58 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.2 m -143.95 174.33 10.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 17' ' ' VAL . 8.7 pt -157.07 166.82 15.81 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.155 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 17' ' ' VAL . 4.2 Cg_exo -76.3 165.26 29.69 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.333 . . . . 0.0 111.398 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 0.0 110.699 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.857 0.361 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 166.72 12.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.431 ' OG ' HG23 ' A' ' 21' ' ' ILE . 65.4 m -132.12 153.53 50.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.408 0.623 . . . . 0.0 111.814 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CZ ' ' HB1' ' A' ' 26' ' ' ALA . 1.6 p90 -135.36 131.62 36.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.122 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.461 HD12 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.51 121.44 38.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.665 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.6 m -102.61 154.89 18.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.758 0.789 . . . . 0.0 112.782 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.9 t80 -119.11 115.69 24.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.198 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.53 162.51 20.57 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.02 -11.7 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.919 2.413 . . . . 0.0 113.333 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 4.8 t0 -170.19 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.144 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.2 mt-30 -160.64 163.58 32.46 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.168 0.509 . . . . 0.0 111.714 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.755 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.91 117.33 47.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.715 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.1 m -123.01 138.17 54.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.444 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 38.9 t -122.38 146.48 47.3 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.343 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -140.1 134.78 31.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.326 0.584 . . . . 0.0 111.9 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 43' ' ' CYS . 3.3 mp -107.39 131.0 58.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.511 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 49.8 m -131.75 -172.84 2.97 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 119.286 -0.966 . . . . 0.0 113.363 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -151.76 60.35 0.87 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.65 0.53 7.22 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 119.998 -1.096 . . . . 0.0 114.063 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -167.5 -160.56 0.36 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.263 1.031 . . . . 0.0 112.759 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HB1' ' CZ ' ' A' ' 9' ' ' PHE . . . -173.23 139.06 0.83 Allowed Pre-proline 0 C--N 1.346 0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.479 ' HD2' ' CE2' ' A' ' 9' ' ' PHE . 51.7 Cg_exo -55.35 142.37 79.75 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.231 1.954 . . . . 0.0 112.019 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.1 tp -64.77 110.04 3.61 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.11 152.55 80.62 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.582 2.188 . . . . 0.0 112.167 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 p -165.81 -50.53 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.99 33.22 1.36 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 122.048 -0.407 . . . . 0.0 111.637 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 160.85 169.14 23.72 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.771 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.97 -163.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -161.52 159.51 27.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.235 0.54 . . . . 0.0 111.146 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.68 153.65 74.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.673 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.36 128.5 25.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.722 2.281 . . . . 0.0 112.37 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.586 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 12.8 t-160 -157.83 89.81 2.35 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.771 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -30.85 -68.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.537 2.824 . . . . 0.0 113.358 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -157.93 -160.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.48 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' CE1' ' A' ' 37' ' ' HIS . . . 171.05 154.31 0.21 Allowed Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 120.614 0.245 . . . . 0.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 56.2 Cg_endo -70.04 -13.89 34.51 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.328 2.019 . . . . 0.0 111.954 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.718 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 90.1 t90 -93.91 -53.49 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.213 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.547 ' O ' HD11 ' A' ' 21' ' ' ILE . 73.8 m -50.02 -33.76 19.1 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -88.44 -39.36 14.31 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 4.1 mt-10 -48.82 -26.84 2.62 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.308 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.3 -23.73 2.85 Favored Glycine 0 C--N 1.36 1.916 0 C-N-CA 118.487 -1.816 . . . . 0.0 113.497 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 60.28 2.48 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.699 0.75 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.3 p -93.11 31.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -125.75 147.12 49.48 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.676 0.274 . . . . 0.0 110.293 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.459 ' CZ3' ' HD3' ' A' ' 59' ' ' ARG . 1.2 m95 -90.21 164.11 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.027 0.441 . . . . 0.0 111.058 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.3 t -147.23 130.42 8.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.595 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -93.83 87.76 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.637 2.225 . . . . 0.0 113.667 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.647 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -100.42 124.93 46.55 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.3 m -42.55 -49.6 5.4 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.027 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -70.88 -32.55 69.55 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.656 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -172.04 179.78 43.47 Favored Glycine 0 C--N 1.359 1.823 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.286 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HG2' ' CE3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -89.95 145.36 25.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 118.354 1.077 . . . . 0.0 110.192 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 m -129.31 177.62 7.04 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 4.6 mmm180 -150.54 126.92 10.71 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.2 m -109.11 137.99 46.15 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 47' ' ' ALA . 1.9 m -142.64 152.33 42.35 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.443 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.465 ' O ' HG23 ' A' ' 63' ' ' ILE . 35.3 m -155.75 156.55 35.03 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 120.656 1.571 . . . . 0.0 112.306 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.718 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 32.2 pt -161.81 156.75 19.86 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.49 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 84.8 Cg_endo -78.12 164.66 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.055 . . . . 0.0 112.22 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.755 ' CD1' HG22 ' A' ' 17' ' ' VAL . 10.8 m-85 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.888 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 . . . . . 0 N--CA 1.461 0.125 0 CA-C-O 120.734 0.302 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.79 140.98 23.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 30.9 t -118.31 152.26 36.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.727 0.775 . . . . 0.0 112.671 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 27' ' ' PRO . 3.3 p90 -130.9 130.85 44.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.016 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 18' ' ' CYS . 0.8 OUTLIER -94.49 126.15 39.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.067 0.46 . . . . 0.0 110.212 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 17.3 m -105.04 154.31 20.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.693 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -130.0 126.6 38.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -114.06 164.69 15.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.321 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.8 -19.14 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.227 2.618 . . . . 0.0 113.955 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.43 28.76 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.0 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.6 mt-30 -153.83 147.2 24.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.016 0.436 . . . . 0.0 111.834 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.638 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -119.97 122.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.002 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.658 ' O ' HD23 ' A' ' 10' ' ' LEU . 74.5 m -134.58 141.77 46.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 41.5 t -122.1 146.43 47.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.82 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.0 139.29 28.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.285 0.565 . . . . 0.0 112.518 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.27 120.32 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.253 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 58.8 m -108.96 -176.16 2.96 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.096 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.58 54.95 0.74 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.24 21.87 7.46 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.544 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -130.76 -157.45 0.82 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.391 0.596 . . . . 0.0 111.99 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -146.57 177.85 1.63 Allowed Pre-proline 0 C--N 1.34 0.179 0 CA-C-O 120.593 0.235 . . . . 0.0 110.902 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 98.3 Cg_endo -81.16 124.06 4.73 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.642 2.228 . . . . 0.0 113.126 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.6 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 3.5 tt -71.24 -35.87 4.38 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.594 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 96.2 Cg_exo -44.81 170.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.516 2.144 . . . . 0.0 112.98 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -151.25 -37.1 0.13 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.92 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -82.79 30.75 0.43 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.59 0.632 . . . . 0.0 111.825 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.56 163.6 34.67 Favored Glycine 0 N--CA 1.466 0.698 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.15 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -100.62 -166.31 1.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.436 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -160.77 159.94 30.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.358 0.599 . . . . 0.0 112.072 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -137.7 173.05 5.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.427 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 74.4 Cg_endo -75.61 135.3 17.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.539 2.16 . . . . 0.0 113.036 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 38' ' ' PRO . 60.9 t-80 -164.37 95.73 0.95 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.76 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' SER . 2.6 Cg_endo -39.71 -81.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.394 2.729 . . . . 0.0 114.21 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -176.03 53.5 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.825 0.078 . . . . 0.0 110.885 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -59.38 174.06 0.45 Allowed Pre-proline 0 N--CA 1.471 0.622 0 O-C-N 122.022 -0.424 . . . . 0.0 111.555 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.2 Cg_endo -65.76 1.74 2.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.575 2.183 . . . . 0.0 113.045 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.618 ' CZ2' HG21 ' A' ' 63' ' ' ILE . 21.1 t90 -90.06 -56.22 3.31 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.447 ' N ' ' HE3' ' A' ' 42' ' ' TRP . 53.2 m -64.74 -32.93 74.84 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -78.06 -44.47 26.26 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.406 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 9.5 tt0 -64.49 -19.64 65.7 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.98 -18.5 6.82 Favored Glycine 0 C--N 1.364 2.09 0 C-N-CA 118.095 -2.002 . . . . 0.0 112.683 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.786 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -93.73 68.28 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.296 0.57 . . . . 0.0 110.434 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 m -89.27 29.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.56 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -145.02 133.31 21.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -95.64 167.8 11.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.218 0.532 . . . . 0.0 111.922 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 59' ' ' ARG . 11.5 p -155.97 139.04 10.79 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.73 120.59 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.597 2.198 . . . . 0.0 113.963 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.621 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -104.53 132.48 50.73 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -61.8 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -26.58 68.02 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.152 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -168.48 176.8 42.74 Favored Glycine 0 C--N 1.359 1.821 0 C-N-CA 118.989 -1.576 . . . . 0.0 112.808 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.0 tt0 -93.15 127.56 38.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.665 1.232 . . . . 0.0 110.447 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -136.82 -173.98 3.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.216 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.658 ' HA ' HG12 ' A' ' 51' ' ' VAL . 6.2 ttp180 -156.66 127.37 6.71 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.1 t -104.05 130.97 51.75 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.786 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -127.93 162.36 26.93 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.9 m -150.91 170.5 19.17 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 119.863 1.21 . . . . 0.0 111.538 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.618 HG21 ' CZ2' ' A' ' 42' ' ' TRP . 5.5 pt -157.19 151.58 20.29 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.605 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' ILE . 7.7 Cg_exo -71.53 125.9 11.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.881 2.387 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.638 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.969 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 p30 . . . . . 0 N--CA 1.461 0.076 0 CA-C-O 120.823 0.344 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -148.11 141.07 24.82 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.617 ' OG ' HG23 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -121.18 148.87 43.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.69 0.757 . . . . 0.0 112.903 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -135.4 132.18 37.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.51 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -97.91 125.58 42.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.07 0.462 . . . . 0.0 109.805 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -103.8 143.54 32.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.163 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.39 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.82 162.6 32.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.883 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -44.29 -18.07 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.399 . . . . 0.0 113.694 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.38 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.413 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.61 166.93 29.69 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.048 0.451 . . . . 0.0 111.704 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.485 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -141.43 108.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.245 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.511 ' O ' HD23 ' A' ' 10' ' ' LEU . 91.1 m -114.37 134.75 54.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 111.818 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.6 t -119.27 144.16 46.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.576 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.644 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -150.81 139.91 21.11 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.907 HD11 ' HB3' ' A' ' 43' ' ' CYS . 1.3 mt -111.86 110.52 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.562 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 1.3 m -86.94 -175.51 5.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.84 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.94 51.71 0.98 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.55 22.5 4.02 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.484 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 56' ' ' GLY . . . -162.54 -156.63 0.41 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.033 0.916 . . . . 0.0 112.051 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -163.68 132.92 2.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD2' ' CE1' ' A' ' 9' ' ' PHE . 15.4 Cg_endo -56.93 145.72 83.4 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.511 2.141 . . . . 0.0 112.647 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.439 HD12 ' OH ' ' A' ' 53' ' ' TYR . 1.2 mp -78.53 111.81 21.91 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.053 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.51 151.46 29.05 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.534 2.156 . . . . 0.0 112.127 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 -55.6 0.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.301 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -95.1 29.52 2.42 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 118.108 0.413 . . . . 0.0 111.55 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.27 -162.53 36.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.75 -162.86 1.15 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.686 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.07 163.29 39.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.107 0.48 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 155.24 72.83 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.77 130.09 28.34 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.615 2.21 . . . . 0.0 112.438 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 17.9 t-160 -157.87 100.68 1.8 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -30.04 -73.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.316 2.677 . . . . 0.0 113.378 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 10.5 t -154.13 -159.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . 178.88 130.42 0.22 Allowed Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 38.8 Cg_exo -56.73 -20.69 36.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.289 1.993 . . . . 0.0 112.088 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.816 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 63.3 t90 -86.9 -47.95 8.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.907 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -42.43 -57.57 2.57 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -69.96 -35.81 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.164 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 71.4 tt0 -46.15 -31.12 2.22 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 118.284 0.493 . . . . 0.0 111.582 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.8 10.68 3.96 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 118.338 -1.887 . . . . 0.0 113.907 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 59' ' ' ARG . . . -92.21 45.76 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.383 0.591 . . . . 0.0 111.24 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.57 33.84 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.99 15.87 4.7 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.745 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -130.24 -175.11 3.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.281 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.3 t 142.82 -42.5 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.08 0 O-C-N 123.746 0.654 . . . . 0.0 110.038 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 98.6 Cg_endo -86.69 78.89 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 114.447 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.614 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.5 t80 -109.35 130.57 55.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.61 -60.49 1.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -67.11 -30.35 70.34 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.407 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.54 -172.59 37.75 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.619 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.742 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -95.19 132.64 39.93 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.53 1.665 . . . . 0.0 109.273 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.705 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 19.1 m -135.99 -174.19 3.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.828 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.644 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.76 132.22 20.84 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 t -125.73 139.77 53.25 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -140.54 162.24 35.82 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.4 m -157.29 146.82 20.31 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 119.96 1.255 . . . . 0.0 111.506 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.816 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 3.5 pt -149.18 165.29 18.04 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.737 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 32.7 Cg_exo -59.54 164.8 10.58 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 0.0 111.979 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-O 121.156 0.503 . . . . 0.0 110.788 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 7' ' ' GLU . 1.5 p30 . . . . . 0 CA--C 1.502 -0.868 0 CA-C-O 122.478 1.132 . . . . 0.0 108.734 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.571 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 9.6 mt-10 -177.64 -167.56 0.15 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.159 -2.291 . . . . 0.0 109.653 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.436 ' HB2' HG12 ' A' ' 21' ' ' ILE . 32.8 t -135.21 142.12 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.316 0.579 . . . . 0.0 111.791 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 31.1 p90 -124.79 132.78 53.32 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.613 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.757 HD12 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -97.74 131.3 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.703 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.9 m -116.36 133.27 56.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.629 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.31 130.71 56.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -126.11 149.85 67.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.496 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.24 4.5 0.13 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.673 2.248 . . . . 0.0 113.358 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' GLN . 3.8 m-20 -117.57 -29.94 5.63 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 15' ' ' ASP . 1.2 mt-30 -172.27 -167.22 0.45 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.684 0.278 . . . . 0.0 110.838 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -125.95 144.83 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.208 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -145.08 145.64 31.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 112.113 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.535 ' CB ' ' CH2' ' A' ' 42' ' ' TRP . 2.3 t -127.38 152.78 47.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.752 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -144.02 135.17 25.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.342 0.591 . . . . 0.0 111.759 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 47' ' ' ALA . 37.8 mt -104.92 110.28 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.225 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.671 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 70.5 m -100.6 172.41 7.12 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.836 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.709 ' HD2' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -148.81 46.86 1.02 Allowed 'General case' 0 C--N 1.354 0.78 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . . . 128.21 30.95 0.7 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.7 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.563 ' HB1' ' CG ' ' A' ' 53' ' ' TYR . . . -123.09 -165.7 1.35 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.203 1.001 . . . . 0.0 112.287 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -125.74 99.07 32.99 Favored Pre-proline 0 C--N 1.344 0.332 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.512 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 32.6 Cg_exo -32.38 90.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.45 2.767 . . . . 0.0 113.485 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 tp -98.7 122.66 52.45 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.8 -170.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.501 2.134 . . . . 0.0 112.119 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 p -149.28 -52.8 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.413 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.86 30.47 3.71 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.252 0.478 . . . . 0.0 111.681 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.36 -146.16 7.27 Favored Glycine 0 N--CA 1.461 0.364 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.365 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -116.46 -169.77 1.69 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.333 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -156.07 166.39 33.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.034 0.445 . . . . 0.0 111.359 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -143.0 168.58 12.73 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.544 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.71 134.99 22.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.67 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.757 ' CD2' HD12 ' A' ' 10' ' ' LEU . 6.9 t60 -157.65 93.13 2.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 39' ' ' THR . 22.0 Cg_exo -28.6 -85.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.9 3.066 . . . . 0.0 114.628 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 38' ' ' PRO . 10.7 p -162.43 55.65 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.463 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.634 ' HB2' ' NE2' ' A' ' 37' ' ' HIS . . . -43.49 166.85 0.09 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 CA-C-N 118.468 0.576 . . . . 0.0 111.869 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 52.6 Cg_exo -56.56 -47.23 24.83 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.213 2.608 . . . . 0.0 113.993 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.706 ' CZ3' HD12 ' A' ' 63' ' ' ILE . 38.5 p-90 -72.65 -45.82 57.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 1.3 m -47.24 -45.66 23.72 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -31.68 21.91 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.865 -0.522 . . . . 0.0 109.951 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 1.7 tm-20 -47.71 -31.72 5.04 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.705 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.51 -11.82 1.46 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 118.214 -1.946 . . . . 0.0 114.711 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.799 ' C ' ' HG2' ' A' ' 59' ' ' ARG . . . -72.14 64.13 0.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.441 1.12 . . . . 0.0 111.635 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.23 52.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.463 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HG2' ' NE ' ' A' ' 59' ' ' ARG . 7.7 pt-20 -134.37 -15.87 2.16 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.858 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.6 t90 -102.33 -166.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.964 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 170.01 -38.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.839 ' HD3' HG23 ' A' ' 51' ' ' VAL . 7.7 Cg_exo -75.59 81.15 2.39 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.178 1.919 . . . . 0.0 116.267 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.563 ' CG ' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -112.57 129.45 56.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.2 p -26.01 -73.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -22.45 50.66 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.44 -165.98 19.3 Favored Glycine 0 C--N 1.356 1.644 0 C-N-CA 118.911 -1.614 . . . . 0.0 111.945 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 4.1 mt-30 -95.26 166.3 11.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.523 2.161 . . . . 0.0 109.321 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.671 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 44.8 t -175.84 -176.54 0.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.333 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.83 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -158.17 145.66 18.18 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 118.515 0.598 . . . . 0.0 111.591 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 60' ' ' THR . 9.5 t -112.58 104.03 12.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.568 ' CG2' ' HB2' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.57 172.63 6.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.128 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m -155.84 158.57 38.29 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 118.993 0.815 . . . . 0.0 111.42 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.706 HD12 ' CZ3' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -153.87 162.19 27.36 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.209 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 51.2 Cg_exo -54.98 160.47 7.83 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.773 2.316 . . . . 0.0 112.623 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.835 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p30 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.766 0.317 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -142.25 153.91 44.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.681 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.464 ' OG ' HG23 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -130.53 149.6 52.12 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 112.596 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -132.61 135.41 45.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.04 178.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.64 118.01 35.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.825 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.2 m -106.44 139.28 41.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.441 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -133.76 151.09 76.39 Favored Pre-proline 0 CA--C 1.511 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.258 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.84 -1.51 1.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.619 1.546 . . . . 0.0 110.861 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.4 t0 -114.34 -29.29 6.95 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.534 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.427 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -179.33 173.5 1.1 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.99 0.424 . . . . 0.0 111.604 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' CZ ' ' A' ' 65' ' ' TYR . 2.3 m -111.57 118.97 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.405 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 3.5 m -110.43 128.9 55.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.814 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 51.8 t -112.19 145.78 39.27 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.341 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -152.29 138.45 18.31 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.821 HD11 ' HB3' ' A' ' 43' ' ' CYS . 1.7 mt -108.83 113.79 45.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.659 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 1.3 m -93.61 -177.3 4.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.528 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 57' ' ' GLN . 18.0 tpt85 -145.19 49.18 1.27 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.42 25.68 3.68 Favored Glycine 0 C--N 1.348 1.211 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -158.51 -157.74 0.65 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.848 0.824 . . . . 0.0 112.154 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -155.43 179.98 1.22 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.32 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 67.2 Cg_endo -91.36 138.7 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.739 2.292 . . . . 0.0 113.219 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.494 HD12 ' OH ' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -108.11 64.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.276 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 27' ' ' PRO . 67.8 Cg_endo -72.11 -161.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.588 2.192 . . . . 0.0 111.994 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.99 -54.87 3.04 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.23 -95.03 0.1 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 39.64 -161.9 0.01 OUTLIER Glycine 0 N--CA 1.474 1.231 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.743 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.1 178.54 7.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 m -157.82 178.99 9.62 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 119.042 0.837 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -157.86 145.31 13.58 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.26 135.25 68.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.527 2.151 . . . . 0.0 112.372 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' SER . 27.3 t60 -161.6 98.65 1.23 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.933 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -29.35 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.377 2.718 . . . . 0.0 113.448 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -155.43 -161.95 1.26 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 177.72 158.89 0.55 Allowed Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.026 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 72.8 Cg_endo -74.74 -16.38 20.95 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.446 2.097 . . . . 0.0 112.131 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.676 ' HZ2' HG23 ' A' ' 63' ' ' ILE . 44.4 t90 -87.1 -51.97 5.69 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.272 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.821 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -45.3 -57.68 3.84 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -35.8 80.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.416 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 2.9 mt-10 -48.56 -30.81 5.69 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.351 0.523 . . . . 0.0 111.813 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.12 17.68 2.53 Favored Glycine 0 C--N 1.357 1.75 0 C-N-CA 118.208 -1.949 . . . . 0.0 113.842 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 59' ' ' ARG . . . -107.52 58.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 111.141 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.4 p -93.85 31.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.301 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.744 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.51 119.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.886 0.374 . . . . 0.0 111.703 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.744 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 1.6 t90 155.86 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.167 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 11.1 m -50.31 -32.18 5.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.105 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 2.9 Cg_exo -77.27 62.65 7.63 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.983 1.789 . . . . 0.0 114.678 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.603 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 2.5 t80 -106.41 116.49 32.02 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -36.7 -58.34 0.74 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.469 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.98 69.98 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.003 -0.523 . . . . 0.0 112.0 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.21 -178.96 42.04 Favored Glycine 0 C--N 1.361 1.921 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.761 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.9 tt0 -96.72 124.21 40.64 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.373 -1.075 . . . . 0.0 109.791 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.623 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.1 m -131.62 -172.95 2.99 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -150.36 133.45 16.17 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 85.1 m -117.62 147.81 42.52 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.744 HG21 ' HA ' ' A' ' 43' ' ' CYS . 1.8 t -151.58 174.09 13.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.78 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 159.92 3.94 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 118.865 0.757 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.676 HG23 ' HZ2' ' A' ' 42' ' ' TRP . 1.7 pt -149.38 151.74 34.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.425 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 68.3 Cg_endo -90.02 93.76 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.226 2.617 . . . . 0.0 112.283 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.443 ' CZ ' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.841 0.353 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -143.11 140.59 30.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 37' ' ' HIS . 13.3 t -111.78 147.95 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.726 0.774 . . . . 0.0 112.372 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.847 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 2.0 p90 -134.07 137.26 44.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.328 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.56 127.17 43.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.978 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.1 m -107.36 142.83 36.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 111.976 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.7 t80 -108.95 130.9 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.262 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.499 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -138.97 142.35 33.17 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.07 6.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.619 2.213 . . . . 0.0 113.321 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.1 p30 -118.95 -33.53 4.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.475 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.3 mp0 -169.4 -170.22 1.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.76 117.23 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.4 146.79 40.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.092 0.473 . . . . 0.0 112.212 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 51.9 t -125.68 150.58 47.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.625 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -149.49 140.44 22.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 21' ' ' ILE . 3.7 mp -103.85 118.42 50.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.662 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 94.0 m -107.43 -174.03 2.43 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.2 57.37 0.71 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.95 -19.92 1.11 Allowed Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.622 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.567 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . . . -174.77 -155.44 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.289 0.545 . . . . 0.0 110.62 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 9' ' ' PHE . . . 173.56 -58.24 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 26' ' ' ALA . 9.2 Cg_endo -51.06 78.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.288 2.658 . . . . 0.0 114.631 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 53' ' ' TYR . 18.7 tp -134.01 50.5 5.23 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 89.8 Cg_endo -77.83 -171.74 1.28 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.706 2.271 . . . . 0.0 112.727 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 t -159.44 -56.4 0.06 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.9 32.21 4.06 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.012 -0.43 . . . . 0.0 111.617 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 175.12 -152.19 13.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.297 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.55 -167.75 1.99 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 m -156.68 157.11 34.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.756 0.313 . . . . 0.0 110.629 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.57 151.43 75.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 141.06 93.48 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' SER . 82.0 t60 -169.19 97.49 0.51 Allowed Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.813 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -30.54 -71.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.455 2.77 . . . . 0.0 113.551 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -156.51 -157.89 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.799 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 177.3 167.3 0.49 Allowed Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 120.6 0.238 . . . . 0.0 111.082 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.695 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 72.7 Cg_endo -76.09 -25.85 9.81 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.614 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 26.9 p-90 -92.44 -41.14 10.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.413 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 96.6 m -51.68 -37.94 52.8 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.43 -36.12 17.9 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 121.711 -0.618 . . . . 0.0 109.369 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -46.85 -29.77 2.15 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.003 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.18 -10.73 4.53 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.781 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 43' ' ' CYS . . . -94.42 45.15 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.857 0.829 . . . . 0.0 111.091 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 44' ' ' ARG . 7.9 m -95.09 32.06 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.51 143.26 33.71 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -79.82 151.75 30.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.0 p -162.75 94.72 1.17 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.863 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -42.16 110.73 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.931 2.42 . . . . 0.0 113.635 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.649 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.7 t80 -93.26 145.84 24.14 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -32.87 -89.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 44.7 m -68.53 -7.78 35.52 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -166.16 173.1 41.66 Favored Glycine 0 C--N 1.363 2.031 0 C-N-CA 118.769 -1.682 . . . . 0.0 112.679 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -78.04 152.98 32.72 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.706 1.253 . . . . 0.0 109.663 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.8 t -159.67 -171.71 3.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.692 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.619 ' HA ' HG12 ' A' ' 51' ' ' VAL . 1.6 ptt-85 -155.15 125.94 7.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -105.59 136.98 44.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -140.82 171.39 14.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.615 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.7 m -154.76 168.73 25.87 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.578 1.081 . . . . 0.0 111.688 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 17' ' ' VAL . 28.4 pt -154.15 137.29 10.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.841 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.49 124.98 3.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.763 2.308 . . . . 0.0 112.795 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.833 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 N--CA 1.461 0.102 0 CA-C-O 120.829 0.347 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.31 141.21 33.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -121.7 146.27 47.19 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.505 0.669 . . . . 0.0 111.921 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.541 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -130.6 130.74 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.701 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.84 121.07 33.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.656 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 m -102.65 145.24 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 0.0 112.637 -178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.456 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.4 t80 -110.54 113.26 25.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -117.77 140.69 27.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' OH ' ' A' ' 65' ' ' TYR . 52.1 Cg_exo -55.87 7.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.699 2.266 . . . . 0.0 113.443 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 13' ' ' GLN . 5.6 t0 -118.63 -37.08 3.34 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.245 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.52 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 8.4 mp0 -165.77 -175.49 3.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.543 HG22 ' HD1' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -114.06 113.97 45.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 m -110.09 129.68 55.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 43.6 t -108.1 140.32 41.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.744 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.655 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -135.36 143.95 46.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 112.746 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' ARG . 2.5 mp -116.84 138.28 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.489 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 16.9 m -145.81 -171.1 3.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.64 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -156.82 60.74 0.53 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.79 8.86 5.04 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 119.897 -1.145 . . . . 0.0 114.355 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -167.13 -160.54 0.38 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.67 1.235 . . . . 0.0 113.157 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.541 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . -173.49 132.05 0.58 Allowed Pre-proline 0 C--N 1.347 0.481 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.7 Cg_endo -49.84 147.2 14.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 112.159 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.36 111.28 5.72 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.2 152.39 16.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.653 2.235 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 t -166.31 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.131 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.54 33.93 1.37 Allowed 'General case' 0 C--N 1.352 0.695 0 O-C-N 122.068 -0.395 . . . . 0.0 111.548 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 168.18 167.9 29.5 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.829 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.53 -161.49 0.84 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -159.73 160.38 33.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -139.12 152.72 70.43 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.617 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.43 127.52 21.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.263 . . . . 0.0 112.452 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 39' ' ' THR . 12.9 t-160 -160.58 82.51 2.12 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.22 -63.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.782 2.988 . . . . 0.0 113.443 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -140.53 -161.39 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.103 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 172.81 131.41 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.005 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 31.2 Cg_exo -58.22 -18.66 38.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.076 1.851 . . . . 0.0 111.726 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 48.1 t90 -86.36 -51.89 5.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.357 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -45.54 -56.37 5.19 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.57 -36.18 83.4 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.0 tt0 -49.68 -34.39 18.42 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.73 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.49 -2.94 2.81 Favored Glycine 0 C--N 1.358 1.767 0 C-N-CA 118.405 -1.855 . . . . 0.0 114.376 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.859 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -95.13 63.41 2.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.861 0.831 . . . . 0.0 110.356 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 48' ' ' VAL . 14.9 t -94.44 32.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.387 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -124.55 136.15 53.74 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.679 ' CZ3' ' HG2' ' A' ' 57' ' ' GLN . 4.2 t-105 -96.24 135.84 37.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.518 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 9.6 p -131.93 120.61 17.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.987 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.562 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 71.8 Cg_endo -76.6 114.92 3.96 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.619 2.213 . . . . 0.0 114.091 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.604 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 1.1 t80 -104.61 128.14 52.55 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -42.63 -48.01 5.37 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.933 -0.122 . . . . 0.0 111.242 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.08 -30.74 61.03 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -172.46 179.57 43.92 Favored Glycine 0 C--N 1.359 1.84 0 C-N-CA 118.948 -1.596 . . . . 0.0 113.253 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.679 ' HG2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -81.62 120.31 24.92 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 118.544 1.172 . . . . 0.0 110.337 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -117.94 -178.84 3.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.655 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -160.67 133.81 6.57 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -120.3 130.59 54.52 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.859 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -139.43 164.79 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 t -176.87 155.56 1.26 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 120.506 1.503 . . . . 0.0 112.515 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.571 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 7.8 pt -159.08 161.81 27.33 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.118 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 5.3 Cg_endo -47.16 174.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.6 2.2 . . . . 0.0 112.482 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.543 ' HD1' HG22 ' A' ' 17' ' ' VAL . 2.4 m-30 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.709 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 . . . . . 0 N--CA 1.461 0.097 0 CA-C-O 120.848 0.356 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 1.1 pt-20 -142.07 141.04 32.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.417 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' HIS . 29.3 t -117.11 141.32 48.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.628 0.727 . . . . 0.0 112.54 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -132.94 137.97 46.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.605 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.52 128.53 50.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.138 0.494 . . . . 0.0 110.475 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 74.0 m -107.98 139.24 42.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.108 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -119.4 128.48 54.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.04 146.39 56.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.866 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.76 3.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 113.38 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' GLN . 32.0 m-20 -111.67 -36.74 5.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.588 0.232 . . . . 0.0 111.109 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -172.51 -175.31 1.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.907 0.384 . . . . 0.0 111.181 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.22 130.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.123 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 99.9 m -128.81 129.66 45.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 112.047 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 34.5 t -112.99 152.72 29.08 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.836 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.842 ' CE2' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -154.48 133.59 12.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.069 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.604 HD11 ' HB2' ' A' ' 43' ' ' CYS . 3.7 mp -101.33 102.14 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.585 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 68.9 m -90.04 -172.46 3.51 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.628 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.83 60.18 0.67 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.63 16.43 9.39 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.16 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.423 ' HB2' ' C ' ' A' ' 55' ' ' THR . . . -164.7 -161.17 0.55 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.86 151.78 16.93 Favored Pre-proline 0 C--N 1.34 0.18 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.285 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 20' ' ' PHE . 73.4 Cg_endo -75.79 132.77 14.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.474 2.116 . . . . 0.0 112.234 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 29' ' ' PRO . 14.5 tp -74.05 112.08 15.22 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 28' ' ' LEU . 86.8 Cg_endo -82.32 -174.46 2.11 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.4 p -164.23 -55.8 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.535 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -102.1 33.4 3.08 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.99 -0.444 . . . . 0.0 111.924 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.91 -176.05 47.72 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.673 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -120.15 -164.85 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.7 m -154.15 178.42 10.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.995 0.426 . . . . 0.0 111.442 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.8 165.59 18.44 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.957 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.04 137.77 41.93 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.848 2.365 . . . . 0.0 112.729 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 11.0 t-160 -163.08 92.67 1.18 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 8' ' ' SER . 37.1 Cg_exo -25.49 -71.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.865 3.043 . . . . 0.0 113.819 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -160.38 -161.07 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.463 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' CE1' ' A' ' 37' ' ' HIS . . . 173.6 142.2 0.17 Allowed Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.024 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 20.2 Cg_exo -64.95 -12.44 34.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.411 2.074 . . . . 0.0 112.106 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.657 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 67.2 t90 -91.56 -52.73 4.63 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.321 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.792 ' HA ' HG21 ' A' ' 61' ' ' THR . 11.1 m -49.55 -36.23 22.92 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -37.27 20.14 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.735 -0.603 . . . . 0.0 109.754 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -51.12 -25.55 5.32 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.604 179.555 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.48 -6.96 4.52 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 118.221 -1.942 . . . . 0.0 114.192 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -92.01 61.34 4.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.051 0.926 . . . . 0.0 111.259 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 48' ' ' VAL . 18.8 t -111.98 38.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.45 13.41 1.96 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.903 0.382 . . . . 0.0 111.844 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.852 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -128.5 169.04 14.82 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.363 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 158.17 -34.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.473 0.709 . . . . 0.0 110.801 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.717 ' HD3' HG23 ' A' ' 51' ' ' VAL . 73.2 Cg_endo -93.3 68.41 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.083 1.856 . . . . 0.0 113.725 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.793 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 76.4 t80 -97.12 126.84 42.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -37.31 -57.6 0.89 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.423 ' C ' ' HB2' ' A' ' 25' ' ' ALA . 66.1 m -69.7 -27.3 64.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.793 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -174.06 -178.27 43.86 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.325 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -95.54 126.73 41.03 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 119.582 1.691 . . . . 0.0 109.203 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.779 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 43.3 t -142.42 -178.76 5.91 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.174 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.78 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 15.5 mmm-85 -138.3 134.14 33.94 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.842 HG23 ' CE2' ' A' ' 20' ' ' PHE . 91.8 m -117.2 142.78 46.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 43' ' ' CYS . 1.4 t -147.46 160.38 42.64 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.81 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 61' ' ' THR . 81.7 m -158.01 160.73 37.78 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-N 119.541 1.064 . . . . 0.0 110.879 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 3.5 pt -151.65 154.45 33.19 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.444 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 69.1 Cg_endo -89.77 126.39 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.183 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.254 179.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.752 ' N ' ' O ' ' A' ' 22' ' ' CYS . 1.9 m-20 . . . . . 0 CA--C 1.506 -0.741 0 CA-C-O 122.532 1.158 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 162.01 -176.46 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.484 -2.144 . . . . 0.0 110.728 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 6.9 t -119.43 158.45 26.19 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.296 0.569 . . . . 0.0 112.136 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.506 ' CE2' ' HB2' ' A' ' 20' ' ' PHE . 2.1 p90 -141.32 126.87 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.257 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.63 128.61 39.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 m -111.2 142.86 42.84 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.996 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.76 128.05 54.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.82 145.82 52.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.759 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.38 5.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.809 2.339 . . . . 0.0 113.423 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -116.6 -34.92 4.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.214 -0.194 . . . . 0.0 111.343 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.2 mt-30 -174.54 -174.28 0.83 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.664 HG13 ' CE1' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -114.58 121.08 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.958 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -114.69 125.72 54.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 1.5 p -107.01 138.31 43.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -140.04 147.24 40.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.97 0.891 . . . . 0.0 112.82 178.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 59' ' ' ARG . 25.7 mt -132.38 142.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.461 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 6' ' ' ASP . 4.5 m -142.94 -179.12 6.16 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.938 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.482 ' HA ' ' CG ' ' A' ' 6' ' ' ASP . 0.0 OUTLIER -154.71 69.77 0.75 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' ' CG ' ' A' ' 6' ' ' ASP . . . 132.6 -5.62 5.2 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.235 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.902 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -126.73 -162.14 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.58 0.69 . . . . 0.0 111.788 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -134.45 171.59 8.76 Favored Pre-proline 0 C--N 1.34 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.918 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 64.3 Cg_endo -87.46 114.38 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.876 2.384 . . . . 0.0 112.901 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.413 ' HB2' ' OH ' ' A' ' 53' ' ' TYR . 1.9 tp -113.79 83.56 7.57 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.015 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 27' ' ' PRO . 32.6 Cg_exo -57.59 -172.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.644 2.229 . . . . 0.0 112.263 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -55.37 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.246 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 2.2 pt-20 -115.81 29.23 8.12 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.94 -0.475 . . . . 0.0 111.672 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.75 -161.85 26.76 Favored Glycine 0 N--CA 1.462 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.394 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.32 -166.7 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.748 0.274 . . . . 0.0 110.777 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 171.26 19.75 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.293 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -149.76 153.71 36.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.23 128.91 25.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.627 2.218 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' ' 8' ' ' SER . 42.9 t60 -158.3 114.08 1.73 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.772 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -38.89 -77.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.654 2.236 . . . . 0.0 112.947 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -156.55 -158.64 0.8 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -177.51 143.7 0.52 Allowed Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.264 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 24.6 Cg_exo -62.65 -15.9 49.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.489 2.126 . . . . 0.0 112.203 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.758 ' HZ2' HG23 ' A' ' 63' ' ' ILE . 32.6 t90 -84.68 -50.33 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.871 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -45.13 -53.02 8.55 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.26 -36.42 82.95 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 25.1 tt0 -47.41 -36.89 10.43 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.351 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.26 2.56 1.14 Allowed Glycine 0 C--N 1.359 1.814 0 C-N-CA 118.112 -1.994 . . . . 0.0 115.224 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.564 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -82.65 65.03 7.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.404 1.102 . . . . 0.0 110.136 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -49.35 -22.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.69 160.45 32.62 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.057 -0.402 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.463 ' CZ2' ' NH1' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -161.07 15.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.952 HG23 ' HG3' ' A' ' 57' ' ' GLN . 7.6 p -156.0 6.29 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.735 ' CD ' ' H ' ' A' ' 51' ' ' VAL . 14.5 Cg_endo -56.51 32.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 N-CA-C 118.795 2.575 . . . . 0.0 118.795 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.902 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -137.21 116.62 12.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.26 1.391 . . . . 0.0 109.669 176.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.8 t -46.64 -53.25 11.96 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.356 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 m -70.57 -21.12 62.73 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.95 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 53' ' ' TYR . . . -159.53 167.77 35.23 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.836 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.952 ' HG3' HG23 ' A' ' 51' ' ' VAL . 5.0 mt-30 -80.75 129.47 34.54 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 121.683 -0.893 . . . . 0.0 109.288 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 52' ' ' PRO . 1.1 m -120.77 -169.03 1.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.95 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.737 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.7 OUTLIER -162.46 132.97 4.77 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.6 t -131.59 132.87 44.42 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -143.9 169.0 18.62 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.128 177.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.416 ' N ' HG23 ' A' ' 61' ' ' THR . 0.1 OUTLIER -170.62 156.32 5.28 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.47 1.032 . . . . 0.0 111.161 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.758 HG23 ' HZ2' ' A' ' 42' ' ' TRP . 3.4 pt -149.5 156.1 39.17 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.539 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.21 125.32 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.206 2.604 . . . . 0.0 111.921 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.664 ' CE1' HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.408 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p 58.18 27.5 15.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 111.056 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.02 125.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.9 p -128.51 149.36 71.53 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.82 -162.9 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.651 2.234 . . . . 0.0 112.097 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.583 ' HB2' HG22 ' A' ' 21' ' ' ILE . 1.6 p30 -69.74 151.93 45.24 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.522 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -150.56 141.81 23.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.675 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.783 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.1 t -110.91 145.89 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -127.22 130.99 50.7 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.407 178.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.15 103.54 15.58 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 59.4 m -87.61 152.65 22.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.281 0.562 . . . . 0.0 111.903 -178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 11.1 t80 -125.33 138.29 54.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.767 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.96 158.38 75.54 Favored Pre-proline 0 C--N 1.331 -0.217 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 31' ' ' GLU . 5.0 Cg_endo -46.87 -14.19 0.14 Allowed 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 123.164 2.576 . . . . 0.0 113.628 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.512 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 15.8 t70 -164.94 29.18 0.06 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.776 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -153.85 165.56 35.69 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.175 0.512 . . . . 0.0 111.812 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -144.03 131.16 17.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.904 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 20' ' ' PHE . 11.7 m -124.37 135.85 53.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.965 0.412 . . . . 0.0 112.078 -178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.813 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 17.7 p -116.97 111.08 19.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.846 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.852 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -134.7 136.4 42.71 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.894 HD12 HG23 ' A' ' 60' ' ' THR . 4.0 mt -108.47 95.26 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 CA-C-N 113.686 -1.597 . . . . 0.0 107.377 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.531 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 5.0 m -76.82 -176.95 4.09 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.905 -177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.605 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.66 62.89 1.32 Allowed 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 179.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.33 17.91 7.43 Favored Glycine 0 C--N 1.351 1.364 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.414 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.749 ' HB1' ' CE2' ' A' ' 53' ' ' TYR . . . -138.5 -159.7 0.98 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 117.621 0.71 . . . . 0.0 111.857 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.847 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -140.38 179.5 1.25 Allowed Pre-proline 0 C--N 1.339 0.132 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.847 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 88.3 Cg_endo -83.61 111.1 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.293 1.995 . . . . 0.0 112.791 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.62 111.71 15.76 Favored Pre-proline 0 N--CA 1.466 0.343 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.728 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.11 161.82 26.22 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.564 2.176 . . . . 0.0 112.34 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.25 -52.11 0.4 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.016 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -145.68 30.49 1.09 Allowed 'General case' 0 C--N 1.352 0.701 0 O-C-N 122.01 -0.431 . . . . 0.0 111.663 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . -167.95 -139.07 2.6 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.301 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.67 -165.28 1.71 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 117.259 0.529 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 10.6 m -155.74 169.97 23.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.728 0.299 . . . . 0.0 110.379 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -144.68 162.2 39.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.254 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.26 129.85 10.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.724 2.283 . . . . 0.0 112.508 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.8 t-80 -161.14 114.75 1.3 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -35.48 -68.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.741 2.294 . . . . 0.0 113.009 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.505 ' CG2' HD11 ' A' ' 21' ' ' ILE . 0.2 OUTLIER -141.11 -154.56 0.52 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.628 179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -156.21 133.19 6.37 Favored Pre-proline 0 N--CA 1.466 0.355 0 O-C-N 122.417 -0.177 . . . . 0.0 111.331 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 4.4 Cg_exo -74.44 -23.75 14.79 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.85 2.366 . . . . 0.0 112.659 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.813 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 5.4 p-90 -84.98 -38.3 19.44 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.841 ' SG ' HG22 ' A' ' 60' ' ' THR . 0.1 OUTLIER -45.96 -59.28 2.93 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.442 178.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mtp180 -66.88 -36.08 81.49 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 21.0 tt0 -55.24 -17.34 4.35 Favored 'General case' 0 C--N 1.357 0.903 0 CA-C-O 118.255 -0.879 . . . . 0.0 112.477 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -133.36 -31.42 0.42 Allowed Glycine 0 C--N 1.369 2.376 0 C-N-CA 117.124 -2.465 . . . . 0.0 114.048 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.801 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -103.8 -115.44 0.22 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.258 0.551 . . . . 0.0 112.305 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.71 HG13 ' H ' ' A' ' 49' ' ' GLU . 1.1 p 175.53 -73.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.651 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.71 ' H ' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -151.37 -166.92 2.65 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.849 ' CE3' ' HB2' ' A' ' 58' ' ' CYS . 3.9 t90 -154.73 -146.09 0.18 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.321 -178.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 50' ' ' TRP . 1.2 t 153.07 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.478 0.938 0 CA-C-N 117.877 0.308 . . . . 0.0 111.294 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.45 ' HD3' ' HB ' ' A' ' 51' ' ' VAL . 7.2 Cg_exo -75.38 92.22 1.02 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 122.742 2.295 . . . . 0.0 115.34 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.749 ' CE2' ' HB1' ' A' ' 25' ' ' ALA . 41.3 t80 -128.01 129.99 47.6 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -36.23 -70.0 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.6 t -73.31 -19.32 61.06 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.65 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.09 -168.33 25.97 Favored Glycine 0 C--N 1.362 1.974 0 C-N-CA 118.348 -1.882 . . . . 0.0 113.416 -178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.683 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.1 tt0 -103.44 136.6 42.89 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 119.373 1.586 . . . . 0.0 108.49 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.849 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 56.0 m -123.92 -172.32 2.51 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.901 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.581 ' HA ' ' CB ' ' A' ' 50' ' ' TRP . 39.6 ptt85 -166.03 111.45 0.85 Allowed 'General case' 0 N--CA 1.478 0.951 0 O-C-N 122.0 -0.438 . . . . 0.0 110.752 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.894 HG23 HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER 164.0 -160.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.202 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.801 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 6.4 t -144.37 -173.87 4.15 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.724 ' O ' HG23 ' A' ' 63' ' ' ILE . 1.8 m -143.78 153.09 42.04 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 122.916 0.486 . . . . 0.0 109.96 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.724 HG23 ' O ' ' A' ' 62' ' ' CYS . 0.1 OUTLIER -166.7 163.39 10.98 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.244 179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' O ' ' CG2' ' A' ' 17' ' ' VAL . 18.0 Cg_exo -66.07 -161.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.595 2.196 . . . . 0.0 111.439 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.512 ' CE2' ' HA ' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -75.54 -144.71 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.457 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 15.8 t -82.41 -27.15 8.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.745 0.307 . . . . 0.0 111.098 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.923 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 t -58.63 150.94 21.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.728 0.299 . . . . 0.0 110.876 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.85 -41.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.427 ' CB ' ' CD ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -170.73 -62.81 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.999 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 4' ' ' THR . 38.2 Cg_endo -66.92 64.68 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.482 2.121 . . . . 0.0 112.48 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -149.16 140.39 23.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.491 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -169.33 157.56 7.56 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 48.2 t -104.21 152.4 22.21 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.3 0.572 . . . . 0.0 112.162 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -129.07 137.09 51.06 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.542 178.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.4 117.35 29.99 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.726 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 27' ' ' PRO . 74.2 m -100.36 141.36 33.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.256 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -128.19 130.12 47.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.59 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.448 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -142.02 150.01 54.48 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.27 5.54 0.23 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.377 2.051 . . . . 0.0 113.097 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.5 m-20 -126.58 -17.34 5.08 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -165.71 172.03 12.28 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.201 -178.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.753 HG13 ' CE1' ' A' ' 65' ' ' TYR . 0.3 OUTLIER -134.07 119.28 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.041 178.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.0 m -121.85 149.16 43.76 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.896 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 12.3 p -132.52 124.41 28.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.13 -0.941 . . . . 0.0 108.839 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.836 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -141.16 138.75 33.65 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -179.736 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 60' ' ' THR . 6.7 mt -101.1 125.59 55.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 175.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' HB2' ' A' ' 26' ' ' ALA . 7.8 m -145.72 -172.59 3.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 118.291 -1.364 . . . . 0.0 114.289 -176.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -144.61 63.53 1.31 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . 150.95 -36.44 0.89 Allowed Glycine 0 C--N 1.348 1.212 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.442 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.487 ' HB3' ' HB ' ' A' ' 55' ' ' THR . . . 175.36 -161.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.839 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . . . 179.82 -57.71 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.839 ' HD3' ' HB3' ' A' ' 26' ' ' ALA . 56.4 Cg_endo -101.49 111.64 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 122.775 2.316 . . . . 0.0 114.28 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.5 tt -80.06 112.24 28.59 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -39.09 113.22 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.961 2.44 . . . . 0.0 113.001 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.4 m -142.63 -49.63 0.35 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.328 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.67 34.22 0.45 Allowed 'General case' 0 C--N 1.353 0.76 0 CA-C-N 118.443 0.565 . . . . 0.0 112.168 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -173.49 46.26 Favored Glycine 0 N--CA 1.463 0.438 0 C-N-CA 119.968 -1.111 . . . . 0.0 112.608 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.86 -165.15 1.47 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.671 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.9 m -154.08 179.32 9.04 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.999 0.428 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.23 163.94 22.44 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.868 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.25 136.8 32.58 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.894 2.396 . . . . 0.0 112.631 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 8' ' ' SER . 5.2 t-160 -171.3 101.83 0.4 Allowed Pre-proline 0 N--CA 1.467 0.408 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.064 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 8' ' ' SER . 47.5 Cg_exo -33.33 -65.8 0.1 Allowed 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.165 2.577 . . . . 0.0 113.29 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.404 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 51.8 p -151.3 -157.43 0.81 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 123.301 0.376 . . . . 0.0 110.397 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.802 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -165.5 173.6 3.5 Favored Pre-proline 0 N--CA 1.47 0.565 0 CA-C-O 120.763 0.316 . . . . 0.0 111.456 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.802 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 86.2 Cg_endo -81.45 -48.07 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.893 2.395 . . . . 0.0 112.701 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.896 ' CH2' ' HB3' ' A' ' 19' ' ' CYS . 19.2 p-90 -71.87 -41.14 68.42 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.823 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.02 -56.65 3.23 Favored 'General case' 0 C--N 1.363 1.174 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -78.37 -33.14 49.15 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.204 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.474 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 1.4 tp10 -41.15 -37.02 0.82 Allowed 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 119.06 -0.495 . . . . 0.0 112.134 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.42 10.67 0.85 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 118.106 -1.997 . . . . 0.0 113.875 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 1.012 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -108.49 75.9 1.0 Allowed 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 117.504 0.652 . . . . 0.0 111.416 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.579 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -23.83 -82.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.047 178.108 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 175.09 -132.57 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.559 ' N ' ' HB2' ' A' ' 59' ' ' ARG . 5.4 m95 -0.05 132.54 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 N-CA-C 114.919 1.451 . . . . 0.0 114.919 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.6 t -162.94 136.56 4.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 112.921 -1.945 . . . . 0.0 108.099 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.76 121.5 2.51 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.144 1.896 . . . . 0.0 114.303 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.585 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 53.4 t80 -118.69 121.88 41.18 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.6 m -39.51 -47.47 1.88 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.102 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 25' ' ' ALA . 72.5 m -77.82 -29.43 50.66 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 118.339 0.518 . . . . 0.0 112.271 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.585 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.06 175.67 37.7 Favored Glycine 0 C--N 1.359 1.843 0 C-N-CA 118.787 -1.673 . . . . 0.0 113.471 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.1 tt0 -87.87 112.25 22.3 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 118.114 0.957 . . . . 0.0 109.77 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 1.6 m -99.83 -171.64 2.09 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -178.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 21' ' ' ILE . 11.3 ptt180 172.08 101.25 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.836 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 170.63 -150.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -176.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.012 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 14.6 t -141.25 -176.8 4.84 Favored 'General case' 0 CA--C 1.556 1.207 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.828 ' O ' HG23 ' A' ' 63' ' ' ILE . 1.3 m -148.67 153.08 37.77 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 123.422 0.689 . . . . 0.0 109.188 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.852 HD11 ' CZ3' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -172.11 164.75 4.11 Favored Pre-proline 0 N--CA 1.469 0.476 0 CA-C-O 120.854 0.359 . . . . 0.0 111.796 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 71.7 Cg_endo -97.64 153.93 0.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.786 2.99 . . . . 0.0 112.086 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.753 ' CE1' HG13 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -136.06 -147.94 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.45 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 9.7 p -93.87 155.04 3.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 110.835 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.914 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 t 60.59 179.86 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.752 0.311 . . . . 0.0 110.999 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -176.62 -40.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.901 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -59.96 154.94 46.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.915 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -73.69 60.76 4.4 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.566 2.177 . . . . 0.0 112.49 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -109.54 159.88 16.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.714 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -142.65 140.18 31.51 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.794 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.823 ' HB2' HG23 ' A' ' 39' ' ' THR . 3.4 t -119.43 154.53 33.56 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.865 0.84 . . . . 0.0 112.438 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 1.1 p90 -143.43 140.53 30.46 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.65 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.17 137.13 37.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.887 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 91.9 m -117.45 150.76 38.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.341 0.591 . . . . 0.0 111.771 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.591 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 22.8 t80 -113.44 124.9 53.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.803 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -134.72 144.6 51.33 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.74 5.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 122.693 2.262 . . . . 0.0 113.548 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -116.03 -34.72 4.63 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.442 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -176.01 -169.18 0.31 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.815 0.341 . . . . 0.0 110.968 -179.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.81 115.64 49.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -102.8 132.72 48.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.798 ' HB3' ' OG1' ' A' ' 61' ' ' THR . 5.4 t -112.57 148.65 34.08 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.942 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.425 0.631 . . . . 0.0 111.714 178.066 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.752 HD11 ' HB2' ' A' ' 43' ' ' CYS . 2.1 mp -107.13 122.08 60.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.259 178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 37.8 m -110.11 -175.13 2.65 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.502 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -155.7 51.49 0.56 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.387 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 119.81 13.71 5.98 Favored Glycine 0 C--N 1.347 1.154 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.295 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.572 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -169.85 -160.03 0.23 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.904 0.852 . . . . 0.0 112.058 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.422 ' HA ' ' HD2' ' A' ' 27' ' ' PRO . . . -174.55 123.66 0.38 Allowed Pre-proline 0 C--N 1.345 0.378 0 C-N-CA 121.28 -0.168 . . . . 0.0 110.977 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.497 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 7.8 Cg_endo -50.13 143.68 24.62 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.411 2.074 . . . . 0.0 112.01 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -71.64 114.65 30.18 Favored Pre-proline 0 N--CA 1.468 0.437 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.212 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.62 169.79 2.99 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.609 2.206 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 m -170.77 -45.4 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.719 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 13' ' ' GLN . 0.8 OUTLIER -91.43 30.54 1.28 Allowed 'General case' 0 C--N 1.353 0.727 0 CA-C-N 118.267 0.485 . . . . 0.0 112.287 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 150.24 -146.14 14.94 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.094 -1.05 . . . . 0.0 112.863 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -128.49 -169.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.897 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 6.3 m -156.51 173.69 16.54 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 121.123 0.487 . . . . 0.0 111.396 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -151.62 164.41 20.36 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.491 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.96 145.64 56.57 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.575 2.183 . . . . 0.0 112.473 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 8' ' ' SER . 15.6 t-80 -172.58 111.83 0.36 Allowed Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' C ' ' O ' ' A' ' 37' ' ' HIS . 52.7 Cg_exo -29.59 -72.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.05 2.5 . . . . 0.0 112.85 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.823 HG23 ' HB2' ' A' ' 8' ' ' SER . 0.0 OUTLIER -174.11 -163.15 0.15 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.358 179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.851 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -164.49 161.64 15.68 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 74.8 Cg_endo -77.72 -14.15 15.88 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.475 2.117 . . . . 0.0 112.452 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.786 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 24.0 p-90 -94.68 -51.19 4.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 119.477 -0.297 . . . . 0.0 110.675 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.851 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -48.44 -49.25 36.09 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 119.0 -1.08 . . . . 0.0 108.129 178.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.466 ' O ' ' C ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -70.31 -41.67 72.98 Favored 'General case' 0 C--N 1.372 1.561 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.999 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -38.94 -34.95 0.17 Allowed 'General case' 0 C--N 1.361 1.092 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.749 178.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.63 63.46 0.29 Allowed Glycine 0 C--N 1.357 1.739 0 C-N-CA 119.911 -1.137 . . . . 0.0 111.095 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 1.092 ' HB3' ' HB ' ' A' ' 61' ' ' THR . . . -78.87 1.11 24.6 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.737 HG11 HG23 ' A' ' 60' ' ' THR . 55.8 t -163.11 -90.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.607 ' N ' HG12 ' A' ' 48' ' ' VAL . 0.9 OUTLIER -170.99 150.37 3.09 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.723 0.296 . . . . 0.0 111.58 -178.067 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 60.5 t-105 -73.63 152.6 40.46 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.492 ' CG2' ' HD2' ' A' ' 52' ' ' PRO . 7.8 p -160.42 145.17 10.81 Favored Pre-proline 0 N--CA 1.468 0.453 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.495 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.492 ' HD2' ' CG2' ' A' ' 51' ' ' VAL . 69.7 Cg_endo -93.74 122.13 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.857 2.372 . . . . 0.0 113.584 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.572 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 1.9 t80 -98.7 139.44 34.4 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -42.86 -62.66 0.95 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -68.6 -25.55 64.92 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -167.77 176.6 42.39 Favored Glycine 0 C--N 1.358 1.803 0 C-N-CA 119.237 -1.459 . . . . 0.0 112.228 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.8 OUTLIER -100.3 129.4 46.29 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.107 1.454 . . . . 0.0 111.262 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 8.3 t -142.45 -177.68 5.39 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -162.34 140.9 8.97 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 122.162 -0.336 . . . . 0.0 110.413 -179.512 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.737 HG23 HG11 ' A' ' 48' ' ' VAL . 2.7 t -89.36 158.71 17.68 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 1.092 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 1.5 p -152.05 173.28 15.08 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.557 ' H ' ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -177.1 153.05 0.94 Allowed 'General case' 0 C--N 1.353 0.757 0 CA-C-N 120.075 1.307 . . . . 0.0 111.953 179.2 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 ' CE3' ' A' ' 42' ' ' TRP . 5.0 pt -161.82 166.5 14.41 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.19 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.514 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 50.8 Cg_exo -53.91 171.47 0.34 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.118 1.879 . . . . 0.0 111.575 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -71.66 -143.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.46 178.64 4.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.156 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -146.08 -60.02 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 0.0 110.854 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -84.33 170.2 13.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.97 59.83 7.48 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -83.71 46.95 2.17 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.824 2.349 . . . . 0.0 112.826 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -123.63 144.48 49.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.651 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.0 140.33 17.68 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.876 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.7 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 22.7 t -114.19 149.48 35.69 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -128.29 145.22 51.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.49 HD21 ' HZ2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -103.55 130.34 50.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.413 ' SG ' ' CE1' ' A' ' 20' ' ' PHE . 99.4 m -106.06 145.95 30.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.217 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.3 m-85 -126.25 136.79 53.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.194 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.435 ' HG3' ' HB2' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -131.14 159.39 71.78 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.656 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 10.0 Cg_endo -51.62 -10.79 0.6 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.776 2.317 . . . . 0.0 113.199 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.549 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 2.0 t70 -162.61 31.24 0.11 Allowed 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.466 -0.494 . . . . 0.0 112.014 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.485 ' CG ' ' HA ' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -163.1 171.29 16.61 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.542 -179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 65' ' ' TYR . 16.2 m -146.15 139.39 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.015 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.18 134.38 44.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.714 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.764 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 47.4 t -119.28 136.74 54.09 Favored 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.368 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.882 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.2 OUTLIER -144.13 122.72 12.5 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.991 HG12 HG23 ' A' ' 39' ' ' THR . 1.0 OUTLIER -110.7 99.61 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 176.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 76.4 m -106.62 -164.94 1.04 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 119.754 -0.778 . . . . 0.0 112.487 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.88 66.11 0.79 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.9 -1.38 9.97 Favored Glycine 0 C--N 1.347 1.186 0 C-N-CA 120.016 -1.088 . . . . 0.0 112.779 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.497 ' HB1' ' HB ' ' A' ' 55' ' ' THR . . . -165.51 -160.65 0.47 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.378 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.691 ' HB1' ' CE2' ' A' ' 20' ' ' PHE . . . -175.88 129.79 0.39 Allowed Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 116.87 -0.15 . . . . 0.0 110.647 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD2' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -43.43 140.9 3.75 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.737 2.291 . . . . 0.0 112.203 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.8 tp -82.18 118.1 70.78 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.63 -173.91 1.93 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.597 2.198 . . . . 0.0 111.94 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.23 -51.87 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.427 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 3.5 pm0 -93.31 31.95 1.41 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 118.237 0.471 . . . . 0.0 112.086 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.05 -166.27 39.1 Favored Glycine 0 N--CA 1.462 0.368 0 C-N-CA 119.989 -1.1 . . . . 0.0 112.723 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 6.7 pm0 -120.53 -169.59 1.84 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.4 ' SG ' ' C ' ' A' ' 33' ' ' GLU . 3.1 m -155.95 176.82 12.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.926 0.393 . . . . 0.0 111.198 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 51.4 p-10 -162.44 159.05 20.47 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.817 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 35' ' ' ASN . 18.1 Cg_endo -59.47 151.83 65.96 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.795 2.33 . . . . 0.0 112.941 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 8' ' ' SER . 29.8 t-80 179.24 110.24 0.18 Allowed Pre-proline 0 N--CA 1.471 0.611 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.742 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.503 ' O ' ' HB3' ' A' ' 8' ' ' SER . 35.1 Cg_exo -27.91 -75.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.339 2.692 . . . . 0.0 113.728 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.991 HG23 HG12 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -163.6 -169.69 2.0 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.883 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -160.27 146.46 11.76 Favored Pre-proline 0 C--N 1.345 0.406 0 CA-C-N 118.382 0.537 . . . . 0.0 111.25 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.626 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 58.6 Cg_endo -71.64 -6.17 18.59 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.634 2.222 . . . . 0.0 112.866 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.764 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 61.6 p-90 -96.65 -35.77 10.93 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -55.54 -43.12 75.49 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 -41.05 24.52 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 36.1 tt0 -59.99 -9.4 3.04 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 118.669 -0.681 . . . . 0.0 111.618 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.16 -31.34 2.46 Favored Glycine 0 C--N 1.37 2.447 0 C-N-CA 117.827 -2.13 . . . . 0.0 111.639 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.77 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -129.8 -109.78 0.27 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.385 0.612 . . . . 0.0 111.86 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER 176.56 -85.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.826 -178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.546 ' CG ' ' HB2' ' A' ' 59' ' ' ARG . 51.2 mt-10 -162.14 158.9 25.33 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.817 ' CZ3' ' HB3' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -155.37 69.29 0.7 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.79 1.281 . . . . 0.0 111.884 178.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.889 HG23 ' HD3' ' A' ' 52' ' ' PRO . 10.7 m -46.31 -39.37 13.54 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 112.875 -1.966 . . . . 0.0 113.885 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.889 ' HD3' HG23 ' A' ' 51' ' ' VAL . 37.0 Cg_endo -64.12 74.22 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 121.313 1.342 . . . . 0.0 114.343 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.61 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 65.0 t80 -115.82 129.12 56.31 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.6 m -41.94 -58.85 1.91 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.497 ' HB ' ' HB1' ' A' ' 25' ' ' ALA . 63.2 m -65.37 -30.64 71.48 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 118.204 0.457 . . . . 0.0 112.161 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -176.98 -161.97 26.62 Favored Glycine 0 CA--C 1.545 1.924 0 C-N-CA 119.017 -1.563 . . . . 0.0 112.897 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.718 ' HG2' HG12 ' A' ' 51' ' ' VAL . 8.4 tt0 -88.36 130.03 35.25 Favored 'General case' 0 C--N 1.361 1.098 0 CA-C-N 119.793 1.796 . . . . 0.0 108.748 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.817 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 1.2 m -121.5 167.62 12.64 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.053 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.783 ' O ' ' HG2' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -163.96 100.79 0.88 Allowed 'General case' 0 C--N 1.37 1.47 0 CA-C-N 118.784 0.72 . . . . 0.0 111.476 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.882 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 167.38 -157.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.77 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 7.5 t -161.66 -163.29 0.96 Allowed 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' O ' HG23 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -135.5 167.07 21.76 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 123.117 0.567 . . . . 0.0 110.23 179.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG1' HG23 ' A' ' 17' ' ' VAL . 8.0 pt -158.68 157.0 28.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.033 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 30.0 Cg_endo -63.15 -16.89 57.3 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.424 2.083 . . . . 0.0 113.302 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.825 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER 165.64 -140.49 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.45 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 11.9 m -105.63 -37.52 4.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 120.823 0.344 . . . . 0.0 111.11 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.909 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 83.2 p -117.68 39.55 3.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.902 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -103.43 73.74 1.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.843 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.411 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -78.0 -54.14 1.34 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.062 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 4' ' ' THR . 97.6 Cg_endo -80.03 -178.5 4.56 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.531 2.154 . . . . 0.0 112.506 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -102.27 140.16 36.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.728 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -157.85 154.33 27.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.328 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.559 ' HB2' ' CG1' ' A' ' 21' ' ' ILE . 2.4 t -113.11 159.67 18.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.305 0.574 . . . . 0.0 112.131 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.756 ' CE1' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -134.1 133.95 41.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.274 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.61 117.52 30.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.231 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 70.9 m -102.0 138.25 39.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.776 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -123.94 144.22 49.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.41 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.89 162.36 56.3 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.604 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 9.7 Cg_endo -52.11 -12.92 1.62 Allowed 'Trans proline' 0 N--CA 1.464 -0.222 0 C-N-CA 122.638 2.225 . . . . 0.0 112.879 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -160.67 32.22 0.16 Allowed 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.617 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 64' ' ' PRO . 16.2 mt-30 -158.49 156.14 29.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.313 0.578 . . . . 0.0 112.349 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.707 HG22 ' HA ' ' A' ' 65' ' ' TYR . 15.8 m -141.28 106.45 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.064 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 12.9 m -113.43 118.78 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.806 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.665 ' O ' ' HB ' ' A' ' 60' ' ' THR . 0.9 OUTLIER -108.77 134.02 52.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.865 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -143.6 139.36 29.63 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 179.273 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.713 HD12 HG23 ' A' ' 60' ' ' THR . 3.4 mt -110.91 136.16 47.8 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.561 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.2 m -146.27 -174.92 4.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 119.058 -1.057 . . . . 0.0 113.367 -177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -146.07 63.59 1.23 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.17 -33.57 0.6 Allowed Glycine 0 C--N 1.346 1.128 0 C-N-CA 120.129 -1.034 . . . . 0.0 112.458 -178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.62 ' HB2' HG22 ' A' ' 55' ' ' THR . . . -177.12 -154.26 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 117.006 0.403 . . . . 0.0 111.292 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.756 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . . . -156.92 157.78 30.91 Favored Pre-proline 0 N--CA 1.463 0.19 0 CA-C-O 120.524 0.202 . . . . 0.0 110.485 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 37.4 Cg_exo -57.52 151.41 54.19 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.4 2.067 . . . . 0.0 112.089 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.38 109.22 18.02 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.028 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.02 178.57 5.2 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.454 2.102 . . . . 0.0 112.215 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 10.9 t -160.4 -55.33 0.05 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.356 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.428 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 6.2 pm0 -94.25 32.53 1.51 Allowed 'General case' 0 C--N 1.352 0.692 0 O-C-N 122.022 -0.424 . . . . 0.0 111.714 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.81 -169.54 41.98 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.577 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -128.69 -164.43 1.39 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 121.159 -0.217 . . . . 0.0 110.532 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.9 m -154.46 178.07 10.47 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.036 0.446 . . . . 0.0 111.189 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -153.72 161.98 27.84 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.21 135.99 33.26 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.544 2.163 . . . . 0.0 112.581 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -165.38 106.84 0.77 Allowed Pre-proline 0 N--CA 1.466 0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.294 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' O ' ' HB3' ' A' ' 8' ' ' SER . 68.1 Cg_exo -37.63 -70.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.96 2.44 . . . . 0.0 113.133 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 21.8 p -154.42 -158.92 0.9 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.349 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 179.53 148.84 0.46 Allowed Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.803 0.335 . . . . 0.0 111.585 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 55.9 Cg_endo -69.7 -24.47 29.93 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.655 2.237 . . . . 0.0 111.631 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.899 ' CZ2' HD11 ' A' ' 63' ' ' ILE . 90.4 t90 -73.34 -45.74 53.44 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.537 -0.756 . . . . 0.0 108.961 178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -44.87 -49.05 11.13 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -84.18 -33.08 24.27 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 2.5 tt0 -48.93 -20.62 0.53 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.319 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.68 -35.25 0.86 Allowed Glycine 0 C--N 1.363 2.029 0 C-N-CA 118.381 -1.866 . . . . 0.0 112.085 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.799 ' CB ' ' HB ' ' A' ' 61' ' ' THR . . . -141.87 100.16 3.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 116.991 0.395 . . . . 0.0 111.217 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.505 ' C ' ' O ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -24.4 -90.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 123.745 0.653 . . . . 0.0 110.439 179.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 59' ' ' ARG . 2.2 mt-10 172.24 130.73 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.678 ' HA ' ' CE3' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 141.96 136.32 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 112.927 -1.942 . . . . 0.0 111.72 176.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.3 p 175.45 83.9 0.08 OUTLIER Pre-proline 0 N--CA 1.47 0.555 0 CA-C-N 114.226 -1.352 . . . . 0.0 109.911 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 51' ' ' VAL . 1.6 Cg_endo -42.88 140.63 2.94 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.284 2.656 . . . . 0.0 113.607 -178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.67 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 47.8 t80 -133.46 132.57 41.21 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.518 -0.764 . . . . 0.0 108.953 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -43.06 -50.92 5.97 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.833 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.62 HG22 ' HB2' ' A' ' 25' ' ' ALA . 19.5 m -73.72 -30.94 63.12 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 121.959 -0.463 . . . . 0.0 112.031 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.67 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -163.58 173.69 39.71 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.358 -1.401 . . . . 0.0 112.399 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ARG . 4.6 tt0 -87.03 112.63 22.04 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 118.904 1.352 . . . . 0.0 110.005 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.561 ' HA ' ' CB ' ' A' ' 22' ' ' CYS . 1.5 m -97.42 -171.98 2.32 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.406 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.615 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 25.7 ptt180 173.66 102.25 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.941 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.865 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 172.72 -150.68 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.799 ' HB ' ' CB ' ' A' ' 47' ' ' ALA . 14.6 t -157.2 -170.71 3.35 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.813 ' C ' HD13 ' A' ' 63' ' ' ILE . 19.6 t -165.77 156.7 13.56 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.899 HD11 ' CZ2' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -152.65 166.83 14.54 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.696 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' ' CG ' ' A' ' 65' ' ' TYR . 9.3 Cg_endo -51.88 -24.35 18.58 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.261 1.974 . . . . 0.0 112.282 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.707 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER 175.67 -144.99 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.182 179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.554 HG13 ' O ' ' A' ' 66' ' ' VAL . 11.0 p -117.75 113.45 42.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.832 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.9 t 61.02 84.71 0.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.822 0.344 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -83.59 117.19 22.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.82 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.6 102.63 39.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -51.95 109.28 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.434 2.089 . . . . 0.0 112.351 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' HB2' HG22 ' A' ' 21' ' ' ILE . 2.9 p30 -119.06 160.74 21.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.796 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -144.37 141.19 29.53 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.722 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 35.2 t -113.29 143.99 43.49 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.488 0.661 . . . . 0.0 112.704 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 134.77 48.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.108 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.49 HD12 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -96.67 119.07 34.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.023 0.439 . . . . 0.0 110.606 -179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.4 m -100.81 128.74 46.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.331 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -113.9 137.61 51.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 -179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.479 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.4 OUTLIER -138.64 145.82 47.95 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.32 179.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.41 -0.71 0.06 OUTLIER 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 122.705 2.27 . . . . 0.0 113.663 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.8 t0 -122.2 -30.83 3.95 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -158.8 -175.16 5.14 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.187 0.518 . . . . 0.0 111.779 -178.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.776 HG22 ' HA ' ' A' ' 65' ' ' TYR . 8.3 m -141.24 126.74 18.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.909 179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 57.1 m -118.06 141.13 48.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.632 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.737 ' O ' ' HB ' ' A' ' 60' ' ' THR . 41.8 t -123.97 131.61 53.59 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.831 ' HA ' ' OG1' ' A' ' 60' ' ' THR . 0.0 OUTLIER -137.94 136.31 36.89 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.75 HD12 HG23 ' A' ' 60' ' ' THR . 2.4 mt -103.43 103.93 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.9 m -95.13 -174.2 3.16 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 119.8 -0.76 . . . . 0.0 112.757 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -150.47 60.51 0.95 Allowed 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 55' ' ' THR . . . 100.71 26.22 8.16 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.011 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.834 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -151.2 -161.26 1.29 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.04 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -178.04 114.53 0.23 Allowed Pre-proline 0 N--CA 1.468 0.448 0 CA-C-O 120.449 0.166 . . . . 0.0 110.682 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.484 ' HG2' ' CD2' ' A' ' 20' ' ' PHE . 70.1 Cg_exo -49.78 142.93 24.24 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.467 2.111 . . . . 0.0 112.414 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.87 112.49 22.84 Favored Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.42 173.89 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.617 2.211 . . . . 0.0 112.128 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.4 m -155.55 -52.33 0.09 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.638 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -124.39 33.47 5.25 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 118.288 0.494 . . . . 0.0 112.106 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.96 -169.61 41.56 Favored Glycine 0 N--CA 1.462 0.432 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.792 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -121.29 -162.77 0.99 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 110.443 -0.206 . . . . 0.0 110.443 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -154.83 164.12 39.29 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.099 0.476 . . . . 0.0 111.344 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -140.84 167.66 16.84 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.666 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.22 136.56 29.46 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.587 2.191 . . . . 0.0 112.691 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.49 ' ND1' HD12 ' A' ' 10' ' ' LEU . 20.9 t-160 -165.06 93.91 0.9 Allowed Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.935 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -30.93 -70.33 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.359 2.706 . . . . 0.0 113.627 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -142.25 -159.19 0.94 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.747 -0.206 . . . . 0.0 110.815 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.934 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -176.63 169.15 1.25 Allowed Pre-proline 0 N--CA 1.471 0.58 0 CA-C-O 120.699 0.285 . . . . 0.0 111.373 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.678 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 93.8 Cg_endo -83.66 -35.14 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.015 2.477 . . . . 0.0 112.848 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.564 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 17.2 p-90 -88.05 -42.57 12.32 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.934 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -42.62 -58.44 2.29 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -36.63 73.65 Favored 'General case' 0 C--N 1.349 0.554 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.219 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 5.3 tt0 -42.96 -32.35 0.63 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.105 0.411 . . . . 0.0 111.492 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -139.94 13.38 3.11 Favored Glycine 0 C--N 1.356 1.666 0 C-N-CA 118.868 -1.634 . . . . 0.0 112.756 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 43' ' ' CYS . . . -66.14 66.53 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.844 0.354 . . . . 0.0 111.896 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 48' ' ' VAL . 21.5 t -141.8 53.26 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.96 23.44 0.66 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.262 0.937 . . . . 0.0 112.845 -179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.925 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -148.85 -173.53 4.38 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.925 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.5 t 153.08 -44.8 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 123.621 0.769 . . . . 0.0 110.022 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 4.7 Cg_endo -87.82 91.18 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.844 2.362 . . . . 0.0 114.796 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.834 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 10.0 t80 -121.88 128.85 52.05 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 m -40.3 -55.99 2.07 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 24' ' ' GLY . 64.3 m -66.98 -29.17 68.94 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.766 ' N ' ' HB2' ' A' ' 25' ' ' ALA . . . -177.38 -173.07 42.56 Favored Glycine 0 C--N 1.359 1.822 0 C-N-CA 119.272 -1.442 . . . . 0.0 112.324 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.67 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 1.7 tm0? -100.07 125.9 46.21 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 119.637 1.719 . . . . 0.0 109.488 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.774 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 50.1 t -136.19 -178.78 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.726 -178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.797 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.3 OUTLIER 174.68 137.71 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.741 1.155 . . . . 0.0 111.594 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.831 ' OG1' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER 179.44 -147.08 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.473 ' H ' ' HB ' ' A' ' 60' ' ' THR . 9.0 t -151.12 -171.13 3.85 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.604 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.516 ' O ' HG23 ' A' ' 63' ' ' ILE . 69.7 m -146.23 173.08 12.54 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-O 120.778 0.323 . . . . 0.0 110.653 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 17' ' ' VAL . 6.3 pt -158.07 156.54 28.17 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.782 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.499 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 19.4 Cg_endo -58.24 -19.42 42.24 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.406 2.071 . . . . 0.0 113.012 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.776 ' HA ' HG22 ' A' ' 17' ' ' VAL . 0.1 OUTLIER 166.24 -141.12 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.945 -179.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.509 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 12.2 p -100.44 -31.24 3.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 120.863 0.363 . . . . 0.0 110.961 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.866 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m 61.01 90.4 0.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 0.0 110.944 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.431 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 3.4 t-80 -118.25 -55.75 2.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.652 HG22 ' HD3' ' A' ' 5' ' ' PRO . 7.7 t -82.54 -31.61 0.54 Allowed Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.185 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD3' HG22 ' A' ' 4' ' ' THR . 38.7 Cg_exo -60.79 119.59 6.84 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.132 1.888 . . . . 0.0 112.564 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.449 ' HB2' HG22 ' A' ' 21' ' ' ILE . 4.4 p30 -124.86 154.46 41.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.344 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -151.43 141.06 21.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.206 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 8.5 t -118.11 144.33 45.74 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.85 133.12 54.88 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.348 177.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.492 HD21 ' CZ2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -91.53 123.08 34.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.885 0.374 . . . . 0.0 110.504 -179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -99.2 138.86 35.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.213 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 12' ' ' TYR . 1.0 OUTLIER -118.45 129.79 55.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.064 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.48 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.9 OUTLIER -138.34 146.79 52.87 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.857 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.7 4.48 0.16 Allowed 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 122.45 2.1 . . . . 0.0 112.698 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -115.97 -32.65 5.34 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.525 0.202 . . . . 0.0 111.216 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.4 OUTLIER -172.92 -170.58 0.67 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.872 0.368 . . . . 0.0 111.265 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.458 ' CG2' ' CE1' ' A' ' 65' ' ' TYR . 1.8 t -133.36 124.7 49.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.29 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 96.5 m -124.54 141.35 52.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.131 0.491 . . . . 0.0 111.747 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.637 ' HB3' ' CH2' ' A' ' 42' ' ' TRP . 3.1 p -117.03 147.11 42.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.861 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -148.65 128.02 13.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 178.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.514 HD13 ' NE ' ' A' ' 59' ' ' ARG . 1.1 mp -97.6 106.86 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 114.453 -1.248 . . . . 0.0 108.344 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 2.2 m -84.86 -178.03 6.74 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.0 -1.08 . . . . 0.0 112.011 -178.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.12 55.89 1.05 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.27 25.33 6.74 Favored Glycine 0 C--N 1.347 1.185 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.247 -177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.648 ' HB2' ' CA ' ' A' ' 56' ' ' GLY . . . -155.53 -160.59 1.05 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.729 0.764 . . . . 0.0 112.043 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -179.88 94.66 0.19 Allowed Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.326 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HG3' ' CH2' ' A' ' 50' ' ' TRP . 72.0 Cg_exo -34.7 141.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 123.238 2.625 . . . . 0.0 113.14 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 tp -80.8 112.76 34.71 Favored Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -56.17 169.05 1.64 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.531 2.154 . . . . 0.0 112.324 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.5 t -153.66 -57.86 0.12 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.207 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -108.65 29.52 7.34 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.01 -0.431 . . . . 0.0 111.426 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.17 -169.65 42.3 Favored Glycine 0 N--CA 1.46 0.289 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.514 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.61 -161.43 0.89 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 121.225 -0.19 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.13 161.18 39.38 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.153 0.501 . . . . 0.0 111.391 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.4 173.59 4.36 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.753 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -74.75 136.26 20.71 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.066 2.511 . . . . 0.0 112.924 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.448 ' O ' ' O ' ' A' ' 8' ' ' SER . 4.4 t-80 -173.84 93.29 0.34 Allowed Pre-proline 0 N--CA 1.468 0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.882 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -29.15 -71.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.608 2.872 . . . . 0.0 113.846 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.413 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 13.8 p -151.2 -155.79 0.66 Allowed 'General case' 0 CA--C 1.535 0.391 0 O-C-N 123.136 0.272 . . . . 0.0 110.762 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . 179.93 164.84 0.84 Allowed Pre-proline 0 N--CA 1.473 0.704 0 CA-C-O 120.69 0.281 . . . . 0.0 111.5 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.15 -28.51 10.73 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.17 2.58 . . . . 0.0 112.193 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.711 ' CE3' HD13 ' A' ' 63' ' ' ILE . 20.8 p-90 -86.71 -39.87 15.61 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -43.6 -58.42 2.66 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -33.07 65.25 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.229 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 42' ' ' TRP . 2.8 tt0 -39.6 -42.82 1.23 Allowed 'General case' 0 C--N 1.361 1.089 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.081 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 48' ' ' VAL . . . -146.1 16.42 1.72 Allowed Glycine 0 C--N 1.357 1.723 0 C-N-CA 118.173 -1.965 . . . . 0.0 112.456 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 43' ' ' CYS . . . -51.92 90.63 0.01 OUTLIER 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.42 0.629 . . . . 0.0 112.562 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 48' ' ' VAL . 7.7 p -65.82 49.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.169 -1.378 . . . . 0.0 107.936 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -26.57 116.81 0.07 Allowed 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 58' ' ' CYS . 0.0 OUTLIER -121.94 73.85 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.358 177.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.856 ' HA ' ' H ' ' A' ' 58' ' ' CYS . 14.0 m -57.32 -38.53 69.04 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-N 114.146 -1.388 . . . . 0.0 113.71 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 51' ' ' VAL . 9.7 Cg_endo -51.97 77.53 0.02 OUTLIER 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 121.594 1.53 . . . . 0.0 113.587 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.685 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 62.3 t80 -121.7 132.96 54.92 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.5 m -45.26 -58.97 2.9 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.5 m -61.91 -30.64 71.02 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 122.014 -0.429 . . . . 0.0 111.923 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.685 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -179.01 -165.88 34.08 Favored Glycine 0 C--N 1.357 1.701 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.916 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.803 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 2.7 mt-30 -109.98 127.7 54.95 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 120.179 1.99 . . . . 0.0 110.045 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.856 ' H ' ' HA ' ' A' ' 51' ' ' VAL . 14.0 m -131.93 -171.26 2.58 Favored 'General case' 0 CA--C 1.553 1.074 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 4.9 ttp180 -140.06 135.03 32.19 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.557 HG23 HG13 ' A' ' 48' ' ' VAL . 8.8 t -119.38 135.31 54.79 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -177.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.68 ' OG1' ' CA ' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -135.21 165.96 24.2 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 176.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 75.7 m -156.74 153.44 28.41 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 119.894 1.225 . . . . 0.0 110.56 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.711 HD13 ' CE3' ' A' ' 42' ' ' TRP . 12.9 pt -148.98 136.72 11.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.606 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -88.53 134.28 2.82 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.925 2.417 . . . . 0.0 112.277 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.458 ' CE1' ' CG2' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -141.83 -148.59 0.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.165 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 21.2 t -149.97 105.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.82 0.343 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.884 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -84.47 136.72 33.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 61.15 97.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.916 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.1 m -159.27 58.44 1.22 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.83 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.11 135.86 25.92 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.642 2.228 . . . . 0.0 112.37 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -129.44 148.43 51.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -130.03 140.26 50.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.3 m -123.67 155.41 37.81 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.523 0.678 . . . . 0.0 112.211 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.511 ' CZ ' ' HD2' ' A' ' 27' ' ' PRO . 0.8 OUTLIER -136.58 129.38 30.77 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.866 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.446 HD11 ' HZ2' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -93.07 124.82 37.32 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.8 m -105.58 153.04 22.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.761 0.791 . . . . 0.0 112.86 -177.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 21.9 t80 -118.68 114.56 22.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.129 -1.396 . . . . 0.0 111.521 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -120.11 144.76 38.48 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 19.5 Cg_endo -58.35 6.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.602 2.201 . . . . 0.0 113.338 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.4 m-20 -118.42 -33.05 4.45 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.205 -0.198 . . . . 0.0 111.462 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -170.25 -165.16 0.45 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.584 HG13 ' CE1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -122.93 122.58 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.02 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.7 m -118.36 148.36 42.59 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 39.3 t -128.28 143.56 51.04 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.567 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -138.96 138.5 37.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.422 0.629 . . . . 0.0 112.188 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.685 HD12 ' HD3' ' A' ' 59' ' ' ARG . 3.3 mt -112.39 140.63 31.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.759 178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 13.1 m -143.64 -173.62 4.01 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 119.336 -0.946 . . . . 0.0 113.165 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -149.59 60.58 1.01 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 152.16 -29.09 0.89 Allowed Glycine 0 C--N 1.35 1.316 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.441 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' HB ' ' A' ' 55' ' ' THR . . . -176.14 -156.05 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.68 0.74 . . . . 0.0 111.907 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -150.09 154.52 36.78 Favored Pre-proline 0 N--CA 1.464 0.272 0 CA-C-O 120.561 0.22 . . . . 0.0 110.714 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.511 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 40.3 Cg_endo -66.86 159.23 52.59 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.373 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -74.48 111.79 14.46 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 161.91 38.51 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.573 2.182 . . . . 0.0 112.215 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 t -164.9 -49.55 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.409 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.418 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 13.8 pm0 -92.73 32.59 1.22 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.123 0.42 . . . . 0.0 111.784 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 163.44 169.22 26.6 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.182 -1.008 . . . . 0.0 112.461 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -101.82 -164.27 1.08 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 120.566 -0.454 . . . . 0.0 110.588 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.59 161.04 35.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.074 0.464 . . . . 0.0 110.853 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -140.98 147.5 48.17 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.49 129.3 33.97 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.621 2.214 . . . . 0.0 112.431 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 39' ' ' THR . 6.5 t-160 -159.55 102.31 1.5 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.962 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -33.19 -70.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.18 2.586 . . . . 0.0 113.36 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.42 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -147.55 -157.77 0.84 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.655 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . -175.54 151.82 1.3 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-O 120.687 0.28 . . . . 0.0 111.116 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 73.6 Cg_endo -75.68 -26.57 9.74 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.589 2.193 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.94 ' CE3' HD13 ' A' ' 63' ' ' ILE . 40.9 p-90 -90.69 -40.38 11.9 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.824 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.836 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -44.06 -59.79 2.16 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -33.93 61.06 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.225 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.738 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.0 OUTLIER -47.86 -30.0 3.74 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 119.003 0.82 . . . . 0.0 111.667 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -130.72 -2.55 4.8 Favored Glycine 0 C--N 1.357 1.718 0 C-N-CA 118.527 -1.796 . . . . 0.0 113.758 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' A' ' 61' ' ' THR . . . -83.98 62.04 6.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.618 0.709 . . . . 0.0 110.643 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 48' ' ' VAL . 12.2 p -85.11 27.91 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.759 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.99 142.92 38.33 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.711 0.291 . . . . 0.0 110.262 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -105.18 158.36 16.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.975 0.416 . . . . 0.0 111.334 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.609 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.6 p -138.69 104.05 7.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.211 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.55 111.3 1.62 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.546 2.164 . . . . 0.0 113.275 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.627 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 5.1 t80 -101.57 129.29 47.64 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.24 -45.6 5.83 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.251 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 18.5 m -78.14 -32.73 50.48 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 119.248 -0.406 . . . . 0.0 112.075 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.627 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -164.57 171.74 40.12 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 119.083 -1.532 . . . . 0.0 113.032 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 23' ' ' ARG . 20.8 tt0 -83.57 122.96 29.27 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.499 1.149 . . . . 0.0 109.688 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -112.46 -174.82 2.54 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.685 ' HD3' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -161.62 132.98 5.37 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.4 m -116.86 139.31 50.77 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.727 1.381 . . . . 0.0 114.727 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.465 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -148.35 167.25 25.72 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.074 177.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.426 ' N ' HG23 ' A' ' 61' ' ' THR . 81.0 m -156.7 158.35 36.78 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 119.501 1.046 . . . . 0.0 110.852 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.94 HD13 ' CE3' ' A' ' 42' ' ' TRP . 9.2 pt -155.47 157.25 31.57 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HA ' ' HG2' ' A' ' 16' ' ' GLN . 9.5 Cg_endo -51.85 167.53 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.575 2.183 . . . . 0.0 112.092 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.584 ' CE1' HG13 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -77.45 -142.3 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.963 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 66' ' ' VAL . 7.1 p -126.34 95.33 3.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.991 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p -167.47 130.94 1.74 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.944 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -135.62 -178.07 4.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.0 p -70.87 114.83 30.18 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -56.7 -164.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.392 2.061 . . . . 0.0 112.301 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -105.33 149.62 25.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.62 147.56 45.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.035 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 33.8 t -130.83 155.87 45.97 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.515 0.674 . . . . 0.0 111.907 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -139.28 137.65 36.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.07 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -95.26 131.61 41.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.698 179.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 84.3 m -113.93 154.16 28.04 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.557 0.694 . . . . 0.0 111.955 -178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.692 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 16.3 t80 -125.53 130.68 52.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.506 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -133.81 139.9 34.89 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 178.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.442 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 18.4 Cg_endo -59.26 7.35 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.445 2.096 . . . . 0.0 112.888 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 13' ' ' GLN . 1.0 OUTLIER -119.79 -32.65 4.2 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.752 -0.204 . . . . 0.0 111.441 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 11.0 mt-30 -164.47 -168.86 1.62 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.039 0.447 . . . . 0.0 111.306 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.597 ' HB ' HD11 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.14 145.92 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.316 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.5 m -151.52 139.95 20.5 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.571 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 49.4 t -120.41 150.86 40.12 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.199 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.587 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -146.55 133.55 20.29 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.533 0.682 . . . . 0.0 112.748 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.733 HD11 ' HB3' ' A' ' 43' ' ' CYS . 3.1 mp -105.41 139.26 27.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.29 177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 61.6 m -139.88 -170.75 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 119.201 -1.0 . . . . 0.0 113.353 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.443 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.68 58.66 0.81 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.03 18.08 9.07 Favored Glycine 0 C--N 1.349 1.299 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.359 -179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.82 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -157.09 -166.63 2.12 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.707 0.754 . . . . 0.0 112.051 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.429 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . 179.81 129.19 0.24 Allowed Pre-proline 0 N--CA 1.469 0.483 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD2' ' CZ ' ' A' ' 9' ' ' PHE . 50.3 Cg_exo -53.89 140.58 68.34 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.134 1.89 . . . . 0.0 112.051 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.1 111.83 7.52 Favored Pre-proline 0 N--CA 1.469 0.51 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.0 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -82.26 162.14 17.56 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.699 2.266 . . . . 0.0 112.331 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.6 m -174.83 -39.32 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.516 -179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.442 ' O ' ' HD2' ' A' ' 14' ' ' PRO . 1.1 pm0 -91.08 32.6 1.0 Allowed 'General case' 0 C--N 1.354 0.764 0 O-C-N 121.932 -0.48 . . . . 0.0 111.929 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.692 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 158.53 -163.79 33.21 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.683 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -121.81 -169.8 1.94 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 117.179 0.489 . . . . 0.0 110.616 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 4.3 m -156.98 161.47 39.59 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.835 0.35 . . . . 0.0 110.614 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -135.35 150.82 73.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.891 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.27 140.48 81.61 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.594 2.196 . . . . 0.0 112.363 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.403 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.7 t-160 -168.62 90.07 0.63 Allowed Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -31.68 -73.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.48 2.787 . . . . 0.0 113.379 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.568 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 30.6 p -157.28 -163.95 1.49 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 168.92 158.87 0.17 Allowed Pre-proline 0 N--CA 1.474 0.734 0 CA-C-O 120.701 0.286 . . . . 0.0 110.93 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 71.8 Cg_endo -76.73 -3.44 13.79 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.47 2.113 . . . . 0.0 112.119 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.669 ' CH2' HD12 ' A' ' 63' ' ' ILE . 66.1 t90 -93.75 -55.23 3.32 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.275 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.733 ' HB3' HD11 ' A' ' 21' ' ' ILE . 33.6 m -54.12 -32.54 55.34 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -84.59 -41.83 16.04 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.915 -0.49 . . . . 0.0 109.734 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.1 tt0 -51.32 -24.53 4.74 Favored 'General case' 0 C--N 1.357 0.926 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.549 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.47 -16.82 4.99 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 118.38 -1.867 . . . . 0.0 113.316 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.9 ' HB2' ' CB ' ' A' ' 61' ' ' THR . . . -106.84 67.88 0.72 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.381 0.59 . . . . 0.0 111.091 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 48' ' ' VAL . 14.2 p -90.37 30.4 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.351 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.9 pm0 -130.74 142.72 50.42 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.657 0.265 . . . . 0.0 110.403 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.412 ' CZ2' ' NH2' ' A' ' 59' ' ' ARG . 33.6 m95 -94.96 149.64 21.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.96 0.409 . . . . 0.0 111.297 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 51' ' ' VAL . 7.5 p -139.56 107.85 7.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.131 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.48 120.31 7.42 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.528 2.152 . . . . 0.0 113.762 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.82 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 1.2 t80 -107.45 135.04 49.6 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.97 -54.66 6.29 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -69.48 -29.15 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.678 ' N ' ' HB2' ' A' ' 25' ' ' ALA . . . -174.35 -178.23 44.09 Favored Glycine 0 C--N 1.357 1.74 0 C-N-CA 119.208 -1.472 . . . . 0.0 112.291 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ARG . 2.3 tt0 -81.91 142.42 32.49 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-N 119.334 1.567 . . . . 0.0 110.16 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.2 m -136.03 -179.2 5.52 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.309 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.587 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 25.7 ttm180 -161.72 122.59 2.7 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.3 t -108.17 144.86 35.01 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.9 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . 0.4 OUTLIER -147.89 158.26 43.95 Favored 'General case' 0 CA--C 1.557 1.214 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.12 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 63' ' ' ILE . 91.6 m -155.41 162.09 40.85 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 120.045 1.293 . . . . 0.0 111.463 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.669 HD12 ' CH2' ' A' ' 42' ' ' TRP . 0.1 OUTLIER -158.93 166.11 17.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.614 179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 30.4 Cg_exo -61.87 161.42 25.58 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.502 2.134 . . . . 0.0 112.463 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.429 ' HB3' ' H ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.69 -140.16 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.062 179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.429 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 9.0 p -110.2 -25.53 3.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.127 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.866 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 p -176.44 89.93 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -140.02 -70.06 0.4 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.917 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.437 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -91.25 -49.88 0.33 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.4 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 4' ' ' THR . 75.4 Cg_exo -50.97 136.47 44.21 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.46 2.107 . . . . 0.0 112.607 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -137.16 165.57 25.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.715 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.6 139.14 33.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.056 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 20' ' ' PHE . 5.8 t -119.1 149.03 42.37 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -129.71 144.56 51.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.036 178.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 132.76 47.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.26 -179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.42 ' SG ' ' HE1' ' A' ' 20' ' ' PHE . 64.4 m -106.86 146.81 30.52 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.996 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -125.21 132.44 52.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.867 0.365 . . . . 0.0 111.207 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -118.26 157.16 49.77 Favored Pre-proline 0 CA--C 1.51 -0.559 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.128 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.92 -11.46 2.52 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.797 1.665 . . . . 0.0 110.975 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.11 28.21 0.07 Allowed 'General case' 0 C--N 1.342 0.239 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.503 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.5 154.37 31.7 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.397 -0.521 . . . . 0.0 112.204 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.833 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -130.0 128.8 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.519 179.078 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.5 m -133.43 138.14 46.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.477 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 16.4 t -127.9 152.71 47.52 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.484 178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -151.7 141.98 22.39 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -178.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 43' ' ' CYS . 2.8 mp -112.15 122.97 67.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.184 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 11.4 m -116.43 -176.04 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -152.02 58.72 0.85 Allowed 'General case' 0 C--N 1.348 0.509 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 139.46 -13.74 3.22 Favored Glycine 0 C--N 1.348 1.21 0 C-N-CA 120.18 -1.01 . . . . 0.0 113.184 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.837 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -174.38 -154.96 0.06 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.434 0.617 . . . . 0.0 111.682 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . . . -158.54 138.41 8.68 Favored Pre-proline 0 C--N 1.34 0.17 0 CA-C-O 120.661 0.267 . . . . 0.0 111.045 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 18.2 Cg_endo -59.64 159.6 23.65 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.661 2.241 . . . . 0.0 112.179 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.657 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -86.15 156.46 57.35 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.14 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -74.47 -179.99 5.34 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.656 2.238 . . . . 0.0 112.148 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 m -149.52 -52.09 0.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.26 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.27 33.3 3.61 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.583 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 177.26 -162.71 30.94 Favored Glycine 0 N--CA 1.463 0.454 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.438 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.4 ' C ' ' SG ' ' A' ' 34' ' ' CYS . 7.1 pm0 -116.72 -171.86 2.09 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 2.8 m -155.82 177.49 11.34 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 118.185 0.448 . . . . 0.0 111.019 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.4 m120 -159.56 167.72 13.61 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 35' ' ' ASN . 49.6 Cg_endo -69.11 150.79 72.54 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.565 2.177 . . . . 0.0 112.809 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' SER . 16.5 t-80 -172.78 104.87 0.33 Allowed Pre-proline 0 N--CA 1.467 0.421 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.501 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' C ' ' O ' ' A' ' 37' ' ' HIS . 35.8 Cg_exo -28.09 -81.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.303 2.669 . . . . 0.0 113.476 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -160.46 -160.29 0.76 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 174.61 148.72 0.24 Allowed Pre-proline 0 N--CA 1.472 0.666 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.04 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -63.87 -16.4 54.58 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.487 2.125 . . . . 0.0 111.989 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.752 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 91.1 t90 -92.46 -51.09 5.3 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.451 ' O ' ' CB ' ' A' ' 47' ' ' ALA . 58.9 m -51.96 -34.97 44.55 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.246 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.03 -39.76 20.83 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.5 OUTLIER -50.98 -24.7 3.88 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.412 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -126.33 -6.1 5.85 Favored Glycine 0 C--N 1.363 2.06 0 C-N-CA 118.498 -1.811 . . . . 0.0 113.797 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 43' ' ' CYS . . . -85.64 52.32 2.43 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 117.641 0.72 . . . . 0.0 110.943 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.3 32.86 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.857 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 2.1 tt0 -128.96 127.36 41.54 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.864 0.364 . . . . 0.0 110.207 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.439 ' CZ3' ' HD2' ' A' ' 59' ' ' ARG . 4.1 m95 -81.36 152.54 27.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.376 0.608 . . . . 0.0 111.748 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.724 HG12 ' O ' ' A' ' 58' ' ' CYS . 7.2 p -149.53 99.41 3.37 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.907 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.43 98.78 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.429 2.086 . . . . 0.0 113.277 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.499 ' CB ' ' O ' ' A' ' 56' ' ' GLY . 0.3 OUTLIER -93.22 129.65 39.19 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.528 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 t -40.5 -36.05 0.52 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.054 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.837 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -102.19 -23.48 14.03 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 118.547 0.612 . . . . 0.0 112.6 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -163.23 169.2 38.26 Favored Glycine 0 C--N 1.36 1.896 0 C-N-CA 118.784 -1.674 . . . . 0.0 113.501 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.448 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -98.42 137.38 37.2 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 117.841 0.82 . . . . 0.0 109.979 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.724 ' O ' HG12 ' A' ' 51' ' ' VAL . 24.1 t -148.42 179.74 7.57 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -147.06 126.55 13.22 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.4 t -115.79 135.84 53.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.99 168.01 16.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.358 177.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.517 ' O ' HG23 ' A' ' 63' ' ' ILE . 94.4 m -154.45 169.35 23.97 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.201 0.909 . . . . 0.0 111.553 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.833 HG13 HG23 ' A' ' 17' ' ' VAL . 11.2 pt -160.28 130.19 3.41 Favored Pre-proline 0 C--N 1.332 -0.187 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.698 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.6 118.83 0.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.711 2.274 . . . . 0.0 112.549 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.584 ' OH ' HG13 ' A' ' 17' ' ' VAL . 40.2 m-85 -44.02 -28.31 0.46 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.277 0.56 . . . . 0.0 112.106 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 m -96.15 110.97 25.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.063 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.926 -179.961 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.92 81.27 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -106.06 168.8 8.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.96 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.5 m 61.42 66.52 1.57 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.97 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.15 131.23 20.27 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.553 2.169 . . . . 0.0 112.211 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -121.56 139.79 53.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.035 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.11 141.62 38.11 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.636 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 5.6 t -115.46 154.52 29.15 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.777 0.799 . . . . 0.0 112.742 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.885 ' CE1' ' HB1' ' A' ' 26' ' ' ALA . 1.3 p90 -138.87 129.78 26.47 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.62 -1.173 . . . . 0.0 109.531 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.452 HD12 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -89.71 122.55 32.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.842 0.354 . . . . 0.0 110.217 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.5 m -108.2 133.28 52.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.225 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 1.7 m-85 -107.71 137.12 46.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.559 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.55 157.39 39.39 Favored Pre-proline 0 CA--C 1.51 -0.567 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.207 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.18 -8.81 2.76 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.784 1.656 . . . . 0.0 110.885 177.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -164.09 29.7 0.08 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.245 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -164.16 162.4 22.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.189 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -128.6 140.41 49.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.89 179.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 68.3 m -151.21 137.73 18.67 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.599 ' O ' ' HB ' ' A' ' 60' ' ' THR . 46.5 t -126.61 131.08 51.57 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 177.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.897 ' HA ' ' CB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -130.12 143.62 50.89 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.77 HD12 HG23 ' A' ' 60' ' ' THR . 5.1 mt -115.42 123.36 70.85 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.961 177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.495 ' CB ' ' HA ' ' A' ' 58' ' ' CYS . 4.7 m -125.86 -174.19 3.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -177.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -145.7 63.77 1.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' ' HA3' ' A' ' 56' ' ' GLY . . . 157.98 -28.97 0.47 Allowed Glycine 0 C--N 1.346 1.126 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.942 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.816 ' CB ' HG23 ' A' ' 55' ' ' THR . . . -176.17 -157.2 0.05 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.885 ' HB1' ' CE1' ' A' ' 9' ' ' PHE . . . 179.68 -58.72 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.605 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.365 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.564 ' CD ' ' HB3' ' A' ' 26' ' ' ALA . 7.2 Cg_exo -34.87 78.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 124.17 3.247 . . . . 0.0 115.01 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 53' ' ' TYR . 5.2 tp -105.46 69.13 0.19 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.176 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' CD ' ' O ' ' A' ' 27' ' ' PRO . 36.7 Cg_endo -65.29 122.68 10.46 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.492 2.128 . . . . 0.0 112.408 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.5 m -157.01 -51.65 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -122.35 29.8 6.81 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.113 0.415 . . . . 0.0 111.793 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.97 -153.56 24.84 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.264 -0.969 . . . . 0.0 112.63 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.39 -168.31 1.89 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.2 m -156.03 171.57 19.89 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.862 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.7 OUTLIER -143.24 170.67 8.19 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.208 179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 52.1 Cg_endo -69.45 137.59 36.75 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.425 2.083 . . . . 0.0 112.71 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.452 ' CD2' HD12 ' A' ' 10' ' ' LEU . 7.7 t-80 -163.43 93.55 1.11 Allowed Pre-proline 0 N--CA 1.466 0.344 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.794 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 8' ' ' SER . 59.7 Cg_exo -37.45 -77.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.4 2.733 . . . . 0.0 114.211 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 t -177.16 43.06 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.361 0.124 . . . . 0.0 111.032 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -50.01 172.11 0.12 Allowed Pre-proline 0 N--CA 1.474 0.747 0 CA-C-O 120.931 0.396 . . . . 0.0 111.631 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.614 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 44.4 Cg_exo -57.46 -17.12 26.1 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.999 2.466 . . . . 0.0 113.337 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.591 ' CZ3' ' HB3' ' A' ' 19' ' ' CYS . 6.4 t90 -71.88 -65.84 0.72 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.679 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -50.79 -53.59 30.7 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -35.28 75.96 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.491 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.477 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 1.8 mt-10 -49.33 -40.66 36.11 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-N 118.461 0.573 . . . . 0.0 111.209 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' A' ' 61' ' ' THR . . . -126.35 5.61 7.67 Favored Glycine 0 N--CA 1.481 1.638 0 C-N-CA 118.355 -1.878 . . . . 0.0 113.48 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 60' ' ' THR . . . -70.1 54.55 0.14 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.993 0.397 . . . . 0.0 111.677 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.585 ' O ' HG12 ' A' ' 48' ' ' VAL . 16.3 t -106.03 36.61 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.519 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -147.83 152.04 36.97 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 111.016 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.594 ' CE3' ' HB3' ' A' ' 59' ' ' ARG . 12.7 m95 -92.62 158.87 15.74 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.706 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 52' ' ' PRO . 68.6 t -151.18 144.34 17.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.332 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.405 ' HD2' HG13 ' A' ' 51' ' ' VAL . 58.5 Cg_endo -99.29 121.84 0.12 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.049 2.5 . . . . 0.0 113.805 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.748 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 35.5 t80 -121.51 130.83 53.79 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 t -39.09 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.816 HG23 ' CB ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER -70.17 -11.43 60.89 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -154.3 168.49 32.58 Favored Glycine 0 C--N 1.366 2.216 0 C-N-CA 118.167 -1.968 . . . . 0.0 114.398 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ARG . 8.6 tt0 -94.55 117.99 30.98 Favored 'General case' 0 C--N 1.348 0.531 0 O-C-N 121.878 -0.777 . . . . 0.0 110.397 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 59' ' ' ARG . 5.1 m -97.2 178.86 5.1 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 118.919 -0.562 . . . . 0.0 111.134 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.594 ' HB3' ' CE3' ' A' ' 50' ' ' TRP . 22.4 ptt180 171.03 115.84 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 119.106 0.867 . . . . 0.0 110.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.897 ' CB ' ' HA ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -179.49 -147.87 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 46' ' ' GLY . 6.3 t -142.8 -172.11 3.58 Favored 'General case' 0 CA--C 1.551 1.013 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -178.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.2 m -143.95 174.33 10.93 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.427 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.531 HG13 HG23 ' A' ' 17' ' ' VAL . 8.7 pt -157.07 166.82 15.81 Favored Pre-proline 0 N--CA 1.462 0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.155 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 17' ' ' VAL . 4.2 Cg_exo -76.3 165.26 29.69 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.799 2.333 . . . . 0.0 111.398 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.2 -140.35 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.127 0.489 . . . . 0.0 110.699 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.2 m -120.55 116.71 50.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.039 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.247 -0.883 . . . . 0.0 110.904 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -169.76 -46.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.867 0.365 . . . . 0.0 110.854 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.7 p-80 -177.32 -173.89 0.46 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.779 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 4' ' ' THR . 4.1 t -49.76 103.67 0.38 Allowed Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.963 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -91.41 33.13 0.3 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.887 2.392 . . . . 0.0 112.808 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -107.34 137.64 45.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.72 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.06 166.72 12.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.034 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.431 ' OG ' HG23 ' A' ' 21' ' ' ILE . 65.4 m -132.12 153.53 50.4 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.408 0.623 . . . . 0.0 111.814 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CZ ' ' HB1' ' A' ' 26' ' ' ALA . 1.6 p90 -135.36 131.62 36.6 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.122 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.461 HD12 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.51 121.44 38.33 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.665 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 8.6 m -102.61 154.89 18.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.758 0.789 . . . . 0.0 112.782 -177.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.9 t80 -119.11 115.69 24.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.224 -1.353 . . . . 0.0 111.198 -179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.0 OUTLIER -100.53 162.51 20.57 Favored Pre-proline 0 C--N 1.332 -0.162 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -48.02 -11.7 0.13 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.919 2.413 . . . . 0.0 113.333 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HA ' ' CE2' ' A' ' 65' ' ' TYR . 4.8 t0 -170.19 32.32 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.144 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.458 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.2 mt-30 -160.64 163.58 32.46 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.168 0.509 . . . . 0.0 111.714 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.755 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.1 OUTLIER -126.91 117.33 47.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.597 -0.728 . . . . 0.0 109.715 179.268 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 89.1 m -123.01 138.17 54.76 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.444 ' CB ' ' HZ3' ' A' ' 42' ' ' TRP . 38.9 t -122.38 146.48 47.3 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.343 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -140.1 134.78 31.79 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.326 0.584 . . . . 0.0 111.9 -179.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 43' ' ' CYS . 3.3 mp -107.39 131.0 58.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.511 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 49.8 m -131.75 -172.84 2.97 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 119.286 -0.966 . . . . 0.0 113.363 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.434 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -151.76 60.35 0.87 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 126.65 0.53 7.22 Favored Glycine 0 C--N 1.351 1.376 0 C-N-CA 119.998 -1.096 . . . . 0.0 114.063 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.647 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -167.5 -160.56 0.36 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.263 1.031 . . . . 0.0 112.759 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' HB1' ' CZ ' ' A' ' 9' ' ' PHE . . . -173.23 139.06 0.83 Allowed Pre-proline 0 C--N 1.346 0.452 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.479 ' HD2' ' CE2' ' A' ' 9' ' ' PHE . 51.7 Cg_exo -55.35 142.37 79.75 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.231 1.954 . . . . 0.0 112.019 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.1 tp -64.77 110.04 3.61 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.767 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.11 152.55 80.62 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.582 2.188 . . . . 0.0 112.167 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.7 p -165.81 -50.53 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.192 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -93.99 33.22 1.36 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 122.048 -0.407 . . . . 0.0 111.637 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 160.85 169.14 23.72 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.036 -1.078 . . . . 0.0 112.771 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -97.97 -163.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.471 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -161.52 159.51 27.95 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.235 0.54 . . . . 0.0 111.146 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.68 153.65 74.25 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.673 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -61.36 128.5 25.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.722 2.281 . . . . 0.0 112.37 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.586 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 12.8 t-160 -157.83 89.81 2.35 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.771 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -30.85 -68.74 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.537 2.824 . . . . 0.0 113.358 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -157.93 -160.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.48 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HB2' ' CE1' ' A' ' 37' ' ' HIS . . . 171.05 154.31 0.21 Allowed Pre-proline 0 N--CA 1.472 0.659 0 CA-C-O 120.614 0.245 . . . . 0.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' O ' ' CG ' ' A' ' 45' ' ' GLU . 56.2 Cg_endo -70.04 -13.89 34.51 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.328 2.019 . . . . 0.0 111.954 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.718 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 90.1 t90 -93.91 -53.49 3.98 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.213 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.547 ' O ' HD11 ' A' ' 21' ' ' ILE . 73.8 m -50.02 -33.76 19.1 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.2 ttt-85 -88.44 -39.36 14.31 Favored 'General case' 0 C--N 1.358 0.953 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 4.1 mt-10 -48.82 -26.84 2.62 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.308 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -120.3 -23.73 2.85 Favored Glycine 0 C--N 1.36 1.916 0 C-N-CA 118.487 -1.816 . . . . 0.0 113.497 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' N ' ' OG1' ' A' ' 61' ' ' THR . . . -78.27 60.28 2.48 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 117.699 0.75 . . . . 0.0 111.071 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.3 p -93.11 31.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.219 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -125.75 147.12 49.48 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.676 0.274 . . . . 0.0 110.293 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.459 ' CZ3' ' HD3' ' A' ' 59' ' ' ARG . 1.2 m95 -90.21 164.11 14.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.027 0.441 . . . . 0.0 111.058 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.3 t -147.23 130.42 8.08 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.595 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -93.83 87.76 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.637 2.225 . . . . 0.0 113.667 -178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.647 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -100.42 124.93 46.55 Favored 'General case' 0 C--N 1.334 -0.095 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.3 m -42.55 -49.6 5.4 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.027 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -70.88 -32.55 69.55 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.656 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -172.04 179.78 43.47 Favored Glycine 0 C--N 1.359 1.823 0 C-N-CA 119.032 -1.556 . . . . 0.0 113.286 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HG2' ' CE3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -89.95 145.36 25.18 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 118.354 1.077 . . . . 0.0 110.192 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.6 m -129.31 177.62 7.04 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 4.6 mmm180 -150.54 126.92 10.71 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 37.2 m -109.11 137.99 46.15 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 47' ' ' ALA . 1.9 m -142.64 152.33 42.35 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.443 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.465 ' O ' HG23 ' A' ' 63' ' ' ILE . 35.3 m -155.75 156.55 35.03 Favored 'General case' 0 C--N 1.362 1.112 0 CA-C-N 120.656 1.571 . . . . 0.0 112.306 -178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.718 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 32.2 pt -161.81 156.75 19.86 Favored Pre-proline 0 N--CA 1.462 0.159 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.49 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 84.8 Cg_endo -78.12 164.66 26.84 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.382 2.055 . . . . 0.0 112.22 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.755 ' CD1' HG22 ' A' ' 17' ' ' VAL . 10.8 m-85 -74.01 -145.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 109.888 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 t -106.05 55.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.908 179.979 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.97 -69.45 0.78 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.794 0.33 . . . . 0.0 110.883 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 58.25 166.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.843 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 m -60.27 114.43 9.97 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.869 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.27 155.48 70.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.399 2.066 . . . . 0.0 112.294 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -98.02 158.85 15.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.75 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.79 140.98 23.08 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.864 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 38' ' ' PRO . 30.9 t -118.31 152.26 36.12 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.727 0.775 . . . . 0.0 112.671 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CE1' ' HB3' ' A' ' 27' ' ' PRO . 3.3 p90 -130.9 130.85 44.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.016 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.658 HD23 ' O ' ' A' ' 18' ' ' CYS . 0.8 OUTLIER -94.49 126.15 39.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.067 0.46 . . . . 0.0 110.212 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 17.3 m -105.04 154.31 20.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.693 -178.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -130.0 126.6 38.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.195 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -114.06 164.69 15.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.321 179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_exo -42.8 -19.14 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.281 0 C-N-CA 123.227 2.618 . . . . 0.0 113.955 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.43 28.76 0.05 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.389 -0.524 . . . . 0.0 112.0 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 36.6 mt-30 -153.83 147.2 24.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.016 0.436 . . . . 0.0 111.834 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.638 HG22 ' CD1' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -119.97 122.43 68.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.882 179.002 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' O ' HD23 ' A' ' 10' ' ' LEU . 74.5 m -134.58 141.77 46.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB3' ' HZ3' ' A' ' 42' ' ' TRP . 41.5 t -122.1 146.43 47.22 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.82 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.0 139.29 28.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.285 0.565 . . . . 0.0 112.518 178.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -109.27 120.32 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.253 178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 58.8 m -108.96 -176.16 2.96 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.096 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -153.58 54.95 0.74 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.24 21.87 7.46 Favored Glycine 0 C--N 1.351 1.371 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.544 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.621 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -130.76 -157.45 0.82 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 117.391 0.596 . . . . 0.0 111.99 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.916 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -146.57 177.85 1.63 Allowed Pre-proline 0 C--N 1.34 0.179 0 CA-C-O 120.593 0.235 . . . . 0.0 110.902 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.916 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 98.3 Cg_endo -81.16 124.06 4.73 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.642 2.228 . . . . 0.0 113.126 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.6 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 3.5 tt -71.24 -35.87 4.38 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.594 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 96.2 Cg_exo -44.81 170.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.516 2.144 . . . . 0.0 112.98 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -151.25 -37.1 0.13 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.92 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -82.79 30.75 0.43 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 118.59 0.632 . . . . 0.0 111.825 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.56 163.6 34.67 Favored Glycine 0 N--CA 1.466 0.698 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.15 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -100.62 -166.31 1.3 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 121.026 -0.27 . . . . 0.0 110.436 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -160.77 159.94 30.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.358 0.599 . . . . 0.0 112.072 -179.771 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.424 ' CB ' ' HD2' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -137.7 173.05 5.82 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.427 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.424 ' HD2' ' CB ' ' A' ' 35' ' ' ASN . 74.4 Cg_endo -75.61 135.3 17.82 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.539 2.16 . . . . 0.0 113.036 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 38' ' ' PRO . 60.9 t-80 -164.37 95.73 0.95 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.76 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' SER . 2.6 Cg_endo -39.71 -81.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.394 2.729 . . . . 0.0 114.21 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -176.03 53.5 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 O-C-N 122.825 0.078 . . . . 0.0 110.885 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.956 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . -59.38 174.06 0.45 Allowed Pre-proline 0 N--CA 1.471 0.622 0 O-C-N 122.022 -0.424 . . . . 0.0 111.555 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.956 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 37.2 Cg_endo -65.76 1.74 2.07 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.575 2.183 . . . . 0.0 113.045 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.618 ' CZ2' HG21 ' A' ' 63' ' ' ILE . 21.1 t90 -90.06 -56.22 3.31 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.447 ' N ' ' HE3' ' A' ' 42' ' ' TRP . 53.2 m -64.74 -32.93 74.84 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -78.06 -44.47 26.26 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.406 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' A' ' 41' ' ' PRO . 9.5 tt0 -64.49 -19.64 65.7 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.98 -18.5 6.82 Favored Glycine 0 C--N 1.364 2.09 0 C-N-CA 118.095 -2.002 . . . . 0.0 112.683 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.786 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -93.73 68.28 3.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.296 0.57 . . . . 0.0 110.434 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 m -89.27 29.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.56 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.428 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.9 OUTLIER -145.02 133.31 21.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -95.64 167.8 11.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.218 0.532 . . . . 0.0 111.922 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 59' ' ' ARG . 11.5 p -155.97 139.04 10.79 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.029 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.73 120.59 1.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.597 2.198 . . . . 0.0 113.963 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.621 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -104.53 132.48 50.73 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.039 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.49 -61.8 1.41 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -26.58 68.02 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 119.174 -0.441 . . . . 0.0 112.152 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.478 ' O ' ' CB ' ' A' ' 53' ' ' TYR . . . -168.48 176.8 42.74 Favored Glycine 0 C--N 1.359 1.821 0 C-N-CA 118.989 -1.576 . . . . 0.0 112.808 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ARG . 6.0 tt0 -93.15 127.56 38.75 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.665 1.232 . . . . 0.0 110.447 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 9.5 t -136.82 -173.98 3.59 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.216 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.658 ' HA ' HG12 ' A' ' 51' ' ' VAL . 6.2 ttp180 -156.66 127.37 6.71 Favored 'General case' 0 C--N 1.348 0.502 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.1 t -104.05 130.97 51.75 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.786 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -127.93 162.36 26.93 Favored 'General case' 0 CA--C 1.552 1.042 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.9 m -150.91 170.5 19.17 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 119.863 1.21 . . . . 0.0 111.538 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.618 HG21 ' CZ2' ' A' ' 42' ' ' TRP . 5.5 pt -157.19 151.58 20.29 Favored Pre-proline 0 C--O 1.238 0.455 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.605 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 63' ' ' ILE . 7.7 Cg_exo -71.53 125.9 11.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.881 2.387 . . . . 0.0 111.582 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.638 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -80.76 -139.07 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.969 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.507 ' H ' ' HB3' ' A' ' 65' ' ' TYR . 12.2 p -100.19 125.03 54.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.994 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.837 -179.936 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 112.456 -0.258 . . . . 0.0 112.456 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -63.56 146.0 54.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.886 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.69 102.68 15.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.68 115.22 28.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.911 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.66 176.98 5.23 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.365 2.043 . . . . 0.0 112.287 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -120.98 163.88 17.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -148.11 141.07 24.82 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.49 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.617 ' OG ' HG23 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -121.18 148.87 43.66 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.69 0.757 . . . . 0.0 112.903 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.475 ' CE1' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -135.4 132.18 37.21 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.922 -1.036 . . . . 0.0 108.51 178.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -97.91 125.58 42.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.07 0.462 . . . . 0.0 109.805 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.1 m -103.8 143.54 32.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.163 -177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -117.99 131.72 56.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.39 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.82 162.6 32.14 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.883 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -44.29 -18.07 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.898 2.399 . . . . 0.0 113.694 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.38 31.59 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.413 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.61 166.93 29.69 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.048 0.451 . . . . 0.0 111.704 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.485 HG23 HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -141.43 108.48 2.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.245 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.511 ' O ' HD23 ' A' ' 10' ' ' LEU . 91.1 m -114.37 134.75 54.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.828 0.347 . . . . 0.0 111.818 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 50.6 t -119.27 144.16 46.94 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.576 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.644 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -150.81 139.91 21.11 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 178.452 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.907 HD11 ' HB3' ' A' ' 43' ' ' CYS . 1.3 mt -111.86 110.52 32.52 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-N 114.394 -1.276 . . . . 0.0 108.562 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 1.3 m -86.94 -175.51 5.39 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.84 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.576 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -148.94 51.71 0.98 Allowed 'General case' 0 C--O 1.237 0.399 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 178.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.55 22.5 4.02 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.901 -0.591 . . . . 0.0 112.484 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 56' ' ' GLY . . . -162.54 -156.63 0.41 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.033 0.916 . . . . 0.0 112.051 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' O ' ' CE2' ' A' ' 53' ' ' TYR . . . -163.68 132.92 2.99 Favored Pre-proline 0 N--CA 1.465 0.282 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.297 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD2' ' CE1' ' A' ' 9' ' ' PHE . 15.4 Cg_endo -56.93 145.72 83.4 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.511 2.141 . . . . 0.0 112.647 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.439 HD12 ' OH ' ' A' ' 53' ' ' TYR . 1.2 mp -78.53 111.81 21.91 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.053 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.51 151.46 29.05 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.534 2.156 . . . . 0.0 112.127 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.61 -55.6 0.09 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.301 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -95.1 29.52 2.42 Favored 'General case' 0 C--N 1.353 0.72 0 CA-C-N 118.108 0.413 . . . . 0.0 111.55 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.27 -162.53 36.33 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.237 -0.982 . . . . 0.0 112.46 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.75 -162.86 1.15 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.686 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -152.07 163.29 39.64 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.107 0.48 . . . . 0.0 111.379 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 155.24 72.83 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.537 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.77 130.09 28.34 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.615 2.21 . . . . 0.0 112.438 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 17.9 t-160 -157.87 100.68 1.8 Allowed Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -30.04 -73.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.316 2.677 . . . . 0.0 113.378 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 10.5 t -154.13 -159.65 0.99 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 43' ' ' CYS . . . 178.88 130.42 0.22 Allowed Pre-proline 0 N--CA 1.468 0.446 0 C-N-CA 121.021 -0.272 . . . . 0.0 111.032 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 38.8 Cg_exo -56.73 -20.69 36.14 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.289 1.993 . . . . 0.0 112.088 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.816 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 63.3 t90 -86.9 -47.95 8.58 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.948 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.907 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -42.43 -57.57 2.57 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -69.96 -35.81 74.76 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.164 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 71.4 tt0 -46.15 -31.12 2.22 Favored 'General case' 0 C--N 1.36 1.058 0 CA-C-N 118.284 0.493 . . . . 0.0 111.582 179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.8 10.68 3.96 Favored Glycine 0 C--N 1.357 1.742 0 C-N-CA 118.338 -1.887 . . . . 0.0 113.907 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 59' ' ' ARG . . . -92.21 45.76 1.22 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.383 0.591 . . . . 0.0 111.24 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.0 m -99.57 33.84 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.449 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.99 15.87 4.7 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.054 0.454 . . . . 0.0 111.194 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.745 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -130.24 -175.11 3.53 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.281 179.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 50' ' ' TRP . 2.3 t 142.82 -42.5 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.08 0 O-C-N 123.746 0.654 . . . . 0.0 110.038 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 51' ' ' VAL . 98.6 Cg_endo -86.69 78.89 1.86 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.37 2.047 . . . . 0.0 114.447 -178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.614 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.5 t80 -109.35 130.57 55.49 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -40.61 -60.49 1.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -67.11 -30.35 70.34 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.407 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.614 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.54 -172.59 37.75 Favored Glycine 0 C--N 1.358 1.805 0 C-N-CA 119.08 -1.533 . . . . 0.0 112.619 -178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.742 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -95.19 132.64 39.93 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.53 1.665 . . . . 0.0 109.273 179.721 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.705 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 19.1 m -135.99 -174.19 3.6 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 119.067 -1.053 . . . . 0.0 113.828 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.644 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -144.76 132.22 20.84 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 179.591 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.0 t -125.73 139.77 53.25 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 43' ' ' CYS . 0.0 OUTLIER -140.54 162.24 35.82 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.242 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 96.4 m -157.29 146.82 20.31 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 119.96 1.255 . . . . 0.0 111.506 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.816 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 3.5 pt -149.18 165.29 18.04 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.737 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 32.7 Cg_exo -59.54 164.8 10.58 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.387 2.058 . . . . 0.0 111.979 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.04 -139.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.156 0.503 . . . . 0.0 110.788 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.58 85.06 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.033 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.918 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.14 0 N-CA-C 112.431 -0.268 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -144.58 -179.62 6.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.832 0.349 . . . . 0.0 111.047 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -158.75 -56.42 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.776 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.832 HG22 ' HD2' ' A' ' 5' ' ' PRO . 0.3 OUTLIER 64.01 159.27 0.12 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 179.801 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.832 ' HD2' HG22 ' A' ' 4' ' ' THR . 5.7 Cg_exo -73.83 154.11 48.36 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.979 2.453 . . . . 0.0 112.263 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 7' ' ' GLU . 1.5 p30 -80.6 -53.7 6.32 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-O 122.478 1.132 . . . . 0.0 108.734 178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.571 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 9.6 mt-10 -177.64 -167.56 0.15 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 112.159 -2.291 . . . . 0.0 109.653 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.436 ' HB2' HG12 ' A' ' 21' ' ' ILE . 32.8 t -135.21 142.12 45.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.316 0.579 . . . . 0.0 111.791 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.591 ' CE1' ' HB2' ' A' ' 20' ' ' PHE . 31.1 p90 -124.79 132.78 53.32 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.613 179.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.757 HD12 ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -97.74 131.3 44.4 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.703 -179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 76.9 m -116.36 133.27 56.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.629 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.31 130.71 56.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.359 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -126.11 149.85 67.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.496 179.12 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.24 4.5 0.13 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.673 2.248 . . . . 0.0 113.358 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' GLN . 3.8 m-20 -117.57 -29.94 5.63 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 15' ' ' ASP . 1.2 mt-30 -172.27 -167.22 0.45 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.684 0.278 . . . . 0.0 110.838 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' O ' HD13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -125.95 144.83 34.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.208 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 94.2 m -145.08 145.64 31.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.094 0.473 . . . . 0.0 112.113 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.535 ' CB ' ' CH2' ' A' ' 42' ' ' TRP . 2.3 t -127.38 152.78 47.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.276 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.752 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -144.02 135.17 25.55 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.342 0.591 . . . . 0.0 111.759 178.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 47' ' ' ALA . 37.8 mt -104.92 110.28 30.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.225 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.671 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 70.5 m -100.6 172.41 7.12 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.836 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.83 ' HB3' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -148.81 46.86 1.02 Allowed 'General case' 0 C--N 1.354 0.78 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 56' ' ' GLY . . . 128.21 30.95 0.7 Allowed Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 114.739 -1.119 . . . . 0.0 113.7 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.563 ' HB1' ' CG ' ' A' ' 53' ' ' TYR . . . -123.09 -165.7 1.35 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.203 1.001 . . . . 0.0 112.287 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -125.74 99.07 32.99 Favored Pre-proline 0 C--N 1.344 0.332 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.512 ' HB3' ' CG ' ' A' ' 9' ' ' PHE . 32.6 Cg_exo -32.38 90.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.45 2.767 . . . . 0.0 113.485 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.6 tp -98.7 122.66 52.45 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.161 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.8 -170.34 0.6 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.501 2.134 . . . . 0.0 112.119 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 p -149.28 -52.8 0.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.413 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -133.86 30.47 3.71 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-N 118.252 0.478 . . . . 0.0 111.681 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.36 -146.16 7.27 Favored Glycine 0 N--CA 1.461 0.364 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.365 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -116.46 -169.77 1.69 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.333 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 3.6 m -156.07 166.39 33.6 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.034 0.445 . . . . 0.0 111.359 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -143.0 168.58 12.73 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.544 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.71 134.99 22.99 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.543 2.162 . . . . 0.0 112.67 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.757 ' CD2' HD12 ' A' ' 10' ' ' LEU . 6.9 t60 -157.65 93.13 2.19 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' O ' HG23 ' A' ' 39' ' ' THR . 22.0 Cg_exo -28.6 -85.78 0.0 OUTLIER 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.9 3.066 . . . . 0.0 114.628 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 38' ' ' PRO . 10.7 p -162.43 55.65 0.22 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.463 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.634 ' HB2' ' NE2' ' A' ' 37' ' ' HIS . . . -43.49 166.85 0.09 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 CA-C-N 118.468 0.576 . . . . 0.0 111.869 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.549 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 52.6 Cg_exo -56.56 -47.23 24.83 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.213 2.608 . . . . 0.0 113.993 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.706 ' CZ3' HD12 ' A' ' 63' ' ' ILE . 38.5 p-90 -72.65 -45.82 57.04 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.426 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 1.3 m -47.24 -45.66 23.72 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.0 -31.68 21.91 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.865 -0.522 . . . . 0.0 109.951 178.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 1.7 tm-20 -47.71 -31.72 5.04 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.705 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -134.51 -11.82 1.46 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 118.214 -1.946 . . . . 0.0 114.711 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.799 ' C ' ' HG2' ' A' ' 59' ' ' ARG . . . -72.14 64.13 0.53 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.441 1.12 . . . . 0.0 111.635 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.23 52.54 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.463 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' HG2' ' NE ' ' A' ' 59' ' ' ARG . 7.7 pt-20 -134.37 -15.87 2.16 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.858 ' O ' HG13 ' A' ' 51' ' ' VAL . 8.6 t90 -102.33 -166.05 1.25 Allowed 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.964 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 50' ' ' TRP . 0.0 OUTLIER 170.01 -38.43 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.839 ' HD3' HG23 ' A' ' 51' ' ' VAL . 7.7 Cg_exo -75.59 81.15 2.39 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.178 1.919 . . . . 0.0 116.267 -176.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.563 ' CG ' ' HB1' ' A' ' 25' ' ' ALA . 0.3 OUTLIER -112.57 129.45 56.36 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 175.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.2 p -26.01 -73.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -22.45 50.66 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -161.44 -165.98 19.3 Favored Glycine 0 C--N 1.356 1.644 0 C-N-CA 118.911 -1.614 . . . . 0.0 111.945 -178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.708 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 4.1 mt-30 -95.26 166.3 11.96 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.523 2.161 . . . . 0.0 109.321 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.671 ' CB ' ' HA ' ' A' ' 22' ' ' CYS . 44.8 t -175.84 -176.54 0.85 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.333 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.83 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 0.0 OUTLIER -158.17 145.66 18.18 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 118.515 0.598 . . . . 0.0 111.591 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 60' ' ' THR . 9.5 t -112.58 104.03 12.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.848 0.685 . . . . 0.0 112.848 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.568 ' CG2' ' HB2' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -103.57 172.63 6.7 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.128 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.5 m -155.84 158.57 38.29 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 118.993 0.815 . . . . 0.0 111.42 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.706 HD12 ' CZ3' ' A' ' 42' ' ' TRP . 0.2 OUTLIER -153.87 162.19 27.36 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.209 179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 51.2 Cg_exo -54.98 160.47 7.83 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.773 2.316 . . . . 0.0 112.623 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -78.55 -140.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.835 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.453 HG13 ' N ' ' A' ' 67' ' ' GLU . 12.0 p -124.11 -43.08 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.084 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.453 ' N ' HG13 ' A' ' 66' ' ' VAL . 12.8 pt-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.939 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 t -88.78 -52.43 5.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -89.76 -45.09 9.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.794 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.483 HG23 ' HD2' ' A' ' 5' ' ' PRO . 81.7 m 63.4 139.43 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.016 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HD2' HG23 ' A' ' 4' ' ' THR . 33.9 Cg_endo -64.16 -161.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.512 2.141 . . . . 0.0 112.029 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -67.17 152.85 45.01 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.454 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -142.25 153.91 44.33 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.681 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.464 ' OG ' HG23 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -130.53 149.6 52.12 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.578 0.704 . . . . 0.0 112.596 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.0 OUTLIER -132.61 135.41 45.87 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.04 178.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -99.64 118.01 35.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.825 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 92.2 m -106.44 139.28 41.17 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.136 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -115.69 136.98 52.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.817 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.441 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -133.76 151.09 76.39 Favored Pre-proline 0 CA--C 1.511 -0.547 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.258 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -60.84 -1.51 1.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.619 1.546 . . . . 0.0 110.861 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.4 t0 -114.34 -29.29 6.95 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.534 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.427 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -179.33 173.5 1.1 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.99 0.424 . . . . 0.0 111.604 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' CZ ' ' A' ' 65' ' ' TYR . 2.3 m -111.57 118.97 58.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.405 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 3.5 m -110.43 128.9 55.81 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.884 0.373 . . . . 0.0 111.814 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 51.8 t -112.19 145.78 39.27 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.341 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -152.29 138.45 18.31 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 179.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.821 HD11 ' HB3' ' A' ' 43' ' ' CYS . 1.7 mt -108.83 113.79 45.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.659 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 1.3 m -93.61 -177.3 4.35 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.528 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 57' ' ' GLN . 18.0 tpt85 -145.19 49.18 1.27 Allowed 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.42 25.68 3.68 Favored Glycine 0 C--N 1.348 1.211 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.439 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.478 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -158.51 -157.74 0.65 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 117.848 0.824 . . . . 0.0 112.154 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -155.43 179.98 1.22 Allowed Pre-proline 0 N--CA 1.464 0.236 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.32 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 67.2 Cg_endo -91.36 138.7 2.26 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.739 2.292 . . . . 0.0 113.219 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.494 HD12 ' OH ' ' A' ' 53' ' ' TYR . 0.2 OUTLIER -108.11 64.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.276 179.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 27' ' ' PRO . 67.8 Cg_endo -72.11 -161.79 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.588 2.192 . . . . 0.0 111.994 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.99 -54.87 3.04 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.23 -95.03 0.1 Allowed 'General case' 0 C--N 1.351 0.67 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.093 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 39.64 -161.9 0.01 OUTLIER Glycine 0 N--CA 1.474 1.231 0 C-N-CA 121.06 -0.59 . . . . 0.0 112.743 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.1 178.54 7.98 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 m -157.82 178.99 9.62 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 119.042 0.837 . . . . 0.0 111.042 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -157.86 145.31 13.58 Favored Pre-proline 0 N--CA 1.465 0.28 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.693 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.26 135.25 68.14 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.527 2.151 . . . . 0.0 112.372 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' SER . 27.3 t60 -161.6 98.65 1.23 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 109.933 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -29.35 -75.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.377 2.718 . . . . 0.0 113.448 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.429 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -155.43 -161.95 1.26 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 177.72 158.89 0.55 Allowed Pre-proline 0 N--CA 1.469 0.499 0 C-N-CA 121.015 -0.274 . . . . 0.0 111.026 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 72.8 Cg_endo -74.74 -16.38 20.95 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.446 2.097 . . . . 0.0 112.131 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.676 ' HZ2' HG23 ' A' ' 63' ' ' ILE . 44.4 t90 -87.1 -51.97 5.69 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.272 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.821 ' HB3' HD11 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -45.3 -57.68 3.84 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 178.787 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -35.8 80.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.416 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 2.9 mt-10 -48.56 -30.81 5.69 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 118.351 0.523 . . . . 0.0 111.813 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.12 17.68 2.53 Favored Glycine 0 C--N 1.357 1.75 0 C-N-CA 118.208 -1.949 . . . . 0.0 113.842 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.642 ' HB1' ' HB2' ' A' ' 59' ' ' ARG . . . -107.52 58.37 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.267 0.556 . . . . 0.0 111.141 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.619 HG22 ' O ' ' A' ' 48' ' ' VAL . 13.4 p -93.85 31.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.301 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.744 ' O ' ' HB2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -165.51 119.4 1.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.886 0.374 . . . . 0.0 111.703 -179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.744 ' HB2' ' O ' ' A' ' 49' ' ' GLU . 1.6 t90 155.86 -0.54 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.167 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 57' ' ' GLN . 11.1 m -50.31 -32.18 5.72 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.105 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.568 ' HD3' ' CG2' ' A' ' 51' ' ' VAL . 2.9 Cg_exo -77.27 62.65 7.63 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.983 1.789 . . . . 0.0 114.678 -178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.603 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 2.5 t80 -106.41 116.49 32.02 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -36.7 -58.34 0.74 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.469 -178.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -28.98 69.98 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 119.003 -0.523 . . . . 0.0 112.0 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.603 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -171.21 -178.96 42.04 Favored Glycine 0 C--N 1.361 1.921 0 C-N-CA 118.688 -1.72 . . . . 0.0 113.761 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.9 tt0 -96.72 124.21 40.64 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.373 -1.075 . . . . 0.0 109.791 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.623 ' HB2' ' CE3' ' A' ' 50' ' ' TRP . 10.1 m -131.62 -172.95 2.99 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.642 ' HB2' ' HB1' ' A' ' 47' ' ' ALA . 0.2 OUTLIER -150.36 133.45 16.17 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 85.1 m -117.62 147.81 42.52 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.744 HG21 ' HA ' ' A' ' 43' ' ' CYS . 1.8 t -151.58 174.09 13.86 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.885 -1.052 . . . . 0.0 109.78 177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 159.92 3.94 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 118.865 0.757 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.676 HG23 ' HZ2' ' A' ' 42' ' ' TRP . 1.7 pt -149.38 151.74 34.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.425 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 16' ' ' GLN . 68.3 Cg_endo -90.02 93.76 0.3 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.226 2.617 . . . . 0.0 112.283 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.474 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -100.14 -147.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.494 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.474 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 19.2 t -97.07 128.65 48.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.837 0.351 . . . . 0.0 111.045 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.926 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.7 t -170.7 -45.66 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -162.63 177.15 9.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.6 p -89.67 146.26 35.22 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.47 -166.48 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.511 2.141 . . . . 0.0 112.297 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -92.07 153.22 19.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.788 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -143.11 140.59 30.93 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.406 ' O ' ' O ' ' A' ' 37' ' ' HIS . 13.3 t -111.78 147.95 34.58 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.726 0.774 . . . . 0.0 112.372 -179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.847 ' CD1' ' HB1' ' A' ' 26' ' ' ALA . 2.0 p90 -134.07 137.26 44.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.328 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.56 127.17 43.31 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.978 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 93.1 m -107.36 142.83 36.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.45 0.643 . . . . 0.0 111.976 -178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.515 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.7 t80 -108.95 130.9 55.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.262 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.499 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -138.97 142.35 33.17 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.07 6.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.619 2.213 . . . . 0.0 113.321 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 13' ' ' GLN . 2.1 p30 -118.95 -33.53 4.16 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.475 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 2.3 mp0 -169.4 -170.22 1.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.858 0.361 . . . . 0.0 111.065 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.823 HG23 HG13 ' A' ' 63' ' ' ILE . 0.1 OUTLIER -125.76 117.23 48.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.4 146.79 40.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.092 0.473 . . . . 0.0 112.212 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HB2' ' CH2' ' A' ' 42' ' ' TRP . 51.9 t -125.68 150.58 47.51 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.625 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -149.49 140.44 22.87 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 21' ' ' ILE . 3.7 mp -103.85 118.42 50.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.662 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 58' ' ' CYS . 94.0 m -107.43 -174.03 2.43 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.2 57.37 0.71 Allowed 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.95 -19.92 1.11 Allowed Glycine 0 C--N 1.348 1.231 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.622 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.567 ' HB3' ' CE1' ' A' ' 53' ' ' TYR . . . -174.77 -155.44 0.06 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.289 0.545 . . . . 0.0 110.62 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 9' ' ' PHE . . . 173.56 -58.24 0.0 OUTLIER Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 26' ' ' ALA . 9.2 Cg_endo -51.06 78.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.288 2.658 . . . . 0.0 114.631 -178.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 53' ' ' TYR . 18.7 tp -134.01 50.5 5.23 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.293 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 28' ' ' LEU . 89.8 Cg_endo -77.83 -171.74 1.28 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.706 2.271 . . . . 0.0 112.727 -179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.9 t -159.44 -56.4 0.06 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -103.9 32.21 4.06 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.012 -0.43 . . . . 0.0 111.617 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 175.12 -152.19 13.26 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.297 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.55 -167.75 1.99 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.14 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.0 m -156.68 157.11 34.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.756 0.313 . . . . 0.0 110.629 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.57 151.43 75.98 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.985 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -56.92 141.06 93.48 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.406 ' O ' ' O ' ' A' ' 8' ' ' SER . 82.0 t60 -169.19 97.49 0.51 Allowed Pre-proline 0 N--CA 1.465 0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.813 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -30.54 -71.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.455 2.77 . . . . 0.0 113.551 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -156.51 -157.89 0.74 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.799 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.695 ' HB1' ' HD2' ' A' ' 41' ' ' PRO . . . 177.3 167.3 0.49 Allowed Pre-proline 0 N--CA 1.471 0.599 0 CA-C-O 120.6 0.238 . . . . 0.0 111.082 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.695 ' HD2' ' HB1' ' A' ' 40' ' ' ALA . 72.7 Cg_endo -76.09 -25.85 9.81 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.691 2.261 . . . . 0.0 112.317 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.614 ' CH2' ' HB2' ' A' ' 19' ' ' CYS . 26.9 p-90 -92.44 -41.14 10.47 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.413 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 96.6 m -51.68 -37.94 52.8 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -87.43 -36.12 17.9 Favored 'General case' 0 C--N 1.36 1.046 0 O-C-N 121.711 -0.618 . . . . 0.0 109.369 178.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HB3' ' O ' ' A' ' 41' ' ' PRO . 0.0 OUTLIER -46.85 -29.77 2.15 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 120.286 -0.565 . . . . 0.0 111.003 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -125.18 -10.73 4.53 Favored Glycine 0 C--N 1.359 1.846 0 C-N-CA 118.556 -1.783 . . . . 0.0 113.781 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 43' ' ' CYS . . . -94.42 45.15 1.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.857 0.829 . . . . 0.0 111.091 179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 44' ' ' ARG . 7.9 m -95.09 32.06 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.187 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.51 143.26 33.71 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -79.82 151.75 30.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.249 0.547 . . . . 0.0 111.343 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.664 ' O ' HG13 ' A' ' 51' ' ' VAL . 12.0 p -162.75 94.72 1.17 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.863 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -42.16 110.73 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.931 2.42 . . . . 0.0 113.635 -178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.649 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 3.7 t80 -93.26 145.84 24.14 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -32.87 -89.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' A' ' 25' ' ' ALA . 44.7 m -68.53 -7.78 35.52 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -166.16 173.1 41.66 Favored Glycine 0 C--N 1.363 2.031 0 C-N-CA 118.769 -1.682 . . . . 0.0 112.679 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -78.04 152.98 32.72 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 118.706 1.253 . . . . 0.0 109.663 179.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 1.8 t -159.67 -171.71 3.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.692 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.619 ' HA ' HG12 ' A' ' 51' ' ' VAL . 1.6 ptt-85 -155.15 125.94 7.01 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -105.59 136.98 44.19 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -140.82 171.39 14.16 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.177 -0.92 . . . . 0.0 108.615 177.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 93.7 m -154.76 168.73 25.87 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 119.578 1.081 . . . . 0.0 111.688 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.823 HG13 HG23 ' A' ' 17' ' ' VAL . 28.4 pt -154.15 137.29 10.25 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.841 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -84.49 124.98 3.28 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.763 2.308 . . . . 0.0 112.795 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CD1' HG22 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -133.44 -150.45 0.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.833 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 24.1 t -143.77 -58.24 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.818 0.342 . . . . 0.0 110.968 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.828 179.897 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.424 -0.27 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 t 61.18 64.39 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.895 0.378 . . . . 0.0 110.738 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.492 ' C ' HG22 ' A' ' 4' ' ' THR . 10.7 m80 -131.62 49.44 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.036 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.601 HG23 ' CD ' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -169.51 -61.98 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.601 ' CD ' HG23 ' A' ' 4' ' ' THR . 57.1 Cg_endo -70.62 167.87 24.31 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.275 1.983 . . . . 0.0 112.226 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -115.12 148.62 38.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.31 141.21 33.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.693 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.7 m -121.7 146.27 47.19 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.505 0.669 . . . . 0.0 111.921 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.541 ' HZ ' ' HA ' ' A' ' 26' ' ' ALA . 0.2 OUTLIER -130.6 130.74 44.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.701 179.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.84 121.07 33.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.656 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 2.6 m -102.65 145.24 29.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 0.0 112.637 -178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.456 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 23.4 t80 -110.54 113.26 25.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.285 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.534 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -117.77 140.69 27.97 Favored Pre-proline 0 C--N 1.328 -0.357 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 178.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' HA ' ' OH ' ' A' ' 65' ' ' TYR . 52.1 Cg_exo -55.87 7.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.699 2.266 . . . . 0.0 113.443 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 13' ' ' GLN . 5.6 t0 -118.63 -37.08 3.34 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.245 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.52 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 8.4 mp0 -165.77 -175.49 3.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.845 0.355 . . . . 0.0 110.72 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.543 HG22 ' HD1' ' A' ' 65' ' ' TYR . 0.2 OUTLIER -114.06 113.97 45.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.3 m -110.09 129.68 55.65 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.543 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 43.6 t -108.1 140.32 41.46 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.744 178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.655 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -135.36 143.95 46.37 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.66 0.743 . . . . 0.0 112.746 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 59' ' ' ARG . 2.5 mp -116.84 138.28 47.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.489 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 16.9 m -145.81 -171.1 3.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.571 -0.851 . . . . 0.0 112.64 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.611 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -156.82 60.74 0.53 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 125.79 8.86 5.04 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 119.897 -1.145 . . . . 0.0 114.355 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 53' ' ' TYR . . . -167.13 -160.54 0.38 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.67 1.235 . . . . 0.0 113.157 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.541 ' HA ' ' HZ ' ' A' ' 9' ' ' PHE . . . -173.49 132.05 0.58 Allowed Pre-proline 0 C--N 1.347 0.481 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.605 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HA ' ' CE1' ' A' ' 53' ' ' TYR . 9.7 Cg_endo -49.84 147.2 14.65 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.616 2.211 . . . . 0.0 112.159 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.36 111.28 5.72 Favored Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.658 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.2 152.39 16.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.653 2.235 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.6 t -166.31 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.131 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -94.54 33.93 1.37 Allowed 'General case' 0 C--N 1.352 0.695 0 O-C-N 122.068 -0.395 . . . . 0.0 111.548 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 12' ' ' TYR . . . 168.18 167.9 29.5 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.048 -1.072 . . . . 0.0 112.829 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -103.53 -161.49 0.84 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -159.73 160.38 33.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.159 0.504 . . . . 0.0 111.083 179.8 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -139.12 152.72 70.43 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.617 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.43 127.52 21.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.695 2.263 . . . . 0.0 112.452 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.425 ' CD2' ' O ' ' A' ' 39' ' ' THR . 12.9 t-160 -160.58 82.51 2.12 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -30.22 -63.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.782 2.988 . . . . 0.0 113.443 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -140.53 -161.39 1.2 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.103 179.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' HB2' ' O ' ' A' ' 39' ' ' THR . . . 172.81 131.41 0.1 OUTLIER Pre-proline 0 N--CA 1.47 0.542 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.005 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 31.2 Cg_exo -58.22 -18.66 38.34 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.076 1.851 . . . . 0.0 111.726 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.565 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 48.1 t90 -86.36 -51.89 5.95 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.357 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -45.54 -56.37 5.19 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -64.57 -36.18 83.4 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 14.0 tt0 -49.68 -34.39 18.42 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.73 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.49 -2.94 2.81 Favored Glycine 0 C--N 1.358 1.767 0 C-N-CA 118.405 -1.855 . . . . 0.0 114.376 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.859 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -95.13 63.41 2.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 117.861 0.831 . . . . 0.0 110.356 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 48' ' ' VAL . 14.9 t -94.44 32.32 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.387 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' O ' ' CD ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -124.55 136.15 53.74 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.93 0.395 . . . . 0.0 110.901 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.679 ' CZ3' ' HG2' ' A' ' 57' ' ' GLN . 4.2 t-105 -96.24 135.84 37.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.518 -179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' N ' ' CE3' ' A' ' 50' ' ' TRP . 9.6 p -131.93 120.61 17.48 Favored Pre-proline 0 N--CA 1.466 0.336 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.987 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.562 ' HA ' ' CH2' ' A' ' 50' ' ' TRP . 71.8 Cg_endo -76.6 114.92 3.96 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.619 2.213 . . . . 0.0 114.091 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.604 ' HD2' ' HB1' ' A' ' 25' ' ' ALA . 1.1 t80 -104.61 128.14 52.55 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -42.63 -48.01 5.37 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.933 -0.122 . . . . 0.0 111.242 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.08 -30.74 61.03 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -172.46 179.57 43.92 Favored Glycine 0 C--N 1.359 1.84 0 C-N-CA 118.948 -1.596 . . . . 0.0 113.253 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.679 ' HG2' ' CZ3' ' A' ' 50' ' ' TRP . 0.2 OUTLIER -81.62 120.31 24.92 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 118.544 1.172 . . . . 0.0 110.337 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' CYS . 0.8 OUTLIER -117.94 -178.84 3.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.655 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -160.67 133.81 6.57 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -120.3 130.59 54.52 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -177.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.859 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.5 OUTLIER -139.43 164.79 28.93 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 t -176.87 155.56 1.26 Allowed 'General case' 0 C--N 1.355 0.822 0 CA-C-N 120.506 1.503 . . . . 0.0 112.515 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.571 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 7.8 pt -159.08 161.81 27.33 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.118 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 63' ' ' ILE . 5.3 Cg_endo -47.16 174.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.6 2.2 . . . . 0.0 112.482 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.543 ' HD1' HG22 ' A' ' 17' ' ' VAL . 2.4 m-30 -67.65 -143.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.709 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.417 ' O ' HG23 ' A' ' 66' ' ' VAL . 30.6 m -121.71 124.62 71.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 p -122.25 167.93 12.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.822 0.344 . . . . 0.0 110.819 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -143.17 115.22 8.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.997 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.528 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 1.5 m -172.1 -63.78 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.696 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HD3' ' HB ' ' A' ' 4' ' ' THR . 74.1 Cg_endo -74.32 77.61 2.83 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.393 2.062 . . . . 0.0 112.186 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -123.66 158.8 30.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 1.1 pt-20 -142.07 141.04 32.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.417 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 37' ' ' HIS . 29.3 t -117.11 141.32 48.41 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.628 0.727 . . . . 0.0 112.54 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -132.94 137.97 46.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.605 178.382 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.52 128.53 50.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.138 0.494 . . . . 0.0 110.475 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 74.0 m -107.98 139.24 42.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.108 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 12' ' ' TYR . 0.2 OUTLIER -119.4 128.48 54.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.87 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.477 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.04 146.39 56.42 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.866 179.513 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.76 3.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.723 2.282 . . . . 0.0 113.38 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 13' ' ' GLN . 32.0 m-20 -111.67 -36.74 5.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.588 0.232 . . . . 0.0 111.109 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.419 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -172.51 -175.31 1.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.907 0.384 . . . . 0.0 111.181 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.22 130.21 74.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.123 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 99.9 m -128.81 129.66 45.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.005 0.431 . . . . 0.0 112.047 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.542 ' HB2' ' HZ3' ' A' ' 42' ' ' TRP . 34.5 t -112.99 152.72 29.08 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.836 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.842 ' CE2' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -154.48 133.59 12.45 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.069 179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.604 HD11 ' HB2' ' A' ' 43' ' ' CYS . 3.7 mp -101.33 102.14 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 114.619 -1.173 . . . . 0.0 108.585 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HA ' ' CB ' ' A' ' 58' ' ' CYS . 68.9 m -90.04 -172.46 3.51 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.628 -177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -154.83 60.18 0.67 Allowed 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.63 16.43 9.39 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.16 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.423 ' HB2' ' C ' ' A' ' 55' ' ' THR . . . -164.7 -161.17 0.55 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.011 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -159.86 151.78 16.93 Favored Pre-proline 0 C--N 1.34 0.18 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.285 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.501 ' HG3' ' CD1' ' A' ' 20' ' ' PHE . 73.4 Cg_endo -75.79 132.77 14.73 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.474 2.116 . . . . 0.0 112.234 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 29' ' ' PRO . 14.5 tp -74.05 112.08 15.22 Favored Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 28' ' ' LEU . 86.8 Cg_endo -82.32 -174.46 2.11 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.636 2.224 . . . . 0.0 112.272 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.4 p -164.23 -55.8 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.535 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -102.1 33.4 3.08 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.99 -0.444 . . . . 0.0 111.924 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.91 -176.05 47.72 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.673 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -120.15 -164.85 1.12 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 3.7 m -154.15 178.42 10.0 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.995 0.426 . . . . 0.0 111.442 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.8 165.59 18.44 Favored Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.957 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.04 137.77 41.93 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.848 2.365 . . . . 0.0 112.729 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 11.0 t-160 -163.08 92.67 1.18 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 8' ' ' SER . 37.1 Cg_exo -25.49 -71.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.865 3.043 . . . . 0.0 113.819 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -160.38 -161.07 0.83 Allowed 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.463 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.569 ' HB2' ' CE1' ' A' ' 37' ' ' HIS . . . 173.6 142.2 0.17 Allowed Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.024 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 20.2 Cg_exo -64.95 -12.44 34.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.411 2.074 . . . . 0.0 112.106 179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.657 ' CZ2' HD13 ' A' ' 63' ' ' ILE . 67.2 t90 -91.56 -52.73 4.63 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.321 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.792 ' HA ' HG21 ' A' ' 61' ' ' THR . 11.1 m -49.55 -36.23 22.92 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.32 -37.27 20.14 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.735 -0.603 . . . . 0.0 109.754 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.522 ' HB2' ' HA ' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -51.12 -25.55 5.32 Favored 'General case' 0 C--N 1.356 0.878 0 CA-C-O 119.064 -0.493 . . . . 0.0 111.604 179.555 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -128.48 -6.96 4.52 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 118.221 -1.942 . . . . 0.0 114.192 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.542 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -92.01 61.34 4.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.051 0.926 . . . . 0.0 111.259 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.579 ' O ' HG12 ' A' ' 48' ' ' VAL . 18.8 t -111.98 38.71 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.256 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -142.45 13.41 1.96 Allowed 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.903 0.382 . . . . 0.0 111.844 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.852 ' O ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -128.5 169.04 14.82 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.363 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 50' ' ' TRP . 0.1 OUTLIER 158.17 -34.7 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.706 0 C-N-CA 123.473 0.709 . . . . 0.0 110.801 -179.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.717 ' HD3' HG23 ' A' ' 51' ' ' VAL . 73.2 Cg_endo -93.3 68.41 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.083 1.856 . . . . 0.0 113.725 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.793 ' HB3' ' O ' ' A' ' 56' ' ' GLY . 76.4 t80 -97.12 126.84 42.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -37.31 -57.6 0.89 Allowed 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.423 ' C ' ' HB2' ' A' ' 25' ' ' ALA . 66.1 m -69.7 -27.3 64.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.793 ' O ' ' HB3' ' A' ' 53' ' ' TYR . . . -174.06 -178.27 43.86 Favored Glycine 0 C--N 1.361 1.923 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.325 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.704 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -95.54 126.73 41.03 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 119.582 1.691 . . . . 0.0 109.203 179.48 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.779 ' HB3' ' CZ3' ' A' ' 50' ' ' TRP . 43.3 t -142.42 -178.76 5.91 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 119.118 -1.033 . . . . 0.0 113.174 -177.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.78 ' HA ' ' HB3' ' A' ' 50' ' ' TRP . 15.5 mmm-85 -138.3 134.14 33.94 Favored 'General case' 0 C--N 1.362 1.137 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.842 HG23 ' CE2' ' A' ' 20' ' ' PHE . 91.8 m -117.2 142.78 46.61 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.792 HG21 ' HA ' ' A' ' 43' ' ' CYS . 1.4 t -147.46 160.38 42.64 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.81 177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 61' ' ' THR . 81.7 m -158.01 160.73 37.78 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-N 119.541 1.064 . . . . 0.0 110.879 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.657 HD13 ' CZ2' ' A' ' 42' ' ' TRP . 3.5 pt -151.65 154.45 33.19 Favored Pre-proline 0 N--CA 1.464 0.253 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.444 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' CG ' ' A' ' 16' ' ' GLN . 69.1 Cg_endo -89.77 126.39 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.134 2.556 . . . . 0.0 112.183 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.431 ' CG ' ' N ' ' A' ' 66' ' ' VAL . 1.2 p90 -133.83 -148.32 0.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.254 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.431 ' N ' ' CG ' ' A' ' 65' ' ' TYR . 31.2 m -99.1 178.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.812 0.339 . . . . 0.0 111.192 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.852 -179.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 t -87.12 -55.32 3.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.817 0.341 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -96.09 42.06 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.895 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.49 ' N ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -59.17 -61.29 8.14 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.131 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.528 ' HA ' ' CB ' ' A' ' 23' ' ' ARG . 2.7 Cg_endo -39.53 153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.474 2.783 . . . . 0.0 112.619 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.752 ' N ' ' O ' ' A' ' 22' ' ' CYS . 1.9 m-20 -63.29 -43.14 98.73 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-O 122.532 1.158 . . . . 0.0 109.377 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 162.01 -176.46 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 112.484 -2.144 . . . . 0.0 110.728 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.48 ' HB3' ' O ' ' A' ' 37' ' ' HIS . 6.9 t -119.43 158.45 26.19 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.296 0.569 . . . . 0.0 112.136 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.506 ' CE2' ' HB2' ' A' ' 20' ' ' PHE . 2.1 p90 -141.32 126.87 18.89 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.257 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.63 128.61 39.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.46 -179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.7 m -111.2 142.86 42.84 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.996 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.76 128.05 54.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.198 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.488 ' C ' ' H ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -136.82 145.82 52.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.759 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.38 5.62 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.809 2.339 . . . . 0.0 113.423 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -116.6 -34.92 4.38 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 121.214 -0.194 . . . . 0.0 111.343 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.469 ' O ' ' HG2' ' A' ' 13' ' ' GLN . 1.2 mt-30 -174.54 -174.28 0.83 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.971 0.415 . . . . 0.0 111.411 -179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.664 HG13 ' CE1' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -114.58 121.08 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.958 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' HB3' ' CZ ' ' A' ' 20' ' ' PHE . 1.3 m -114.69 125.72 54.06 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.491 ' HB3' ' CZ3' ' A' ' 42' ' ' TRP . 1.5 p -107.01 138.31 43.42 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.737 ' HB3' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -140.04 147.24 40.07 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.97 0.891 . . . . 0.0 112.82 178.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.508 ' O ' ' N ' ' A' ' 59' ' ' ARG . 25.7 mt -132.38 142.72 41.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.461 178.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.752 ' O ' ' N ' ' A' ' 6' ' ' ASP . 4.5 m -142.94 -179.12 6.16 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.938 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.528 ' CB ' ' HA ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -154.71 69.77 0.75 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' ' CG ' ' A' ' 6' ' ' ASP . . . 132.6 -5.62 5.2 Favored Glycine 0 C--N 1.345 1.08 0 C-N-CA 120.033 -1.079 . . . . 0.0 113.235 -178.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.902 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -126.73 -162.14 1.13 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 117.58 0.69 . . . . 0.0 111.788 -179.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 27' ' ' PRO . . . -134.45 171.59 8.76 Favored Pre-proline 0 C--N 1.34 0.195 0 CA-C-O 120.764 0.316 . . . . 0.0 110.918 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 26' ' ' ALA . 64.3 Cg_endo -87.46 114.38 0.99 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.876 2.384 . . . . 0.0 112.901 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.413 ' HB2' ' OH ' ' A' ' 53' ' ' TYR . 1.9 tp -113.79 83.56 7.57 Favored Pre-proline 0 CA--C 1.531 0.226 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.015 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 27' ' ' PRO . 32.6 Cg_exo -57.59 -172.08 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.644 2.229 . . . . 0.0 112.263 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -55.37 0.1 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.246 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' GLN . 2.2 pt-20 -115.81 29.23 8.12 Favored 'General case' 0 C--N 1.353 0.745 0 O-C-N 121.94 -0.475 . . . . 0.0 111.672 -179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -177.75 -161.85 26.76 Favored Glycine 0 N--CA 1.462 0.43 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.394 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.32 -166.7 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.748 0.274 . . . . 0.0 110.777 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 171.26 19.75 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-O 121.116 0.484 . . . . 0.0 111.293 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -149.76 153.71 36.64 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.72 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.23 128.91 25.23 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.627 2.218 . . . . 0.0 112.094 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' ' 8' ' ' SER . 42.9 t60 -158.3 114.08 1.73 Allowed Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.772 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -38.89 -77.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.654 2.236 . . . . 0.0 112.947 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.411 ' O ' ' CD2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -156.55 -158.64 0.8 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -177.51 143.7 0.52 Allowed Pre-proline 0 N--CA 1.469 0.478 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.264 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 24.6 Cg_exo -62.65 -15.9 49.31 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.489 2.126 . . . . 0.0 112.203 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.758 ' HZ2' HG23 ' A' ' 63' ' ' ILE . 32.6 t90 -84.68 -50.33 7.73 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.871 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -45.13 -53.02 8.55 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.26 -36.42 82.95 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' PRO . 25.1 tt0 -47.41 -36.89 10.43 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-O 119.017 -0.516 . . . . 0.0 112.351 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.26 2.56 1.14 Allowed Glycine 0 C--N 1.359 1.814 0 C-N-CA 118.112 -1.994 . . . . 0.0 115.224 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.564 ' HB2' ' HB ' ' A' ' 61' ' ' THR . . . -82.65 65.03 7.59 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 118.404 1.102 . . . . 0.0 110.136 178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.9 p -49.35 -22.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.69 160.45 32.62 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.057 -0.402 . . . . 0.0 110.854 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.463 ' CZ2' ' NH1' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -161.07 15.21 0.1 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.952 HG23 ' HG3' ' A' ' 57' ' ' GLN . 7.6 p -156.0 6.29 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.735 ' CD ' ' H ' ' A' ' 51' ' ' VAL . 14.5 Cg_endo -56.51 32.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.913 0 N-CA-C 118.795 2.575 . . . . 0.0 118.795 -176.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.902 ' CD2' ' HB1' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -137.21 116.62 12.76 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 120.26 1.391 . . . . 0.0 109.669 176.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 26.8 t -46.64 -53.25 11.96 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.356 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.6 m -70.57 -21.12 62.73 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 119.385 -0.34 . . . . 0.0 110.95 179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.649 ' O ' ' O ' ' A' ' 53' ' ' TYR . . . -159.53 167.77 35.23 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 118.844 -1.646 . . . . 0.0 113.836 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.952 ' HG3' HG23 ' A' ' 51' ' ' VAL . 5.0 mt-30 -80.75 129.47 34.54 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 121.683 -0.893 . . . . 0.0 109.288 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.646 ' O ' ' HD2' ' A' ' 52' ' ' PRO . 1.1 m -120.77 -169.03 1.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.95 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.737 ' O ' ' HB3' ' A' ' 20' ' ' PHE . 0.7 OUTLIER -162.46 132.97 4.77 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.6 t -131.59 132.87 44.42 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 0.6 OUTLIER -143.9 169.0 18.62 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.128 177.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.416 ' N ' HG23 ' A' ' 61' ' ' THR . 0.1 OUTLIER -170.62 156.32 5.28 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.47 1.032 . . . . 0.0 111.161 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.758 HG23 ' HZ2' ' A' ' 42' ' ' TRP . 3.4 pt -149.5 156.1 39.17 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.539 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -90.21 125.32 1.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.206 2.604 . . . . 0.0 111.921 179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.745 ' CD2' HG22 ' A' ' 66' ' ' VAL . 1.0 OUTLIER -134.43 -145.78 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.408 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.745 HG22 ' CD2' ' A' ' 65' ' ' TYR . 30.5 m -66.24 -26.57 38.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.716 0.294 . . . . 0.0 111.256 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' CB ' ' CZ ' ' A' ' 65' ' ' TYR . 2.8 tt0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.836 179.864 . . . . . . . . 1 1 . 1 stop_ save_